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Background: Anorexia nervosa (AN) is a severe psychiatric condition and evidence on how to best treat it
is limited.
Objectives: This programme consists of seven integrated work packages (WPs) and aims to develop and
test disseminable and cost-effective treatments to optimise management for people with AN across all
stages of illness.
Methods: WP1a used surveys, focus groups and a pre–post trial to develop and evaluate a training
programme for school staff on eating disorders (EDs). WP1b used a randomised controlled trial (RCT)
[International Standard Randomised Controlled Trial Number (ISRCTN) 42594993] to evaluate a prevention
programme for EDs in schools. WP2a evaluated an inpatient treatment for AN using case reports,
interviews and a quasi-experimental trial. WP2b used a RCT (ISRCTN67720902) to evaluate two outpatient
psychological therapies for AN. WP3 used a RCT (ISRCTN06149665) to evaluate an intervention for carers
of inpatients with AN. WP4 used actimetry, self-report and endocrine assessment to examine physical
activity (PA) in AN. WP5 conducted a RCT (ISRCTN18274621) of an e-mail-guided relapse prevention
DOI: 10.3310/pgfar05160 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 16
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Schmidt et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
vii
programme for inpatients with AN. WP6 analysed cohort data to examine the effects of maternal EDs on
fertility and their children’s diet and growth. WP7a examined clinical case notes to explore how access to
specialist ED services affects care pathways and user experiences. Finally, WP7b used data from this
programme and the British Cohort Study (1970) to identify the costs of services used by people with AN
and to estimate annual costs of AN for England.
Results: WP1a: a brief training programme improved knowledge, attitudes and confidence of school staff
in managing EDs in school. WP1b: a teacher-delivered intervention was feasible and improved risk factors
for EDs in adolescent girls. WP2a: both psychological therapies improved outcomes in outpatients with
AN similarly, but patients preferred one of the treatments. WP2b: the inpatient treatment (Cognitive
Remediation and Emotional Skills Training) was acceptable with perceived benefits by patients, but showed
no benefits compared with treatment as usual (TAU). WP3: compared with TAU, the carer intervention
improved a range of patient and carer outcomes, including carer burden and patient ED symptomatology.
WP4: drive to exercise is tied to ED pathology and a desire to improve mood in AN patients. PA was not
increased in these patients. WP5: compared with TAU, the e-mail-guided relapse prevention programme
resulted in higher body mass index and lower distress in patients at 12 months after discharge. WP6: women
with an ED had impaired fertility and their children had altered dietary and growth patterns compared with
the children of women without an ED. WP7a: direct access to specialist ED services was associated with higher
referral rates, lower admission rates, greater consistency of care and user satisfaction. WP7b: the annual costs
of AN in England are estimated at between £45M and £230M for 2011.
Conclusions: This programme has produced evidence to inform future intervention development and has
developed interventions that can be disseminated to improve outcomes for individuals with AN. Directions
for future research include RCTs with longer-term outcomes and sufficient power to examine mediators
and moderators of change.
Trial registration: Current Controlled Trials ISRCTN42594993, ISRCTN67720902, ISRCTN06149665
and ISRCTN18274621.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research programme and will be published in full in Programme Grants for Applied Research;
Vol. 5, No. 16. See the NIHR Journals Library website for further project information.
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Plain English summary
Anorexia nervosa (AN) is an eating disorder (ED) with serious consequences for sufferers and theirfamilies. We do not currently know how best to treat people with AN, especially those with a severe
illness. We carried out 10 studies to improve our understanding.
We evaluated six interventions: teacher training on managing EDs, school lessons aiming to prevent EDs,
an outpatient talking therapy for adults, an inpatient treatment for adults, an intervention for carers of
people with AN, and an online intervention to prevent relapse after treatment.
We also studied two things that will help us to develop better treatments in the future: the levels of
physical activity (PA) in people with AN, and fertility problems in women with EDs and the growth and diet
of their children.
Finally, we studied the importance of specialist services in treating EDs and the cost of treatments for AN
and the total costs of AN in England each year.
We found that participants liked the new interventions; most of the interventions were more helpful than
treatment as usual; the new outpatient treatment was as helpful as an established gold-standard treatment
and better liked; people with EDs were different from healthy individuals in some aspects of their PA, their
fertility, and the growth and diet of their children; having access to specialist services meant that patients
had more positive experiences; and AN costs between £45M and £230M in England each year.
Overall, these studies have greatly improved our understanding of how best to help individuals with AN.
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Scientific summary
Background
Anorexia nervosa (AN) is characterised by self-starvation, weight loss, hyperactivity and, in some cases,
bingeing and purging. Psychological features include morbid fear of fatness and body image disturbance.
Neurocognitive and social cognitive impairments may contribute to onset and maintenance of the illness.
Physical complications affect all organs. The risk of death or disability is high and quality of life is poor. The
family are usually the main carers and they experience significant distress in this role. Those who become
pregnant have high-risk pregnancies and have difficulties feeding and playing with their children. Many
parts of the UK lack NHS provision of specialist services for AN. There is therefore a need to develop better
treatments and disseminate specialist interventions.
Aims and objectives
The overall aim of this programme was to improve knowledge of optimal disease management for people
with AN at all stages of illness. To achieve this, seven work packages (WPs) had the following objectives:
WP1a, to develop a training programme for school staff to enable them to detect and manage eating
disorders (EDs); WP1b, to develop and test a schools-based prevention programme for risk factors of EDs;
WP2a, to develop an improved outpatient treatment for adults with AN and to evaluate the efficacy and
cost-effectiveness of this treatment; WP2b, to test components of this treatment, designed as intensive
modules for inpatients with AN; WP3, to evaluate the efficacy and cost-effectiveness of a carer skills training
intervention; WP4, to produce improved understanding of the nature of a debilitating core symptom of AN
(i.e. hyperactivity); WP5, to develop and test a relapse prevention programme for inpatients with AN; WP6,
to obtain information on the needs of mothers with an ED and the risks for their offspring to inform the
development of an intervention for mothers with an ED; WP7a, to study existing care pathways for AN,
with a focus on the impact of having access to specialist eating disorder services; and WP7b, to study
service utilisation and cost of illness in EDs.
Work package 1a: detection and early intervention
This WP designed and evaluated a teacher training programme to improve school staff’s knowledge
and attitudes about EDs and their confidence to manage EDs in school. Studies 1 and 2 explored the
experiences of EDs in 511 secondary school students and 826 school staff, using online questionnaires.
Only 7% of students would confide in a teacher about an ED. Seventy-four per cent of staff had received
no training on EDs. In study 3, 63 members of staff from 29 UK schools participated in focus groups
asking them about their training needs in relation to early detection and management of EDs. In study 4,
45 school staff participated in a 1-day ED training programme based on the earlier findings. Participants
completed a questionnaire about their ED knowledge, attitudes and confidence pre-intervention, post
intervention and at follow-up after 3 months. The intervention had a significant positive impact on these
outcomes, with gains maintained at 3 months.
Work package 1b: prevention
This WP aimed to design and evaluate a universal prevention programme for EDs in secondary schools.
The intervention consisted of six sessions, delivered by teachers targeting risk factors for EDs, and was
evaluated using a cluster randomised controlled trial (RCT) comparing intervention lessons with a
curriculum-as-usual control in 448 female school students. Participants completed questionnaire measures
pre-intervention, post intervention and at follow-up after 3 months. There were significant between-group
differences in body esteem favouring the intervention group post intervention (d = 0.12) and at the
3-month follow-up (d = 0.19). There were also significant between-group differences in thin-ideal
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internalisation (d = 0.17, maintained at follow-up, d = 0.16) and self-esteem (d = 0.20, not maintained at
follow-up). There were no between-group differences in the other outcomes. Fidelity to intervention
material and acceptability of the programme varied across the three schools.
Work package 2a: outpatient treatment
This WP evaluated the efficacy of a novel psychological therapy for AN (Maudsley Model of Anorexia
Nervosa Treatment for Adults; MANTRA) compared with specialist supportive clinical management (SSCM)
in a multicentre RCT. Participants were adult outpatients meeting Diagnostic and Statistical Manual of
Mental Disorders-Fourth Edition criteria for AN or an AN-type eating disorder not otherwise specified,
recruited from four specialist ED services in England. Participants were randomised to 20 once-weekly
sessions of MANTRA or SSCM and optional additional sessions depending on severity and clinical need.
Seventy-two patients were allocated to MANTRA and 70 were allocated to SSCM. Patients in both
treatment groups improved significantly in terms of body mass index (BMI), ED and other outcomes, with
no differences between groups. Patients rated MANTRA as more acceptable and credible than SSCM
at 12 months. As such, both treatments appear to have value as first-line outpatient treatments of adults
with AN.
Work package 2b: inpatient treatment
This WP aimed to evaluate Cognitive Remediation and Emotional Skills Training (CREST) for inpatients with
AN. CREST is an intervention teaching cognitive, emotion regulation, recognition and processing skills.
The evaluation involved a qualitative study of service users’ views about CREST and a quasi-experimental
comparison of CREST plus treatment as usual (TAU) versus TAU alone in two inpatient settings. The
qualitative assessments demonstrated CREST to be acceptable to patients. However, the quantitative data
showed no difference between CREST and TAU groups in neuropsychological or clinical outcomes. Future
work will focus on revisions to the CREST manual.
Work package 3: carer interventions
This WP aimed to examine the impact of the addition of Experienced Carers Helping Others (ECHO), a
skills-training programme for carers, to standard inpatient care. Patients with AN and their carers were
recruited from 15 inpatient services in the UK. Patients were randomly allocated to either receive ECHO
[a book, digital versatile discs (DVDs) and 10 telephone coaching sessions] added to TAU or TAU only. One
hundred and seventy-eight families were recruited and patient and carer outcomes were measured at
discharge and 6 and 12 months after discharge. Compared with TAU-only patients, patients in the ECHO
group had significantly reduced ED psychopathology and improved quality of life at 6 months. Carers in
the ECHO group spent less time caregiving and had lower carer burden and lower levels of unhelpful
caregiving behaviour at 6 months than carers in the TAU-only group. Sharing skills and information with
family members is therefore of benefit for patients and carers.
Work package 4: activity in anorexia nervosa
This WP aimed to explore physical activity (PA) in AN and associations between drive to exercise, ED
pathology, anxiety and endocrine measures. Female participants were recruited into four groups: AN
outpatients (n = 37), AN inpatients (n = 18), those with anxiety (n = 34) and healthy controls (n = 30).
Actigraphy and self-report were used to measure PA, together with drive/reasons for exercise, ED and
general psychopathology, BMI, body composition, salivary cortisol and serum leptin levels. Psychopathology
and endocrine measures were consistent with diagnosis. Levels of (especially self-reported) PA were highly
variable. Objective PA levels did not differ significantly between groups, yet AN groups reported 57–92%
higher total PA than healthy controls. Drive to exercise was significantly higher in AN groups, who rated
improving tone and affect regulation as important, and health and enjoyment as less important exercise
motivators.
Work package 5: relapse prevention
This WP aimed to assess the feasibility of a relapse prevention programme and to acquire information to
inform a future RCT. Participants (n = 41) were inpatients with AN who were randomly allocated at
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discharge from hospital to receive a manual-based e-mail-guided self-care intervention [internet-based
Maudsley Model of Anorexia Nervosa Treatment for Adults (iMANTRA); see Work package 2a: outpatient
treatment] for 12 months combined with TAU or TAU alone. Outcome assessments included BMI, ED and
general psychopathology, quality of life and service utilisation. At 6 months post randomisation there
was little difference between groups. At 12 months, patients receiving the experimental intervention
had a higher BMI (d = 0.41) and lower scores on the Depression Anxiety and Stress Scales (d = 0.64).
Readmission rates were 5 out of 22 (22.7%) in the experimental group and 5 out of 16 (31.2%) in the
TAU group. These findings suggest that this low-intensity relapse prevention intervention has potential in
the aftercare of inpatients with AN and that a large-scale RCT is justified.
Work package 6: mothers with an eating disorder
This WP consisted of three studies examining the effects of maternal EDs on fertility and their offspring’s
diet and growth. Participants were 11,088 women from the Avon Longitudinal Study of Parents and
Children birth cohort and their children. The outcome measures were maternal report of fertility
difficulties, maternal report of child diet (up to 103 months), and child weight and height (up to age
10 years). Women with EDs reported more fertility difficulties. There was a complex pattern of differences
in diet, trajectories of height, Ponderal Index and BMI between the children of women with an ED and the
children of those without an ED. These results suggest that continuity of care from pre-conception to the
postnatal period is paramount for women with an ED.
Work package 7a: service utilisation
This WP aimed to explore how access to specialist outpatient eating disorders services affects rates of
referrals, admissions for inpatient treatment, continuity of care and service user experiences. Mental
health services in London were asked to identify adolescents who presented for treatment of an ED over a
period of 2 years. Retrospective data about service use was collected from case notes. A small sample of
adolescents and parents were interviewed about their experiences of services. Direct access to specialist
outpatient services was associated with higher referral rates, lower admission rates and greater consistency
of care. Service users identified a number of advantages of specialist service provision. This suggests that
facilitating direct access to specialist services for adolescents with AN may result in better outcomes, lower
costs and higher satisfaction among service users.
Work package 7b: economic evaluation
This WP aimed to identify services and treatments used by people with AN and associated costs, estimate
unit costs of ED treatments, explore cost variations by patient characteristics, explore the economic
consequences of AN and estimate the annual costs of AN for England. Data collected in WPs 2a, 3 and 7a
and from the British Cohort Study (1970) were used. Service costs were driven by hospital admissions.
Costs vary based on age, ethnicity, severity of illness and treatment history. Those treated in non-specialist
outpatient services incurred higher costs than those treated in specialist services only, but there were no
differences in outcome. Women with AN were more likely to be long-term sick or disabled in adulthood,
to receive benefits and to have completed a degree, with no differences in weekly income or employment
compared with people without AN. The annual costs of AN in England are estimated at between £45M
and £230M.
Overall conclusions
This programme has focused on development of interventions for AN and related EDs. The programme’s
studies have a number of important implications for the management of AN (and ED) across the full course
of this disorder. Future research is essential to further our understanding of optimal disease management
for AN.
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Recommendations for health care
l Brief training can improve school staff knowledge and attitudes towards EDs. Staff can also be trained
to deliver efficacious preventative interventions. Following effectiveness testing, these interventions may
improve management and prevention of ED in schools.
l In adult outpatients with AN both MANTRA and SSCM significantly improve clinical outcomes, but
patients see MANTRA as more acceptable and credible. Both interventions can be considered as
first-line outpatient treatments.
l In adult inpatients with AN, CREST is valued by patients, but the addition of CREST to TAU is not
superior to TAU alone. Further work is needed to determine CREST’s role in inpatient care.
l The addition of an intervention for carers of people with AN to inpatient treatment reduces carer time
caregiving, burden and unhelpful caregiving behaviours. Patients show reduced ED psychopathology
and improved quality of life. Skills sharing with family members benefits patients and carers.
l Exercise is driven and rewarding to sufferers with AN. Clinicians need to develop interventions that
address the pathological drive to exercise rather than exercise per se.
l iMANTRA is a feasible and safe intervention that has promise in the aftercare of inpatients with AN.
l EDs are common in pregnancy and they are associated with unplanned pregnancies and fertility
treatment. Children of mothers with EDs are at risk of growth difficulties and disordered eating
patterns. Interventions for mothers with EDs may benefit them and their children.
l There are clear benefits in having specialist community-based outpatient services which are easily
accessible from primary care: they provide good clinical outcomes with significantly lower rates of
hospital admissions and better continuity of care than generic services can deliver.
l AN is associated with a high risk of adult disability. Effective prevention and early intervention to
prevent long-term disability are therefore likely to provide patient benefit and cost savings. Although
inpatient treatment is the largest contributor to treatment costs, participants with AN access a wide
range of services. There may be scope to develop collaborations with community-based services to
improve early identification and ensure appropriate treatment.
Recommendations for research
l To carry out a fully powered study to test the effectiveness of the school staff training programme
developed in WP1a.
l To conduct a large-scale cluster RCT of the prevention programme developed in WP1b to determine
effectiveness of this programme in a range of school environments.
l To gain 2-year follow-up data from the RCT in WP2a, which are essential to determine the relative
efficacy of the two psychological treatments and the maintenance of treatment gains.
l To conduct a RCT to explore benefits of CREST (examined in WP2b) in comparison with other
manualised treatments of similar length.
l To examine whether or not adding the carer intervention evaluated in WP3 onto standard outpatient
care improves outcomes and to examine whether or not adding a more intensive family intervention
(workshops) improves inpatient care.
l To replicate findings from WP4 in a larger sample and to develop and test interventions targeting drive
to exercise in AN.
l To carry out a large-scale RCT of iMANTRA (piloted in WP5), with economic analyses and longer-term
follow-ups.
l To follow the children and women with EDs into adolescence and develop and test a tailored
intervention for pregnant women with EDs.
l To evaluate the role of specialist ED services beyond the metropolitan London context in a larger
scale study.
l To conduct a longitudinal study investigating the impact of AN on education, employment and
potential earnings differential and to use longer-term follow-ups of clinical trials with accompanying
economic evaluation to better reflect the longer-term costs of treatment.
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Trial registration
These trials are registered as ISRCTN42594993, ISRCTN67720902, ISRCTN06149665
and ISRCTN18274621.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Background and structure of the report
Introduction
Anorexia nervosa (AN) has existed throughout different epochs and cultures.1 Key symptoms are restricted
food intake, weight loss, hyperactivity, and in some cases bingeing and purging. Psychological features
include morbid fear of fatness and body image disturbance. AN typically affects young females, although
it also affects some men.2 AN usually starts in adolescence, when brain development is incomplete.3
Starvation can impair brain function in a lasting way.4 Early intervention is essential in producing good
outcomes.5 Treatments in the later stages of illness are much less successful. AN is highly heritable but
environmental factors are aetiologically important.6,7 Progress has been made in identifying risk factors for
AN (e.g. premorbid feeding problems, obsessive compulsive and anxious traits, high levels of exercising
and overinvolved parenting).6,7 Research on the genetic, epigenetic and neurobiological underpinnings of
eating disorder (ED) psychopathology8–13 has identified neurocognitive and social cognitive biomarkers,
such as impaired set-shifting, poor central coherence or emotion processing impairments, including poor
theory of mind,14–18 which have the potential to inform predictions of treatment outcome and prognosis.
A key challenge is to utilise all this knowledge to develop targeted treatments. To this end, we have
developed a model of how AN arises and is maintained, informed by these and other clinical neuroscience
findings and with the aim of guiding treatment.19,20
People with AN consult their general practitioner (GP) significantly more than others in the 5 years prior to
diagnosis.21 A single consultation about eating or weight/shape concerns strongly predicts the subsequent
emergence of AN.22 Although GPs exclusively treat 20% of cases with AN,23 they are often not confident
at managing AN,24 and there is usually a considerable delay between a diagnosis being made in primary
care and the point when more specialist help becomes available.25
Many parts of the UK lack NHS provision of specialist services for AN.26,27 Treatment by non-specialists is
problematic as many patients are admitted unnecessarily and for lengthy periods,28 with extra costs to the
NHS.29 For example, 35% of people with AN seen in non-specialist Child and Adolescent Mental Health
Services (CAMHS) are admitted to hospital, contrasting with only 10% of those seen in specialist ED
services.30 More child and adolescent psychiatric beds (20%) are occupied by young people with AN than
any other diagnostic group.31 Weight gain32 and longer-term outcomes33 are poor in non-specialist units
and the mortality is higher.34,35 Thus, there is a need to disseminate specialist knowledge of this illness.
Transitions between services (e.g. from child to adult services, home to university health services, inpatient
to follow-up care) are common and can result in fragmented care, thus putting patients at risk.36,37
Lifetime prevalence rates for AN are 1.6% in women and 0.3% in men.7 The median duration of illness is
6 years.38 Physical complications affect all organs39 and the risk of death is the highest of any psychiatric
disorder.40 If they become pregnant the pregnancy is considered high risk and they experience difficulties
feeding and playing with their children.41 Severe psychiatric comorbidity is common.42 Quality of life is
severely impaired,43 more so than in depression.44 The cost per case of AN is at least that of schizophrenia.45,46
AN accounts for the highest proportion of admissions of duration > 90 days (26.8%) and the longest median
length of stay (36 days).28 Eating disorders are one of the leading causes of disease burden in terms of years
of life lost through death or disability in young women.47 The family are usually the main carers. They report
similar difficulties to carers of people with psychosis, but are more distressed.25,48 The burden of caregiving
and other societal costs have never been examined in economic terms.
This report presents the results of seven independent but integrated work packages (WPs), which form
the Applied Research into Anorexia Nervosa and Not Otherwise Specified Eating Disorders (ARIADNE)
programme. These WPs focus on optimal disease management for people with AN at all stages of illness,
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from prevention and detection through to treatment and preventing relapse. The studies focus on a range
of populations, including samples from the community, those drawn from inpatient and outpatient
settings, as well as specialist groups, such as mothers with an ED and carers of those with an ED. The
majority of our WPs focus on building evidence on the efficacy and effectiveness of interventions for
these populations, grounded in our clinical neuroscience model of AN. We report on findings from six
independent interventions that have been developed and tested by the ARIADNE group during this
programme. In addition, we present analyses of the economic and clinical implications of existing care
pathways and patterns of service use.
Aims and objectives of the ARIADNE programme
Broad aims
Responding to the need for high-quality research into the management of AN, the overarching aims of the
ARIADNE programme were to:
1. produce, validate and disseminate improved evidence-based interventions for AN
2. collaborate with patients and carers throughout the project
3. improve clinical outcomes in AN, by early detection and intervention, by reducing chronicity and
relapse, and by improving carer outcomes
4. improve acceptability and cost-effectiveness of AN treatments
5. deliver standardised, trainable and disseminable AN treatments
6. assess service utilisation and NHS costs of AN and implications of changes in clinical practice for patient
care and resources.
Objectives
Our objectives were: WP1a, to develop a training programme for school staff to enable them to detect and
manage EDs; WP1b, to develop and test a school-based prevention programme for risk factors for EDs;
WP2a, to develop an improved treatment for adults with AN that targets disease-maintaining factors, is
matched to symptoms, personality and neuropsychological profile and which can be used as a first-line
treatment in outpatient settings, and to evaluate the efficacy and cost-effectiveness of this treatment;
WP2b, to test and validate components of this treatment, designed as intensive modules for inpatients
with AN (i.e. those with severe, chronic or treatment-resistant AN); WP3, to evaluate the efficacy and
cost-effectiveness of a carer skills training intervention, and to assess its impact on carer outcomes (e.g.
distress, caregiving efficacy) and patient outcomes; WP4, to improve understanding of the nature of a
debilitating core symptom of AN (i.e. hyperactivity); WP5, to develop and test a relapse prevention
programme for inpatients with AN; WP6, to obtain information on the needs of mothers of children with
an ED and the risks of the maternal ED for their offspring and to use this information to inform the
development of an intervention for mothers with an ED to minimise the impact of their ED on their
children; WP7a, to study existing care pathways for AN, with a focus on the impact of having access to
specialist ED services; and WP7b, to study service utilisation and cost of illness in EDs.
Patient and public involvement in the ARIADNE programme
Patient, carer and public involvement has been central to the research in the ARIADNE programme.
Mrs Susan Ringwood, the Chief Executive Officer of Beat (the main UK patient carer organisation for EDs)
was a co-applicant on the programme. As such, she was involved in the development of the overall
programme aims, ensuring that the research questions were aligned with patients’ and carers’ needs.
Patients and carers were also part of the Programme Steering Group.
Examples of patient and public involvement (PPI) in specific WPs are as follows.
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Example 1: early intervention in schools
Wok package 1a involved the development and pilot testing of a teacher training programme for EDs (see
Chapter 2). This research was devised and led by a former ED service user. It involved an extensive period
of public consultation, which was used to assess the needs of both school staff and school students in this
area. Thorough consultation was achieved through online surveys reaching over 800 school staff and over
500 students. Intervention materials for the training programme were then developed using an iterative
process in which two panels of school staff (six members per panel) reviewed draft materials and their
feedback was incorporated. PPI ensured that the training materials being developed were responding to a
genuine need and were aligned with the needs of the school staff that would be using them.
Example 2: prevention
The intervention development in WP1b for the prevention programme (see Chapter 3) was informed by
focus groups with 22 adolescent girls, who provided their experiences of body dissatisfaction, disordered
eating and their recommendations for a preventative intervention. The intervention materials were then
developed in conjunction with a panel of key stakeholders, which included a young person with a history
of an ED, two young people without a history of an ED, and three secondary school teachers. Feedback
provided by this panel was incorporated into the materials in an iterative process.
Example 3: carers interventions
Work package 3 evaluated an intervention for carers of people with AN, which was used as an adjunct
to inpatient treatment (see Chapter 6). It included extensive PPI, with several members of the research
team having personal experiences of an ED. The self-help materials (Experienced Carers Helping Others;
ECHO) were developed in collaboration with patients and carers.49 In addition, the majority of telephone
coaching sessions offered during the intervention were provided by trained individuals with personal
experience of an ED (either having recovered from the disorder themselves or as a carer). The findings from
this trial are being disseminated to the public through a website dedicated to carers of those with an ED
[URL: www.thenewmaudsleyapproach.co.uk (accessed 3 July 2017)], a newsletter, the database of ED
volunteers and the annual carer’s conference which we run with Beat – the main national organisation for
people with EDs and their families.
From the above, it is clear that patients and carers were involved in designing the programme,
implementing the WPs and disseminating findings. Such collaboration between researchers and service
user representatives has been highlighted as exemplifying good practice in service user involvement by the
Mental Health Research Network (MHRN).50
Report structure
The overarching aims of the ARIADNE programme were realised through seven independent, but
integrated, WPs which are presented in detail in this report. An outline of the chapters is as follows:
Work package 1: prevention and early intervention
Chapters 2 and 3 focus on prevention, detection and early intervention of EDs. In Chapter 2, we present
the development and evaluation of a learning package for school staff on how to recognise symptoms
of EDs, how to communicate about EDs sensitively and how to assess risk. Chapter 3 outlines the
development of a teacher-delivered prevention programme for EDs, and the results of a cluster randomised
controlled trial (RCT) evaluating its efficacy.
Work package 2: treatment
Chapters 4 and 5 focus on treatment of AN. In Chapter 4 we present the evaluation of the Maudsley
Model of Anorexia Nervosa Treatment for Adults (MANTRA) using a large RCT with individuals in an
outpatient setting. Chapter 5 explores the use of components of this treatment in an inpatient setting,
designed as intensive modules for severe, chronic or treatment-resistant AN. Here, we evaluate this
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approach through case report, qualitative evaluation and a pilot trial comparing it to treatment as
usual (TAU).
Work package 3: carers interventions
Chapter 6 presents an intervention for those caring for individuals with AN. We present findings from a
large RCT assessing the impact of a guided self-help intervention for carers of individuals with AN (ECHO),
in addition to standard inpatient care. We report on outcomes for both carers and for patients up to
12 months post discharge from inpatient care.
Work package 4: physical activity in anorexia nervosa
Chapter 7 focuses on the assessment of activity levels and endocrine changes in individuals with AN. We
present data from an observational study. Individuals with AN (inpatients and outpatients) are compared
with individuals with anxiety and healthy controls (HCs) using a range of methods, including body
composition, endocrine measurements, self-report and actimetry.
Work package 5: relapse prevention
Chapter 8 focuses on relapse prevention. Here, we present a feasibility RCT on a novel e-mail-guided
manual-based intervention to be used in the post-hospitalisation aftercare of patients with AN.
Work package 6: mothers with an eating disorder
In Chapter 9, we present research on mothers with an ED, a special population that may need tailored
services. We report findings regarding fertility difficulties in women with an ED, and associations between
maternal EDs and their children’s diet and growth trajectories.
Work package 7: care pathways and economic evaluations
Chapter 10 presents results regarding service use, focusing on how access to specialist services affects rates
of referrals, admissions for inpatient treatment, continuity of care and service user experiences. Chapter 11
uses data from ARIADNE WPs (WPs 2, 3, 5 and 7a), plus the British Cohort Study (1970) (BCS-70), to
identify the costs of services and treatments used by people with AN and to estimate its annual costs
for England.
General discussion
Chapter 12 draws together the findings from the seven WPs and highlights clinical implications and
recommendations for future research based on this programme.
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Chapter 2 The development and feasibility
testing of an eating disorders training programme for
UK school staff (work package 1a)
Abstract
Work package 1a composed of four studies.
Study 1: 511 school students aged 11–19 years completed an online questionnaire exploring their
experiences of EDs at school. Respondents provided actionable recommendations about improvements
that could be made.
Study 2: 826 school staff completed an online questionnaire exploring their ED experiences. Participants
highlighted a lack of understanding and knowledge within their schools and a willingness to access
training and support.
Study 3: 63 members of staff from 29 UK schools participated in focus groups to further develop the
themes explored in study 2. Five salient themes emerged from the focus group discussions.
1. There was little general knowledge about EDs among staff.
2. Mental health issues, including EDs, were not openly talked about among staff.
3. School staff do not feel confident or comfortable teaching students about EDs.
4. When they exist, positive relationships with parents contribute to ED recovery, but sometimes
relationships with parents are very negative.
5. More support is needed for school staff involved in the care of students undergoing ED recovery.
Study 4: a 1-day training programme for UK school staff aimed at improving attitudes towards, confidence
in supporting and knowledge about EDs was tested for feasibility and acceptability, and was found to
have a positive, significant impact with medium and large effect sizes (ESs) that were maintained after
3 months.
Introduction
Eating disorders have a high rate of onset during adolescence,51,52 the period during which young people
attend secondary/high school. Research indicates that up to 1.5% of secondary school students suffer
from a diagnosable eating disorder53–55 and up to 15% experience subclinical eating disturbance.56
However, many of these cases go undetected and untreated.57
As students spend an average of 40 hours a week attending school,58 school staff are in a good position
to pick up on the physical and behavioural symptoms that are present during the early stages of eating
disorders.59 Furthermore, school staff are well placed to offer ongoing support as young people have
indicated that they are up to nine times more likely to talk to a teacher than a parent about food-related
difficulties.60
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Work package 1a is a series of interlinked studies designed to understand the current context of EDs in
school and use this understanding alongside school staff and student recommendations in the development
of a face-to-face training programme. The WP culminated in the training programme being feasibility tested.
Study 1: student experiences of eating disorders within the
school setting – an online survey
Methods
First- and second-hand student experiences of suffering with an ED at school were explored using an online
questionnaire (see Appendix 1, Student questionnaire), completed by 511 students aged 11–19 years
[mean = 15.4 years, standard deviation (SD) = 2.3 years, 72% female]. Note that n varies by question as not
all participants responded to all questions.
The questionnaire included free-text responses, which were coded using content analysis.61,62 A
categorisation system was developed by analysing responses and classifying them into categories ,with
care being taken to ensure that the coding system was comprehensive, while avoiding overlapping of
categories. A second researcher independently applied the categories, blind to the original researcher’s
decisions. An inter-rater reliability of 94% was achieved.
Results
Students’ experiences and recommendations
Thirty-eight per cent (n = 195) reported a current or previous ED, although 49% (n = 96) of these students
had not received a diagnosis which confirms this. In total, 53% (n = 115) reported being friends with a
student suffering with an ED.
Quantitative data are summarised in Table 1. Qualitative data are summarised in Table 2. Below, both
forms of data are considered together under three salient themes which emerged during data analysis:
1. recognition of early symptoms
2. encouraging and supporting sufferer help-seeking
3. providing a supportive school environment for recovery.
Recognition of early symptoms
Seventy-nine per cent (n = 361) of students surveyed were confident that they would recognise the
symptoms of an ED in a friend. Thirty per cent of students had been taught about EDs as part of a
planned programme of study at school, but this was not generally well received, with 82% (n = 124)
reporting that these lessons could have been better.
Fifty-nine per cent (n = 185) of students surveyed recommendeded that ED education be improved for
both students and their teachers. In free-text responses, 16% (n = 46) of students stated that school staff
had minimal or no knowledge about EDs. Reducing stigma and enabling friends to recognise and respond
to early symptoms were the key motivators outlined in responses.
Encouraging and supporting sufferer help-seeking
Students expressed a reluctance to highlight ED concerns about a friend with a teacher, with only 7%
(n = 33) of students stating they would be happy to do so. Several barriers for this type of help seeking
emerged including:
l fear a teacher would dismiss their concerns
l fear a teacher would over-react to their concerns
l fear that a teacher would not treat their concerns in confidence.
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When school staff help was sought, students shared a clear preference for face-to-face discussions
(73%; n = 337) above writing/e-mail (22%; n = 102), or sharing concerns via telephone/text (5%; n = 22).
The positive impact of school staff on student outcomes was shared by 49 respondents. Four students
claimed that the support provided by school staff was instrumental in preventing them from dying as a
consequence of their ED.
TABLE 1 Summary: student responses to eating disorders survey – quantitative data
Topic Response
Could you spot
eating disorder
warning signs in a
friend? (n = 458)
Yes – I have
done so
before
Yes – I would
know the signs
I’m not sure No
257 (56%) 104 (23%) 64 (14%) 33 (7%)
Have you learnt
about eating
disorders at
school? Was it
helpful? (n= 499)
Taught – it
was helpful
Taught – it was
not helpful
I’ve not been
taught
I’m not sure
27 (5%) 124 (25%) 332 (67%) 16 (3%)
What would you
do if you spotted
eating disorder
warning signs in a
friend? (n = 505)
I’d help my
friend if they
came to me
I’d proactively
offer my friend
my help
I would tell a
teacher
I would
anonymously
tell a teacher
I would talk
to a trusted
adult outside
school
I would
watch and
wait
137 (27%) 263 (52%) 33 (7%) 15 (3%) 29 (6%) 28 (6%)
If you shared your
concerns with a
teacher, what
would you want
them to do?
(n = 479)
Speak with
my friend
Support me in
helping my
friend
Talk to my
friend’s
parents
Arrange for
support from
a counsellor
or doctor
Listen
122 (25%) 216 (45%) 11 (2%) 78 (16%) 52 (11%)
If you shared your
concerns with a
teacher, what
would you expect
them to actually
do? (n= 474)
Speak with
my friend
Support me in
helping my
friend
Talk to my
friend’s
parents
Arrange for
support from
a counsellor
or doctor
Listen
106 (22%) 24 (5%) 229 (48%) 50 (11%) 65 (14%)
What would be
your preferred way
of communicating
your concerns to a
member of school
staff? (n = 461)
In person By telephone Text/SMS/IM E-mail/in
writing
337 (73%) 5 (1%) 17 (4%) 102 (22%)
Do you consider
your school to be a
supportive place
for someone
recovering from an
eating disorder?
(n = 504)
Strongly
agree
Agree Neutral Disagree Strongly
disagree
12 (2%) 41 (8%) 81 (16%) 133 (26%) 237 (47%)
IM, instant messaging; SMS, short message service.
Reproduced with permission from Knightsmith P, Sharpe H, Breen O, Treasure J, Schmidt U. ‘My teacher saved my life’
versus ‘Teachers don’t have a clue’: an online survey of pupils’ experiences of eating disorders. Child Adolesc Ment Health
2014;19:131–7.63 © 2013 The Authors. Child and Adolescent Mental Health. © 2013 Association for Child and Adolescent
Mental Health.
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Providing a supportive school environment for recovery
Seventy-three per cent of respondents (n = 370) did not view their schools as a supportive environment for
facilitating recovery from an ED. Key reasons cited were:
l bullying from peers
l poor reintegration into school
l staff uncertainty about how to support.
Students whose experiences had been more positive outlined the important role of the school and
school staff in their recovery. When asked to describe the ideal approach from school staff, respondents
highlighted their desire for honesty (n = 71), openness (n = 19), a non-judgemental approach (n = 23) and
someone who felt approachable (n = 29).
Discussion
This was the first UK study of student experiences of EDs. Respondents provided valuable insight into the
experiences of UK school students with EDs and, further, provided actionable recommendations about
improvements that could be made.
TABLE 2 Summary: student responses to eating disorders survey – qualitative responses
Topic Response
How could your school
help students understand
more about eating
disorders? (n= 351)
Psychoeducation Better services
available at
school
Talk more
openly about
eating disorders
Improve teacher
knowledge
Be less
judgemental
185 (59%) 68 (22%) 22 (7%) 19 (14%) 18 (7%)
Teachers take
more caring
approach
School cannot
help
Improve access
to services in
school
Better resources
16 (6%) 10 (4%) 9 (3%) 4 (1%)
How could your school
be more supportive to
students during eating
disorder recovery?
(n = 342)
Reduced stigma
about eating
disorders
Bespoke
support
Specialist
support
Nothing Support groups
133 (43%) 72 (23%) 46 (15%) 27 (9%) 25 (8%)
Confidentiality Peer mentors Promote school
services
20 (6%) 12 (4%) 7 (2%)
How has the school
helped you or a friend in
response to an eating
disorder? (n= 169)
They referred
the case to a
specialist
Staff were
supportive
They spoke to
parents
They were flexible
re schooling
They provided
on-going support
67 (22%) 63 (20%) 19 (6%) 10 (3%) 10 (3%)
Have you had any
negative school-based
experiences in response
to an eating disorder?
(n = 321)
No one noticed I was punished I was not
appropriately
consulted
I did not get the
specialist help I
needed
Staff broke my
confidence
89 (27%) 31 (10%) 31 (10%) 27 (8%) 21 (6%)
Judgemental Lack of
knowledge
Problems with
the services
Negative experience
not expanded upon
12 (4%) 10 (3%) 8 (2%) 92 (28%)
Reproduced with permission from Knightsmith P, Sharpe H, Breen O, Treasure J, Schmidt U. ‘My teacher saved my life’
versus ‘Teachers don’t have a clue’: an online survey of pupils’ experiences of eating disorders. Child Adolesc Ment Health
2014;19:131–7.63 © 2013 The Authors. Child and Adolescent Mental Health. © 2013 Association for Child and Adolescent
Mental Health.
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A strength of the study was that both male and female students were surveyed, which has not previously
been the norm.64 Future work could explore moderators (e.g. gender, school type) of student experiences.
The opportunity for students to recognise and respond to early ED symptoms in their friends, and for
schools to provide a safe and supportive recovery environment, was clearly highlighted by respondents.
However, it is clear that more work needs to be done if this potential is to be realised in UK schools.
Psychoeducation and training for students and teachers was suggested by respondents as a key method
for addressing this.
Study 2: school staff experiences of eating disorders within the
school setting – an online survey
Methods
A total of 1250 UK school staff were invited to respond to an anonymous online survey exploring their
experiences of EDs within the school setting (see Appendix 1, Staff questionnaire). A total of 826 (66%) of
the convenience sample chose to participate.
Free-text responses were analysed using content analysis.61,62 A categorisation system was developed by
analysing responses and classifying them into categories, with care being taken to ensure that the coding
system was comprehensive while avoiding overlapping of categories. A second researcher independently
applied the categories, blind to the original researcher’s decisions. An inter-rater reliability of 89% was
achieved (κ = 0.471; p < 0.001).
Results
Multiple-choice questions generated quantitative data, which have been summed and recorded in Table 3.
Content analysis was used to interrogate the large amount of qualitative data produced in the form of
free-text responses to open questions. This is summarised in Table 4.
Below, both forms of data are considered together under four salient themes which emerged during
data analysis:
1. supporting students with EDs
2. ED training and policies
3. teaching about EDs
4. reintegrating students who were absent as the result of an ED.
Supporting students with eating disorders
Only 40% (n = 316) of respondents stated that they would feel confident following up ED-related
concerns in a student.
Eating disorders training and policies
Sixty-one per cent (n = 317) of respondents found policies to be an effective tool within schools. Despite
this, only 32% (249) of respondents reported that their school had a policy that made any reference to
EDs and, of these, only 5% (n = 41) were specific ED policies.
Thirty-one per cent (n = 160) of respondents found school policies to be ineffective in most cases. This was
attributed to a lack of understanding of the role of frontline staff by senior leaders who developed policies.
The majority of respondents (74%; n = 583) reported that their school had never provided training about
EDs. Ninety-one per cent (n = 316) of respondents who had not been trained said that they would
welcome the opportunity.
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TABLE 3 Summary: staff responses to eating disorders survey – quantitative data
Topic Response
Is there an eating disorders
policy at your school? (n= 774)
No Yes – within
another policy
I’m not sure Yes – we have a
specific policy
320 (41%) 208 (27%) 205 (26%) 41 (5%)
Do you think eating disorders
policies are effective? (n= 519)
Very effective Effective Ineffective Very ineffective
42 (8%) 317 (61%) 148 (29%) 12 (2%)
Have you been offered eating
disorders training at school?
(n = 791)
No Yes
583 (74%) 208 (26%)
Who was the training for?
(n = 147)
Specialist staff
members (three
or fewer)
All school staff All pastoral staff All senior and
middle leaders
82 (56%) 43 (29%) 19 (13%) 3 (2%)
How was the training
delivered? (n = 161)
Seminar Lecture Written materials
107 (66%) 37 (23%) 17 (11%)
If you have not received any
training, do you think you
would find eating disorders
training useful? (n= 346)
Very useful Quite useful Not very useful Not at all useful
160 (46%) 156 (45%) 30 (9%) 0 (0%)
Are there any current or past
eating disorders cases in your
school? (n= 530)
Yes, I am directly
involved with at
least one case
Yes, but I am not
directly involved
No
266 (50%) 181 (34%) 83 (16%)
At your school, what should a
student do if they are worried a
friend may have an eating
disorder? (n= 781)
They can talk to
any member of
the school’s staff
This is something
that has never
been discussed/
agreed
There is a specific
member of staff
they should
speak to
There is a system
in place for
anonymously
raising concerns
364 (47%) 287 (37%) 112 (14%) 18 (2%)
How comfortable would you
feel teaching students about
eating disorders? (n= 785)
I would feel very
uncomfortable
I would feel
uncomfortable
I would feel
comfortable
I would feel very
comfortable
419 (54%) 273 (35%) 84 (11%) 9 (1%)
Has your school ever had to
reintegrate a student after a
period of absence caused by an
eating disorder? (n= 487)
Yes we have No we have not
329 (68%) 158 (32%)
Did you receive any guidance
about how to support students
returning following a period of
absence? (n= 317)
Yes we did No we did not
240 (76%) 77 (24%)
All questions were optional. When not all participants recorded a response to a question, percentages were calculated
according to the number of respondents to the specific question.
Reproduced with permission from Knightsmith P, Treasure J, Schmidt U. We don’t know how to help: an online survey of
school staff. Child Adolesc Ment Health 2014;19:208–14.65 © 2013 The Authors. Child and Adolescent Mental Health
© 2013 Association for Child and Adolescent Mental Health.
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TABLE 4 Summary: staff responses to eating disorders survey – qualitative responses
Topic Response
Perceived benefits
of eating disorders
training that had been
completed (n= 142)
An increase in
confidence
supporting eating
disorders
I learned how
I can support
someone with an
eating disorder
I now know what
warning signs to
look out for
It was good to
share ideas with
other people
Nothing
specific just
generally
useful
39 (27%) 31 (22%) 21 (15%) 15 (11%) 14 (10%)
Learned about
referral processes
Raised awareness
of ED
Not useful
12 (8%) 7 (5%) 3 (2%)
How could the training
have been improved
(n = 96)
If it was more in
depth
If it had been
available to more
staff
Booster sessions The use of real
case studies
Nothing the
training was
comprehensive
24 (25%) 17 (18%) 10 (10%) 10 (10%) 7 (7%)
More practical
suggestions about
how to support
If it was more
tailored to a
student causing
concern
A better teacher Information
about developing
policies or
making referrals
Being taught
in a smaller
group
7 (7%) 6 (6%) 6 (6%) 5 (5%) 4 (4%)
What staff would do
next if worried that a
student might have an
eating disorder (n= 782)
I’m not sure I’d refer to my
school’s policy
I would ask a
more experienced
colleague
I would speak
with the pupil
I would talk to
the pupil’s
parents
316 (40%) 168 (21%) 146 (19%) 107 (14%) 25 (3%)
I would make an
external referral
I would watch
and wait
13 (2%) 7 (1%)
Reasons given for
feeling uncomfortable
teaching students
about eating disorders
(n = 546)
Too little
knowledge of the
topic
Fear of iatrogenic
effects
It’s not necessary
as students
have a good
understanding
I would not know
how to manage
disclosures
312 (57%) 109 (20%) 64 (12%) 61 (11%)
How parents have
responded to being told
their child has an eating
disorder (n= 781)
Parent has
responded with
denial or refusal to
speak to us
Both positive and
negative reactions
Difficult at first
but relations
improved
Parents have
been angry
accusing us of
criticising their
parenting
364 (47%) 287 (37%) 112 (14%) 18 (2%)
Support that staff
suggested would be
helpful during the
reintegration of a
student with an eating
disorder into school
(n = 105)
Tailored
information based
on the specific
student’s needs
More or better
training than is
currently provided
More people
should be involved
in training
(including e.g.
parents, students)
Training should
be provided for
all relevant staff
Specialist
support and
advice on an
ongoing basis
30 (29%) 25 (24%) 17 (16%) 13 (12%) 8 (8%)
Students need to
be supported in
the run up to their
friend’s return
Other
8 (8%) 4 (4%)
All questions were optional. When not all participants recorded a response to a question, percentages were calculated
according to the number of respondents to the specific question.
Reproduced with permission from Knightsmith P, Treasure J, Schmidt U. We don’t know how to help: an online survey of
school staff. Child Adolesc Ment Health 2014;19:208–14.65 © 2013 The Authors. Child and Adolescent Mental Health
© 2013 Association for Child and Adolescent Mental Health.
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Twenty-six per cent (n = 208) of respondents reported that their school had provided training. In most
instances (56%; n = 82) this was for specialised groups of three or fewer staff.
Those staff who had received training outlined a range of benefits, including:
l an increase in confidence (27%; n = 39)
l practical strategies (22%; n = 31)
l awareness of early symptoms (11%; n = 15).
They also outlined suggestions for improvement, including:
l greater depth (25%; n = 24)
l more widely available (18%; n = 17)
l booster sessions (10%; n = 10).
Teaching about eating disorders
Eighty-nine per cent (n = 692) of respondents reported that they would not feel comfortable teaching their
students about EDs. Reasons given for this included:
l they lacked the appropriate knowledge (57%; n = 312)
l fear of iatrogenic effects (20%; n = 109)
l students’ knowledge exceeded teacher knowledge (n = 64; 12%)
l uncertainty about how to manage resulting disclosures (n = 61; 11%).
Reintegrating students who were absent as the result of an eating disorder
Sixty-eight per cent (n = 329) of respondents reported that their school had reintegrated one or more
students following absence caused by an ED. Twenty-four per cent (n = 77) of these reported receiving no
training, support or advice about how best to manage this transition.
Those who had received support outlined suggestions for improvement including:
l training more heavily tailored to the needs of the specific returning student (24%; n = 25)
l training for a wider range of people including parents and students as well as the teachers (16%; n = 17).
Discussion
This was the first UK study of school experiences of EDs. Respondents provided valuable insight into the
experiences of UK school staff with EDs and, further, provided actionable recommendations about
improvements that could be made.
Study 3: recommendations from school staff about spotting and
supporting eating disorders
Methods
Participants for study 3 were recruited from those in study 2. Of 826 respondents in study 2, there were
109 expressions of interest in participating in further studies. Sixty-three of these went on to take part in
the focus groups conducted in study 3.
A total of eight focus groups were held with 63 members of school staff from 29 schools in the UK. Topic
guides were developed to explore school staff experience and opinion with relation to:
l school culture
l knowledge of school staff about EDs
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l understanding of school staff about EDs
l communication with students
l support strategies
l working with parents
l working with external agencies.
The interviews were recorded and transcribed verbatim. Following initial familiarisation with the transcripts,
a categorisation system was developed using content analysis.61,62 Transcripts were analysed and classified
into categories, with care being taken to ensure the categorisation system was comprehensive while
avoiding overlapping of categories. The transcripts were independently catergorised by two researchers
and inter-rater reliability was 87%, with a few minor discrepancies caused by one researcher applying
more categories to some items than the other. There were no instances of the two researchers failing to
agree on the primary category for a transcript section.
Results
Five salient themes emerged from the focus group discussions:
1. There was little general knowledge about EDs among staff.
2. Mental health issues, including EDs, were not openly talked about among staff.
3. School staff do not feel confident or comfortable teaching students about EDs.
4. When they exist, positive relationships with parents contribute to ED recovery, but sometimes
relationships with parents are very negative.
5. More support is needed for school staff involved in the care of students undergoing ED recovery.
These themes are outlined briefly below. An extended discussion, including supporting quotes, is provided
by Knightsmith et al.65
There was little general knowledge about eating disorders among staff
In general, the staff attending the focus groups stated that their own knowledge of EDs was relatively
good, but that this was not reflected in colleagues throughout the staff body. Staff reported a lack of
knowledge of the major types of EDs and their symptomology.
Staff also reported a lack of misunderstanding of EDs, with many colleagues belieivng that EDs are a
teenage phase students will grow out of. Colleagues were reported not to realise that EDs are mental
health issues that frequently require specialist medical and psychological intervention.
Mental health issues, including eating disorders, were not openly talked about among
staff
Participants frequently reported a lack of open discusion about mental health issues, including EDs, at their
schools. Many cited a fear of iatrogenic effects of discussing EDs either among staff or with students,
whereas others shared senior management concern that being seen to be focusing on EDs would result in
potential students and parents gaining a negative impression of the school.
School staff do not feel confident or comfortable teaching students about
eating disorders
Staff expressed a lack of confidence and knowledge about how to talk safely to students about EDs, both
in the context of speaking directly to sufferers and in the context of teaching students about EDs as part
of a structured curriculum. Staff feared saying or doing the wrong thing and in so doing promoting ED
behaviours either in students during their recovery or among the general student population.
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When they exist, positive relationships with parents contribute to eating disorder
recovery, but sometimes relationships with parents are very negative
Participants highlighted the importance of the role of the parent during recovery and the need for schools
and parents to work closely together during the period of recovery. However, many staff also outlined
incidents that illustrated very negative school–parent relationships. Negative responses were reported most
often as a result of the initial disclosure from school to parents about a child’s ED and negative reactions
from parents included:
l parents seeing the school as interfering unnecssarily
l parents believing that the school was accusing them of poor parenting
l parents suggesting that the school was over-reacting.
Focus group participants highlighted the importance of the initial conversation with parents as a key time
for setting the tone for the school–parent relationship.
More support is needed for school staff involved in the care of students undergoing
eating disorder recovery
Focus group participants highlighted the need for further support for school staff during the recovery
period. They expressed a need for practical guidance on a range of topics including:
l student participation in sports, exercise or physical education lessons
l supporting mealtimes
l academic expectations including expectations around homework.
Discussion
Focus group participants provided detailed, actionable insights into the current of confidence,
understanding, knowledge and attititudes of UK school staff from a range of geographically and
socioeconomically diverse schools.
Although the group reported themselves to be more than usually interested in and informed about EDs
and other mental health issues, they drew widely on the knowledge, experience and attitudes of
colleagues during the course of the focus groups.
Development of content and outcome measures
A day-long training programme for school staff on the topic of EDs was developed in line with the
National Institute for Health and Care Excellence (NICE) Behaviour Change: The Principles for Effective
Interventions.66 Data from studies 1–3 were drawn on significantly during programme development.
Furthermore, school staff and clinicians were heavily involved in the authoring and piloting of training
materials to ensure that the resulting training programme was relevant and practical for use within a UK
school setting, while also drawing on the most recent evidence-based practice.
Content outline
Based on school staff feedback about what is feasible in terms of in-service training days, the intervention
was designed to be delivered in four 90-minute sessions, which could be delivered within the space of 1 day.
Each 90-minute session had clearly designed objectives and focus. These were:
l session 1 – EDs introduction
l session 2 – when and how to talk to students causing concern
l session 3 – working with parents, staff and students
l session 4 – providing a supportive environment during recovery.
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Outcome measures
An outcome measure of school staff ED attitude, confidence and knowledge was developed for use during
the current study as there was no existing tool. The new tool drew on existing measures of GP attitudes,67
and the feedback of school staff and students shared in studies 1–3.
A self-report style tool was developed which captured attitudes, confidence and knowledge about EDs.
A copy of the self-report measure is included in Appendix 1, Eating disorders attitudes and knowledge
questionnaire.
Study 4: feasibility study of a 1-day eating disorders training programme
for UK secondary school staff
Methods
Forty-five members of UK school staff completed a 1-day face-to-face training programme designed
to improve their knowledge about, attitudes towards and confidence in managing EDs. Participants
completed self-report measures of knowledge, attitudes and confidence at the beginning of the day,
before training commenced (T1, baseline), at the end of the day, once training was completed (T2, post
intervention) and again 3 months later (T3, follow-up).
The significance of intragroup changes was determined using generalised estimating equation models.
Results
The full results of the statistical analyses are shown in Tables 5 and 6. There was a statistically significant
improvement (all p-values < 0.001) in participants’ self-reported knowledge, attitude and confidence scores
post intervention (T2) compared with baseline (T1), with a large ES on all three comparisons.68 These differences
were maintained at the 3-month follow-up (T3) and there was no significant difference between the
knowledge, attitude or confidence scores measured post intervention (T2) and at the 3-month follow-up (T3).
Participants all completed a post-course evaluation form designed to assess the acceptability of the
intervention. All delegates (n = 45) considered the course either good (16%) or very good (84%) in terms
of course content, course materials and for providing practical strategies they could use at school.
Discussion
A 1-day training programme for UK school staff aimed at improving attitudes towards, confidence in
supporting, and knowledge about EDs was tested for feasibility and acceptability and was found to have a
positive, significant impact with medium and large ESs, which were maintained after 3 months. However,
the study was limited by the use of outcome measures, which were entirely subjective/self-reported and in
the lack of a longer-term measure of maintenance of positive outcomes.
TABLE 5 Estimated means and standard errors
Measure
Time point
Baseline (T1) Post intervention (T2) Follow-up (T3)
n Mean (SE) n Mean (SE) n Mean (SE)
Knowledge 45 17.1 (0.76) 45 29.9 (0.78) 45 29.3 (0.76)
Attitude 45 29.9 (0.17) 45 37.9 (0.56) 45 37.2 (0.53)
Confidence 45 24.9 (1.44) 45 48.7 (1.40) 45 47.0 (1.38)
SE, standard error.
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General discussion
Strengths
All four studies conducted as part of this WP were the first of their type within the UK setting. The
contribution of male viewpoints is a significant strength of the current work as this has not previously been
the norm.64 A further strength of the studies was the large number of participants for studies of this type
(511 student survey responses in study 1 and 826 school staff responses in study 2), and the depth of
responses provided by these participants. A key strength of study 4 was the immediate and lasting impact
of the intervention on participant attitudes, confidence and knowledge about EDs despite its brevity. A
programme that took longer to deliver or the effects of which were not lasting would not be feasible or
relevant for use in UK schools. Data collection at baseline, post intervention and 12 weeks post intervention
is recommended, but not widely practised.69,70
Limitations of the studies
It was not feasible to include both experimental and control groups within each school participating in
study 4 owing to the possibility of trial arm contamination resulting from sharing of information between
school staff, especially post intervention. In future studies, a stepped-wedge design could be employed to
overcome this, with every participant completing both the control and intervention conditions.
The positive outcomes reported from study 4 in terms of an improvement in staff attitudes, confidence and
knowledge were based entirely on self-report measures. Future studies could include some additional
objective measures.
Study 4 looked only at school staff outcomes; the impact of the intervention was not extrapolated to
explore the impact on student outcomes. Similar studies have similarly failed to provide such evidence,69,70
but appropriate measures should be considered for inclusion in future studies.
Future directions
The implementation of a fully powered stepped-wedge design in order to fully test the training
programme developed in study 4 is a key future direction. Another possibility for exploration is the
development of online training materials that could be accessed remotely in order to increase the reach
and cost-effectiveness of the programme.
TABLE 6 Post hoc analyses
Measure β ES
95% CI Hypothesis test
Lower Upper Sig.
Baseline (T1) to post intervention (T2)
Knowledge 12.8 0.8 11.3 14.4 < 0.001
Attitude 8.1 0.8 7.0 9.1 < 0.001
Confidence 23.8 0.8 21.2 26.4 < 0.001
Baseline (T1) to follow-up (T3)
Knowledge 12.2 0.7 9.9 14.5 < 0.001
Attitude 7.4 0.8 6.3 8.4 < 0.001
Confidence 22.1 0.8 17.9 26.3 < 0.001
CI, confidence interval; sig., statistical significance.
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Conclusions
The aim of the current WP was to develop and feasibility test an ED training programme for school staff
aimed at improving attitudes, confidence and knowledge.
This aim was achieved through a series of studies that drew extensively on the experiences and
understanding of UK school staff and students in relation to EDs.
The work of all four studies was unique within the UK setting and the outcomes were promising and
provide clear pathways for future research.
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Chapter 3 Body image in the classroom:
developing and testing a teacher-delivered eating
disorder prevention programme using a clustered
randomised controlled trial (work package 1b)
An abbreviated version of this chapter has been published in the British Journal of Psychiatry.71
Abstract
Objectives
To design and evaluate a universal prevention programme for EDs in secondary schools.
Trial design
Clustered RCT comparing intervention lessons with curriculum-as-usual control.
Participants
Students in years 8 and 9.
Intervention
Six-session Me, You & Us programme delivered by teachers.
Outcomes
Questionnaires at baseline, post intervention and at the 3-month follow-up, assessing body esteem
(primary outcome), eating pathology, thin-ideal internalisation, appearance conversations, peer support,
depressive symptoms and self-esteem.
Randomisation
Unrestricted randomisation of intact classes using random number generator.
Blinding
Teachers, students and researchers were not blinded to group assignment.
Numbers randomised
Sixteen classes were allocated to the intervention (nine classes, 261 students) or control group (seven
classes, 187 students). No participants dropped out.
Results
There were significant between-group differences in body esteem favouring the intervention group at post
intervention (d = 0.12) and 3-month follow-up (d = 0.19). There were also significant between-group
differences in thin-ideal internalisation (d = 0.17, maintained at follow-up, d = 0.16) and self-esteem
(d = 0.20, not maintained at follow-up). There were no between-group differences for the other outcomes.
Fidelity to intervention material and acceptability of the programme varied across the three schools.
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Harms
There was no evidence of reduction in body esteem.
Conclusions
The Me, You & Us programme improved body esteem, thin-ideal internalisation and self-esteem, but no
other outcomes. Further work to increase efficacy across the range of outcomes and improve fidelity
would be valuable.
Trial registration
Current Controlled Trials International Standard Randomised Controlled Trial Number (ISRCTN) 42594993.
Introduction
Eating disorders are valuable targets for prevention because they are linked with poor outcomes, elevated
mortality rates and associated personal and financial costs.72–77 Universal prevention programmes are a
useful element of the prevention portfolio as they allow us to tackle elements of the social environment
that are known to be risk factors for EDs, such as perceived pressure from peers towards thinness.78,79
Universal interventions also do not face some of the difficulties of selective programmes, namely the
stigma associated with participating and the low uptake of those identified as being at risk.80
Secondary school teachers are in a unique position to deliver prevention material widely and with minimal
costs, as they have regular contact with almost all of the adolescent population. However, given the
difficulties of achieving randomisation in the school setting, very few teacher-delivered interventions have
been evaluated by means of a RCT,81–86 and none have done so within the UK. In addition, several of these
trials have small sample sizes making them underpowered.82,85,86 The current state of evidence regarding
the efficacy of teacher-delivered interventions for eating disorders is therefore very poor. Given the
potential scope for these universal interventions, this lack of high quality evidence is problematic.
In 2012, the UK All Party Parliamentary Group on Body Image recommended that all schools (primary and
secondary) include mandatory lessons on body image in response to the high levels of body dissatisfaction
and disordered eating in the adolescent population.87 However, the lack of evidence base in this field
means that teachers and school staff are unable to make evidence-based decisions about how best to
implement this recommendation. This has resulted in some programmes, such as Media Smart [developed
by the Advertising Standards Agency, URL: www.mediasmart.org.uk/resources/bodyimage (accessed
3 July 2017)] being widely disseminated without any evidence for their efficacy. This is problematic as,
aside from the potential for wasted resources, some trials of interventions for eating disorders88 and
depression89 in schools have found evidence of detrimental effects. There is therefore a need for safe and
effective, evidence-based eating disorder prevention programmes that are deliverable by school teachers.
This study describes the evaluation of a universal teacher-delivered eating disorder prevention programme
called ‘Me, You & Us’. The intervention material was based on identified risk factors for EDs and body
dissatisfaction:6,90,91 thin-ideal internalisation, appearance conversations with friends, negative affect
and low self-esteem. Intervention development was supported by a panel of experts and stakeholders,
including PPI representatives; clinicians and researchers specialising in EDs; teachers and school nurses;
and young people with and without a history of EDs.
In addition, three focus groups with 21 adolescent girls were used to determine young people’s
experiences of body dissatisfaction and eating pathology, their understanding of the aetiology of these
problems, and their recommendations for preventative strategies. These groups revealed that young
people largely endorse a sociocultural approach to body dissatisfaction and EDs, in which media literacy
and building networks of support are seen as helpful. These recommendations informed intervention
development with the aim of improving the acceptability of the material produced.
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Based on this review of empirical literature, including previous universal interventions, and the consultation
period, a facilitator’s guide and student workbook were developed (Sharpe H, Treasure J, Schmidt U.
King’s College London, London. Me, You & Us: Facilitator’s Guide. Unpublished manual; 2011). There
were six interactive 50-minute lessons, with the following topics.
Lessons 1 and 2: media literacy
The aim of the first two lessons was to help participants to critique media presentations of ideal beauty
through exploring how conceptions of beauty have varied over time and place, what messages are hidden
in media images and how to take action.
Lessons 3 and 4: fat talking
Lessons 3 and 4 focused on perceived peer pressure towards thinness, introducing the concept of fat
talking, and examining why we might fat talk as well as possible consequences. The lessons went on
to challenge negative appearance-related commentary through exploring the giving and receiving of
compliments.
Lessons 5 and 6: personal strengths and well-being
The remaining lessons focused on tackling negative affect and low self-esteem, through learning about
personal strengths and how to use them. Simple exercises to promote well-being were explored in the
final lesson, including writing a gratitude letter and carrying out small acts of kindness.
Aims and hypotheses
The aims of this study were to assess the efficacy, feasibility and acceptability of Me, You & Us,
a teacher-delivered universal prevention programme for EDs. The following hypotheses were generated.
Main hypothesis
1. Students receiving the intervention will show significant improvements in body esteem, internalisation,
peer support, appearance conversations, depressive symptoms, self-esteem and eating pathology
compared with students in the control group at post intervention and at a 3-month follow-up.
Subsidiary hypotheses
2. Students will find the material in the intervention acceptable, in that they will report enjoying the
lessons and perceive them as useful.
3. It will be feasible to train secondary school teachers to deliver an ED prevention programme from a
manual and student workbook with high fidelity.
The aims of the trial were to determine the acceptability, feasibility and efficacy of this universal prevention
programme for EDs.
Methods
Trial design
The study used a cluster RCT design with intact classes of students allocated in a 1 : 1 ratio to intervention
or control arms (trial registration: ISRCTN42594993, including protocol).
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Participants
Eligibility criteria
Participants were adolescents in years 8 and 9 in a secondary school in the UK. Secondary schools provided
the point of access to participants. Schools were eligible to take part if they:
l were based in the UK
l had classes of students in years 8 and/or 9
l had a sufficiently flexible timetable to manage random allocation of lessons to participating classes.
Participants were eligible to take part if they:
l attended years 8 or 9 in a participating secondary school
l were deemed by a member of school staff (head teacher, form teacher, school nurse) to have sufficient
English language reading ability to be able to comprehend consent procedures and manage written
questionnaires.
Settings and location of data collection
All data were collected within the school setting. School staff administered questionnaires within regular
school hours, based on protocols provided by the researcher. Data collection took place between
September 2011 and May 2012.
Intervention
The programme involved six 50-minute lessons which teachers delivered to existing classes. The
intervention content was described in a Facilitators’ Manual and Student Workbook, both of which are
available from the first author (HS). As discussed above, the material targeted risk factors for EDs and
body dissatisfaction, namely thin-ideal internalisation, peer factors, depression and low self-esteem.6,91
Participating teachers received a standardised 2-hour session, involving education about EDs and
introduction to the Me, You & Us manual.
The control group received their usual curriculum. The content of these lessons was not determined by the
research team.
Outcomes
Age, ethnicity and parental education were provided by participant self-report 1 week before the
intervention began (‘pre-intervention’). Participants also completed an ED screening tool, the Eating
Disorder Diagnostic Scale,92 which identifies Diagnostic and Statistical Manual of Mental Disorders-Fourth
Edition (DSM-IV) diagnostic criteria for AN, bulimic nervosa and binge ED.
All primary and secondary outcome measures were administered at pre-intervention, 1 week following the
intervention period (‘post intervention’) and at approximately 3 months following the intervention period
(‘3-month follow-up’).
Primary outcome
Body esteem
Body esteem was assessed using the Body Esteem Scale for Adults and Adolescents,93 a 23-item self-report
measure in which participants have to rate the frequency with which they agree with statements about
confidence with their appearance on a five-point Likert scale. Note, that higher scores represent greater
body esteem (i.e. lower body dissatisfaction).
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Secondary outcomes
Presence of binge eating
The presence of binge eating was assessed using the Eating Disorder Diagnostic Scale92 and was defined as
self-reported binge eating with loss of control at least once a week for 3 months.
Presence of compensatory behaviours
Compensatory behaviours were also assessed using the Eating Disorder Diagnostic Scale92 and were
defined as self-reporting of at least one of the following behaviours at least once per week for 3 months:
vomiting, laxative/diuretic use, meal skipping or excessive exercise.
Thin-ideal internalisation
The extent to which participants adhered to the media portrayal of the ideals of thinness was assessed
using the General Internalisation subscale of the Sociocultural Attitudes Towards Appearances Scale-3.94
The General Internalisation subscale consists of nine items about appearances and the media (TV,
magazines, films), such as ‘I would like my body to look like the models who appear in magazines’, with
which participants have to agree or disagree on a five-point Likert scale. Higher scores represented greater
thin-ideal internalisation.
Appearance conversations with peers
The frequency with which participants engaged with friends on the topic of appearances was measured
using the Appearance Conversations with Friends Scale.95 The five items are designed to assess ‘how often
students talked with their friends about expectations for their bodies and for appearance enhancements’,95
and take the form of statements such as ‘my friends and I talk about the size and shape of our bodies’,
with which participants have to agree or disagree on a five-point Likert scale. Higher scores represent more
frequent appearance conversations.
Peer support
Perceived social support was measured using the Friend subscale of the Multidimensional Scale of
Perceived Social Support.96 This four-item scale assesses perceived support from friends through responses
on a seven-point Likert scale to items such as ‘My friends really try to help me’. Higher scores represented
greater perceived social support.
Depressive symptoms
Depressive symptoms were assessed using the Depression subscale of the short version of the Depression
Anxiety and Stress Scales (DASS-21).97 The DASS-21 Depression subscale is a seven-item scale in which
participants are required to state how often particular statements, for example ‘I felt that I had nothing to
look forward to’, applied to them over the past week. Higher scores represent greater depressive symptoms.
Self-esteem
A single item – ‘How positive do you feel about yourself?’ – was used to assess self-esteem. Participants
were required to respond on a five-point Likert scale from ‘Not at all positive’ to ‘Very positive’. Higher
scores represent higher self-esteem.
Acceptability
The programme’s acceptability was assessed using two five-point Likert scales. The first asked ‘How much
did you enjoy Me, You & Us?’, and the second asked ‘How useful did you find Me, You & Us?’. The Likert
scales ranged from ‘Not at all’ to ‘Very much’. Higher scores represent greater acceptability.
Fidelity to intervention guide
In order to determine fidelity to the intervention manual, two lessons were observed and rated in each
school against adherence to planned content. Each activity in the Facilitator’s Guide was scored as
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‘completed’ or ‘not completed’. Free text was used to note whether or not any additional material
was covered.
Sample size
To account for clustering, the sample size calculation was increased by an inflation factor [1 + (average
cluster size – 1) intracluster correlation (ICC)]. The inflation factor for this trial was based on a small ICC
(ICC = 0.05).98 With an average class size of 28 students the estimated inflation factor was 2.35.
G*Power 3 (University of Düsseldorf) was used for sample size calculations.99 Assuming a 1 : 1 ratio, a
small ES (d = 0.20)100 and power set to 0.80, the basic sample size requirement was 394 participants per
group, which increased to 926 per group when the estimated inflation factor was taken into account.
Randomisation and blinding
Intact classes were randomly allocated to intervention and control arms. As classes were enrolled into the
trial, an unrestricted random allocation was generated by an online random number generator.101 One
researcher (HS) carried out the enrolment of classes, the generation of the random allocation sequence
and the allocation of classes to conditions. Participants’ allocation in trial arm was based on their class
membership. Informed consent for participants was obtained from all participants’ parents/carers following
randomisation. In addition, participants provided written assent post randomisation, when completing the
pre-intervention questionnaire measures.
The trial design precluded blinding of school staff or students participants as intervention materials, such as
the student workbooks, would have been identifiable to staff and students as being distinct from their
usual curriculum. Researchers were also unblinded.
Statistical analyses
Full details of statistical analyses, including managing of missing data, are reported by Sharpe et al.71
All analyses were based on originally assigned groups. The main hypothesis was tested using linear and
logistic mixed-effects models. Two continuous outcomes that were not normally distributed (depression,
peer support) were dichotomised for all analyses.
In addition to significance testing, ESs (d) for continuous outcomes were calculated using the differences in
adjusted means at each time point. Reliable and clinically significant changes were also computed102 using
reliability data and clinical cut-off points from previous work.103
Results
Participant flow and characteristics
Three schools agreed to participate in the trial. One additional school refused participation because it did
not want to trial previously untested resources. Each of the schools was state maintained and had 100%
female intake. The three schools varied in their average level of deprivation (free school meal eligibility
ranged from 2% to 24%), and in the ethnic background of their students (the percentage of students
from black and ethnic minority backgrounds ranged from 28% to 77%). Random allocation of 16 intact
classes from year 8 or 9 in these schools resulted in nine classes allocated to the intervention arm and
seven classes allocated to the control arm. Of the 479 students from these classes, 31 were excluded
because of lack of parental consent. This resulted in 261 students in the intervention arm and 187 students
in the control arm. Between 92% and 98% of students provided data at each data collection point.
All missing data were due to school absence. No participants withdrew from the trial.
There were no significant differences between the two trial arms at the beginning of the trial. Participants
had a mean age of 13.06 (SD = 0.59) years in the intervention group and 12.99 (SD = 0.54) years in the
control group. Equal proportions of participants came from ethnic minority backgrounds (intervention = 47%,
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control= 53%), and had parents with university-level education (intervention = 76%, control = 78%).
There was also no difference on reports of body esteem (intervention: mean = 2.30, SD= 0.75; control:
mean= 2.27, SD= 0.70), or across any of the other clinical outcomes for the trial. Eight participants scored
above the cut-off point in the ED screening tool and so were excluded from analyses on the grounds that the
aim of the programme was prevention of future difficulties.
Acceptability and feasibility
Students in the intervention arm were asked to rate how useful and enjoyable they found the lessons in
the intervention. The results are shown in Table 7. Looking across both ratings of lessons being enjoyable
and useful, the acceptability are notably higher in two schools (A and C) compared with the third school
(B). Whereas few students (3–16%) in schools A and C rated the programme negatively, this figure was
nearer 50% for school B.
These findings mirror the results of the feasibility assessment, in which the teachers’ fidelity to the
intervention manual was assessed. A greater amount of intervention content was delivered in schools A
and C than in school B (78% activities rated as ‘completed’ in schools A and C compared with 50% in
school B). School B did not deliver material outside the programme, but instead took longer to complete
each activity, meaning that fewer activities were completed within the set lesson time.
Body esteem
Results from the mixed-effects models showed an overall marginal effect of the intervention on
improvements in body esteem [β = 0.09, standard error (SE) = 0.05; p = 0.08]. Post hoc analyses at each
time point showed a marginal difference between the groups post intervention (intervention: mean = 2.31,
SE = 0.32; control: mean = 22.2, SE = 0.39; p = 0.07) and a significant difference between the groups at
the 3-month follow-up (intervention: mean = 2.37, SE = 0.32; control: mean = 2.22, SE = 0.39; p = 0.006).
In each case the results favoured the intervention over the control condition. The ESs for these group
differences were small (d = 0.12–0.19).
Reliable and clinically significant change from baseline to post intervention was calculated separately
for those above and below the clinical cut-off point at baseline. As this was a community sample, few
participants were above the clinical cut-off point at baseline (n = 60). Of those above the cut-off point
initially, 50% (n = 17) of participants in the intervention group showed clinically significant improvement,
compared with 38% (n = 10) in the control group. However, this difference was not statistically significant
[χ2(1) = 0.79; p = 0.37]. When considering reliable change, 32% (n = 11) of participants in the intervention
group showed reliable improvement, compared with 8% (n = 2) in the control group. This difference was
statistically significant [χ2(1) = 5.97; p = 0.02].
TABLE 7 Acceptability of intervention lessons by school
Acceptability
School, %
A (n= 31) B (n= 79) C (n= 80)
Enjoyable
Negative 3 48 9
Neutral 34 36 48
Positive 63 16 43
Useful
Negative 10 51 16
Neutral 39 30 41
Positive 51 19 43
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Considering those participants that began the trial in the normal range for body esteem, it was notable
that there were no participants that experienced clinically significant worsening of symptoms. Some
participants did, however, show reliable improvements in body esteem. In the intervention group, 12%
participants (n = 20) experienced reliable improvement compared with 4% in the control group (n = 4).
This difference was statistically significant [χ2(1) = 6.58; p = 0.01].
Secondary outcomes
A linear mixed-effects model for continuous secondary outcomes showed that there was a main effect of
group for thin-ideal internalisation (β = –1.53, SE = 0.74; p = 0.04) and self-esteem (β = 0.19, SE = 0.09;
p = 0.04). There was no significant main effect for appearance conversations (β = –0.04, SE = 0.32;
p = 0.90). For thin-ideal internalisation, looking separately at each time point showed significant
differences between the groups both post intervention (intervention: mean = 21.94, SE = 0.47; control:
mean = 23.47, SE = 0.57; p = 0.04) and at the 3-month follow-up period [χ2(1) = 3.84; p = 0.05]. At each
time point the results favoured the intervention. For self-esteem, the comparisons between the groups at
each of the time points revealed a significant difference post intervention (intervention: mean = 3.52,
SE = 0.06; control: mean = 3.33, SE = 0.07; p = 0.04), but no difference by the 3-month follow-up
(intervention: mean = 3.47, SE = 0.06; control: mean = 3.34, SE = 0.07; p = 0.15).
Logistic mixed-effects models were used to explore intervention effects for binary outcomes. There were
no main effects of group for binge eating [odds ratio (OR) = 4.44, 95% CI 0.39 to 51.22; p = 0.23],
compensatory behaviours [OR = 1.69, 95% CI 0.74 to 3.89; p = 0.22], peer support [OR = 1.40, 95% CI
0.64 to 3.06; p = 0.40] or depressive symptoms [OR = 1.49, 95% CI 0.46 to 4.78; p = 0.50]. Rates of each
of these outcomes at each time point are reported in detail elsewhere.71
Discussion
This study described the design of a teacher-delivered ED-prevention programme and its first rigorous
evaluation in UK secondary schools. The results suggest that the approach is feasible and that a
programme of this kind can have benefits for adolescents’ mental health.
The programme produced significant improvements in participants’ body esteem compared with their peers
who received their usual school curriculum, and this impact was maintained through the 3-month follow-up
period. The programme also improved several of the secondary outcomes. First, thin-ideal internalisation
was reduced, meaning that the participants were less likely to endorse social ideals associated with
thinness. Second, self-esteem was greater in those who received the intervention, although the effects
were not maintained at the post-intervention assessment. In contrast to these findings, there were no
effects for eating pathology, appearance conversations, peer support or depressive symptoms. There was
also clear evidence that intervention delivery and reception varied substantially between the three schools.
This suggests that understanding the best way to support delivery of materials such as these in a wide
range of schools is a key aspect to take forward from this research.
It is difficult to compare these results with previous work, difficult because most body image interventions
in schools have been delivered not by teachers but rather by external expert facilitators.100,104 The small ESs
found in this trial are in line with work outside the UK in which teacher-delivered interventions have been
tested.81,105 Existing work has also reported similar null findings for the broader impact of ED-prevention
programmes. For example, other work has found like effect on depressive symptoms despite some content
dedicated to this factor.81,85 Given that interventions focusing specifically on depression are more intensive,
it may be that the problem is one of dosage.106 Similarly, few teacher-delivered prevention programmes
have successfully impacted on eating pathology,84,85 although one study with considerably more intensive
teacher training has shown promise in this area.82
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Strengths and limitations
A number of factors limit the conclusions of this trial. First, there was a risk of control group
contamination, due to random allocation of classes within the same school. Second, we did not use an
active control condition. Potentials for sham interventions that have been used in previous similar trials
include activities such as expressive writing,107 educational brochures108 and healthy eating programmes.109
Third, the sample size recruited was below that required for desired statistical power. Post hoc estimates of
achieved power using the ES for the primary outcome at the 3-month follow-up (d = 0.19) show that the
trial only had 49% power to detect group differences. Fourth, the assessment of intervention fidelity was
coarse (two lesson observations per school). Ideally, the trial would have involved recording all sessions and
having these rated by independent researchers. Finally, the follow-up period in this trial was limited to
3 months. Valuable information about whether or not effects are maintained in the medium to long term
would be gained from longer follow-up.
The generalisability of the results was bolstered by the fact that the schools involved represented a wide
range of different participants, including many from ethnic minority backgrounds as well as a range of
economic backgrounds. It is also of significance that the trial was conducted in state-funded schools, and
was not delivered by specialist school staff. However, it should be pointed out that the reliance on girls’
schools does limit the generalisability of these findings, as typical state-maintained schools in the UK are
coeducational. Replication of these findings in coeducational schools is a priority going forwards with
this work.
Conclusions
Overall, this study suggests that it is possible to design a teacher-delivered ED-prevention programme
that is efficacious, manageable for teachers and liked by students. The between-school differences in
acceptability and fidelity suggest that further work is needed to increase the suitability of the materials
across a range of school settings and also to examine best practice around training teachers for taking on
the delivery of this programme. Efficacy was not found across all outcomes and so there was also scope
for improvements to the materials for which intended impacts were not observed. In addition, further trials
will be essential to replicate these findings and to ensure that materials provided for schools are a safe
and effective use of school resources in tackling EDs.
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Chapter 4 A randomised controlled multicentre
trial comparing the Maudsley Model of Anorexia
Nervosa Treatment for Adults with specialist
supportive clinical management in outpatients with
broad anorexia nervosa (work package 2a)
An abbreviated version of this chapter has been published in the Journal of Consulting and ClinicalPsychology.110
Abstract
Objectives
To assess the efficacy of a new psychological treatment for AN (MANTRA) versus specialist supportive
clinical management (SSCM) in a RCT.
Trial design
Multicentre two-arm superiority trial.
Setting
Four specialist ED services within the south of England.
Participants
Adult outpatients, aged between 18 and 65 years, meeting DSM-IV criteria for AN or an eating disorder
not otherwise specified – anorexia nervosa subtype (EDNOS-AN), with a body mass index (BMI) of
< 18.5 kg/m2.
Intervention
Twenty once-weekly treatment sessions of MANTRA or SSCM (extended to 30 sessions in those with a BMI
of < 15 kg/m2) and optional extras (carers’ sessions, dietetic sessions).
Outcomes
Primary
Body mass index.
Secondary
Eating Disorders Examination (EDE), depression, anxiety and clinical impairment; neurocognitive and social
cognitive measures; rates of recovery; and utilisation of other services.
Outcomes were assessed at baseline, 6 months and 12 months.
Randomisation
Completed independently from trial team using a restricted stratified randomisation algorithm with (1) BMI
of > or ≤ 15 kg/m2, (2) AN subtype and (3) previous ED admission, as stratifiers.
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Blinding
Research assessors were blind, but patients and therapists were not blinded to treatment allocations.
Numbers randomised
Seventy-two patients allocated to MANTRA and 70 allocated to SSCM.
Results
There was no difference in outcome between groups. In both treatments, patients showed significant
improvements in BMI, ED symptoms and other clinical outcomes. Patients rated MANTRA as more
acceptable and credible than SSCM at 12 months.
Harms
One SSCM patient died during treatment.
Conclusions
Both MANTRA and SSCM can be used as outpatient treatments in adults with AN.
Trial registration
Current Controlled Trials ISRCTN67720902.
Introduction
Anorexia nervosa is a severe mental disorder, and has the highest rate of premature death of any
psychiatric disorder. It also is accompanied by much somatic and psychological comorbidity and results in
poor quality of life.111,112 Positive treatment outcomes are difficult to achieve because the disorder is valued
by sufferers. In addition, the anxious and obsessional personality traits with which patients commonly
present impede recovery. Neurocognitive and socioemotional functioning are often impaired,16,113,114 which
makes engagement in treatment an even greater challenge.
Anorexia nervosa puts a great burden on families,115 as relatives are typically closely involved in supporting
the person with the illness. Family members carry a burden comparable to that of carers of individuals with
psychosis.48 The financial burden for the health service is also substantial with the cost per case of AN
equating to that of schizophrenia.45,46 Recent reports from the UK and Australia point to considerable costs
of EDs to the health-care sector, sufferers and their families.116–118
Psychotherapy is the recommended first-line treatment for most people with AN, but treatment outcomes
greatly depend on the stage of the illness. For adolescents with a shorter duration of illness the response
to the usually family-based psychological treatment is excellent.119 In contrast, for adults with a longer
illness duration, treatment outcomes are much less positive and dropout rates are high.120 Different
professional bodies on both sides of the Atlantic have highlighted the need to develop better treatments
for adults with AN.121–124
A Cochrane review of outpatient treatment for AN identified seven small and underpowered treatment
trials, two of which included children or adolescents.125 No treatment approach was consistently better
than any other. To date, only one sufficiently powered RCT has been conducted. This compared individual
psychodynamic therapy, cognitive–behavioural therapy (CBT) and an optimised TAU. Here, once again,
no clear differences in weight outcomes were found between groups at the end of treatment.
A potential reason for the unimpressive treatment outcomes in adults with AN is that treatments that
have been tested in RCTs were originally developed in the context of other disorders and have then been
modified for use in AN. Available treatments are therefore not suitably tailored to the requirements and/or
specific maintenance factors of AN. In an attempt to rectify this problem, we have developed a new
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treatment for AN, based on our group’s research into neurocognitive, social cognitive and personality
characteristics of these patients,19,20,126 the MANTRA. This treatment is unique in including maintenance
factors that are intrapersonal or interpersonal. It also includes therapeutic strategies to address these.
The treatment is manualised and contains a number of treatment modules. The content of these can be
tailored to the needs of each individual. This novel treatment is compared here against a gold-standard
comparison treatment, SSCM. SSCM was designed as a comparison treatment in a small trial of outpatient
therapies for AN,127 and was found to be superior on a range of outcomes compared with CBT and
interpersonal therapy (IPT) in the treatment of adult AN.
Aims
l The central aim of this work is to test the efficacy and cost-effectiveness of MANTRA in adult
outpatients with AN versus SSCM using a randomised controlled design. (Only efficacy data are
reported here; cost-effectiveness data are not yet available and will be reported elsewhere
when complete.)
l The subsidiary aim is to assess the impact of the experimental treatment on the requirement for any
intensive (i.e. day care or inpatient) treatment and to identify mediators and moderators of treatment
outcome. (These results are not currently available and will be published elsewhere when complete.)
Hypotheses
l MANTRA will be superior to SSCM in producing higher weight increase and greater reduction in ED
symptoms in adults with AN at 6 and 12 months.
l MANTRA will be more cost-effective than SSCM, being less costly at 6 and 12 months. Specifically,
MANTRA patients will need fewer and briefer hospitalisations during the study period compared with
SSCM. (Only the hospitalisation aspect of this hypothesis is addressed here; the full cost-effectiveness
data are not yet available and will be published elsewhere when complete.)
Methods
The methods presented here are taken from the published Maudsley Outpatient Study of Treatments for
Anorexia Nervosa and Related Conditions (MOSAIC) trial protocol.128
Trial design
This is a superiority trial conducted in four NHS specialist ED units. The trial evaluated the efficacy and
cost-effectiveness of MANTRA versus SSCM in consecutively referred adult outpatients with AN. Patients
were allocated to one of two treatment arms: MANTRA or SSCM. Further details on the randomisation
procedure are given below.
Outcomes were measured pre-randomisation, at 6 months post randomisation (i.e. designed to broadly
coincide with the end of weekly treatment) and at 12 months post randomisation (follow-up). Outcomes
were assessed by researchers who were not involved in the treatment and efforts were made to keep
researchers blind to patients’ treatment allocation. As much as possible, patients who had terminated
treatment early were followed up to enable intention-to-treat (ITT) analysis.
Ethics approval
We obtained ethics approval for the MOSAIC trial from Central London Research Ethics Committee (REC) 4,
National Research Ethics Service, Royal Free Hospital, London (NHS REC Reference: 10/H0714/9). All
participants provided informed written consent prior to entering the study. The study was conducted in
compliance with the Helsinki Declaration.
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Participants
Inclusion criteria
Consecutive patients referred for outpatient treatment to one of the participating centres by their GP were
offered participation if they were:
l aged between 18 and 60 years
l had a BMI of ≤ 18.5 kg/m2
l had a DSM-IV diagnosis of AN or eating disorder not otherwise specified (EDNOS). We defined EDNOS
as in the meta-analysis by Thomas et al.129 and included individuals who fulfilled all diagnostic criteria
of AN, with the exception of the weight criterion; those who still had menstrual bleeds; those who did
not have a fat phobia; and those with a partial AN syndrome (i.e. they had features of AN but failed to
meet two or more of the four diagnostic criteria).
The meta-analysis by Thomas et al.129 shows that EDNOS patients with a more lenient BMI cut-off point and
without amenorrhoea are very similar to those with more narrowly defined AN. The BMI cut-off point of
18.5 kg/m2 was selected to be concordant with the World Health Organization’s cut-off point for being
underweight. Additionally, this cut-off point was also used in previous studies by our group and others.128,130,131
Exclusion criteria
We excluded patients if they had severe, medically unstable AN that necessitated inpatient treatment;124
had poor command of English and thus were unable to understand assessment and treatment; had a
learning disability; had significant other mental or physical illness that required intervention (e.g. psychotic
illness or diabetes mellitus); were alcohol or substance dependent; or were pregnant.
We did not exclude patients on stable doses of antidepressants, defined as having taken the medication
for ≥ 4 weeks.
Locations of data collection
Patients were recruited from several centres: South London and Maudsley NHS Foundation Trust; North
East London Foundation Trust Eating Disorders Service; Barnet, Enfield & Haringey Mental Health NHS
Trust; Oxford Health NHS Foundation Trust.
Interventions
Common features of delivery of Maudsley Model of Anorexia Nervosa Treatment for
Adults and specialist supportive clinical management
In both groups patients were offered 20 individual therapy sessions, which took place once a week. In
addition, there were 4-monthly follow-up sessions. In severely underweight patients (BMI ≤ 15 kg/m2)
sessions were extended to 30 meetings plus four follow-up sessions. In both MANTRA and SSCM, patients
were offered two additional sessions with a family member or close other. Finally, in both groups patients
could access dietetic sessions if deemed appropriate by their clinician. In both treatments physical risk was
monitored on an ongoing basis. Therapy sessions in MANTRA lasted ≈50 minutes throughout treatment,
whereas, in SSCM, from the middle of treatment sessions could be briefer (i.e. about 30 minutes) in
accordance with the SSCM protocol (available from the authors).132 This was done to ensure comparability
of our study with other trials using SSCM.
Maudsley Model of Anorexia Nervosa Treatment for Adults
The MANTRA model19 suggests that AN typically develops in people with anxious and obsessional
personality traits at times of stress or increased developmental demands. Dietary restriction becomes a way
of managing negative emotions and coping with stress, and, once established, the illness is maintained by
four key maintenance factors in the cognitive, emotional and interpersonal domains. First, this includes an
information processing style that is characterised by perfectionism with high standards and fear of making
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mistakes, excessive detail focus and poor ability to assess ‘gist’ and cognitive rigidity (i.e. an inability to
switch between tasks or task demands). Second, there are impairments in emotion generation and
regulation (intense emotions, lack of emotional clarity, avoidance and suppression of emotions/emotion
expression, reduced ability to adaptively reappraise emotional stimuli). Third, together these cognitive and
emotional styles give rise to AN becoming valued by the person (i.e. the person develops positive beliefs
about how AN helps them in their life).133–135 Finally, the inadvertent response of family members or close
others, who may be anxious, critical or hostile, may contribute to illness maintenance.
A treatment workbook is given to each patient (see data supplement DS1 in Schmidt et al.126,136 for details).
This has both core and optional chapters, thus the information contained in the manual can be tailored to the
requirements of each patient. Throughout the style of therapy is that of motivational interviewing.137 This
means that the therapist draws on the patient’s experience and is responsive and reflective. Based on a
thorough biopsychosocial assessment an individual case formulation is developed collaboratively. This also
includes a focus on the person’s personality traits, strengths and supports. Normative and ipsative feedback
(e.g. about medical risk and thinking style) is given to foster discussions about and interest in change. Health
behaviour change principles and techniques are used to guide individuals towards better health and
recovery.138,139 The structure, sequence and hierarchy of treatment procedures are clearly defined. This largely
depends on an individual’s clinical severity and also takes into account motivation for change, medical risk
and available individual resources and supports. Family members are asked to attend sessions as necessary.
Specialist supportive clinical management
This treatment was designed as a credible comparison against CBT and IPT in a RCT.127 Full details are given
in McIntosh et al.140 There is a manual for therapists (available from the authors),132 which contains patient
handouts giving them relevant information on topics such as the risks of commonly used weight control
behaviours and the impact of starvation on body and mind. These handouts are used flexibly throughout
treatment.132 SSCM is designed to be delivered by ED experts and aims ‘to mimic outpatient treatment that
could be offered to individuals with AN in usual clinical practice’. SSCM combines principles of good clinical
management (emphasising care, safety and expert knowledge) and supportive psychotherapy (emphasising
warmth, acceptance, reassurance and information giving as needed). A central feature of SSCM is the focus
on the patient’s underweight and abnormal eating behaviour. Patients are given practical advice on how to
work on these issues and the key message to them is that if they manage to improve their nutrition their
physical and emotional health will also improve. All other therapy content is ad hoc and is dependent on
what the patient wishes to discuss in a particular session.
Therapists
Twenty-eight ED therapists delivered the trial therapies across the four centres. Therapists were trained in
MANTRA and SSCM (2 days were provided as an introduction to each treatment). Additionally, further
training days were offered periodically to ensure uniform delivery of treatments across centres and to
protect against ‘therapeutic drift’. Therapists had to deliver both treatments to minimise allegiance effects.
Supervision was provided to therapists on a weekly basis by designated trained supervisors in each team.
To avoid cross-therapy contamination, this was delivered separately for MANTRA and SSCM. Patients were
allocated to therapists based on availability. To ensure that treatments were delivered competently and as
planned, audio-recordings of sessions were carried out and three tapes per patient were chosen randomly
to assess treatment adherence in both groups.
For each of their patients, therapists recorded details, including number, duration and content of sessions,
and details of any additional treatment.
Outcomes
All outcome measures were collected at baseline, 6 months after randomisation (i.e. approximately end of
weekly sessions) and 12 months after randomisation (i.e. follow-up). Treatment credibility and acceptability
ratings were taken only at 6 and 12 months. Potential outcome mediator variables were also taken at 3 months
(mid-treatment). These results are not yet available and will be published elsewhere when complete.
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Primary outcome
l BMI (kg/m2) at 12 months.
Secondary outcomes
l BMI (kg/m2) at 6 months.
l EDE global score and subscales.141 The EDE is a semistructured interview that has four subscales: dietary
restraint, eating concern, weight concern and shape concern. The global score is created from the
mean of these four subscales. Patients that were either unwilling or unable to participate in the EDE
interview were asked instead to complete the questionnaire version of this measure (Eating Disorders
Examination-Questionnaire; EDE-Q). The EDE-Q has comparable psychometric properties to the
EDE interview.142
Other psychopathology
The DASS-2197 and the Obsessive Compulsive Inventory-Revised (OCI-R).143
Potential mediators
The Cognitive Flexibility Scale,144 Beliefs about Emotions Scale,145 the Emotion Regulation Questionnaire146
and a visual analogue scale assessing motivation and social support. These results are not yet available and
will be published elsewhere when complete.
Treatment credibility and acceptability
Visual analogue scales of credibility and acceptability of treatment were specifically developed for this trial.
Neurocognitive and social cognitive measures
l The Wisconsin Card Sorting Test (WCST)147,148 is a widely used measure of set-shifting (i.e. it tests the
ability to flexibly switch between different tasks or rules). The participant has to match stimulus cards
with one of four category cards. The stimuli are multidimensional according to colour, shape and
number. The matching rules change over time and the participant has to adapt to these. We used
perseverative errors as the outcome.
l The Brixton Spatial Anticipation Test149 also assesses set-shifting. Participants have to predict the
movement of a blue circle across different positions, adapting their predictions according to the pattern
of movement. Error rates are assessed.
l The Rey–Osterrieth Complex Figure Test (REY)150,151 tests participants’ central coherence (i.e. their ability
to plan, organise and assemble complex information). Participants have to copy a complex figure
design and are assessed on their approach to this. The more fragmented and detail focused their
approach to the task, the lower their score.
l Baron-Cohen’s Reading the Mind in Film Task (RMF)152 assesses theory of mind based on 22 brief film
clips. After viewing a clip the participant is required to select one of four words to describe how the
protagonist is feeling in the given situation.
Costs and psychosocial impairment
l The Client Services Receipt Inventory (CSRI):153 we used a self-report version of this inventory of service
use. It was adapted for the present trial to cover a range of mental and physical health services,
medications, impact on employment and additional personal expenditure due to the ED. Results
relating to the CSRI are not yet available and will be published elsewhwere when complete.
l The Clinical Impairment Assessment (CIA):154 this is a questionnaire measure assessing psychosocial
impairment arising from the individual’s ED behaviours.
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Sample size
Full details of our sample size calculation, including the data and assumptions on which this is based,
can be found in our protocol paper.128 In brief, we assumed that we would need a sample size of
69 patients per group to have 90% power to detect a difference in mean weight gain of 2.5 kg, using
an independent-samples t-test with a significance level of α = 0.05 and correcting for 20% attrition.
Randomisation and implementation
The randomisation sequence was generated and implemented independently from the study team by the
King’s College London Clinical Trials Unit (CTU). After participant recruitment and baseline assessment,
the research assessor entered patient identification and stratification details into the online CTU system.
Participants were then allocated to one of the two treatments based on a restricted stratified randomisation
algorithm. The strata were (1) BMI below or above 15 kg/m2, (2) restricting or binge/purge subtype of
AN and (3) previous hospitalisation in an ED unit. These factors are known to affect treatment outcome
and rates of potential future inpatient treatment. The stratification was implemented by minimised
randomisation with a random component. The first n cases (n would not be disclosed) were allocated
entirely at random to further enhance allocation concealment.
Blinding
Although patients and therapists were not blinded, the research assessors were blind to treatment
allocation. In order to assess whether or not researcher blinding was successful, they had to make a guess
at the end of 12 months’ assessment as to which treatment they believed the person had received.
Statistical methods
The objective of the statistical analyses was the comparison of those offered MANTRA with those offered
SSCM on a number of outcomes. The primary clinical outcome was BMI (kg/m2) at 12 months after
randomisation. Secondary outcomes were continuous measures at 6 or 12 months’ follow-up (see above).
All statistical analyses were based on the ITT principle; thus, patients were analysed in the treatment arm
to which they were randomised irrespective of whether or not they received the allocated treatment. All
analyses were carried out in Stata® 12 (StataCorp LP, College Station, TX, USA).
All outcomes were analysed using linear mixed models. Full details of the analysis plan can be found
elsewhere.110,128 Outcome variables contained considerable numbers of missing values. Full details of the
treatment of missing variables can be found elsewhere.110
Results
Participant flow and recruitment
Flow of participants through the trial is shown in Figure 1. Of the 319 patients approached, 142 agreed to
participate in the trial. Following baseline assessments, random allocation of the 142 participants across all
four study sites resulted in 72 patients in the MANTRA arm and 70 in the SSCM arm. Three patients did
not receive their allocated therapy (see Figure 1).
Treatment completion was defined at the start of the study as attending ≥ 15 therapy sessions
(i.e. receiving more than three-quarters of the weekly treatment sessions). This definition is in line with
other studies’ definitions of treatment adherence.127,131 Overall, 66.9% of participants were treatment
completers, with 75% of MANTRA participants and 59% of SSCM participants completing treatment
[χ2(1) = 1.19; p = 0.28].
Non-completion of treatment predicted loss to follow-up at 12 months. At the 12-month follow-up,
primary outcome data were missing for 45.2% of non-completing participants, compared with 10.5% of
completers. Details of the reasons for missing data can be found in Figure 1.
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Excluded
(n = 177)
Not meeting inclusion criteria
(n = 48)
Declined to participate
(n = 73)
Other reasons
(n = 23)
• Outside of age limit, n = 2
• BMI >18.5 kg/m2, n = 34
• No current DSM-IV diagnosis of 
   AN or EDNOS-AN, n = 12
Met exclusion criteria, n = 33
• Severe physical risk, n = 13
• Psychiatric comorbidity, n = 13
• Received MANTRA in past year, n = 3
• Receiving treatment elsewhere, n = 3
• Pregnancy, n = 1
Assessed for eligibility
(n = 319)
Randomised
(n = 142)
Allocated to MANTRA
(n = 72)
Missing, n = 2 (2.8%)
Mean number of therapy sessions
attended: 19 (SD 6.6)
Allocated to SSCM
(n = 70)
Missing, n = 3 (4.3%)
Mean number of therapy sessions
attended: 16.7 (SD 7.6)
Analysed
(n = 72)
Excluded from analysis
 (n = 0)
Analysed
(n = 70)
Excluded from analysis
 (n = 0)
Completed BMI assessment:
• Baseline, n = 72/72 (100%)
• 6 months, n = 63/72 (88%)
• 12 months, n = 60/72 (83%)
Completed EDE interview:
• Baseline, n = 72/72 (100%)
• 6 months, n = 64/72 (89%)
• 12 months, n = 60/72 (83%)
Completed 3-month assessment: 
n = 59/72 (82%)
Completed BMI assessment:
• Baseline, n = 70/70 (100%)
• 6 months, n = 55/70 (79%)
• 12 months, n = 51/70 (73%)
Completed EDE interview:
• Baseline, n = 70/70 (100%)
• 6 months, n = 55/70 (79%)
• 12 months, n = 51/70 (73%)
Completed 3-month assessment:
n = 52/70 (74%)
FIGURE 1 Consolidated Standards of Reporting Trials flow diagram (WP2a). Copyright © 2015 by the American
Psychological Association (APA). Reproduced with permission. The official citation that should be used in
referencing this material is Schmidt U, Magill N, Renwick B, Keyes A, Kenyon M, Dejong H, et al. (2015). The
Maudsley Outpatient Study of Treatments for Anorexia Nervosa and Related Conditions (MOSAIC): Comparison
of the Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA) with specialist supportive clinical
management (SSCM) in outpatients with broadly defined anorexia nervosa: a randomized controlled trial. Journal
of Consulting and Clinical Psychology, 83(4), 796–807.110 The use of APA information does not imply endorsement
by APA.
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All 142 participants were included in the primary outcome analysis.
The trial was conducted between June 2010 and November 2013. Between June 2010 and November
2012, participants were recruited into the trial via their initial clinical assessment with the EDs service,
which was followed by a pre-intervention assessment. Delivery of the intervention occurred between
June 2010 and November 2013. End of weekly treatment session follow-up assessments (month 6) were
completed during December 2010 to May 2013 and end of treatment follow-up assessments (month 12)
occurred throughout June 2011 to November 2013.
Service utilisation
Use of additional dietitian sessions was not different between groups [MANTRA 33/72 (46%); SSCM 31/70
(44%)]. Sixty-seven of 72 (93%) MANTRA patients and 64 of 70 (91.4%) SSCM patients provided
information on additional service utilisation (outside the study protocol) during the study period. Eighteen
of 131 patients for whom this information was available (13.7%) had additional treatment during the
study period. This was categorised into ED inpatient or day care treatment, general psychiatric inpatient
treatment or other treatment. Eight of these patients had been allocated to MANTRA. Two of these had
ED inpatient treatment (217 and 66 days, respectively), one of these also had 30 days of ED day care
treatment and 1 day of ‘other treatment’. Three further patients only had ED day care (175 days, 144 days
and 1 day, respectively). One of these also had a 10-day inpatient alcohol detoxification programme. Two
further patients had brief general psychiatric admissions (in one case 7 days and in the other 10 days),
because of suicidal or self-harm behaviour; one of these also had 1 day of ‘other treatment’. One further
patient had 1 day of ‘other’ treatment only.
Ten patients who needed additional treatment had been allocated to SSCM (15.6%). Five of these had ED
inpatient care (of 45, 62, 110, 140 and 198 days), with one of these having a second 8-day ED admission.
Three patients had ED day care (for 2, 54, 183 days); one of these also had a 50-day general psychiatric
admission following depression and suicidal behaviour. One further patient had a 1-day general psychiatry
admission followed by 11 days of home treatment, and one patient had 1 day of ‘other treatment’.
Proportions of people needing additional treatment were not different between MANTRA and SSCM.
There was also no significant difference between the two treatment arms in the number of days per
admission or admission days per patient.
Baseline data
The baseline characteristics of patients in both groups were comparable (Table 8) Overall, the mean
baseline BMI was 16.6 (SD 1.2) kg/m2 and the duration of illness was 8.3 (SD 7.3) years. Sixty-three
(44.4%) patients presented with restrictive AN.
Primary outcome
Tables 9 and 10 show that the two treatments did not differ in their effect on BMI at 6 months (p > 0.05)
or at 12 months (p > 0.05) (primary outcome).
Tables 11 and 12 demonstrate, however, that there was a significant overall effect of receiving treatment,
with BMI in the total sample increasing from baseline to month 6 by 0.74 [95% confidence interval (CI)
0.4 to 1.08] and from baseline to month 12 by 1.19 (95% CI 0.59 to 1.79).
Secondary outcomes
Tables 9 and 10 show that the two treatments did not differ in their effect on the EDE global score at
either the 6- or 12-month time point (all p > 0.05).
Tables 11 and 12, however, demonstrate that there was a significant overall effect of receiving treatment,
with mean EDE global score decreasing from baseline to month 6 by 0.63 (95% CI –0.85 to –0.42) and
from baseline to month 12 by 0.84 (95% CI –1.08 to 10.59).
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Tables 9 and 10 show that there was no difference between the two treatments at 6 or 12 months’
follow-up for all other secondary outcomes (all p > 0.05).
Again, Tables 11 and 12 demonstrate that there was a significant overall effect of receiving treatment
for all EDE subscales, DASS-21, CIA, WCST and Brixton Spatial Anticipation Test scores after month 6
(all p < 0.01), whereas OCI-R, REY and RMF did not change significantly (all p > 0.05).
At month 12 there was a significant overall effect of treatment for all EDE subscales, DASS-21, CIA,
Brixton Spatial Anticipation Test and REY scores (all p < 0.01), whereas OCI-R, WCST and RMF did not
change significantly (all p > 0.05).
Recovery rates
At 12 months’ follow-up, participants were split into three groups: recovered, partially recovered and not
recovered. These were defined as (1) recovered, BMI of > 18.5 kg/m2 and EDE global score of < 2.77;
(b) partially recovered, BMI of ≤ 17.5 kg/m2 and EDE global score of < 2.77, BMI of > 17.5 kg/m2 and
TABLE 8 Demographic and clinical characteristics at baseline
Characteristic
Whole group MANTRA SSCM
n n n
Demographic details
Age at randomisation (years): mean (SD) 142 26.7 (7.7) 72 27.5 (8.1) 70 25.9 (7.1)
Male : female, n 142 3 : 139 72 0 : 72 70 3 : 67
Years in education, mean (SD) 125 15.8 (2.3) 63 16.1 (2.1) 62 15.5 (2.5)
Has a partner, n (%) 138 50 (35.2) 72 21 (29.2) 66 29 (41.4)
Clinical details
Diagnosis, n (%) 142 72 70
AN-R 63 (44.4) 35 (48.6) 28 (40.0)
AN-BP 44 (31.0) 22 (30.6) 22 (31.4)
EDNOS 35 (24.7) 15 (20.8) 20 (28.6)
BMI (kg/m2), mean (SD) 142 16.64 (1.2) 72 16.61 (1.2) 70 16.62 (1.3)
Weight (kg), mean (SD) 142 45.1 (4.9) 72 44.8 (4.5) 70 45.4 (5.4)
Age at onset (years), mean (SD) 132 17.7 (6.5) 67 17.3 (6.5) 65 18.1 (6.6)
Illness duration (years), mean (SD) 134 8.3 (7.3) 67 9.3 (7.9) 67 7.2 (6.5)
Previous eating disorder treatment, n (%) 140 80 (56.3) 70 41 (56.9) 70 39 (55.7)
EDE, mean (SD) 142 3.3 (1.3) 72 3.1 (1.3) 70 3.5 (1.3)
DASS-21, mean (SD) 138 30.5 (12.7) 69 29.6 (11.5) 69 31.4 (13.8)
CIA, mean (SD) 141 32.6 (8.9) 71 32.1 (9.0) 70 33.0 (8.9)
Current antidepressant medication, n (%) 140 55 (38.7) 70 29 (40.3) 70 26 (37.1)
AN-BP, anorexia nervosa binge eating/purging type; AN-R, anorexia nervosa restricting type.
Copyright © 2015 by the American Psychological Association (APA). Reproduced with permission. The official citation that
should be used in referencing this material is Schmidt U, Magill N, Renwick B, Keyes A, Kenyon M, Dejong H, et al. (2015).
The Maudsley Outpatient Study of Treatments for Anorexia Nervosa and Related Conditions (MOSAIC): Comparison of the
Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA) with specialist supportive clinical management
(SSCM) in outpatients with broadly defined anorexia nervosa: a randomized controlled trial. Journal of Consulting and
Clinical Psychology, 83(4), 796–807.110 The use of APA information does not imply endorsement by APA.
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≤ 18.5 kg/m2 or BMI of > 18.5 kg/m2 and EDE global score of > 2.77; and (c) not recovered, BMI of
≤ 17.5 kg/m2 and EDE global score of > 2.77.
The proportions of participants falling into these categories at 12 months were as follows:
l MANTRA: recovered, 13 of 72 (18.1%); partially recovered, 36 out of 72 (50%); and not recovered,
9 out of 72 (12.5%);
l SSCM: recovered 8 out of 70 (11.4%); partially recovered, 32 out of 70 (45.7%); and not recovered,
9 out of 70 (12.9%).
There was no association between treatment allocation and recovery [χ2(3) = 2.80; p = 0.42].
Baseline body mass index as a potential moderator of primary and secondary outcomes
We also examined whether or not baseline BMI was a potential moderator of treatment effect on BMI at
6 and 12 months, dividing participants into those with a baseline BMI of < 17.5 kg/m2 (77% of MANTRA
and 70% of SSCM participants) and those with a BMI of > 17.5 kg/m2 (18.1% of MANTRA and 25.7% of
SSCM participants). (This information was missing for 4.2% and 4.3% of participants in MANTRA and
SSCM groups, respectively.)
TABLE 9 Maudsley Model of Anorexia Nervosa Treatment for Adults vs. SSCM: estimated treatment effects at
6 months post randomisation
Outcome
Predicted mean (SE),
baseline fixed to sample
average Estimated
group
differencea Test 95% CIa
Standardised
coefficientaMANTRA SSCM
BMI (kg/m2) 17.52 (0.21) 17.24 (0.23) 0.28 t = 0.91; p = 0.36 –0.32 to 0.88 0.23
EDE global 2.72 (0.14) 2.63 (0.15) 0.09 t = 0.48; p = 0.63 –0.29 to 0.48 0.07
EDE restraint 2.48 (0.29) 2.43 (0.30) 0.05 t = 0.13; p = 0.90 –0.68 to 0.78 0.03
EDE eating
concern
2.27 (0.16) 2.28 (0.18) –0.01 t = –0.05; p = 0.96 –0.47 to 0.45 –0.01
EDE shape concern 3.16 (0.18) 2.01 (0.20) 0.14 t = 0.55; p = 0.58 –0.37 to 0.65 0.08
EDE weight
concern
2.74 (0.19) 2.68 (0.21) 0.07 t = 0.24; p = 0.81 –0.48 to 0.61 0.04
DASS-21 27.12 (1.54) 27.25 (1.62) –0.12 t = –0.06; p = 0.96 –4.50 to 4.25 –0.01
OCI-R 23.01 (1.86) 21.58 (1.97) 1.42 t = 0.58; p = 0.56 –3.41 to 6.26 0.10
CIA 26.96 (1.58) 26.93 (1.69) 0.03 t = 0.01; p = 0.99 –4.25 to 4.31 < 0.01
WCST 1.74 (0.13) 1.58 (0.20) 0.15 t = 0.69; p = 0.49 –0.29 to 0.60 0.21
Brixton Spatial
Anticipation Test
10.49 (0.65) 10.24 (0.79) 0.25 t = 0.30; p = 0.77 –1.43 to 1.94 0.04
REY 1.36 (0.04) 1.31 (0.05) 0.05 t = 0.72; p = 0.48 –0.08 to 0.17 0.18
RMF 13.91 (0.45) 13.08 (0.48) 0.84 t = 1.38; p = 0.17 –0.35 to 2.02 0.30
a Coefficients represent estimated treatment effect of MANTRA – SSCM.
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TABLE 10 Maudsley Model of Anorexia Nervosa Treatment for Adults vs. SSCM: estimated treatment effects at
12 months post randomisation
Outcome
Predicted mean (SE),
baseline fixed to sample
average Estimated
group
differencea Test 95% CIa
Standardised
coefficientaMANTRA SSCM
BMI (kg/m2) 18.04 (0.32) 17.72 (0.35) 0.31 t = 0.67; p= 0.50 –0.60 to 1.22 0.25
EDE global 2.37 (0.16) 2.58 (0.17) –0.22 t = –0.95; p= 0.34 –0.66 to 0.23 –0.17
EDE restraint 2.49 (0.22) 2.67 (0.24) –0.18 t = –0.55; p= 0.58 –0.82 to 0.46 –0.12
EDE eating
concern
1.82 (0.18) 2.17 (0.20) –0.35 t = –1.33; p= 0.18 –0.87 to 0.17 –0.25
EDE shape concern 2.83 (0.18) 2.89 (0.19) –0.06 t = –0.24; p= 0.81 –0.57 to 0.44 –0.04
EDE weight
concern
2.32 (0.20) 2.61 (0.22) –0.29 t = –1.00; p= 0.32 –0.86 to 0.28 –0.18
DASS-21 26.00 (1.54) 25.16 (1.70) 0.84 t = 0.37; p= 0.72 –3.69 to 5.37 0.07
OCI-R 22.01 (1.96) 20.81 (2.10) 1.20 t = 0.46; p= 0.64 –3.87 to 6.28 0.09
CIA 23.56 (1.57) 24.62 (1.82) –1.06 t = –0.42; p= 0.67 –6.00 to 3.89 –0.12
WCST 1.82 (0.13) 1.83 (0.20) –0.01 t = –0.05; p= 0.96 –0.44 to 0.42 –0.01
Brixton Spatial
Anticipation Test
9.34 (1.71) 5.87 (2.13) 3.47 t = 1.41; p= 0.16 –1.39 to 8.33 0.60
REY 1.43 (0.05) 1.39 (0.07) 0.03 t = 0.42; p= 0.68 –0.12 to 0.18 0.11
RMF 13.88 (0.68) 13.39 (0.65) 0.49 t = 0.63; p= 0.53 –1.05 to 2.02 0.18
a Coefficients represent estimated treatment effect of MANTRA – SSCM.
TABLE 11 Estimated change in mean outcome between baseline and month 6 (average of both treatment arms)
Outcome Estimated change SE Test 95% CI
BMI (kg/m2) 0.74 0.17 t = 4.31; p < 0.001 0.40 to 1.08
EDE global –0.63 0.11 t = –5.80; p < 0.001 –0.85 to –0.42
EDE restraint –1.30 0.24 t = –0.13; p < 0.001 –1.77 to –0.83
EDE eating concern –0.57 0.14 t = –4.10; p < 0.001 –0.84 to –0.30
EDE shape concern –0.41 0.15 t = –2.65; p < 0.01 –0.71 to –0.11
EDE weight concern –0.45 0.15 t = –2.94; p < 0.01 –0.74 to –0.15
DASS-21 –3.38 1.14 t = –2.97; p < 0.01 –5.62 to –1.14
OCI-R –0.90 1.62 t = –0.55; p = 0.58 –4.12 to 2.32
CIA –5.41 1.43 t = –3.79; p < 0.001 –8.23 to –2.59
WCST –0.36 0.13 t = –2.84; p < 0.01 –0.61 to –0.11
Brixton Spatial Anticipation Test –2.02 0.50 t = –4.02; p < 0.001 –3.02 to –1.03
REY 0.05 0.04 t = 1.43; p = 0.15 –0.02 to 0.13
RMF 0.52 0.36 t = 1.46; p = 0.15 –0.18 to 1.22
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There was no evidence of a statistically significant interaction between treatment group and whether
baseline BMI was above or below 17.5 kg/m2 when BMI was the outcome. However, on visual inspection
of the estimated effects, it does appear that the effect of treatment (favouring MANTRA) was larger
among those with lower baseline BMI (Table 13).
Baseline BMI was also investigated as a potential moderator of secondary outcomes. No evidence of a
statistically significant interaction between treatment group and whether baseline BMI was more or less
than 17.5 kg/m2 was found for these other outcomes.
Harms
One SSCM patient died. No other harms were noted.
Treatment acceptability and credibility
There were no significant differences in acceptability and credibility ratings between MANTRA and SSCM
at 6 months {acceptability: MANTRA = 8.5 [2.0], SSCM = 8.0 [2.2] [t(100) = 1.33; p = 0.18]; credibility:
MANTRA = 6.4 [3.1], SSCM= 5.8 [2.7] [t(100)= 1.1; p = 0.29]}. However, at 12 months, MANTRA was given
TABLE 12 Estimated change in mean outcome between baseline and month 12 (average of both treatment arms)
Outcome Estimated change SE Test 95% CI
BMI (kg/m2) 1.19 0.30 t = 3.91; p< 0.001 0.59 to 1.79
EDE global –0.84 0.12 t = –6.78; p< 0.001 –1.08 to –0.59
EDE restraint –1.16 0.17 t = –6.81; p< 0.001 –1.49 to –0.82
EDE eating concern –0.85 0.17 t = –5.05; p< 0.001 –1.18 to –0.52
EDE shape concern –0.64 0.14 t = –4.55; p< 0.001 –0.92 to –0.37
EDE weight concern –0.70 0.17 t = –4.09; p< 0.001 –1.04 to –0.36
DASS-21 –5.02 1.18 t = –4.25; p< 0.001 –7.34 to –2.70
OCI-R –1.59 1.88 t = –0.85; p= 0.40 –5.31 to 2.13
CIA –8.56 1.18 t = –7.28; p< 0.001 –10.87 to –6.25
WCST –0.23 0.13 t = –1.74; p= 0.09 –0.49 to 0.03
Brixton Spatial Anticipation Test –4.42 1.59 t = –2.78; p< 0.01 –7.58 to –1.27
REY 0.12 0.05 t = 2.40; p= 0.02 0.02 to 0.23
RMF 0.64 0.55 t = 1.16; p= 0.25 –0.46 to 1.74
TABLE 13 Estimated effects of treatment on BMI at the different levels of baseline BMI (whether less than or more
than 17.5 kg/m2)
Variable Level Estimated group differencea t-score p-value
6 months after randomisation
Baseline BMI ≤ 17.5 kg/m2 0.41 1.32 0.19
> 17.5 kg/m2 –0.04 –0.07 0.94
12 months after randomisation
Baseline BMI ≤ 17.5 kg/m2 0.55 1.26 0.21
> 17.5 kg/m2 –0.08 –0.10 0.92
a Coefficients represent estimated treatment effect of MANTRA – SSCM.
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significantly higher ratings on both acceptability and credibility than SSCM {acceptability: MANTRA= 8.6 [1.8],
SSCM = 7.8 [2.3] [t(91) = 2.01; p < 0.05]; credibility: MANTRA = 6.8 [3.1], SSCM = 5.5 [2.7] [t(91) = 2.24;
p < 0.05]}.
Discussion
Main findings
First, overall, participants showed significant improvements in terms of BMI, ED symptoms, depression,
anxiety and stress and psychosocial impairment after 6 months of weekly treatment sessions. These
improvements were either maintained or increased at 12 months post randomisation. Second, there were
no differential effects between the two treatments in terms of primary and secondary outcomes and
further service utilisation. Therefore, our main hypotheses were not confirmed. However, BMI, EDE and
proportions of recovered participants all somewhat favour MANTRA at 12 months, and exploratory
moderator analysis suggested that the treatment effect in relation to BMI (favouring MANTRA) increased
(non-significantly) at 12 months, especially in those patients who were more severely ill at baseline.
There was a mixed picture of results in terms of neurocognitive and social cognitive performance. There
was no effect of treatment on social cognition; however, participants were not particularly impaired on this
task at baseline,155 so this lack of improvement is unsurprising. Central coherence and cognitive flexibility
as measured by the Brixton Spatial Anticipation Test improved significantly by month 12; however,
cognitive flexibility as measured by the WCST did not, but again participants were not particularly impaired
at baseline.15
Comparison of main findings with those of other trials
The degree of BMI change observed in the MOSAIC trial is comparable to that found in our earlier
single-centre pilot RCT (total n = 72), which used identical study inclusion criteria and which also compared
MANTRA and SSCM,136 suggesting that these treatments can be disseminated to other UK centres with
relatively brief initial training (2 days) of therapists and booster training (1 day).
Comparison against other trials needs to be approached cautiously because of differences in patient
populations. Perhaps the findings from the present study can be compared most easily against the large
German psychotherapy trial by Zipfel et al.,131 which compared focal psychodynamic therapy, CBT and
optimised TAU in outpatients with AN. Patients in this trial had comparable baseline BMIs (between 16.6
and 16.8 kg/m2), but received a somewhat higher ‘dose’ of psychotherapy (40 sessions over 10 months).
Patients were followed up at 13 months post randomisation and at 22 months post randomisation.
Thirteen-month BMI outcomes in the Zipfel et al.131 study were between 17.6 kg/m2 (focal psychodynamic
therapy) and 17.4 kg/m2 (CBT and optimised TAU), whereas our 12-month BMI outcomes were 18.0 kg/m2
in MANTRA and 17.7 kg/m2 in SSCM. Thus, our BMI improvements stand up well in this international
comparison.
Two other previous trials have used SSCM.127,156 Comparison of our data against these trials is difficult.
One of these trials was carried out in patients with a significantly milder form of AN (baseline mean BMI of
17.3 kg/m2),127 and the other specifically focused on chronic patients (mean illness duration of 15.5 and
17.7 years in the CBT and SSCM group, respectively).156 In the McIntosh study, SSCM BMI outcomes were
superior to CBT and IPT BMI outcomes at end of treatment, but not at long-term follow-up.157 In the Touyz
et al.156 study, at 12-month follow-up, BMI gains were modest (0.5 kg/m2) and identical for both groups.
Other findings
Service utilisation
There was no difference in terms of further service utilisation between the two treatments. This is in
contrast to findings from our pilot trial, which also compared SSCM with MANTRA,136 and in which all
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hospital admissions and day care treatment were in the MANTRA group. However, in our earlier smaller
trial there was an imbalance between the two groups at baseline, with a significantly higher proportion
of SSCM than of MANTRA participants having a partner (and therefore being in a prognostically better
group). This may explain the differences between the two treatments in service utilisation in this earlier
trial, and suggests that the previously observed difference was a feature of the pilot sample rather than an
inadequacy in the MANTRA treatment.
Trial retention, treatment completion and acceptability
Participant retention in the trial was very good, with 83% of MANTRA participants and 73% of SSCM
participants, providing BMI and EDE data at 12 months. In comparison, in the trial by Zipfel et al.,131 at the
13-month assessment between 58.5% (optimised TAU) and 82.5% (CBT) of participants provided data.
Treatment completion rates also compare well against those of other studies that used a similar definition
of treatment completion. Seventy-five per cent of MANTRA and 59% of SSCM patients completed
treatment. In the McIntosh et al.127 trial, 62.5% of participants completed treatment, and in the Zipfel
et al.131 trial 66% of focal psychodynamic therapy participants and and 81.3% of CBT participants
completed treatment.
Finally, and of note, there was a significant difference between treatment acceptability and credibility
ratings at month 12, with MANTRA being rated more favourably than SSCM on both. This may be
because MANTRA is a manual-based treatment so that patients continue to have access to key resources
during the course of therapy and beyond. The benefits of the manual may become more apparent
following the end of weekly sessions, leading to a more positive longer-term experience.
Harms
One SSCM patient died during the study. This patient had very severe and chronic AN. It has been
documented in many studies that chronically ill, low-weight AN patients such as the one in our study do
have a much increased mortality risk.72 The causes of death typically are related directly to consequences or
complications of the illness (via malnutrition or abnormal weight control methods), and this is thought to
be the case here. Previous trials of AN outpatient treatment in adults have reported deaths. For example,
in a trial by Dare et al.,33 one patient (out of 84) died over the course of the trial, and in the study by
McIntosh et al.127 there was one death among 56 participants.
Patient and therapist experience of Maudsley Model of Anorexia Nervosa
Treatment for Adults and specialist supportive clinical management
The present trial is so far the only RCT of treatments for AN to include qualitative feedback from patients
and therapists, which we published separately prior to the outcome evaluation, as is recommended for
such process evaluations.158–160 In particular, process data from therapists, who of course were able to
compare and contrast these treatments, identified marked differences between these two treatments, in
terms of the therapy focus, therapeutic strategies and applicability to a wide range of patients.159 Process
data from patients largely agree with these findings, and in addition strongly point to the quality of the
therapeutic relationship, as the basis for a successful therapy.158 Both treatments were perceived as
having strengths and weaknesses. A further process evaluation examined written qualitative feedback
from all study participants at 12 months.160 Eighty-two study participants provided such written feedback,
significantly more from the MANTRA group than from the SSCM group. MANTRA patients also tended to
write in more detail and give more positive feedback than individuals receiving SSCM. Taken together with
quantitative acceptability and credibility ratings, these process evaluation findings suggest that patients
prefer MANTRA and therapists like it too. It thus provides a good alternative to SSCM. Of note, the greater
acceptability of MANTRA may mean that patients are more willing to have further treatment if required or
have better outcomes in the longer term. Assessment of these long-term effects of MANTRA and SSCM is
currently under way.
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Strengths
The strengths of the present study include that it is the largest RCT of first-line psychological treatments for
adults outpatients with AN to be carried within the UK and the second largest in the world.131 The study
had good participation rates at follow-up data points, good treatment completion, and high acceptability
and good outcomes compared with other studies. As such, the MOSAIC trial improves our limited
evidence base regarding outpatient treatments in this hard-to-treat population. This study is also novel in
that it is the first AN trial to incorporate both qualitative and quantitative measures of the therapeutic
process and therefore offers a greater insight into patient and therapist perceptions of the two treatments.
Limitations
The MOSAIC trial also had limitations. First, as the study compared two active treatments and did not
include a no-treatment control group, improvements in clinical outcomes cannot be attributed definitively
to treatment effects. Second, although the trial is the largest ever to be carried out within the UK, it is
still not large enough to perform conclusive mediation and moderation analyses of the core illness
maintenance factors, which MANTRA attempts to target. However, we will be able to amalgamate the
data from the present trial with the data from our earlier smaller RCT,136 which used an identical design
and overlapping assessments, to allow more definitive moderator and mediator analyses. The combined
sample size from both these trials will be 214 patients.
Third, although the ‘lost to follow-up’ rate within our overall sample was acceptable, the rate for
participants assigned to SSCM is 10% greater than for those receiving MANTRA. Therefore, information
on recovery in individuals in this group is more limited.
Finally, we were restricted by funding to a relatively short-term follow-up of 12 months. Further (2-year)
follow-up is necessary to measure the longer-term effects of these two treatments on primary and
secondary outcomes.
Generalisability
The MOSAIC trial included four specialist ED services and the interventions were delivered by a large
number and broad range of therapeutic staff, with different professional backgrounds and different
degrees of experience, so the study can be seen to reflect usual clinical practice. The trial also had very few
exclusion criteria, making the sample as generalisable as possible and leading to the inclusion of a sample
with a very broad range of clinical severity and BMI. As in usual clinical practice, trial therapists were able
to conduct both treatments. Through therapist interviews159 we have been able to confirm that both
treatments were experienced very differently and delivered with fidelity. Further confirmation of this will be
reported separately through analysis of the therapeutic session recordings.
Conclusions and future outlook
The significant improvement of patients in both groups suggests that both of these two very different
treatments have value as first-line outpatient treatments for adults with AN. In the original trial from New
Zealand in which SSCM was first used,127 SSCM was found to outperform two active treatments (CBT and IPT)
against the investigators’ hypothesis, and therefore provides a very high standard of control treatment.
Comparable weight gain and comparable reductions in ED psychopathology between MANTRA and SSCM
are therefore encouraging.
The current report includes an ITT analysis only. In future, we will also conduct a more complete analysis
and an exploratory analysis of potential treatment mediators. As part of this WP we are also in the process
of completing a cost-effectiveness analysis based on the current trial. The results of these analyses will be
published as soon as they are available. Finally, we will also conduct analyses of session recordings to
assess treatment fidelity and therapeutic process. We have completed a 2-year follow-up of the MOSAIC
patients, showing that improvements across clinical outcomes are maintained or increase further.161
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Chapter 5 Cognitive Remediation and Emotional
Skills Training for inpatients with anorexia nervosa
(work package 2b)
Abstract
Objectives
To evaluate the benefits of Cognitive Remediation and Emotional Skills Training (CREST) for patients with
AN receiving inpatient treatment.
Design
This project/chapter has three studies: (1) a case report, (2) a qualitative study of service users’ views about
CREST and (3) a quasi-experimental comparison of CREST and TAU in two inpatient settings.
Participants
Adult inpatients with AN.
Interventions
The main novel intervention used in this project is CREST, which consists of simple cognitive exercises and
simple emotion regulation, recognition and processing skills training, promoting micro skills in social
communication and self-regulation as well as facilitating better self-awareness.
Main outcome measures
Outcomes included qualitative feedback and neuropsychological tests targeting flexibility of thinking,
central coherence and theory of mind. Clinical outcomes (BMI, EDE-Q) were also reported.
Results
Qualitative assessments demonstrated CREST to be acceptable and perceived as beneficial by patients.
Additionally, self-report questionnaires demonstrated improvements. However, quantitative data were less
promising, showing no clear differences between the CREST and TAU groups in terms of cognitive or
clinical outcomes.
Conclusions
Future work will focus on revisions to the CREST manual based on the outcomes of this work, as well as
greater refinement of the measures used in subsequent quantitative evaluations.
Introduction
Inpatient treatment in the majority of countries is reserved for the most severe patients with AN. NICE
guidelines (NICE 2004) encourage treatment innovations for the severely ill eating-disordered
patient population.162
One of the empirically supported models of AN19 suggests inefficiencies in cognitive style and difficulties in
emotion generation and regulation as factors maintaining the illness.14,16,113,163,164 A related division is that
into ‘cold’ cognition, which is based on logic and rational thinking, and ‘hot’ cognition, based on feeling,
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intuition, emotional response and motivation.165 Targeting cognitive styles (‘cold’ cognition) has been
found to be an effective adjunct in treatment of inpatients, using the cognitive remediation treatment,
which improves neuropsychological task performance.
The aim of these three studies was to test a novel intervention that targets ‘cold’ and ‘hot’ cognition in a
manualised individual format for inpatients. CREST is a brief (1 hour, 10 sessions) psychological intervention.
It focuses on inflexible and detail-focused thinking styles (two sessions), and additionally focuses on learning
to recognise emotions, the management and expression of emotions, and recognising and acknowledging
positive emotions (eight sessions). A range of psychoeducational modules and interactive tasks within
CREST have been developed to facilitate individuals to (1) learn about the adaptive function of emotions,
(2) learn how to identify own emotions, (3) identify emotions in other people and (4) express emotion.
Study 1: case study
Setting and referral
Anna is a 21-year-old Caucasian British woman informally admitted to the ED unit with AN and
self-harming behaviour.
Assessment
On admission, Anna had a BMI of 13.1 kg/m2 (the healthy range is between 19 and 25 kg/m2). She fulfilled
diagnostic criteria for the restricting subtype of AN. She was significantly restricting her diet and exercising
excessively prior to her admission, which led to significant weight loss. She also described a number of
rigid rules and ritualistic behaviours surrounding her eating, and would become distressed if her routines
were disrupted. Anna had a distorted body image and body dissatisfaction, and described herself as
‘disgusting’ and ‘fat’, despite being objectively emaciated. She seemed to lack a sense of personal identity,
but felt that AN gave her an identity and a sense of specialness. She rated the importance of change as
2/10 and her perceived ability to change as 2/10.
Prior to her admission Anna was frequently engaging in self-harm, including punching, scratching, and
burning herself (superficially) on her arms and hands. She described using these behaviours as a means of
managing adverse emotional states. She did not have any current suicidal ideation and denied plans to
take her own life.
Anna reported growing up in an emotionally invalidating environment, one in which her feelings and
thoughts were often marginalised by her parents, and she felt that she was ‘second best’ to her
younger brother.
Key triggers for Anna’s eating disorder appeared to be her failing her General Certificate of Secondary
Education (GCSE) exams and being bullied by her peers, who told her she was not ‘good enough’ for her
boyfriend. These events seem to activate and reinforce negative core beliefs that Anna had about herself.
AN may have provided Anna with a sense of achievement and specialness at a time when she was feeling
like a failure in other domains. AN and her subsequent self-harm also gave her a way of managing her
emotions, which she found confusing and aversive.
Intervention
Anna was offered CREST over 10 individual sessions. This was deemed to be a particularly useful treatment
option for Anna, given her difficulties in managing her emotions. Anna’s mother also attended a series of
family meetings with Anna, in which they were supported to gain insight into each other’s perspectives.
These sessions also helped in supporting Anna’s mother in her own struggle to support Anna.
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Outcomes
Anna did not complete the outcome measures given pre and post CREST. However, over the course of her
14-week admission her weight did increase such that her BMI reached 14.7 kg/m2. Her self-reported rating
of the importance of change rose from 2/10 to 5/10, and her perceived ability to change also rose from
2/10 to 5/10. Anna reported that she found the intervention (CREST and family work) very useful in
helping her to reduce her self-harming and in managing her emotions, as well as allowing for a change in
the relationship with her mum to develop. Anna’s mother also said that she found the CREST work very
helpful and felt more confident in her ability to support Anna in her recovery.
Study 2: qualitative evaluation
Aims
The aim of this study was to explore patients’ views and experience of individual CREST.
Methods
Participants
Twenty-eight patients in the National Adult Eating Disorder Inpatient Service completed CREST and were
included in this study. All participants had a DSM-IV166 diagnosis of AN established by an experienced
clinician. Participants’ mean age was 25 (range 13–40) years. The mean BMI before starting CREST was
14.7 (range 11.5–18.1) kg/m2. Eleven patients did not complete all sessions and were excluded from this
study. Four patients were discharged from the hospital before they had completed CREST and seven
disengaged from the inpatient treatment programme.
Data collection
All patients completed an end of therapy reflection form following CREST. This study was reported in detail
by Money et al.167 and the main idea was to assess patients’ reflections on the helpful aspects of therapy
and the points for improvement. Responses were anonymised and then transcribed. All participants were
given information about the study and consented to participation.
Analysis
The participants’ qualitative feedback was rated by two independent researchers. Each question was
analysed based on the methods described in Elo and Kyngäs168 and Joffe and Yardley.169 Initially the two
researchers searched the data independently for codes or instances; thereafter they met to agree on how
these could be grouped together to form different categories. The main categories were, however,
predetermined by the questions asked.
Results
Detailed results tables were reported by Money et al.,167 in which patient responses indicated benefits from
the therapy and directions for improvement. In this chapter we will illustrate what the patients had to say
about CREST with quotes.
In Table 14 we have provided a few illustrations of what patients had to say about the most helpful
aspects of CREST and what we could improve in the future.
Discussion
The main aim of the qualitative study was to evaluate the acceptability of the CREST intervention for
inpatients with AN. In the national inpatient ward where this study took place, the majority of the patients
are nutritionally compromised (according to our annual audit data the mean BMI at admission is 13.0 kg/m2).
In a severely ill AN patient, treatment engagement and meaningful psychological intervention delivery is
challenging. Research shows that acutely ill AN patients have a major difficulty in correctly identifying and
expressing emotions.16,163,170,171 CREST includes information about basic emotion processing skills and aims to
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give patients simple tools and strategies to notice their own emotions and express their needs in a safe way.
Alongside enhancing these skills, CREST also had a benefit in terms of increasing assertiveness. Many of the
patients who received this intervention reported that CREST was helpful and that the strategies they learnt
will be useful in the future. This highlights an improvement in patients’ confidence and perceived ability to
express thoughts and emotions. From the qualitative outcome analysis we could also conclude that CREST
has a positive impact on reducing interpersonal problems known to be present in this population.19,172
Using qualitative outcomes from the study and learning from patients’ personal experiences were very
useful steps in terms of gathering evidence for CREST.
TABLE 14 End of therapy reflection
Were there any aspects that were especially helpful? What do you think could be improved?
Finding out that emotions are telling you that you need
something – now when I feel upset I look at what
needs to be done about it instead of limiting my
food intake
Stop making me eat!
Learning to identify emotions within myself. Learning a
means of communicating these emotions. Realising that
I have rights and that emotions are not ‘good’ or ‘bad’,
they just tell me something about what I need
More sessions
Speaking to psychologists Longer course
Really learning that all feelings are welcome and ok.
Learning how to express myself. Putting names
to feelings
Proper psychological therapy, support on the unit, being
able to talk to someone daily, not being kept waiting
and having to wait all day if necessary just to see
someone to answer a question
I found it useful being in surroundings where you could
see the illness in people and you just want to recover
so badly
Less basic work at the start. A few more sessions
Identifying emotions and needs Possibly a few more sessions. More about identifying and
handling different emotions
Set times to talk about emotions. Focusing on positive
emotions and not being upset when things go wrong
Generic idea, hard to improve when ultimately
cross-section research that is not personal
The calm, relaxed environment. The way that the
therapies can link into everyday experiences. The
visual activities
I found that attempting to identify emotion through
body language, facial expression in others, and as a
colour/sound/animal helped me to understand my own
feelings a little more. Showing me that a negative
emotion, i.e. anger, can be a positive thing as it can
incite change, helped also
I felt a few more sessions may have been beneficial to
me with a bit more focus on different specific emotions.
But on the whole both the content and facilitation of the
therapy was a good, helpful experience
The detail to different types of emotions and also all
the challenges and homework that I had to complete.
I found these really identified and elicited all the factors
I need to work on
I feel another set of CREST should be administered after
1 : 1 psychology is happening with patients. The purpose
would be to look at emotions in a different and more
in-depth way
Everything, talking about different emotions, realising
how I deal with my emotions and learning how to
express my emotions more instead of bottling them up
No, as I found the sessions helpful
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Limitations
This qualitative study had some clear limitations; for example, feedback was not obtained from patients
who dropped out of the treatment. There is also the possibility that patients wanted to please clinical and
research staff with positive comments; therefore, in the future independent evaluation after discharge from
the ward programme might provide more objective data.
A further limitation was that the study was conducted on one inpatient programme only. Future studies
may consider evaluating CREST across multiple sites to explore its generalisability.
From the individual work and analysis of the quotes we have obtained very useful ideas about how to help
patients to implement some of their new skills in real life. Qualitative feedback from the individual format
of CREST led to the idea of developing a group protocol. This allows patients to practise and role play the
skills worked on in the individual sessions and express their needs and feelings in the group.
Study 3: controlled trial
Aims
The aims of this study were to use cognitive (neuropsychological) assessments to (1) investigate changes in
performance on cognitive flexibility, central coherence and emotion processing tasks in inpatients with AN
following CREST and (2) investigate the magnitude of the changes on a cognitive and emotion test battery
used in the study with patients who have received CREST plus TAU (referred to from now on as the CREST
group), compared with patients who have received TAU only (the TAU group).
Hypotheses
1. In both groups we hypothesised weight gain, since both inpatient programmes focus on
nutritional stabilisation.
2. In terms of cognitive and emotion task-related performance, our hypothesis was that improvement after
treatment would be greater in the CREST group than in the TAU group.
Method
Ethics approval was obtained from the Oxfordshire REC NHS Ethics Committee (reference 08/H0606/58).
Study participants were recruited from specialist inpatient ED units receiving national referrals. Patients
receiving CREST were recruited from the South London and Maudsley NHS Foundation Trust inpatient
ward and patients receiving TAU were recruited from Manchester (Cheadle Royal Hospital).
Participants
Consecutively referred adult patients were offered participation in the trial if they had a DSM-IV166
diagnosis. Patients were excluded from the study if they had an additional diagnosis of a learning disability,
psychosis or major physical illness. Each participant was given a detailed information sheet about the study,
and signed consent forms were collected from each study participant.
Interventions
Participants in the London inpatient ward received CREST as detailed above, in addition to TAU.
Participants in the TAU group received standard inpatient care with individual and group therapy. At both
sites TAU involved typical inpatient care: nutrition management; dietetic input; occupational therapy; family
work; individual cognitive behavioural therapy; and group work on self-esteem and body image. In
addition, TAU in London included individual work on psychological assessment and formulation. In
Manchester, TAU additionally included individual cognitive analytic therapy and schema therapy.
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Assessments
Participants in both groups were assessed 10 days after admission to the inpatient wards (within the first
2 weeks, T1). Participants were reassessed 10–11 weeks later [i.e. at the end of treatment (T2)].
Demographic and clinical measures
Pre-morbid intelligence was assessed with the National Adult Reading Test.173 Clinical characteristics
included BMI, illness duration, highest ever BMI and lowest BMI since onset.
Neurocognitive (set-shifting, central coherence) and emotional processing tasks
Set-shifting was assessed using the Brixton Spatial Anticipation Test149 and the WCST.174 Central coherence
was assessed using the Fragmented Pictures Task175 and the Group Embedded Figures Task.176 Emotion
processing was assessed using the Reading the Mind in the Eyes Task (RME)177 and the Pictorial Emotional
Stroop Task.178
Statistical analysis
All statistical analyses were performed in Stata 11. A linear mixed model was used to compare the two
treatments. BMI and the six neuropsychological tasks were the outcome measures. Severity of illness
(measured by BMI), duration of illness (years since diagnosis was established), intelligence quotient
(IQ; measured by National Adult Reading Test total score) and age were included as covariates.
Results
Patient flow
In the CREST group, 46 participants completed the baseline assessments. Nearly one-quarter of these
(24%; n = 11) dropped out of the treatment. Seventy-six per cent (n = 35) of the participants completed
CREST; however, 8.5% (n = 3) did not participate in the post-treatment assessment and 5.7% (n = 2) were
discharged before the post-treatment assessment was due. Thus, 65.2% (n = 30) of CREST and TAU
participants completed the follow-up assessment. In the TAU group, 34 participants completed the
baseline assessments and 73.5% (n = 25) completed post-treatment assessments.
Patient characteristics
In Table 15, patients’ sociodemographic and clinical characteristics are compared using Wilcoxon rank-sum
tests. Both groups were similar in terms of age, IQ and severity of illness.
Within-group changes
There were significant improvements in BMI in both TAU and CREST groups. In terms of neuropsychological
task performance outcomes, there were significant improvements in both groups on the set-shifting
performance-based tasks (Brixton Spatial Anticipation Test and WCST) and significant improvements in the
CREST group only on the Fragmented Pictures Task, measuring ‘bigger picture’ information processing
style. The TAU group showed poorer performance on the second ‘bigger picture’ related task (Group
Embedded Figures Task) and no significant differences were observed in either group on the remaining
TABLE 15 Baseline demographic and clinical characteristics
Characteristic CREST (London), mean (SD) TAU (Manchester), mean (SD) p-value
Age (years) 26.1 (7.6) 26.0 (7.9) 0.85
IQ 105.8 (8.1) 104.5 (7.8) 0.31
Illness duration (years) 10.6 (7.0) 9.9 (7.6) 0.52
Lowest ever BMI (kg/m2) 12.0 (1.9) 12.9 (1.2) 0.13
Highest ever BMI (kg/m2) 18.6 (3.5) 19.8 (3.2) 0.13
WORK PACKAGE 2B
NIHR Journals Library www.journalslibrary.nihr.ac.uk
50
neuropsychological tests (Pictorial Emotional Stroop Task and RME), measuring emotional processing.
The test results are reported in detail in Davies et al.179
Between-group changes
There were no significant differences between the groups concerning the changeover time on any of the
outcomes (details of the outcomes are reported in Davies et al.179).
Additional analysis
An additional analysis was conducted in CREST participants to identify if there was any difference in the
baseline neuropsychological assessment scores between intervention completers and those who dropped
out. No significant differences were found between these two groups.
Discussion
This study aimed to assess the efficacy of the individual format of CREST for inpatients with AN. Both
groups showed significant improvements in BMI, as expected. Our hypothesis, that in within-group analyses
neuropsychological measures would not change over time in the TAU group and would improve in the
CREST group, was only partially supported by the results. Although the TAU group showed no change over
time on central coherence (more ‘bigger picture’ thinking, less attention to detail) or emotion processing
outcomes (less bias towards angry faces or recognition of emotions from the RME task), set-shifting task
performance did improve in this group (this supports the idea that cognitive flexibility improves with weight
restoration). The CREST group also showed set-shifting improvements and additional improvements in
global processing (this could be explained by the fact that CREST has introductory sessions on cognitive
styles addressing global thinking style strategies). The results of the study showed that the TAU group
became more detail focused over time, whereas the CREST group remained stable in their information
processing style (central coherence). There were no changes in emotion processing experimental outcomes
in the CREST group (e.g. less bias towards angry faces and better recognition of emotions). In the between-
group analyses there were no significant differences between the CREST and TAU groups on any of the
neuropsychological domains or weight gain.
This study does not support previous findings suggesting that TAU does not improve set-shifting,180 as the
TAU group improved in set-shifting in this study. This suggests that more longitudinal studies are required
to assess the effects of TAU on set-shifting across different inpatient groups.
It is possible that differences between the groups explain the improvements in cognitive flexibility following
TAU and the non-significant differences between the groups on all measures. Although the groups in
this study were comparable on sociodemographic and clinical characteristics, there was a trend in the
CREST group towards a lower lowest lifetime BMI and a lower highest ever BMI than in the TAU group.
Moreover, although the two groups were recruited from specialist inpatient services, the TAU group
received intensive individual psychological input from a variety of treatment models as part of their TAU
package (e.g. cognitive analytical therapy and schema therapy).
Limitations
This study was designed in a quasi-experimental format, which is less robust than a RCT. As we described
above, CREST plus TAU was delivered in London and TAU in Manchester, which means that TAU differed
significantly between the study sites. The use of a TAU comparison also means that observed effects may
be not due to CREST specifically, but rather to participants receiving additional support of any kind.
A small sample size and several neuropsychological outcomes were clear limitations of the study.
Finally, there is evidence from the literature that self-reported measures correspond poorly with
neuropsychological assessments.181 The benefits recognised by patients were not fully reflected in the
neurocognitive assessments, which raises the issue of how to measure the outcomes of CREST. We could
improve our assessment battery to include tests measuring emotion expression, which is an area into
which CREST taps and which has been found to be impaired in AN.164,179,182 Other important aspects of
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the CREST intervention are learning how to be with other people and communicating one’s feelings. In
future studies a measure of social anhedonia and functional outcomes will be more relevant in the context
of measurable benefits of this intervention.
Conclusions
In summary, this study does not provide clear evidence that the addition of CREST to a multifaceted
inpatient programme produces changes in neuropsychological task performance. Further studies are
needed to corroborate these findings, using a larger sample size and a randomised controlled design with
fewer, more targeted, neuropsychological assessments. From the current study it seems that, in the
inpatient population with AN, it is harder for psychological treatment to address and change ‘hot’
cognition than ‘cold’ cognition. A systematic review of the existing experimental measures for emotional
tasks will inform future studies, enabling us to select fewer and more targeted outcome measures.
General discussion
Cognitive Remediation and Emotional Skills Training was designed to offer support to patients in ward
settings who are physically and medically compromised and find it difficult to engage in psychological
treatment. Our approach in designing this clinical intervention was based on both extensive input from
stakeholders, patients, clinicians and carers,183 and recent findings from experimental studies.16,184,185
The three studies reported here used mixed methods to provide an initial evaluation of CREST in individual
format. The overall results were mixed. The case study (study 1) and qualitative work (study 2) showed
that inpatients valued and benefited from the structured approach and taking simple steps to develop
awareness and skills to manage emotions. In contrast, we found that the neuropsychological changes
were not very impressive or easy to interpret (study 3).
Following on from these findings, our future work will aim to revise the CREST manual in the light of
service users’ feedback and our clinical experience from delivering and supervision of the model. Revising
the current version of the CREST manual will involve taking into account the qualitative feedback,
specifically removing the less relevant exercises (recognising other people’s facial expressions in the social
context as well as cold cognitive exercises) and expanding those that patients found to be most helpful
(e.g. emotion vocabulary development, thinking, recognising and doing positive things). In addition, we
will incorporate recent research findings, such as the lower emotional intelligence relative to the high
IQ in groups of AN patients, poor facial expression of positive emotions, limited vocabulary for describing
positive emotions, social anhedonia and extreme difficulties in private and social leisure activities.179,186,187
Finally, outcomes for the next stage (i.e. a randomised treatment trial) will be optimised. We will aim for a
balance between experimental and self-report measures, and will use measures that are more tailored to
the intervention content in order to detect changes after the treatment.
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Chapter 6 A randomised controlled trial to
evaluate the efficacy of adding a guided self-help
intervention for carers of inpatients with anorexia
nervosa (work package 3)
Abstract
Background
Families express a need for information and help to support people with severe and/or enduring AN.
We have developed a guided self-help, skills training intervention for carers (ECHO).
Objectives
To examine the impact of the addition of ECHO to standard inpatient care on carer and patient outcomes
over time.
Method/design
Patients (aged > 12 years) with a primary diagnosis of AN, and their carers, were ascertained from
15 inpatient services in the UK. Patients were randomised either to receive ECHO [a book, digital versatile
discs (DVDs) and 10 telephone coaching sessions per family] or TAU. Patient (n = 178) and carer (n = 268)
outcomes were measured at discharge and at 6 and 12 months after discharge.
Results
Carers in the ECHO group spent less time caregiving and had less burden and expressed emotion at
discharge and/or 6 months. At 6 months, patients experienced a decrease in ED symptoms and improved
quality of life.
Discussion
Skills-based training improves both patient and carer outcomes.
Introduction
Anorexia nervosa develops in early adolescence, and in over 50% of those affected illness persists for
over 7 years.188 Those who fail to respond to treatment and/or in whom there is high medical risk receive
inpatient care. The admission and discharge criteria and the form and content of inpatient care vary. For
example, the practice in the UK has changed. In the UK, inpatient age at admission has increased since
cohorts in 1959–64,189–192 and inpatients present with more severe and long-lasting cases. The parameters
of inpatient care are mainly driven by clinical consensus rather than evidence-based decision-making as
there has been very little research into this. A recent exception is a RCT that compared standard inpatient
care with a short period of inpatient care followed by day patient care for severely ill adolescent patients in
the early stage of their illness. The study found similar 1-year weight outcomes between the forms of
treatment, but with less expense and better social adjustment with the inpatient/day patient intervention.193
This suggests that reducing the time separated from the family may be of benefit.
In the earlier stages of AN (less than 3 years’ duration), family-based interventions offer the best patient
results.194,195 However, individuals who develop AN later in life or have an illness duration of more than
3 years respond less well to this intervention.194 Therefore, there is uncertainty about whether or not and
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how carers should be involved in those having inpatient care at a later stage of the illness. Families request
help and knowledge about the illness196,197 and experience high levels of burden and distress.198,199 A
variety of psychoeducational interventions have been developed to address this need and the data from a
recent systematic review and meta-analysis of these interventions showed carers experienced less burden
and distress following training.200
It is of interest to know whether or not these psychoeducational interventions for carers have a secondary
beneficial effect on the individuals with an ED. Some of the interventions are based on a theoretical model
suggesting that interpersonal factors, including carers’ levels of expressed emotion201 and accommodating
and enabling behaviours,202 may contribute to the perpetuation of the illness.19,20,203 ECHO is a guided
self-help, skills training intervention. A recent pre-test post-test study showed an improvement in carers’
well-being after the intervention and, consistent with the theoretical framework,204 found that well-being
increased as carers’ expressed emotion, accommodation and enabling decreased.205 However, as yet
there has been no controlled prospective study that has examined the validity of the extended model by
examining whether or not the individuals with EDs benefit from giving their carers guided self-help,
skills training.
This study aimed to evaluate the impact of a psychoeducational intervention for the carers of patients in
the severe and/or enduring stage of AN admitted to day or inpatient care for nutritional rehabilitation.
Carers were randomised to receive ECHO plus TAU or TAU alone. Both carer and patient well-being and
inpatient treatment was followed in the year following discharge. This RCT was registered with Current
Controlled Trials ISRCTN06149665.
Hypotheses
The trial investigated the following experimental hypothesis regarding patient and carer outcomes.
Primary hypotheses
Patient
1. Compared with patients receiving TAU, patients with carers receiving ECHO will be better at maintaining
symptom improvement and will be less likely to relapse [measured monthly based on a body mass
decrease of 2 points (BMI) or readmission to hospital from ED symptoms, whichever comes first].
Carer
1. At the 12-month follow-up, carers with ECHO training will have less distress than carers with TAU.
Secondary hypotheses
Patient
1. Compared with patients receiving TAU, patients in the ECHO group will have a higher BMI and quality
of life, as well as lower ED symptoms and distress.
Carer
1. At all time points, carers of patients in the ECHO group will report fewer negative parenting styles, less
burden and time spent caregiving, and an increase in quality of life.
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Method
Design
This is a pragmatic, two-arm, multicentre, parallel-group RCT. A detailed account of the trial protocol,
including the description of the ECHO carer intervention, has been published.204 Consenting carers from
dyads meeting the inclusion criteria were randomly assigned to either ECHO (plus TAU) or TAU alone.
Guidance for the ECHO intervention was delivered by ‘experienced’ coaches [people with lived experience
of EDs (n = 15) and postgraduate psychologists without clinical training (n = 5)], who were specifically
trained and supervised. Recruitment involved 15 inpatient ED units within the NHS. Baseline and discharge
measures were collected, along with follow-up data at 6 and 12 months post discharge. After ceasing
intensive treatment, patients were considered ‘discharged’. To meet this criteria, they had to receive
inpatient, day patient, or specialised residential treatment on ≥ 4 days per week, and maintain this status
for a minimum of 4 weeks. Those who transferred to general supported housing were included too. Data
regarding whether patients completed treatment or discharged themselves were not accessible for all sites
and are not reported.
Ethics and governance
Main ethics approval was granted by the Royal Free Hospital Ethics Committee (08/H0720/41) with
site-specific ethics and governance approval for all participating sites. The study was adopted by
the MHRN.
Randomisation
Carers of a patient were randomly allocated to one of the two trial arms (ECHO or TAU). The CTU at
King’s College London conducted the randomisation and minimisation was used, stratified by study site
(15 NHS England hospital units) and disease severity categories (one or both of BMI < 15 kg/m2, presence
of compensatory vomiting). Those in the TAU arm could access the intervention after finishing the study.
Recruitment
Patient outcome
One-year relapse rates are around 70% in comparable patient populations,206 with rates dropping to
30–50% in some relapse prevention studies.207 A reduction in relapse rates of at least 20% following
ECHO was considered clinically significant. To detect this decrease using a survival analysis log-rank test at
2.5% significance (adjusting for patient relapse and carer distress) with 80% power, we would need 110
families per treatment arm to detect a hazard ratio of 0.58. The total sample size required from the power
calculation was 316 patients. The limited resources for this trial meant that the final sample size was 178
families. Thus, the study is underpowered, particularly for patient’s relapse rates.
Carer outcome
In our pilot studies, the ES of the decrease in distress for carers who received ECHO with telephone
support was 0.55. We therefore predicted that the potency of the intervention should reach an ES of 0.4
at a 12-month follow-up. For continuous outcomes, an effective sample size of 110 per arm would be able
to detect an ES of 0.42 or larger with 80% power using a t-test at the 2.5% (adjusting for two primary
outcome tests) significance level.
Participating sites
This project involves 15 different centres. Fourteen of the sites are ED specialist inpatient wards in the UK
(13 adult, one adolescent), and one is a general psychiatric ward with specialist ED staff (adolescent). One
of the specialist sites makes local referrals to specialist ED inpatient wards in the UK. All were NHS units,
except one, which is a private collaboration accepting NHS referrals.
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Participants
Patients admitted to the treatment facility with a primary diagnosis of AN or an EDNOS with anorexic
symptoms were approached. The agreement of at least one carer (proposed by the patient) was required for
participation in the study. {Carers are defined as someone who provides unpaid help and support to a child,
partner, relative, friend, or neighbour, who could not manage without their help [URL: www.carers.org
(accessed 3 July 2017)].}
Inclusion criteria
Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition AN, aged ≥ 12 years, able to speak
and comprehend English.
Exclusion criteria
No carer identified (at least one carer had to participate for the patient to be included, although all close
carers were encouraged to take part), patient/carers taking part in another treatment study, or discharged
from their inpatient stay before baseline assessment completed. In addition, participants with a severe
comorbidity at time of admission (e.g. severe learning disability, medical problems, diabetes or psychosis)
were not included in the study.
Recruitment
Patients were approached after admission by participating staff on the wards and offered study details.
Informed consent was from both patient and carer. Clinical studies officers (CSOs) from the MHRN
supported recruitment of patients and administration of the project on eligible sites.
Interventions
Experienced Carers Helping Others
Participants in the ECHO arm received this intervention in addition to TAU. The materials were sent and
the coaching begun immediately after randomisation. ECHO uses a skills training approach consisting
of a book49 and five DVDs (three theoretical, two practical) that complement the skills offered in the book
with role plays and practical examples (presented visually with audio voiceover). A detailed intervention
description is described elsewhere204,208 and a professionally produced version is available through the
charity SUCCEED.209
The intervention package additionally included five telephone coaching sessions per individual (up to
10 per family, e.g. mother and father). The coach contacted participants within 2 weeks. Coaches were
encouraged to complete the sessions within a 5-month period. Calls were made on a regular basis with
time in between (e.g. 2 weeks) for carers to practise the skills. The time taken to complete calls varied
between families depending on individual circumstances. The expectation was that telephone calls
would last up to 40 minutes and a minimum of five calls (per family) would be required to complete the
intervention. Information on coaches, their training and measurement of quality assurance is described in
the published protocol.204
Treatment as usual (inpatient or day patient treatment)
The NICE guidelines specify several grade C recommendations about inpatient care162 and NHS England
has set minimal quality criteria for inpatient units. For this study, day patients were defined as patients who
required non-residential intensive specialist treatment (≥ 4 days a week).
Intervention delivery
All correspondence with carers on the randomisation outcome was by post. Families in the ECHO group
received an intervention pack with the book, five DVDs and supporting documentation (a letter explaining
their contact with the telephone coach, action/goal sheets, details on the transtheoretical model of
change, frequently asked questions and details for technical support). Those receiving TAU were informed
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they could access ECHO after completing the study, and were given contact details for Beat, the leading
ED charity in the UK.
Data collection
All participants (patients and carers) completed self-report assessments by post at inpatient admission,
discharge, and at 6- and 12-month time points post discharge. Finally, for the year following discharge,
patients completed a short monthly assessment on core eating symptoms by telephone, e-mail or post.
Detailed information about data management is described in the published protocol.204
Measures
Those completed by the patient are marked with a (P) and those completed by carers are marked with (C).
Primary outcomes
Relapse (P)
Relapse is defined as a readmission to hospital for AN treatment or a drop of 2 points from discharge BMI
measured on a monthly basis, whichever came first.
Depression Anxiety and Stress Scales (P, C)
A 21-item self-report measure to assess mood state over the past 7 days using a four-point Likert scale.97
Three subscales provide scores for depression, anxiety and stress. Good reliability and validity is reported.210
Secondary outcomes
Short Eating Disorders Symptom Scale (P)
A short questionnaire measuring core ED symptoms (e.g. weight, fear of fatness), relating to the degree of
ED [AN or bulimia nervosa (BN)] symptoms. Good reliability and validity are reported.211
Eating Disorder Examination-Questionnaire (P)
A self-report measure assessing ED symptoms over the previous 28 days.142 The scale yields both
behavioural frequency data and information on specific ED psychopathology. The EDE-Q has good
reliability and validity in ED samples.212
Motivation to change (P)
Patients rate the importance of and confidence to change their ED on a Likert scale (0–10).
World Health Organization’s Quality of Life Questionnaire (short version) (P, C)
The World Health Organization’s Quality of Life Questionnaire (WHOQOL-100) measures an individual’s
perception of their quality of life in 24 areas. Each facet is represented by one item, a five-point Likert
scale, pooled in four domains: physical health, psychological, social relationships and environment.
An additional two items evaluate the ‘Overall Quality of Life and General Health’. The quality of life
questionnaire has good psychometric properties.213
Eating Disorder Symptom Impact Scale (C)
A 24-item self-report measure rates carers’ perceptions of ED-specific burden using a five-point Likert scale.
A total burden score and subscales can also be calculated. The Eating Disorder Symptom Impact Scale
(EDSIS) has good reliability.208
Accommodation and Enabling Scale for Eating Disorders (C)
This 33-item self-report measure measures the degree of accommodating and enabling behaviours to the
ED. A five-point Likert scale is used. A total score and subscale scores can be calculated. This scale has
good psychometric properties.202
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Family Questionnaire (C)
This 20-item self-report measures expressed emotion in carers with a four-point Likert scale. Items relate to both
criticism and emotional overinvolvement. The Family Questionnaire (FQ) has good psychometric properties.214
Time spent caregiving (hours/month) (C)
This study utilised a semistructured interview to report the time carers spend with specific demands of their
caregiving role across five categories in an average month. Following thematic analysis of 22 female and
male carers of someone with an ED describing the demands of their caregiving role, the following categories
emerged: ‘medical’, ‘food’, ‘non-food/medical practical support’, ‘emotional’, and ‘communicating with
non-ED professionals’. Time spent caregiving is summed across domains to quantify the total amount of
care provided to patients in hours per month.
Process evaluation outcomes
Acceptability of intervention (C)
Carers provide quantitative (visual analogue scales) and qualitative feedback on their experience of the
study, caring and, for those who received it, ECHO.
Patient feedback (P)
All patients are asked to provide qualitative feedback on their participation in the study (e.g.
methodology), their observations of their carers’ responses to the illness since their participation in the
project, and their responses to their carers over the course of the study.
Reimbursement
Participants were reimbursed on completion of each set of questionnaires (patients received £25, carers £10).
Statistical analysis
The objective of the statistical analyses was the comparison of those offered ECHO with those allocated to
TAU on a number of primary and secondary outcomes. The primary patient clinical outcome is ‘relapse’.
A linear change was assumed between monthly measurements of BMI and this was used to extrapolate
the day on which two points were estimated to be lost. The variable is right censored since a relapse might
not have occurred by the end of the study period (1 year) or follow-up data for BMI could be missing. If
five consecutive BMI measurements were missed, time to relapse was censored.
The primary carer clinical outcome is distress (measured by the DASS-21) at 12 months after discharge.
To account for two primary outcomes, group differences on these outcomes were tested at a significance
level of 2.5%. Secondary patient and carer outcomes are continuous measures at discharge, 6- or
12-month follow-up (see Secondary outcomes). All statistical analyses were based on the ITT principle,
that is, participants were analysed in the treatment arm to which they were randomised irrespective of
whether or not they received the allocated treatment. Additionally, the statisticians were kept blind to
treatment allocation as long as possible.
Time to relapse was analysed using Cox regression. Explanatory variables in this model were the variable of
interest (treatment arm) and randomisation stratifiers (site and illness severity categories, based on binary
BMI and vomiting). The effect of treatment is estimated by the hazard ratio of relapse comparing ECHO
with TAU.
The continuous secondary patient outcomes were analysed using linear mixed models. The dependent
variable is the outcome at the relevant time point (e.g. BMI at 12 months post discharge) and (fixed)
explanatory variables are given by treatment arm, baseline values of the variable under investigation
(e.g. BMI at pre-randomisation) and randomisation stratifiers. The models can contain random intercepts
for coaches (in ECHO) to allow for correlation in outcomes due to treatment being facilitated by the same
coach. The models were used to estimate differences between treatment arms at each time point.
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Standardised treatment effect estimates were calculated by dividing group differences by the common
pre-randomisation SD of that outcome.
Outcome variables contained considerable numbers of missing values (see Results for details). We
empirically identified a number of baseline variables that were predictive of missing values in outcome and
also found that the primary carer not adhering to ECHO (coded ‘1’ = completed at least five coaching
sessions or read at least half the coaching manual, ‘0’ = did not complete the intervention) was predictive
of loss-to-follow up (see Results for details). To allow for these processes driving missingness, in addition to
allowing randomised group and values of the outcome under investigation at different time points being
predictive of missingness multiple imputation (MI) using chained equations as implemented in the Stata
command ice.215 This allowed us to include predictors of missingness (including the post-randomisation
variable adherence) in the imputation step without having to condition on these variables in the
analyses models.216
The continuous carer outcomes were analysed in a similar fashion except that analyses needed to include
up to two carers per family (a nominated first and second carer). To deal with this, the analysis and
imputation models described for patients were extended for carer outcomes. First, the analysis models
contained additional random intercepts that varied at the level of the patient to allow for similar outcomes
for carers of the same patient. Second, to ensure that correlations were also reflected, the imputed values
imputations in ice were carried out at the level of the patient allowing for two outcome variables – one for
the primary carer and another for secondary carer (set to missing when there was no second carer, with
resulting imputed values discarded before analysis).
To evaluate the effect on primary carer outcome of receiving a sufficient level of intervention (here an
adherence score of ‘1’) without bias, the complier-average causal ECHO effect (CACE) on carer distress
was estimated using a two-stage least squares (instrumental variables) estimator.217
Results
Participant flow
This study represents a unique collaboration of major UK ED treatment centres and describes a large group
of severely ill patients with AN (178 patients and 268 carers). The Consolidated Standards of Reporting
Trials diagram for the study is shown in Figure 2.
Sample characteristics
Patients
The majority of the patients were white (6% were Asian mixed). Twenty per cent were married, 14%
were in work and 41% had higher education. The majority (69%) were living with their carer and prior to
admission 48% had > 21 hours of face-to-face contact per week with their carer. The patient group (n = 178)
included cases from both adolescent (n = 11) and adult (n = 167) services. The median age at onset was
15 (range 5–45) years. The mean lowest ever BMI was 12.9 (SD = 1.8) kg/m2. Median current age was 24.3
(range 12.5–62.7) years with a median duration of illness of 72 (range 9–480) months. The majority of cases
(n = 123, 69%) had been ill for more than 3 years with a subset (n = 83, 55%) having a duration exceeding
6 years (enduring AN).218 The prevalence of comorbidity with depression was 46%, and 44% of patients were
on antidepressants. This was the first admission for approximately one-third of the sample and 8% had five or
more admissions.
The short-term effects comparing admission and on discharge symptoms from inpatient care have been
published.219 The median duration of the admission was 153.5 (range 28–991) days and one patient was
not discharged throughout the 2 years of the study.
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Assessed for eligibility
(n = 599)
Patient consent
(n = 266)
Carers approached
(n = 476)
Patient
Excluded
(n = 346)
• Not meeting inclusion criteria, n = 93
• Declined to participate, n = 252
• Other reasons, n = 1
Carer
Excluded
(n = 214)
• Not meeting inclusion criteria, n = 2
• Declined to participate, n = 212
Carer consent
(n = 262)
Families randomised
(n = 178)
Allocation
Enrolment
Discharge
6-month follow-up
12-month follow-up
Patient
Excluded
(n = 69)
• Carers declined to take part, n = 69
Allocated to intervention
• Patients, n = 86
• Carers, n = 134
Patient
• Primary outcome (BMI), n = 82 (95%)
• Lost to follow-up, n = 4
Carers
• Primary outcome (DASS-21), n = 93 (69%)
• Lost to follow-up, n = 41
Patient
• Primary outcome (BMI), n = 65 (76%)
• Lost to follow-up, n = 17
Carers
• Primary outcome (DASS-21), n = 92 (69%)
• Lost to follow-up, n = 1
Patient
• Primary outcome (BMI), n = 52 (60%)
• Lost to follow-up, n = 13
Carers
• Primary outcome (DASS-21), n = 91 (68%)
• Lost to follow-up, n = 1
Allocated to TAU
• Patients, n = 92
• Carers, n = 134
Patient
• Primary outcome (BMI), n = 80 (87%)
• Lost to follow-up, n = 12
Carers
• Primary outcome (DASS-21), n = 99 (74%)
• Lost to follow-up, n = 35
Patient
• Primary outcome (BMI), n = 64 (70%)
• Lost to follow-up, n = 16
Carers
• Primary outcome (DASS-21), n = 92 (69%)
• Lost to follow-up, n = 7
Patients
• Primary outcome (BMI), n = 60 (65%)
• Lost to follow-up, n = 4
Carers
• Primary outcome (DASS-21), n = 91 (68%)
• Lost to follow-up, n = 1
FIGURE 2 Consolidated Standards of Reporting Trials flow diagram (WP3).
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Carers
A total of 268 carers (178 primary carers, 90 secondary carers) were recruited (144 mothers, 81 fathers,
28 partners, seven siblings, five friends and three other relatives). The median age of the carers was 52.7
(range 19.7–78.9) years and 60% were female. Seventy-nine per cent were married or living with a
partner, 63% were in work and 46% had higher education. Nineteen per cent of the carers self-reported
that they had suffered from an ED themselves, and 24% reported some sort of eating problems in the
family other than that of the patient.
Randomisation
Patient and carer outcomes were well balanced across groups. Roughly 25% at discharge, 30% at
6 months after discharge and slightly over one-third of patients at 12 months showed missing questionnaire
outcome data. At 12 months, the proportion ranged between 0.33 and 0.37 for the different scales. For
the carers, the proportion of missing data was 2–4 percentage points greater at all outcome time points.
The proportion of missing outcome data at 12 months ranged between 0.32 and 0.43. Logistic regression
was used to explore the relationships between a dependent variable that represented whether outcome
data were present or missing at 12 months after discharge, and a number of baseline demographic and
clinical variables, such as participant gender and lowest ever BMI. Any variable that showed a statistically
significant association with the dependent variable was included in the imputation step of the MI procedure.
Non-adherence with ECHO was strongly associated with missingness, with ORs from 1.5 to 2.0 for patients’
data and from 3.3 to 6.2 for carers’ data.
A comparison of inpatient treatment post discharge of the patient groups (carers with
Experienced Carers Helping Others and carers with treatment as usual)
The ECHO group had shorter admission length (median = 148 days, range 28–991 days) than the TAU
group (median = 163 days, range 33–570 days; Mann–Whitney U-test, z = –0.88, p = 0.38). The
readmission rate was 26.7% (n = 23) in the ECHO group and 32% (n = 29) in the TAU group. Relapse in
terms of readmission and/or fall in 2 BMI points occurred in 43% of the ECHO group and 52% of the TAU
group. The median time to relapse for the ECHO group was 262 days and 240 days for TAU. Survival plots
of the time to relapse showed two similar curves (Figure 3). The TAU showed greater relapse-free survival
initially. However, after approximately 8 months, the curves crossed over. Thus, the study did not detect a
statistically significant difference in survival curves and the main assumption of a Cox regression model,
that the hazards are proportional, was broken (a Cox regression which relies on proportional hazards
would give a hazard ratio of 0.82 in favour of ECHO and a p-value of 0.42 for the group difference).
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FIGURE 3 Kaplan–Meier curves for time to relapse.
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Table 16 summarises the clinical outcomes and Table 17 provides estimated outcome differences between
the two treatment arms for both patients and carers at all three time points.
A comparison of carers’ well-being and burden in the Experienced Carers
Helping Others and treatment as usual condition
In all of the outcomes measured, the carers in the ECHO group had improved functioning. Carers in the
ECHO group reported less distress than those in the TAU group, but this difference was not statistically
significant at any time point.
Time spent care giving was reduced 6 months post discharge and was significantly lower in the ECHO
group (p = 0.05; ES = –0.34). Expressed emotion was also significantly lower in the ECHO group at
6 months (p = 0.05; ES = –0.25). Burden was significantly lower in the ECHO group at discharge
(p = 0.04; ES = –0.29).
At discharge, we estimated that carers’ perception of ED burden in the ECHO group was 3.98 points
(95% CI 0.16 to 7.80 points) lower than in the TAU group. At 6 months after discharge, time spent
caregiving in the ECHO group was 63% (95% CI 40% to 100%) of that spent in the TAU group. At the
same time point, expressed emotion in the ECHO group was estimated as 2.24 points (95% CI 0.05 to
4.43 points) less on the FQ than in the TAU group.
A comparison of the clinical status post discharge of the patient groups (carers with
Experienced Carers Helping Others and carers with treatment as usual)
Eating disorder psychopathology and quality of life were significantly better in the ECHO group at 6 months
(ES = –0.38 and 0.38, respectively), but these differences were not significant at 12 months post discharge.
At 6 months after discharge, we found ED psychopathology among the ECHO group to be 0.47 points
(95% CI 0.03 to 0.92 points) less than in the TAU group. At the same time point, we estimated quality of
life as measured on the WHOQOL-100 to be 0.91 points (95% CI 0.04 to 1.78 points) lower in the ECHO
group compared with the TAU group. Estimated differences in distress and BMI pointed towards a
beneficial effect of ECHO, but none of these effects could be shown to be statistically significant.
Important harms or unintended effects
Two patients (one from each trial arm) died during the course of the study.
Semistructured open feedback
Patients
Six months post intervention, 102 of 178 (52 ECHO; 50 TAU) semistructured open feedback forms were
returned from patients and analysed using thematic analysis (Table 18). Overall, > 75% of the sample
reported positive benefits and changes in their interaction with carers, and within this a greater proportion
(66–75%) were from the ECHO group. These aspects included more adaptive, open communication and
understanding, continued support, motivation and encouragement, meal support, better goal-setting and
a calmer family atmosphere. Over one-third reported empathy and concern for their family [a greater
proportion (65%) in the ECHO group].
Carers
At 6 months, 148 (83%) [n = 73 Carers Assessment, Skills and Information Sharing (CASIS); n = 75 TAU]
feedback forms were returned from carers and analysed using thematic analysis (Table 19). Overall, 27%
of carers expressed appreciation for the research study, 82.5% of whom were in ECHO group. Interestingly,
this aspect of the study revealed partial non-adherence to the trial protocol as seven carers in the TAU
group expressed appreciation for the skills training (suggesting that they had possibly purchased the book
themselves but received no coaching). Over half of the carers (64%) reported negative perceptions of
services’ post-discharge support and the majority (60%) were in the TAU group (TAU, n = 57; CASIS,
n = 38). In terms of reports on their observations on the individual with an ED, improved communication
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TABLE 18 Qualitative feedback: patients
Theme
Patients (n) Utterances (frequency)
CASIS TAU CASIS TAU
Project involvement
Positive aspects of participation 45 44 83 79
Problematic aspects of participation 31 34 48 48
Project interest and/or confusion 9 7 9 7
No impact (carer and/or self) 19 31 40 57
Suggestions for improvement 4 5 4 5
Perceived need/appreciation for carer support 16 11 25 13
Altruism 13 16 14 18
Perceived changes in carer style
Reduced expressed emotion/anxiety 16 6 31 8
Greater understanding, awareness and coping abilities 31 22 75 33
Improved relationship and communication 23 13 43 27
More responsibility, space and trust 19 10 32 11
Perceived negative changes 4 12 4 18
Reductions in carer expectations/pressure 4 4 6 5
Reported general improvements 14 6 24 11
Helpful strategies
Adaptive open communication and understanding 38 33 70 50
Continued support, motivation and encouragement 28 26 50 36
Concern for carer(s) and family 9 4 10 4
Increased responsibility, trust and space 17 15 24 35
Non-ED communication and behaviours 8 4 11 4
Calmer family atmosphere 8 7 9 8
Meal support 25 21 36 28
Positive role modelling 1 1 1 1
Practical help 13 17 16 23
Clear boundary setting and expectations 18 17 23 28
Reduced pressure and expectations 4 3 4 4
Collaborative problem-solving and goal-setting 7 5 10 5
Unhelpful strategies
Food, weight and shape talk 11 11 14 13
High expressed emotion and anxiety 29 21 37 44
Detachment, avoidance and distance 15 11 28 18
Pressure of others’ expectations 7 9 14 13
Intrusive, directive or controlling approach 11 7 14 8
Loss of the ‘special’ feeling 1 0 1 0
continued
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TABLE 18 Qualitative feedback: patients (continued )
Theme
Patients (n) Utterances (frequency)
CASIS TAU CASIS TAU
Lack of understanding, communication and confusion 4 9 4 14
Lack of clear boundaries 19 15 21 17
Problematic carer responses and behaviours (general) 13 8 22 12
Family involvement 0 2 0 2
Relationship with carers (general)
Positive relationship, impact and coping abilities 36 3 92 97
Problematic aspects of relationship and support 22 31 67 76
Mixed reports 11 13 13 14
Dependent attachment 0 6 0 6
Loss of intimacy 1 1 1 1
Empathy and concern for carers’ plight 20 11 37 17
Patient reflections
Caring for an adult 5 7 5 10
Professional services 6 3 7 7
Recovery process 4 3 6 3
Own responsibility for recovery 3 5 4 8
Struggles and reflections on situation 7 9 9 11
CASIS, Carers Assessment, Skills and Information Sharing.
TABLE 19 Qualitative feedback: carers
Theme
Carers (n) Utterances (frequency)
CASIS TAU CASIS TAU
Service provision and carer support
Self-discharge 4 7 5 8
Negative perceptions of care services’ post-discharge support 38 57 79 121
Acceptable aspects of post-discharge support/services 33 27 50 44
Importance/appreciation of carer support and research 33 7 51 9
Unhelpful support/no need for support 5 4 6 4
Role perception and relationship with loved one
Positive aspects of relationship 39 35 55 47
Negative or problematic aspects of relationship 12 25 14 40
Full-time caring and/or dependency 15 20 20 25
Continued emotional practical support 54 55 93 117
Reduced caring role 37 31 52 50
Perceived carer impact 35 36 47 40
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TABLE 19 Qualitative feedback: carers (continued )
Theme
Carers (n) Utterances (frequency)
CASIS TAU CASIS TAU
No change or little impact (self or impact on illness) 12 28 15 38
Familial role differentiation 7 11 11 14
Apathy and acceptance 1 9 1 10
Issues unique to partners 0 2 0 5
Perceived improvements in situation
Reports of acceptable functioning in sufferer 44 29 76 47
Slower progress and determination 27 37 43 56
Improved communication and relationships 38 25 66 29
Reduced burden (practicalities) 3 3 3 3
Perceived carer changes
Supporting independence and responsibility 22 24 30 36
Reduced high expressed emotion 25 20 38 25
Adaptive communication and techniques 13 11 16 11
Greater knowledge and understanding 17 15 18 15
Improved coping skills and self-care 12 8 16 11
Boundary setting 5 4 6 4
Separating illness from person 4 3 4 3
Less ED talk 1 5 1 5
Continued difficulties and challenges
Continued struggles and burden 46 48 86 135
Problematic behaviours, patient struggles or relapse 34 42 52 95
Impact on other family members and relationships 15 15 25 19
Concern for the future 6 15 7 22
Problematic carer responses 7 10 11 19
Readmission to hospital 7 11 7 15
Own health problems 6 10 11 17
Sense of loss 5 6 5 8
Poorer communication/relationships 3 6 4 7
Financial issues 5 6 6 6
Stigma 2 6 2 7
Carer coping practices
Social support 41 40 58 60
Hobbies, work 18 16 19 19
Psychoeducation and self-care 20 15 29 21
Less contact, detachment or distraction 10 19 15 25
Spirituality 1 6 1 10
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was reported by 43% of carers (60% in the ECHO group) and acceptable functioning in 49% of carers
(60% in the ECHO group). Overall, this suggests that information and skills training improves expectations
and perceptions of both services and the individual with an ED.
Discussion
The aim was to evaluate whether or not adding a guided self-help, skills training intervention (ECHO) for
carers of people with severe and/or enduring AN is of benefit for both carer(s) and for the patient. Patients
in the ECHO group had significantly reduced ED symptomatology and improved quality of life at 6 months
with no BMI differences. Carers in the ECHO group had a greater reduction in their time caregiving
following admission, and this was associated with a small/moderate reduction in carer burden and reduced
expressed emotion. The majority of the sample (particularly from the ECHO group) reported positive
benefits and changes in their interaction with carers and one-third reported empathy and concern for
their family.
We did not find statistically significant effects of ECHO in terms of our distal primary outcomes, patient
relapse and carer distress, although differences were in the anticipated direction. It is possible that estimated
differences were not found for our primary outcomes because we under-recruited. This will particularly
impact binary/time to event outcomes such as our primary patient outcome relapse. In hindsight, due to
extraneous variables associated with carer distress, perhaps a more ED-specific outcome such as carer burden
should have been used as the primary outcome for carers. It will be important to understand why ECHO
effects on variables targeted by this carer intervention (e.g. on expressed emotion) were not translated
into stronger effects on distal outcomes, and as a next step we plan to carry out mediation modelling to
investigate which hypothesised paths of our theoretical model were active.
The ECHO group made less use of services, as reflected by shorter duration of admission, longer time to
relapse and lower number of relapses/readmissions, and carers in this group expressed less dissatisfaction
with post-discharge care.
These findings suggest that a degree of sustained benefit can be achieved by patients with severe and/or
enduring form of EDs following intensive treatment for nutritional rehabilitation. A previous qualitative
study suggests that patients experience benefits from their parents participating in these interventions.220
The increase in BMI (2.1 kg/m2, 14% increase) at 1 year is smaller than that found in early intervention
cases given inpatient/day patient care (3 kg/m2),193 but greater than that seen in outpatient studies with
less medically compromised adults [1.3 kg/m2 by Schmidt et al.,128 1 kg/m2 (4%) by Touyz et al.156 and
1.4 kg/m2 by Zipfel et al.218]. On the other hand, the reduction (17%) in ED psychopathology is less than
that seen in outpatient care (38%).136
Approximately two-thirds of the patients lived with their carers, with approximately 50% having > 21 hours
of contact time. The levels of parental distress, burden, accommodating and enabling behaviour and expressed
emotion at baseline were within the range of that reported in systematic reviews of carer functioning.198,199
The changes in carer distress, burden and caregiving behaviours are comparable to those found in the
meta-analysis from a recent systematic review of psychoeducational interventions for carers.200 In the
meta-analysis, carer burden fell by 0.39 at the end of treatment and by 0.56 at the end of follow-up. On
the other hand, the change in distress (DASS-21; ES= 0.12 at 6 months) was less marked than found in
previous studies (in the meta-analysis this was 0.31 at the end of treatment and 0.39 at follow-up). Differences
in the stage of illness of the patients and in the outcome measures used may explain this variation. It is
noteworthy that there was a small increase in carer distress and fall in quality of life during the course of the
study in the TAU group. The reduction in accommodating and enabling behaviour was similar to that found in
the meta-analysis (0.2–0.5), as was the fall in carers’ expressed emotion (0.3–0.4). In comparison with the high
intensity of care that the patients were given, the carers had a very low-intensity intervention. This could
explain why the treatment effect occurs at 6 months and then attenuates at the end of 1 year’s follow-up.
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We are in the process of conducting cost-effectiveness analyses for ECHO using the outcome data
collected in this trial. The results of these analyses will be made available through publication on
their completion.
Limitations
This sample is not necessarily representative of the target population as it includes only people who agree
for their carers to be involved and who have carers who are willing to help. Moreover, the study includes
patients at various stages of illness (19% early and 55% enduring), and it is possible that these subsets
have different responses to the interventions. For example, family therapy is effective only as an early
intervention.194 Over half of the patients in this sample (n = 83; 55%) fulfil the criteria for being in a severe
and/or enduring stage of illness. Such patients are considered to be resistant to all forms of treatment.221,222
The sample was powered to detect only moderate overall differences in patient outcome. With 134 carers
in each group and an alpha level of 0.025 (adjusting for multiple primary outcomes), we had 80% power
to detect an ES of 0.38.
Although there are standard quality criteria for inpatient care, the treatment ethos does vary between
services. For example, some services involve carers more than others do. This may have decreased the size
of the effect. However, as the sample was stratified by site, it would not have led to any bias in the
interpretation of the results. The comparison with TAU (rather than an active control), does mean that we
cannot rule out that the apparent benefits of ECHO are non-specific effects of participants receiving a
greater intensity of intervention.
Strengths
This study used the strengths of a pragmatic randomised controlled design to examine the effects of
adding a low-intensity psychoeducational and skills training intervention for carers to inpatient care for AN.
Furthermore, this is a multicentre study in which the majority of NHS England specialised ED centres
participated. Considering that the number of patients with AN requiring inpatient care is small, the sample
size of this study is unique.
Clinical implications
The possible added benefit for patients and for services attained from giving carers psychoeducational
information has been rarely studied, but this study suggests that this is an area that merits more attention.
It is possible that increasing the intensity of the intervention and including it within the service model of
inpatient care might produce improvements for services, patients and carers. This would mean that carers
might become more involved in treatment for adults.
Conclusion
A low-intensity psychoeducational intervention for the carers of patients at a severe and/or enduring stage
of AN produced a decrease in burden and time spent caregiving and a small decrease in distress. Unhelpful
carer behaviours such as high expressed emotion were also decreased. Carers reported higher levels of
functioning in the people with EDs. Moreover, patients had greater improvement in eating psychopathology
and quality of life and noted positive changes in carers’ behaviours. Patients felt more empathy for their
carer. Moreover, carers’ dissatisfaction with services was lower in the ECHO group. It is possible that
increasing the intensity of work with carers may have benefits for clinical services for patients in addition to
benefits for carers themselves.
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Chapter 7 An investigation of issues associated
with physical activity in anorexia nervosa (work
package 4)
An abbreviated version of this chapter has been published in the International Journal of Eating Disorders.223
Abstract
Objectives
This WP examined physical activity (PA) in people with AN and associations between drive to exercise,
ED psychopathology, anxiety, endocrine measures and energy expenditure (EE).
Method
Four groups of women were recruited: AN outpatients (n = 37), AN inpatients (n = 18), those with anxiety
symptoms (n = 34) and HCs (n = 30). Actigraphy and self-report were used to measure PA, together with
the drive and reasons for exercise, ED and general psychopathology, body composition and BMI. Salivary
cortisol was also measured and EE was estimated. Measures were made over 24 weeks.
Results
Objective PA levels did not differ significantly between groups cross-sectionally or longitudinally:
nonetheless, AN groups reported higher total PA than HCs. AN outpatients reported more walking and
moderate PA than HCs. AN inpatients reported more walking but less moderate and vigorous PA than
other groups. In the two AN groups, drive to exercise was significantly higher. These groups also rated
‘improving tone’ as being an important motivator to exercise. Estimates of EE due to PA indicated a
maximum of 400 kcal/day in patients with AN, out of a total EE of approximately 1600 kcal/day.
Discussion
Elevated PA has been reported in AN, but this may reflect patients’ peception of their activity rather than
what is actually done. Drive to exercise in AN seems to be more closely linked to ED psychopathology than
to anxiety. Estimates of EE due to PA provide guidance for therapists who want to introduce exercise
into therapy.
Introduction
Increased PA in AN can be loosely defined as deliberate exercise and/or indirect behaviours such as pacing
and/or fidgeting. These behaviours, however, do not have a well-defined definition,224 yet may contribute
to the maintenance of low BMI225,226 and non-recovery at 2 years.227 High levels of PA prior to admission
and following discharge have also been reported to be associated with poorer outcome.228,229 In relation to
treatment outcomes, commitment to exercise is a problem in inpatients and engagement in excessive sport
in outpatients may be a barrier to treatment.230 In addition, high PA may arise prior to illness231,232 and
remain following recovery.225,233 Therefore, excessive exercise behaviours may also contribute to the
aetiology of AN rather than simply being a symptom of the illness. Furthermore, as high PA levels are
associated with lower BMIs in individuals recovered from AN,225 this may suggest the persistence of illness
behaviours, or show that high levels of PA are a trait rather than a state marker.
Research findings on the prevalence of high levels of PA in AN are mixed. This may be due to different
methodologies, to perceptual differences in levels of PA undertaken in AN compared with controls, or to
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high degrees of individual differences in exercise behaviours. Despite these differences, increased PA has
often been reported in this patient group.232,234–237 Recently, a study reported increased PA in a subgroup
of AN patients only, suggesting that high PA may not be universal in this patient group.238
The hypothesised drivers of increased PA in AN are cognitive desire to lose weight,225 to improve mood230
and to reduce anxiety.239,240 This is supported by the fact that women with AN are reported to value
negative affect regulation as a motivator for exercise more than they value exercising to improve health
and fitness.234,241 Individuals with AN are also more likely to rate body tone, attractiveness and weight
control as relevant motivators than exercising for enjoyment.241 Thus, PA may be a deliberate and
controlled behaviour that is intended to promote weight loss.242
The idea that high PA is driven by anxiety in AN is supported by the often reported comorbidity of the
two,243–245 and the fact that approximately 50% of AN patients also have a lifetime history of anxiety
disorder.2,246 In some AN patients, anxiety disorders are reported to predate the onset of the ED,245,247 are
associated with lower BMI248 and poorer outcome.249 Therefore, anxiety may be a vulnerability factor that is
independent of nutritional state.245 In terms of PA, an association between anxiety and high levels of PA
has been reported in AN patients. Further support for the idea that anxiety may be a driver for PA in AN
patients comes from reports that PA helps to reduce depression, stress and anxiety in adolescents250
and adults.240
This study examined levels of PA, drive to engage in PA, motives for exercise, and a number of associated
physiological and psychological measures in female patients with AN, in HCs and in a group with
moderate levels of anxiety. The study had the following hypotheses:
1. Subjective and objective measures of PA levels together with the drive to exercise will be increased in
AN patients compared with HCs and with the anxious group (these findings will be present both
cross-sectionally and longitudinally over 24 weeks).
2. ED psychopathology and anxiety will be associated with PA levels.
3. Reasons for exercising will differ between groups.
4. In patients with AN, estimates of EE due to PA will show that < 500 kcal/day are used.
Methods
Participants
Women were recruited as four groups: inpatients (n = 18) and outpatients (n = 37) with a diagnosis of AN,
individuals experiencing moderate anxiety (n = 34) and HCs (n = 30). AN patients (binge-purging or
restricting subtype) with a BMI < 17.5 kg/m2 were recruited from in and around London (from specialist ED
services). These services included outpatient treatment (n = 26), day care (n = 10) and inpatient treatment
(n = 18). Patients attending day care treatment were grouped with the outpatient participants. Anxiety and
control participants were recruited via an e-mail circular to students and staff at King’s College London.
Anxiety participants were screened using the Generalised Anxiety Disorder questionnaire, and those with a
score of ≥ 10 were recruited into the study. Participants had a mean age of 27 years in the anxiety group
(range 18–54 years), 29 years in the combined AN groups (range 18–67 years) and 29 years in the HCs
(range 20–52 years). All were English speaking. Recruitment commenced following approval by the local
REC (09/H0807/4). All participants provided informed consent.
Measures
All participants provided data on the following measures.
Demographic information
Contact details, ethnicity, occupation, marital status, physical or mental health problems and lifestyle habits
(such as drinking and smoking).
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Weight and height
Weight and height were measured and used to obtain BMI [weight (kg)/height (m2)].
Structured Clinical Interview for DSM
This is used to diagnose DSM-IV axis I disorders.251 Section H of the research version (Structured Clinical
Interview for DSM-I/P, Patient Edition) was used to establish a diagnosis of AN.
Eating Disorder Examination-Questionnaire
This questionnaire (self-report) has been validated in ED studies.142 It provides a global score and four
subscale scores (weight and shape concern, restraint, eating).
Depression Anxiety and Stress Scales 21-version
This measure (a self-report questionnaire) assesses depression, anxiety and stress.252,253 Scores determine
level of severity for each subscale: normal, mild, moderate, severe and extremely severe.
International Physical Activity Questionnaire
This questionnaire uses self-report. It asks participants to estimate days and minutes spent sitting, walking,
moderately and vigorously exercising per week. Number of days is multiplied by number of minutes on
average spent engaging in each level of exercise to give an estimate (minutes/week) at each level. These
are summed to give a total amount of PA (minutes/week). When participants responded ‘I do not know/
unsure’, total scores were not calculated. A short version of this measure was used, and has been reported
to have good international reliability and validity.254 This questionnaire has been used to estimate PA in
other studies of ED.255,256
Commitment to Exercise Scale
This eight-item Likert scale-based questionnaire assesses commitment to exercise. It measures the degree
to which (1) feelings of well-being are influenced by exercising, (2) adherence to exercise is maintained
even in the face of adverse conditions and (3) exercise regimens interfere with social life.257 It has been
used in ED studies.235,258,259
Obligatory Exercise Questionnaire
This was used to determine the frequency with which participants experience obligatory and compulsory
thoughts, feelings and exercise behaviours.260 The measure has 20 items, where 1 = never, 2 = sometimes,
3 = usually and 4 = always, giving a possible maximum score of 80. Higher scores indicate higher
obligation and drive to exercise. The measure has good validity and reliability261 and has been used in ED
and general population samples.262–264
Exercise Addiction Inventory
This measure (self-report) assesses exercise attitudes and its impact on one’s life.265 It has six items, where
1 = strongly disagree and 5 = strongly agree, giving a possible maximum score of 30. A higher score
indicates greater likelihood of ‘exercise addiction’. The Exercise Addiction Inventory (EAI) is a reliable and
valid tool for assessing risk of exercise addiction.265,266
Reasons for Exercise Inventory
This assesses the importance of seven reasons to exercise: improving physical attractiveness, improving
body tone, improving mood, enjoyment, weight control, health, and fitness. Each subscale has three or
four items scored from 1 = not at all important to 7 = extremely important, and an average for each
subscale is obtained.267 It has been used in studies of AN.234
Body composition
An InBody 3.0 Biospace Co. Ltd machine (Cerritos, CA, USA) was used to measure skeletal muscle, body
fat, total body water and bone mineral content (BMC) in all participants. It is a portable non-invasive
device that uses electrical impedance to obtain the measures.
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Actimetry
An actometer device (Actiwatch AW4, Cambridge Neurotechnology, Cambridge, UK) was worn
continuously by each participant. It was worn on the non-dominant wrist to measure PA over 7 days. This
method has been used by other groups assessing PA in ED participants.268,269 Data from the Actiwatches
were analysed using its software (Motionware Software, CamNtech, Cambridge, UK).
Cortisol
Salivary cortisol was measured by obtaining weekly salivary samples in salivettes. Participants were asked to
chew for 1 minute on a small cotton swab. As cortisol peaks in the morning, this was done 10 minutes
after waking and before smoking or eating breakfast.
Leptin
Serum leptin levels were measured in AN and HC participants only. Blood samples were collected weekly
and were sent to the Department of Clinical Biochemistry in the King’s College London Pathology
Laboratory for analysis.
Data analysis
Five participants from the HCs with a BMI < 18.5 kg/m2 and six from the anxiety group with EDE-Q global
scores > 2.8270 were not used in the analyses. Group means were compared using one-way analyses of
variance (ANOVAs) and Tukey post hoc tests. Kruskal–Wallis tests and post hoc Mann–Whitney tests using
Bonferroni corrections were used to compare means for variables that violated parametric assumptions
[EDE-Q, DASS-21, International Physical Activity Questionnaire (IPAQ) and body fat]. Pearson’s rank
correlations were used to infer relationships between variables before hierarchical multiple regressions
were performed, with drive to exercise as the dependent variable.
Results
Group differences in outcome measures
Eating Disorders Examination-Questionnaire and Depression Anxiety and Stress Scales
Anorexia nervosa outpatients and inpatients had higher scores than the anxiety group and the HCs on
EDE-Q total score (p < 0.001) and across the four subscales (p < 0.001) (Table 20). Restraint and eating
concern scores were lower in the AN inpatient group, yet differences between AN groups were not
significant. The group with anxiety had higher scores than the HCs on all EDE-Q subscales, and these were
significantly higher for eating concern [n = 55, F(3) = 2.76; p < 0.01].
Healthy controls were in the expected range for the DASS-21 subscales (0–7), but the group with anxiety
scored in the moderate–severe range for anxiety (7–12) and in the moderate range for stress and
depression (6–9). The AN outpatients scored ‘severe’ on all three subscales (8–16) and the inpatient group
had scores that assessed them as ‘severe–extremely severe’ for depression (11–14+) and ‘extremely severe’
for stress and anxiety (> 10 and > 17, respectively).
TABLE 20 Diagnostic and psychological measures
Measure HC (n= 27) Anxiety (n= 28) AN outpatient (n= 35) AN inpatient (n= 17)
EDE-Q (total) 0.7 (0.7) 1.2 (0.9) 4.2 (1.2) 4.01 (1.2)
DASS-21 (total) 6.2 (6.3) 27.1 (11.6) 34.9 (12.7) 39.1 (18.4)
Values are means and SDs.
This table is reproduced with permission from Keyes A, Woerwag-Mehta S, Bartholdy S, Koskina A, Middleton B, Connan F,
et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord 2015;48:46–54.223 © 2014 Wiley
Periodicals, Inc.
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There were significant between-group differences in total DASS-21 scores [F(3) = 56.14; p < 0.001], and
for the depression [F(3) = 55.83; p < 0.001], stress [F(3) = 45.1; p < 0.001] and anxiety [F(3) = 49.44;
p < 0.001] subscales (see Table 20). The AN groups reported higher anxiety, depression and stress levels than
the HCs (p < 0.001). AN outpatients (but not inpatients) had higher depression scores than the anxiety group
[F(3) = 3.2; p < 0.01]. The anxious and the AN groups did not significantly differ on other DASS-21 scores.
The anxiety group scored higher than HCs on total DASS-21 [F(3) = 5.71; p < 0.001] and on the anxiety
[F(3) = 5.55; p < 0.001], depression [F(3) = 5.45; p < 0.001] and stress subscales [F(3) = 5.09; p < 0.001].
Physiology
Among AN outpatients, BMI was consistent with diagnosis (mean = 16.04, SD = 1.44). In 97%, body fat
mass was below the normal range and in 67% muscle mass was below the normal range (i.e. muscle was
relatively conserved). In 25% of AN outpatients BMC was below the normal range. Among AN inpatients
body fat mass was below the normal range in 100%, muscle mass below the normal range in 81% and as
BMC below the normal range in 56.3% (presumably reflecting illness severity).
Healthy controls were lean and fit as a group: fat mass (kg) was below the normal range for age and
gender in 44%, and muscle mass (kg) was above the normal range in 26%. Values in the anxiety group
were similar: fat mass was below the normal range for age and gender in 43% and muscle mass was
above the normal range in 21%. However, anxiety participants had a larger range in BMI (a SD of 3.88 vs. 1.5).
No anxiety participants had BMC lower than the normal range.
The groups differed significantly in terms of BMI [F(3) = 63.32; p < 0.001], muscle [F(3) = 27.6; p < 0.001],
body fat [F(3) = 69.8; p < 0.001], total body water [F(3) = 26.81; p < 0.001] and BMC [F(3) = 37.08;
p < 0.001] (Table 21). On all body composition measues, AN participants differed from the HC and anxiety
groups (p < 0.001). BMI did not differ significantly between the two AN groups, but the AN outpatients had
significantly lower BMC (p < 0.01). The anxiety group and the HCs were similar in terms of body composition.
Physical activity
Actimetry: an objective measure of physical activity
Actimetry showed that all groups had similar levels of activity (average and peak activity) (Table 22) and there
were no significant between-group differences [average PA: F(3) = 0.46, p > 0.05; peak PA: F(3) = 0.26,
p > 0.05]. The outpatient group had higher peak and average activity levels than the inpatient group
(average: AN inpatient, mean = 223.63, SD = 61.67, n = 10; average AN outpatient, mean = 249.73,
SD = 73.96, n = 27; peak AN inpatient, mean = 3607.1, SD = 507.83, n = 10; peak AN outpatient,
mean = 3961.15, SD = 1329.39, n = 27), but these differences were not significant (both p > 0.013).
TABLE 21 Physiology
Measure HC (n= 27) Anxiety (n= 28) AN outpatient (n= 35) AN inpatient (n= 17)
BMI (kg/m2) 21.2 (1.5) 22.24 (3.9) 16.0 (1.4) 14.1 (2.1)
Body fat (kg) 12.4 (5.0) 13.4 (7.7) 4.1 (2.8) 1.9 (1.6)
Skeletal muscle (kg) 28.5 (5.5)a 26.4 (2.9) 21.5 (3.5)a 19.1 (3.1)a
BMC 3.1 (0.4) 3.2 (0.4) 2.5 (0.4) 2.1 (0.4)
Total body water (litres) 34.3 (3.9) 34.5 (3.2) 28.7 (4.2) 26.6 (3.5)
RMR 1431.1 (125.9) 1398.6 (96.6) 1221.8 (125. 4) 1151.0 (108.2)
RMR, resting metabolic rate.
a HC (n= 26), AN outpatient (n= 34), AN inpatient (n= 16).
All values are means and SD.
This table is reproduced with permission from Keyes A, Woerwag-Mehta S, Bartholdy S, Koskina A, Middleton B, Connan F,
et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord 2015;48:46–54.223 © 2014 Wiley
Periodicals, Inc.
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International Physical Activity Questionnaire scores: self-reported physical activity
Both of the AN groups recorded higher levels of total PA (minutes/week) than HCs (by 57–92%) (Table 23),
and the difference between the outpatient group and HCs [F(3) = 3.05; p < 0.01] was significant. Both
outpatient and inpatient AN groups reported doing more walking than HCs (250% and 95% higher,
respectively), but the difference was significant only between outpatients and HCs [F(3) = 3.18; p < 0.01].
The outpatient group also reported engaging in more ‘moderate’ exercise than HCs (more than threefold
higher), but the difference was not significant. The inpatient group recorded engaging in less ‘moderate’
exercise than the anxious group [F(3) = –2.99; p < 0.01] and less ‘vigorous’ activity than HCs [F(3) = –2.89;
p < 0.01] and the anxiety group [F(3) = –2.74; p < 0.01]. The inpatient group reported that they engaged in
less moderate and also less vigorous activity than the outpatient group. Finally, the anxiety group, recorded
higher total activity (by 43%) and moderate activity (by 80%) and more walking (by 71%) and lower
vigorous activity (by 34%) than HCs, but none of these differences was significant.
Comparison of subjective and objective measures of physical activity
There were no large between-group differences in objective measures of PA (total or peak activity), but,
subjectively (as assessed by the IPAQ), the AN and anxiety groups reported undertaking more activity.
In addition, in each group, the range is wider at every level of self-reported activity than the actimetry
measures. SDs of subjective total PA are 77% (HCs), 94% (anxiety group), 64% (AN outpatients) and
115% (AN inpatients), whereas comparable SDs from objective measures of average PA (actimetry) are
24%, 23%, 29% and 27%, respectively.
TABLE 22 Actigraphy data
PA
HC Anxiety AN outpatient AN inpatient
n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Average PA 23 250.2 (61.5) 23 249.4 (63.1) 27 249.7 (74.1) 10 223.6 (61.7)
Peak PA 22 3971.3 (1350) 22 3657.1 (1727.0) 27 3961.2 (1329.4) 10 3607.1 (1507.8)
PA values are counts/minute.
This table is reproduced with permission from Keyes A, Woerwag-Mehta S, Bartholdy S, Koskina A, Middleton B, Connan F,
et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord 2015;48:46–54.223 © 2014 Wiley
Periodicals, Inc.
TABLE 23 International Physical Activity Questionnaire scores (minutes)
IPAQ
HC Anxiety AN outpatient AN inpatient
Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n
7 days
PA (total) 489.7 (378.7) 26 699.5 (654.1) 26 942.2 (598.6) 22 768.9 (887.3) 14
Walking 290.7 (336.1) 26 497.9 (607.5) 26 571.4 (393.4) 27 629.7 (712.4) 15
Moderate 70.0 (85.0) 26 125.7 (143.6) 28 219.9 (308.1) 25 67.3 (216.8) 15
Vigorous 124.8 (141.4) 26 82.6 (125.5) 28 163.0 (334.0) 31 58.0 (216.5) 15
Over 5 days
Sitting 1872.2 (649.0) 27 2088.0 (748.7) 25 1597.8 (955.8) 23 1406.3 (625.9) 8
This table is reproduced with permission from Keyes A, Woerwag-Mehta S, Bartholdy S, Koskina A, Middleton B, Connan F,
et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord 2015;48:46–54.223 © 2014 Wiley
Periodicals, Inc.
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Drive to exercise
Both the inpatient and outpatient groups had higher scores than the anxious group and the HCs on the
Commitment to Exercise Scale [F(3) = 9.54; p < 0.001], the EAI [F(3) = 8.67; p < 0.001] and the Obligatory
Exercise Questionnaire [F(3) = 6.86; p < 0.001] (Table 24). These questionnaires have slightly different
elements, but all three show high correlations (r = 0.87; p < 0.01); hence we have created a ‘global drive
to exercise’ (GDES) as single score. It was calculated in the following way. Average scores for each
questionnaire were converted to a percentage of the highest score by any participant, and averages of
these three percentages were then obtained: this has been used previously to create related scales (e.g. for
anxiety and depression).271
Significant between-group differences are observed in drive to exercise [F(3) = 9.42; p < 0.001]. Both the
outpatients and the inpatients had significantly higher scores than the HCs and the group with anxiety
(p < 0.001). No significant differences were seen between anxious participants and HCs or between
inpatient and outpatient groups in their drive to exercise.
Reasons for exercise
There were between-group differences for enjoyment [F(3) = 2.91; p < 0.05] and for health [F(3) = 5.42;
p < 0.01] (Table 25). Between-group differences for exercising for attractiveness approached significance
[F(3) = 2.64; p = 0.054]. Exercising for health reasons was less important for the outpatient group than for
HCs and the anxiety group (HCs vs. AN outpatients, 4.83 vs. 3.55, p < 0.013; anxiety vs. AN outpatients,
4.79 vs. 3.55, p < 0.013). Using exercise for enjoyment and to improve attractiveness was rated less
important in the outpatient group than in the group with anxiety (attractiveness: mean = 3.11 vs. 4.39;
enjoyment: mean = 2.20 vs. 3.17). The results were not, however, significant after applying Bonferroni
corrections (p = 0.47 and p = 0.41). Finally, exercising to improve tone was more important in the two
patient groups and the anxiety group than in the HCs (e.g. HCs vs. AN outpatients, mean = 3.44 vs. 4.70),
but these differences were not significant (p = 0.056).
Endocrine data
A significant between-group difference in cortisol was observed (Table 26). Cortisol level was significantly
higher in the inpatient group than in HCs [F(3) = 2.73; p < 0.05]. No significant differences in cortisol
among the other groups were observed (p > 0.05). Cortisol concentration and the DASS-21 anxiety score
were weakly correlated at baseline, and this approached significance (n = 100, r = 0.19, p = 0.07) across
the group as a whole. When groups were analysed separately, no significant correlations were found
between the DASS-21 anxiety score and baseline cortisol (HC: n = 30, r = –0.05, p = 0.81; anxiety: n = 33,
r = 0.21, p = 0.25; AN outpatients: n = 26, r = 0.1, p = 0.65; AN inpatients: n = 11, r = –0.19, p = 0.58).
TABLE 24 Scales measuring drive to exercise
Scale HC (n= 27)
Anxiety
(n= 28)
AN outpatient
(n= 35)
AN inpatient
(n= 17)
AN groups
(n= 52)
GDTE (%) 40.9 (12.3) 45.7 (11.3) 61.7 (23.0) 65.9 (30.0) 63.1 (25.3)
CES (%)a 0.3 (0.2) 0.3 (0.2) 0.5 (0.2) 0.6 (0.3) 0.5 (0.3)
OEQ (%)b 37.5 (5.9) 41.1 (7.2) 48.1 (14.0) 51.3 (18.3) 49.1 (15.4)
EAI (%)c 11.2 (4.4) 13.1 (3.9) 18.3 (7.4) 18.5 (9.7) 18.4 (8.1)
CES, Commitment to Exercise Scale; GDTE, general drive to exercise; OEQ, Obligatory Exercise Questionnaire.
a Maximum score = 1.
b Maximum score = 80.
c Maximum score = 30.
Values are expressed as means and SD.
This table is reproduced with permission from Keyes A, Woerwag-Mehta S, Bartholdy S, Koskina A, Middleton B, Connan F,
et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord 2015;48:46–54.223 © 2014 Wiley
Periodicals, Inc.
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Serum levels of leptin were measured in the two AN groups and HCs only. There was a significant
between-group difference in leptin [F(2) = 18.55; p < 0.001), in that both the inpatient and outpatient groups
had significantly lower leptin concentrations than HCs (p < 0.001). AN outpatient and AN inpatient groups
did not significantly differ in concentrations of leptin. Across the whole sample, there was a significant
correlation between leptin and body fat (%) (n = 57, r = 0.72, p < 0.001). Within-group analysis revealed
significant correlations between leptin and percentage body fat in each group (HCs: n = 14, r = 0.71,
p < 0.01; AN outpatients: n = 29, r = 0.57, p < 0.001; AN inpatients: n = 14, r = 0.55, p < 0.05).
Associations between outcomes
Subjective and objective measures of activity
When all participants were considered together, average activity (actimetry) was not correlated with total
reported activity (IPAQ) and second, peak activity (actimetry) was not correlated with levels of reported
vigorous activity. There was a significant but weak correlation between average activity (actimetry) and
reported time spent walking (n = 72, r = 0.24; p < 0.05).
Within-group analysis showed that for the HCs, the anxiety group and the AN outpatients, there were no
significant correlations between average/peak activity (actimetry) and any levels of self-reported activity.
In the AN inpatients group, however, there was a strong correlation between the average activity
(actimetry) and self-reported total activity (n = 9, r = 0.76; p < 0.02) and walking (n = 9, r = 0.74; p < 0.02).
TABLE 26 Cortisol and leptin data
Measure
HC Anxiety AN outpatients AN inpatients
Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n
Cortisol (nmol/l) 10.0 (3.7) 30 11.4 (10.4) 31 12.3 (5.6) 26 17.9 (11.7) 11
Leptin (µg/l) 8.9 (4.7) 14 Not measured 2.8 (2.4) 30 2.6 (3.5) 16
TABLE 25 Reasons for exercise inventory
Scale HC (n= 27)
Anxiety
(n= 34)
AN outpatients
(n= 32)
AN inpatients
(n= 15)
AN groups
(n= 47)
Weight control 4.2a (0.9) 4.7 (1.1) 4.6a (2.2) 5.0 (1.7) 4.7a (2.1)
Fitness 4.5 (1.2) 4.4 (1.5) 4.02 (1.8) 4.2a (2.0) 4.1a (1.8)
Mood 4.7 (1.5) 4.6 (1.8) 4.7 (1.7) 4.9a (2.1) 4.8a (1.8)
Health 4.8 (1.3) 4.8 (1.4) 3.6 (1.7) 3.7 (1.7) 3.6 (1.7)
Attractiveness 3.3 (1.9) 4.4 (1.8) 3.1a (1.8) 3.4a (2.3) 3.2a (1.9)
Enjoyment 2.8 (1.5) 3.2 (1.6) 2.2 (1.2) 2.2 (1.2) 2.2 (1.2)
Tone 3.4 (1.5) 4.2 (1.7) 4.7 (1.9) 4.2 (2.5) 4.5 (2.1)
a HC n= 30; AN outpatients: weight control n= 26, attractiveness n = 31; AN inpatients n= 14; AN groups: weight
control n= 51, fitness and mood n= 46, attractiveness n= 45.
Values are means and SD.
This table is reproduced with permission from Keyes A, Woerwag-Mehta S, Bartholdy S, Koskina A, Middleton B, Connan F,
et al. Physical activity and the drive to exercise in anorexia nervosa. Int J Eat Disord 2015;48:46–54.223 © 2014 Wiley
Periodicals, Inc.
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Relationship between actimetry data and other measures
Across the study sample as a whole, there were no significant correlations between actimetry scores and
other measures [e.g. DASS-21, EDE-Q, drive to exercise and Reasons for Exercise Inventory (REI)]. Within-
group analysis showed that, when the two patient groups were combined, peak activity correlated with
EDE-Q global scores (n = 36, r = 0.37; p < 0.05). No significant associations were seen between actimetry
data and other variables in all other groups.
Self-reported activity (International Physical Activity Questionnaire) and other measures
Self-reported total activity, when examined across the whole group, was weakly correlated with global
EDE-Q score (n = 86, r = 0.27; p < 0.01) and with exercising to improve tone (n = 83, r = 0.25; p < 0.02).
No significant associations were found between any levels of self-reported activity and other variables
when within-group analyses were performed.
Drive to exercise and other variables
Drive to exercise may be an important pathological variable and, as we used three scales to create a single
measure (GDES), it was used as one of our main variables.
Across the whole group, drive to exercise (GDES) was most highly correlated with self-reported total
activity (n = 86, r = 0.39; p < 0.01). In addition, correlations were present between drive to exercise and
self-reported walking (n = 94, r = 0.25; p < 0.02), moderate activity (n = 94, r = 0.29; p < 0.01) and
vigorous activity (n = 102, r = 0.37; p < 0.01). All these correlations were, however, < 0.4.
In the AN groups combined, drive to exercise correlated with self-reported total activity (n = 35, r = 0.52;
p < 0.01), self-reported walking (n = 42, r = 0.37; p < 0.02) and the following REI subscales: weight control
(n = 50, r = 0.55; p < 0.01), fitness (n = 46, r = 0.54; p < 0.01), mood (n = 46, r = 0.74; p < 0.01), health
(n = 47, r = 0.43; p < 0.01) and to improve tone (n = 47, r = 0.44; p < 0.01). In addition, correlations were
seen between drive to exercise and vigorous activity (n = 47, r = 0.39; p < 0.01) and peak activity
(measured by actimetry) (n = 36, r = 0.43; p < 0.01) in these groups. In the anxiety group, drive to exercise
correlated with self-reported vigorous activity only (n = 28, r = 0.65; p < 0.01).
Across the groups, drive to exercise correlated (moderately) with EDE-Q global score (n = 107, r = 0.48;
p < 0.01), poorly with the DASS-21 anxiety score (n = 107, r = 0.23; p < 0.02) and inversely with (n = 107,
r = –0.38; p < 0.01). It was also correlated with exercising to control weight (n = 105, r = 0.5; p < 0.01), to
improve tone (n = 102, r = 0.40; p < 0.01), to improve mood (n = 101, r = 0.49; p < 0.01) and for fitness
(n = 101, r = 0.3; p < 0.01).
When the two AN groups were combined, drive to exercise was highly correlated with exercising to
improve mood (n = 46, r = 0.74; p < 0.01), for fitness (n = 46, r = 0.54; p < 0.01), to control weight
(n = 50, r = 0.55; p < 0.01), to improve tone (n = 47, r = 0.44; p < 0.01) and for health (n = 47, r = 0.43;
p < 0.0). In the anxiety group, drive to exercise correlated with exercising to improve mood (n = 28,
r = 0.44; p < 0.02). Last, in the HCs, drive to exercise was not significantly correlated with other measures.
Multivariate models predicting drive to exercise
Hierarchical multiple regression was conducted to examine the extent to which ED pathology, anxiety,
depression, stress and REI subscales predicted drive to exercise (after controlling for percentage muscle and
BMI). Across the groups, BMI and muscle (%) were entered at step 1, and explain roughly 15% of the
variance in drive to exercise. When REI and DASS-21 subscale scores and global EDE-Q score were entered
(step 2), the total variance explained by the model was 57% (p < 0.01). Variables entered at step 2
explained an additional 41.6% of the variance in drive to exercise, after BMI and muscle (%) had been
controlled for. In the final model, those variables that contributed most to the overall variance in drive to
exercise were exercising to improve mood (6.3%; p < 0.01), exercising for weight control (4.9%; p < 0.01)
and global EDE-Q score (3.6%; p < 0.01).
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Following the above, the analysis was repeated for each group. In HCs, the DASS-21 and REI subscale
scores and the global EDE-Q score explained roughly 35% of the variance in drive to exercise, but overall,
the model was not significant (p = 0.74). In the group with anxiety symptoms, these variables explained
roughly 70% of the variance [after controlling for BMI and muscle (%)]: the overall model was significant
[F(11) = 5.54; p < 0.01]. Specifically, stress (DASS-21 subscale) contributed the most to the variance in drive
to exercise (18%, p < 0.01), together with exercising to improve mood (11%; p < 0.01) and global EDE-Q
score (8%; p < 0.05). For the outpatient AN group, DASS-21 and REI subscales and the global EDE-Q score
explained 86% of the variance in drive to exercise [after controlling for BMI and muscle (%)] [F(11) = 10.48;
p < 0.01]. In this group, exercising to improve mood and ED psychopathology contributed the most to the
variance in drive to exercise [EDE-Q: 25% (p < 0.01); REI mood: 27% (p < 0.01)]. Other significant
contributions were made by exercising to improve tone (10%; p < 0.01), exercising to relieve stress (12%;
p < 0.01) and exercising for health (8%; p < 0.01).
The analysis was repeated using self-reported (IPAQ) and objective (actimetry) measures of PA as
dependent variables: the resulting models were not significant.
Longitudinal studies related to physical activity
We also investigated PA longitudinally over 24 weeks in patients with AN. The four groups of participants
were the same and the methodology was similar to that used in the cross-sectional study. PA was
measured continuously for 8 weeks and at follow-up (weeks 12 and 24) by actimetry and self-report
(IPAQ). Measures of general and ED-related psychopathology were made in parallel.
Eating disorder psychopathology and physiological measures remained consistent with diagnosis. Drive to
exercise, depression, stress and anxiety were, as might have been predicted, consistently higher in the two
AN groups than in the HCs and the group with anxiety symptoms. The highest values were seen in the
inpatient AN group. In all four groups, there was a wide range in activity, especially on the self-report
(IPAC) scores, but mean actimetry values were relatively constant over time. In the AN groups (compared
with HCs and the group with anxiety symptoms), self-reported activity was higher on measures of total,
walking and moderate PA. In the two AN groups, the drive to exercise was correlated with self-reported
exercise. The objective measures (actimetry) showed no statistically significant difference in levels of PA
between the four groups.
The data arising from the longitudinal study are in agreement with the results from the cross-sectional
investigation. For example, comparison of the objective and the self-report data suggests that, in the AN
groups, self-reported overactivity is perceived rather than real and may arise from factors such as drive to
exercise. It is also of note that levels of activity remain relatively constant across the duration of the study.
Furthermore, the objective data suggest that levels of PA do not differ between the AN groups and the
HCs. What is perhaps surprising is that levels of activity are not apparently decreased by being in an
inpatient setting, for which limits on activity may have been set. This may be because people in an
inpatient setting spend considerable time walking (e.g. pacing). It suggests that levels of PA are difficult to
regulate in severely ill patients in whom there is a high drive to exercise. However, given that some of the
patients have a very low BMI and high levels of ED pathology, diminished fat reserves and a loss of muscle
tissue (i.e. the AN inpatient group), this relatively ‘normal’ level of activity may be of some clinical concern
and should be considered. In this respect, it should also be seen in the context of setting a balance that
recognises the beneficial effects of exercise on mood and anxiety, and its effects on bone health, EE
and PA.
Energy expenditure and physical activity
A final element of the study was an investigation of EE asociated with PA in AN. The data were derived
from the measures of self-reported activity and from physiological measures such as BMI. PA-related EE
was estimated by converting IPAQ scores to ‘metabolic equivalent of task’ values and then to corrected
metabolic equivalent of task values, to adjust for differences in resting metabolic rate (RMR).
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Compared with the HC group, RMR was lower in the outpatient group (by 11%) and in the inpatient
group (by 17%). When EE is corrected for RMR (corrected metabolic equivalent of task), no group
differences in EE emerged. We estimate that EE (i.e. EE due to PA) is roughly 360 kcal/day in the outpatient
group and 400 kcal/day in the inpatient group. Based on the use of the self-report (IPAQ) data, combining
RMR with EE provides energy neutral points of 1620 kcal/day for the outpatient AN group and 1578 kcal/
day for the inpatient AN group. As the two patient groups report that they undertake higher levels of
exercise than that suggested by the objective actimetry scores, the actual total daily EE in these two clinical
groups is likely to be lower than our estimate (e.g. by roughly 200 kcal/day).
Energy expenditure may be of concern when a patient is at low weight/not eating. However, given that
they have a high drive to exercise and that PA may improve affect, reduce stress and possibly improve
general health, it is arguable that awareness of the caloric consequences of exercising will enable the
desire to exercise to be more easily negotiated in relation to food intake.
Discussion
Summary
The data on psychopathology and on body composition were as expected (i.e. patient groups had
significantly higher ED pathology, anxiety, depression and stress and lower BMI, fat and muscle than the
HCs and the anxiety groups). This information was fairly consistent both cross-sectionally and longitudinally.
The PA data are less easy to interpret. Self-reported PA (IPAQ scores) showed that the two AN groups
reported higher levels of activity across all levels of PA (especially walking) than the anxious and HC
groups. These two patient groups reported slightly different exercise profiles: AN outpatients reported
undertaking more moderate and vigorous activity than the two control groups and the AN inpatients
reported the opposite (i.e. that they engaged in less moderate and vigorous activity than HCs). In contrast,
actimetry showed that average and peak PA levels in the AN groups were quite similar to those reported
by the HCs and anxious participants.
Both the groups with AN had significantly higher drives to exercise than the HCs and the anxious group,
and the groups valued different reasons for exercising as more or less important. For example, the AN
groups rated weight control, improving mood and improving tone as more important motivators for
engaging in exercise. In contrast, the anxiety and HC groups rated health as the most important
exercise motivator.
Physical activity
Physical activity measured by actimetry (both cross-sectionally and longitudinally) shows that the AN groups
spent similar amounts of time exercising, and at similar intensities, as HCs, whereas, on the self-report
measure, the outpatient AN group have higher PA scores at all intensity levels. The self-report data are
therefore consistent with other findings indicating increased PA in AN,232,235,236 and also with our first
hypothesis. The objective data do not support our original hypothesis, but do support the findings of Zipfel
et al.238 that individuals with AN and controls showed similar levels of PA when objective measures are
used (e.g. the doubly labelled water method). Zipfel et al. also reported that not all individuals with AN
have increased levels of PA. However, in the present study, although we saw a range in activity in the AN
group, there was no relationship between illness severity and PA and, last, no evidence of activity-based
subgroups emerged.
The data from the self-report (IPAQ) measure (both cross-sectional and longitudinal) suggest that there are
group differences in the exercise type that is undertaken (e.g. inpatients reported spending significantly
more time walking). This suggests that these individuals choose types of exercise that are appropriate for
their weight and physical ability in order to satisfy their high drive for exercise. It may also be that it is the
most feasible method in an inpatient setting.
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Several potential explanations can be provided for the differences between subjective and objective
measures of PA. For example, objective measures may not accurately detect different intensities or types of
PA. This could occur when arm movements may not be consistent with the intensity of activity (e.g. uphill
walking or cycling). There may also be some limitations to self-report measures in terms of recall accuracy.
Additionally, it is possible that different groups estimate their levels of PA differently. HC participants may
underestimate this whereas, conversely, individuals with AN may perceive themselves to be highly active.
Furthermore, AN patients who are physically compromised may perceive PA at any level as a significant
physical investment, and this may result in them overestimating their activity. This idea is consistent with
the observed large SD and variance in our IPAQ data. Overall, the results suggest that individuals when
they are ill (and possibly in an inpatient setting) are undertaking PA at roughly the same level as HCs and
this in itself is of some clinical concern.
Drive to exercise and physical activity
Consistent with our second hypothesis, both the AN inpatient and outpatient groups had significantly
higher drives to exercise than the HC and the anxiety groups. Second, drive to exercise was not different
between the HC and the anxiety groups. It is therefore suggested that this drive to exercise is linked more
to ED than to anxiety. The absence of a strong relationship between anxiety and the drive to exercise or
objective/subjective measures of PA further supports this. Across the whole sample, there was a moderate
correlation between drive to exercise and all measures of self-reported PA (i.e. with total activity, walking,
moderate activity and vigorous activity). There were also moderate correlations between drive to exercise
and global ED score, exercising to to improve mood, improve tone, for fitness and for weight control.
Last, drive to exercise was inversely correlated with BMI and poorly with the DASS-21 anxiety score.
In the AN inpatient and outpatient groups, there was a significant relationship between drive to exercise
and exercising to control weight, to improve mood, to improve tone, for fitness and health, and peak
activity (based on actimetry). In the group with anxiety symptoms, drive to exercise was highly correlated
with self-reported vigorous activity. Finally, drive to exercise was moderately correlated with exercising to
improve mood in this group.
Hierarchical multiple regression analysis showed that the global EDE-Q score, exercising to control weight
and to improve mood, predicted drive to exercise across the whole sample after controlling for muscle (%)
and for BMI. In the anxiety group alone, stress (DASS-21 subscale) contributed most to the variance in
drive to exercise. For the AN outpatient group, the biggest contributors to variance in drive to exercise
were exercising to improve mood and global EDE-Q score.
Overall, results show that PA has several psychological drivers, as well as exercising to improve fitness and
tone. Engaging in PA seems to be driven by the desire to cope with stress and to improve mood in the
anxiety group. However, in people with AN, the drive may partly be to improve mood, but, in this group,
the absence of a relationship between PA and anxiety scores suggests that drive to exercise is not primarily
a response to anxiety. It appears that these behaviours are associated with body and weight concerns
(i.e. central elements of ED psychopathology). Data thus support our hypotheses and previous findings242
that the drive to exercise in AN is substantially motivated by concerns at the core of ED psychopathology
(e.g. the cognitive issues related to losing/maintaining low weight).
Endocrine findings
Anorexia nervosa inpatients have significantly higher cortisol levels than HCs, which is to be expected given
the higher level of anxiety in this group. A small correlation was observed between cortisol level and
DASS-21 anxiety score. Both AN groups had significantly lower leptin levels than HCs, and there was a
strong and highly significant correlation between leptin and body fat percentage (both these findings are
consistent with expectations).
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Strengths and limitations
A strength of this investigation is that it allowed for PA to be directly compared in people with AN and
with moderate anxiety. Second, participants in each group were of similar ages, which is important when
comparing PA. Additionally, combining both objective and subjective measures allowed us to assess and
compare different methodologies for studying PA. An additional advantage was that measures of ED
psychopathology, general psychopathology and biology were collected along with the activity data. Finally,
the study was conducted cross-sectionally and longitudinally (over 24 weeks).
The investigation had some limitations. First, the more complex analyses used in this study (e.g. group
differences in predictors of reasons for exercise) are probably underpowered. In addition, some data were
missing because participants occasionally forgot to wear the Actiwatches and also because self-report data
were collected retrospectively over a period of 7 days, making such data slightly less reliable. In addition,
there is the possibility of some recruitment bias in the AN groups (i.e. not all of the people with the
problem might be willing to join an investigation assessing PA). Finally, participants were predominantly
white females and, therefore, it might not be possible to generalise our data to men and/or to different
ethnic groups.
Conclusions
Our activity measurements gathered from self-report data indicate that levels of PA are higher in invividuals
with AN than in HCs or those with moderate anxiety, whereas the actimetry data show that these groups
do not differ in their amount or level of PA. It is possible that self-report overestimates the level of PA in
AN patients owing to differences in perception caused by the ED or because these individuals are in poor
physical health. Findings also show that patients with AN have a higher drive to exercise than HC and
anxiety groups. In AN patients, ED pathology, rather than anxiety, appears to be a more important
contributor to their increased drive to exercise. Estimates of RMR and of EE arising from PA will inform
decisions related to the clinical management of people with AN and will also inform discussions on the
role and use of exercise programmes in treatment.
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Chapter 8 Preventing deterioration and relapse in
severe anorexia nervosa: randomised controlled
feasibility trial of an e-mail-guided manual-based
self-care programme based on the Maudsley Model
of Anorexia Nervosa Treatment for Adults
(work package 5)
Abstract
Background
Relapse rates after inpatient treatment of AN are high. The aims of this study were (1) to assess the
feasibility of a relapse prevention programme for people with AN and (2) to acquire information to inform
a large RCT of this intervention.
Methods
Participants were inpatients with AN aged ≥ 16 years. Participants were recruited from seven UK specialist
ED units and randomly allocated to receive either manual-based e-mail-guided self-care for 12 months
combined with TAU or TAU alone. The manual was based on the MANTRA. E-mail support was delivered
weekly by therapists. Outcome assessments included BMI, EDE, depression, anxiety, quality of life and
service utilisation at 6 and 12 months post randomisation. Treatment ESs (Cohen’s d) were calculated.
Results
Forty-one patients participated. At 6 months post randomisation (and post discharge) there was little
difference between groups, with ESs between d = –0.08 and d = 0.3. At 12 months, patients receiving the
experimental intervention had a higher BMI (d = 0.41) and lower scores on the DASS-21 (d = 0.64).
Readmission rates were 5 out of 22 (22.7%) in the experimental group and 5 out of 16 (31.2%) in the
TAU alone group. No harms were detected.
Conclusions
These findings suggest that this low-intensity relapse prevention may be beneficial in the aftercare of
inpatients with AN and that a large-scale RCT of this intervention may be justified.
Trial registration
Current Controlled Trials ISRCTN18274621.
Introduction
Anorexia nervosa is a life-threatening illness that is associated with a mortality rate among inpatients that
is twice that of those with other psychiatric disorders, and a suicide rate 200 times that of the general
population.72,272,273 There are high levels of physical disability and psychological comorbidity and the median
duration of AN is 6 years.274 Although for most patients with AN the treatment of choice is outpatient
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psychological therapy, a proportion of cases with severe and potentially life-threatening illness need skilled
refeeding in hospital. The threshold for inpatient treatment in AN differs in different countries. In continental
Europe, admission to hospital appears to be more common than in the UK, where this treatment is reserved
for the most severe cases. Duration of inpatient care also varies in different health-care systems, with longer
durations of admissions in European countries than in the USA.193 Although patients usually manage to gain
weight in hospital, deterioration and relapse following inpatient treatment is common and typically occurs
within the first year of treatment. Approximately 30–50% of those who remit relapse.228,275–278 The reasons
for these high relapse rates are complex, but may in part be to do with patients’ physical improvements
during inpatient refeeding not being mirrored by similar psychological improvements. Thus, effective
psychological aftercare following inpatient treatment is important. This is echoed by the NICE guidelines
for EDs,279 which recommend that people discharged from inpatient care should be followed up for at least
1 year post discharge. In practice, as patients often live at some distance from a specialist inpatient unit,
this follow-up often is delivered by non-specialists, making aftercare practice variable and haphazard.
Only a handful of studies have addressed the question of how best to reduce relapse rates after inpatient
weight restoration. Antidepressant treatment alone appears to be unacceptable to the majority of eligible
patients,280,281 and ineffective.206 Two studies in adolescents found family therapy to be superior to
individual treatment190,282 or TAU.283 Conversely, in adults with AN, one study found individual therapy to
be somewhat superior to family therapy in preventing relapse,190,282 although a second study using a similar
design found no difference between family therapy and two types of individual therapy.284 In one small
study, CBT was superior to nutritional treatment alone in preventing relapse.207 However, in another study
which compared CBT alone or in combination with fluoxetine alone, dropout rates in all three groups
were too high to draw any conclusions about efficacy,281 casting doubt on the acceptability of these
interventions. Finally, a large-scale RCT (n = 258 participants) from Germany compared an internet-based
cognitive–behavioural relapse prevention programme with TAU. In the ITT analysis, patients receiving the
internet-based relapse prevention programme gained a small amount of weight, whereas those receiving
TAU lost a small amount, although the difference was non-significant. There were significantly more
readmissions to hospital in the relapse prevention group.285
We have designed and piloted a novel manual-based outpatient treatment for adults with AN
(MANTRA).19,126 The content, structure, research underpinning this treatment and iterative development
process have been described in detail elsewhere.20,136,286 In brief, MANTRA is an empirically based cognitive-
interpersonal treatment that is trait focused and targets key intra- and interpersonal maintenance factors
of AN. It is centred around a patient manual and is modularised with a clear hierarchy of procedures,
tailored to the needs of the individual. It has shown promise in pilot studies.136,286 For the purpose of the
present study, this treatment and manual were adapted for use in inpatients following discharge from
hospital. We evaluated here the feasibility of using it as an internet-based-guided self-care treatment,
supported via e-mail, given that many patients live at a considerable distance from specialist ED units
(internet-based Maudsley Model of Anorexia Nervosa Treatment for Adults; iMANTRA).
The aims of the study were (1) to assess the feasibility of using e-mail-guided self-care treatment added to
TAU in the post-admission care of hospitalised AN patients and (2) to acquire key information that would
inform development of a large-scale RCT that will assess the efficacy and cost-effectiveness of this intervention
added to TAU compared with TAU alone. Only efficacy data are reported here; cost-effectiveness data are not
yet available and will be published elsewhere when complete.
The specific objectives of the proposed feasibility study were to:
(a) assess recruitment and treatment uptake rates
(b) determine what is an appropriate frequency of e-mail support for patients
(c) determine the best instruments for measuring outcomes in a full trial by examining the quality,
completeness, and variability in the data
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(d) estimate the treatment ESs and SDs for outcome measures to inform the sample size calculations for
a large-scale RCT
(e) evaluate whether or not the treatment is operating as designed by analysing process measures,
such as worry and intolerance of uncertainty
(f) determine whether or not patients with AN see this treatment as acceptable and credible.
Method
Design
The trial was a multicentre two-arm feasibility trial that compared iMANTRA added to TAU with TAU alone
in consecutive referrals of patients discharged from inpatient treatment for AN. Ethics approval was
obtained from the National REC West Midlands – Edgbaston, reference number: 08/H1208/33. The trial
was registered with Current Controlled Trials ISRCTN18274621. Recruitment and follow-up procedures
took place between March 2009 and December 2012.
Participants and recruitment
Patients were recruited from seven specialist adult or adolescent inpatient units in the UK. These were
South London and Maudsley NHS Foundation Trust; Seacroft Eating Disorders Unit, Leeds Teaching Hospitals
NHS Trust; St Ann’s Hospital, Barnet, Enfield and Haringey Mental Health Trust; South West London and
St George’s Mental Health NHS Trust; Huntercombe Hospitals (Stafford, Edinburgh); The Priory Hospital,
Roehampton; and Royal Victoria Hospital, Newcastle upon Tyne. Patients’ suitability for participation in the
study was checked by a clinician from the EDs team towards the end of their inpatient treatment (i.e. within
1 month of discharge). If the patient was suitable for participation, their fully informed written consent was
sought and after this she/he was introduced to the researcher who completed the research assessment.
Inclusion/exclusion criteria
Inclusion criteria
Patients fulfilling criteria for DSM-IV AN or atypical AN who had undergone a period of inpatient treatment
in one of the participating ED services were eligible for inclusion in the study if they were aged ≥ 16 years;
had reliable access to broadband internet; were available over the full duration of the study; and had
shown clinically significant weight gain during inpatient treatment (a minimum of approximately 3 kg or
1 BMI point).
Exclusion criteria
Unstable AN (i.e. actively losing weight at the end of treatment); insufficient knowledge of English or
literacy levels insufficient to allow understanding of the manual and assessment; psychosis; acute
suicidality; substance dependence; and diabetes mellitus. We did not exclude patients on psychotropic
medication (antidepressants, antipsychotics), which are commonly prescribed in this population.
Comparison groups
Common features
All participants were signed up for regular weighing and physical risk monitoring at their GP surgery. A
crisis plan with names and numbers of who to contact in an emergency was also drawn up with patients
prior to discharge.
Internet-based Maudsley Model of Anorexia Nervosa Treatment for Adults plus
treatment as usual
Those allocated to iMANTRA plus TAU were sent an e-mail informing them of their treatment allocation
and giving them some information about their e-mail therapist and the frequency and nature of the e-mail
contact. E-mail contact was offered one to three times weekly for the first 6 months following discharge
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and then more flexibly (once weekly to monthly) during months 7–12. Participants were also told not to
use their e-mail therapist for urgent out-of-hours or other crisis support and instead use the crisis contacts
on their list. Participants were asked to complete an online questionnaire giving some background
information about themselves, to help their e-mail therapist to get to know them better. This questionnaire
included questions on their current difficulties, struggles and worries; their hopes, ambitions and goals for
the future; their key current relationships, in particular with people who might be able to support them;
their personal history; and any important events that have affected or shaped them and any previous
treatments that they may have had (a copy of this questionnaire can on request be obtained from
the authors).
Patients were also offered an initial telephone call with their online therapist to give both patient and
therapist the opportunity to ask questions and clarify information. Finally, patients were sent the revised
version of the MANTRA workbook. This included (1) a traffic light system of relapse risk for patients to
complete, to increase their awareness of potential indicators of such risk; (2) a nutrition plan that was
designed for weight maintenance and also gave information on what to do if more weight gain was
needed; (3) a module addressing anxiety-related processes, such as worry and intolerance of uncertainty
and strategies to reduce them (this was included as patients with AN generally have high levels of anxiety,
worry and intolerance of uncertainty,287–290 and it was thought that during the post-discharge period this
would be particularly intensive and therefore an important treatment target); and (4) strategies to prevent
and cope with deterioration and lapses.
The role of the therapist was to be motivational and supportive, with the aim to guide patients in their use
of the workbook, by suggesting use of relevant modules, thereby tailoring the intervention to the relapse
risk and clinical profile of the patient. Patients in this group also received TAU from their local Community
Mental Health Team or Child and Adolescent Mental Health Team.
Treatment as usual
Patients randomised to this group did not receive the internet-based intervention. They received TAU from
their local Community Mental Health Team or Child and Adolescent Mental Health Team. They were
followed up at regular intervals using the same assessment measures as patients who received the
iMANTRA intervention.
Measures
Body mass index
Body mass index (weight/height2) was obtained from the medical notes for each patient at admission and
at discharge. At 6 and 12 months this was obtained from treating clinicians or from patient self-report.
Interview measures
These were done at baseline and at 6 and 12 months and included (1) the EDE291 and (2) the CSRI.153
These were completed in person or by telephone.
The EDE is a widely used, semistructured interview that generates four subscale scores: dietary restraint,
eating concern, weight concern and shape concern. The mean of these four subscales is used to create a
global score.
The CSRI is an inventory of service use that facilitates estimation of support costs. It was adapted for the
current study to cover a wide variety of hospital, mental health, and community-based services as well as
medications, impact of employment and additional personal expenditure due to the ED.
Questionnaire measures
These were completed at baseline and at 6 and 12 months.
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Eating disorders pathology
Eating Disorders Examination-Questionnaire141 This is a self-report measure assessing ED symptoms
over the previous 28 days. This instrument has good reliability and validity in ED samples.212 High scores
indicate greater ED psychopathology.
Other psychopathology
Depression Anxiety and Stress Scales short version97 This is a 21-item self-report measure to assess
mood state over the past 7 days using a four-point Likert scale. Total score as a measure of general distress
or depression, anxiety and stress subscales can be used. High scores indicate higher symptomatology. This
measure has good reliability and validity.210
Quality of life
World Health Organization’s Quality of Life Questionnaire213 Items are rated on a five-point Likert
scale pooled in four domains: physical health, psychological, social relationships and environment. Good
psychometric data have been reported for this scale. High scores indicate better quality of life.
Anxiety-related processes
Penn State Worry Questionnaire292 This is a 16-item questionnaire rated on a five-point scale, with
higher scores indicating a greater tendency to worry. The Penn State Worry Questionnaire (PSWQ) has very
good psychometric properties293 and is the most established measure of trait worry.
Intolerance of Uncertainty Scale294 The Intolerance of Uncertainty Scale (IUS) is a 27-item measure
designed to assess the cognitive, emotional and behavioural aspects of intolerance of uncertainty. Items
are scored on a five-point Likert scale. High scores denote high levels of intolerance of uncertainty. The IUS
has very good psychometric properties.295
Acceptability
At 12 months, patients who had been randomised to the active intervention were asked questions about
what they thought had been the most helpful aspects (e-mail, manuals) and also what they thought about
content and structure (e.g. frequency of e-mail contact) of the intervention.
Randomisation, blinding and protection against bias
Randomisation was conducted independently from the trial team by the King’s College London CTU using
a computerised system. Patients were randomised to the iMANTRA intervention plus TAU versus TAU
alone, at a ratio of 1 : 1. Randomisation was carried out using minimisation to balance groups for
prognostic factors (previous hospitalisation; illness subtype). Patients were told about the outcome of
randomisation by an e-mail sent to them by a study administrator. Throughout the trial every effort was
made to ensure that the researcher who conducted outcome assessments remained blind to patients’
treatment allocation.
Therapists
Three experienced ED therapists delivered the e-mail support. All had undergone a 1-day training
programme preparing them to deliver the intervention. The focus of the training was to standardise
delivery of the e-mail contact. Therapists were instructed to keep e-mails brief, be informal, warm and
supportive in tone, point patients in the direction of appropriate materials from their manual that might be
relevant in keeping them well or helping them to make further improvement and provide non-intrusive
monitoring of symptoms via the traffic light relapse prevention tool.
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Statistical analyses
Outcomes were analysed on an ITT basis, that is, participants were analysed in the group to which they
were randomised irrespective of their compliance with the assigned treatment. No formal hypothesis
testing was undertaken, as this is a feasibility study. ESs (Cohen’s d) were calculated for continuous
outcomes at 6 and 12 months from means, SDs and sample sizes using the ES calculator of the Campbell
Collaboration [URL: www.campbellcollaboration.org/effect-size-calculato.html (accessed 3 July 2017).
Results
Patient flow
Figure 4 shows the participant flow through the study. Twenty-four participants were randomised to
iMANTRA plus TAU and 17 to TAU alone.
Screened for eligibility
(n = 210)
Eligible
(n = 103)
Randomised
(n = 41)
Allocated to iMANTRA plus TAU
(n = 24)
• Did not start treatment, n = 3/24 
   (12.5%)
• Started treatment, n = 21/24 (87.5%)
Analysed
(n = 24)
Excluded from analysis, n = 0 
Completed EDE interview or 
questionnaire
• Baseline, n = 24/24 (100%)
• 6 months, n = 22/24 (91.7%)
• 12 months, n = 17/24 (70.8%) 
Completed BMI assessment
• Baseline, n = 24/24 (100%)
• 6 months, n = 23/24 (95.8%)
• 12 months, n = 21/24 (87.5%)
Underwent baseline assessment
(n = 44)
Not included
(n = 59)
Allocated to TAU only
(n = 17)
Analysed
(n = 17)
Excluded from analysis, n = 0 
Completed EDE interview or 
questionnaire
• Baseline, n = 17/17 (100%)
• 6 months, n = 12/17 (70.6%)
• 12 months, n = 10/17 (58.8%) 
Completed BMI assessment
• Baseline, n = 17/17 (100%)
• 6 months, n = 13/17 (76.5%)
• 12 months, n = 14/17 (82.4%)
Not eligible
(n = 107)
• Too ill
• Discharge against medical advice
• Not primary AN diagnosis
• No internet
• Preference for other form of 
   aftercare or not interested in study
• Intensive after-care
• Other
Patient withdrew
(n = 3)
FIGURE 4 Consolidated Standards of Reporting Trials flow diagram (WP5).
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Patient characteristics at baseline
Patients in the two treatment groups were similar in terms of baseline sociodemographic and clinical
characteristics (Table 27), with the exception of the WHOQOL-100 environmental subscale, according to
which the iMANTRA group had significantly poorer quality of life than the TAU group [t(32.6) = –2.34;
p = 0.025]. All had severe AN (mean admission BMI of 14.1 kg/m2), with just over half (51%) having had
at least one additional previous admission to hospital. Patients had made considerable gains in weight
while in hospital (discharge BMI of 18.0 kg/m2) and prior to coming into the study.
Acceptability of internet-based Maudsley Model of Anorexia Nervosa Treatment
for Adults
Twenty-one of 24 (87.5%) patients allocated to iMANTRA plus TAU took up this treatment. Five iMANTRA
patients completed the 12-month acceptability questions. All five said that the e-mail contact was the most
helpful element of the intervention. All five participants rated the frequency of e-mails as ‘the right amount’.
TABLE 27 Baseline clinical and demographic data
Characteristic
Whole group iMANTRA plus TAU TAU only
n Mean (SD) or n (%) n Mean (SD) or n (%) n Mean (SD) or n (%)
Demographic details
Age 41 24.2 (9.6) 24 24.8 (10.1) 17 23.3 (8.9)
Gender ratio (male : female) 41 4 : 37 24 2 : 22 17 2 : 15
Proportion with a partner 41 5/41 (12%) 24 4/24 (16.6%) 17 1/17 (6%)
Clinical details
Diagnosis 41 24 17
AN-R 33/41 (80.5%) 20/24 (83.3%) 13/17 (76.5%)
AN-BP 8/41 (19.5%) 4/24 (16.6%) 4/17 (23.5%)
Age of onset 41 17.6 (6.0) 24 17.8 (4.8) 17 17.4 (7.6)
BMI at hospital admission 38 14.1 (1.4) 23 13.9 (1.7) 15 14.3 (1.0)
Proportion with one or more
previous admissions
41 21/41 (51.2%) 24 12/24 (50%) 17 9/17 (52.9%)
BMI at study entry 41 18.0 (1.9) 24 18.1 (2.2) 17 17.9 (1.4)
EDE global 40 2.8 (1.4) 24 2.9 (1.3) 16 2.7 (1.6)
DASS-21 total score 36 28.6 (18.0) 22 28.7 (17.6) 14 28.3 (19.2)
WHOQOL-100 35 21 14
Physical 47.8 (13.7) 48.0 (10.7) 47.5 (17.7)
Psychological 40.1 (15.7) 37.8 (13.4) 43.4 (18.7)
Social 42.1 (22.3) 37.2 (23.6) 49.5 (18.5)
Environmental 67.2 (19.8) 61.5 (20.8) 75.7 (15.10)
PSWQ 36 62.6 (13.5) 22 63.7 (12.0) 14 60.9 (15.8)
IUS 36 87.9 (27.8) 22 88.3 (27.3) 14 87.2 (29.5)
Proportion currently taking
psychotropic medication
41 24/41 (58.5%) 24 14/24 (58.3%) 17 10/17 (58.8%)
AN-BP, anorexia nervosa, binge-purge type; AN-R, anorexia nervosa, restricting type.
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Treatment outcomes
Table 28 shows outcomes on interview and questionnaire variables at 6 and 12 months.
At 6 months there was little difference in outcomes between groups, with ESs between d = –0.08 and
d = 0.3 (i.e. negligible to small). At 12 months, patients receiving the experimental intervention had a
higher BMI (d = 0.41) and lower total scores on the DASS-21 (d = 0.64). However, CIs were wide and
overlapped with zero.
Service utilisation
Ten patients required readmission to hospital during the trial, 22.7% (5/22) in the iMANTRA group and
31.2% (5/16) in the TAU alone group. This difference was not significant [χ2(1) = 0.347; p = 0.556].
Comparable numbers of patients in each group had GP or outpatient care during the study period
[iMANTRA: 12/18 (66.6%); and TAU alone: 10/15 (66.6%)]. The proportion of patients with no additional
treatment was also similar in both groups [iMANTRA: 1/18 (5.5%); and TAU alone: 1/15 (6.6%)]. No
patient died during the study period.
Harms
No harms were detected.
TABLE 28 Outcomes and estimates of treatment effects at 6 and 12 months
Outcome
iMANTRA plus TAU TAU alone ES
n Mean (SD) n Mean (SD) d 95% CI
BMI at 6 months 23 17.1 (2.9) 13 17.3 (1.88) –0.08 –0.76 to 0.60
BMI at 12 months 21 18.0 (3.3) 14 16.9 (1.4) 0.41 –0.28 to 1.09
EDE global at 6 months 22 2.9 (1.7) 12 2.9 (1.8) 0 –0.70 to 0.70
EDE global at 12 months 17 2.9 (1.7) 10 2.9 (1.9) 0 –0.78 to 0.78
DASS-21 total at 6 months 18 28.6 (16.9) 9 26.6 (20.4) 0.11 –0.69 to 0.91
DASS-21 total at 12 months 15 26.5 (16.4) 6 37.8 (20.7) –0.64 –1.61 to 0.33
WHOQOL-100 at 6 months 17 8
Physical 46.5 (14.8) 43.9 (21.7) 0.15 –0.69 to 0.99
Psychological 39.4 (16.9) 41.6 (20.5) –0.12 –0.96 to 0.71
Social 42.4 (25.3) 39.9 (18.3) 0.10 –0.73 to 0.95
Environmental 61.6 (22.1) 63.5 (15.3) –0.09 –0.93 to 0.75
WHOQOL-100 at 12 months 15 8
Physical 47.5 (16.7) 52.1 (20.6) –0.25 –1.12 to 0.61
Psychological 39.3 (19.8) 32.1 (25.1) 0.33 –0.53 to 1.20
Social 41.7 (26.4) 46.9 (30.2) –0.19 –1.05 to 0.67
Environmental 67.2 (20.5) 66.6 (17.2) 0.03 –0.83 to 0.89
PSWQ at 6 months 19 63.2 (11.1) 9 59.3 (15.2) 0.31 –0.51 to 1.15
PSWQ at 12 months 15 62.5 (11.6) 8 59.9 (14.7) 0.20 –0.66 to 1.06
IUS at 6 months 18 91.4 (25.5) 9 87.4 (27.5) 0.15 –0.65 to 0.95
IUS at 12 months 12 88.3 (30.2) 8 95.3 (29.8) –0.23 –1.13 to 0.66
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Discussion
This study shows that iMANTRA is a feasible and acceptable intervention when added to TAU in the
post-hospitalisation aftercare of patients with AN. Although at 6 months post admission there was little
difference in outcomes (with ESs negligible or small), at 12 months between-group ESs favoured iMANTRA
in terms of its effects on BMI and depression, anxiety and stress (d = 0.4–0.6). Moreover, readmission rates
were somewhat lower in the iMANTRA group. Taken together these findings suggest that this approach
has promise and should be studied further. Further evidence supporting this approach comes from a study
in Germany,296 which adapted the MANTRA relapse prevention manual for a brief post-admission aftercare
intervention with patient and therapist communicating via telemedicine. In an uncontrolled pilot study, this
intervention showed promise.297
In terms of the specific feasibility objectives, the study ascertained that this intervention is not for everyone,
as only 19.5% of inpatients screened for the study were found eligible and agreed to participate (feasibility
objective a). This raises the question as to how representative of the typical inpatient population in the UK
participants was. A recent multicentre cohort study of short-term outcomes of hospital treatment of AN in
the UK found a mean admission BMI of 14 kg/m2, a mean discharge BMI of 17.3 kg/m2 and a mean illness
duration of 8 years for adults.219 This suggests that our case mix was very similar to that of a typical adult
inpatient with AN.
Feasibility objective b was to determine what is an appropriate frequency of e-mail support. Although only
a small number of participating patients (n = 5) answered questions about the acceptability of the
intervention offered, all five felt that the offered frequency of e-mail support (i.e. once or twice a week)
was ‘about right’.
Feasibility objective c was to determine the best instruments for measuring outcomes in a full trial. The
study suggests that both BMI and negative affect (depression, anxiety and stress) are candidate primary
outcomes for future large-scale studies and the ESs obtained would inform sample size calculations for
such a study (feasibility objective d).
Feasibility objective e was to get an idea of whether or not the treatment was operating as designed by
analysing process measures such as worry and intolerance of uncertainty. Between-group ESs at 6 and
12 months were small and mostly not in the expected direction (i.e. did not suggest that reductions in
worry or intolerance of uncertainty were specifically associated with receiving iMANTRA).
Finally, feasibility objective f was to determine whether or not patients with AN see iMANTRA as an
acceptable and credible intervention. The limited feedback patients gave at 12 months seemed to indicate
this. Given the need for regular physical health monitoring in cases of AN, it has previously been said that
self-help treatments are contraindicated in this condition.298 Our findings show that there were no severe
untoward events, suggesting that, if delivered with appropriate physical risk monitoring in place, a
specialist intervention given at a distance can be delivered safely as an adjunct to TAU.
One important question is how findings from the present study compare with those of the only other
(large-scale) study of internet-based aftercare following inpatient treatment.285 Like the patients in the
present study, those in the Fichter et al.285 study were highly selected [i.e. 1802 patients were screened
and 258 of these (14.3%) entered the study]. Age at entry into our study was very similar to that in the
study by Fichter et al., as was patients’ BMI at discharge (i.e. study baseline). However, no information
is available about whether or not Fichter et al.’s patients were as chronically ill or had been as unwell
(in terms of their weight at admission) prior to starting treatment.
Finally, one important lesson for a potential future study utilising this approach concerns the fact that
patients did not know their e-mail therapist. Informal feedback from trial therapists was that this made it
harder for patients and therapists to form a therapeutic relationship. In future studies it would be desirable
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for therapists to meet the patients to whom they are providing iMANTRA, and perhaps this could even be
the therapist the patient had worked with in the inpatient unit.
Strengths
The study recruited patients from a range of specialist units in the UK including those in the NHS and
private sector and the patients recruited seemed representative of a typical AN inpatient population.
Limitations
The sample size was small and TAU-only patients were harder to follow up than those allocated to
iMANTRA. This may reflect TAU-only patients’ disappointment about not being offered the experimental
treatment component. No attempt was made to standardise TAU. Furthermore, the use of a TAU alone
comparison also means that observed effects may not be due to iMANTRA specifically, but rather to
participants receiving additional support of any kind. Future studies should remedy this.
Conclusion
In conclusion, this study shows that a low-intensity e-mail-guided manual-based self-care intervention has
promise in reducing deterioration and relapse in the year following inpatient treatment in patients with
severe AN.
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Chapter 9 Maternal eating disorders: effects on
fertility and child development (work package 6)
Abstract
Objectives
Three studies examining the effects of maternal EDs on (1) fertility, (2) their offspring’s dietary patterns and
(3) growth trajectories.
Design
Data from the Avon Longitudinal Study of Parents and Children (ALSPAC).
Participants
A total of 11,088 women from the ALSPAC birth cohort and their children.
Main outcome measures
(1) Maternal self-report on time taken to conceive and whether they had ever received help to conceive,
(2) maternal report of child diet at 38, 54, 81 and 103 months, and (3) child weight and height at 1, 2,
5 and 10 years.
Results
(1) Women with AN were more likely than women without an ED to have sought fertility treatment and to
have had an unintentional pregnancy; women with AN and BN were more likely than women without an
ED to have received help to conceive and to have taken longer than 6 months to conceive. (2) Children of
mothers with AN and BN were more likely to be ‘health conscious’ in terms of diet and less likely to have a
‘traditional’ type of diet. (3) There was a complex pattern of differences in trajectories of height, Ponderal
Index (PI) and BMI in children of women with an ED compared with children of HCs.
Conclusions
Women with an ED experience difficulties in the pre-conception period and show postnatal differences in
their diet patterns. Growth trajectories in their children were found. Continuity of care from pre-conception
to the postnatal period is paramount for women with an ED.
Introduction
Psychiatric illness and parenting
Children of parents with a mental illness have an increased risk of developing psychological disturbances
and psychiatric disorders themselves.299,300 Within the study of EDs the topic of pregnancy and motherhood
has been investigated only more recently. Nevertheless, there is evidence that an ED can affect parenting
ability and have adverse outcomes on children’s development.301 Furthermore, the offspring of mothers
with an ED are at an increased risk of developing disordered eating themselves, and it has been proposed
that a cycle of risk may be occurring, perpetuating EDs across generations.302 Gaining a greater
understanding of the associations between EDs, pregnancy and child development may extend our current
understanding of the risk of intergenerational transmission of an ED.
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Eating disorders and fertility
The presence of an ED can cause significant disruption to a woman’s menstrual cycle, and impaired fertility
has been shown to exist across the spectrum of EDs. Women with a history of AN have shown to have
greater disturbance in their menses than HCs.303 Furthermore, these differences have been shown to
continue in up to 30% of recovered women.304 Women with a history of BN or EDNOS have also shown
to frequently have greater disturbance in their menses,305,306 even though their body mass is usually within
the normal range.
There is not enough research to understand the effect of EDs on fertility. Past research, based on two small
studies of women looking for infertility treatment, found similar prevalences: 16–20% of women seeking
infertility treatment met clinical criteria for an ED.256,307 However, there have also been contradictory
reports with regards to long-term follow-up studies. For example, Bulik et al.308 found that the rates and
frequencies of pregnancies were similar in women with AN and HCs; furthermore, Crow et al.309 found the
same results in women with BN.310 On the other hand, when looking at births in women with AN, the
number has been reduced to one-third of the expected rate.
A better and more precise measure of fertility may be time taken to conceive.311,312 A majority of women
will become pregnant after trying to conceive for between 3 and 6 months, with 90% of them succeeding
after 12 months.313 Therefore, and based on the data, infertility has been defined as inability to become
pregnant after trying to conceive for a period of 12 months or longer,314 with delays in conception being a
good measure of a range of underlying fertility problems.
Dietary patterns in children of mothers with eating disorders
There is evidence that mothers with an ED may find catering for the nutritional needs of their children
especially challenging. However, only a small number of studies have examined the impact of a maternal
ED on their child’s diet. The literature indicates a high risk for feeding difficulties in children of women
with an ED.315 These difficulties may lead to different nutritional intake in their children and have long-term
implications for health and development.
Only one previous study has investigated the dietary intake in children whose mothers have an ED;316
although this study found the diet of the children to be generally unaffected, there was some suggestion
that children of women with an ED consumed less junk food than children in the control group. However,
this particular study was limited by the small sample size and the fact that the sample comprised children
at different ages at a single time point. No previous studies have longitudinally investigated dietary
patterns and nutritional intake in children of women with an ED.
Growth in the offspring of women with an eating disorder
Taking into consideration the possibility of an association between a maternal ED and their offspring’s
feeding and eating habits, it is important to also consider the possibility of an association between a
maternal ED and their offspring’s growth.
Maternal EDs, particularly AN, at the time of pregnancy are associated with higher risk of fetal growth
restriction and low birthweight.317,318 Conversely, it has recently been reported that women with binge
ED during pregnancy are more likely to deliver babies that are large for gestational age.319 Although
preliminary studies have suggested that these children may reach an adequate postnatal growth in
favourable environments,320 others indicate that altered growth patterns may continue throughout infancy
and childhood.321
The large majority of studies in the past have used small samples and included large age ranges, making it
difficult to generalise findings. To the best of our knowledge, only one study has investigated growth in
the offspring of mothers with an ED in a longitudinal manner, reaching the conclusion that children of
women with an ED gained less weight at 1 year compared with HCs;322 however, their BMI was similar to
those of controls when the children reached the age of 10 years.323
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Aims
The overall aim of the studies undertaken was to further investigate the effects of EDs on women’s fertility
and the dietary patterns and growth trajectories of their offspring. Three separate studies are outlined to
achieve the overall aims. The specific aims of each study are outlined below.
Study 1: time taken to conceive among women with eating disorders
The aim of study 1 was to investigate the length of time taken to conceive and the prevalence of fertility
problems and unintentional pregnancies in women with EDs, compared with women without an ED.
Study 2: longitudinal dietary patterns in the offspring of mothers with eating disorders
The aim of this study was to explore different dietary patterns among children of women with EDs,
compared with children of women without an ED, longitudinally between 3 and 9 years.
Study 3: growth trajectories in the offspring of mothers with eating disorders
The aim of this study was to study the differences in growth trajectories (between birth and 10 years) in
children of women with an ED, compared with children of women without an ED and children of women
with other psychiatric disorders, in a large prospective population-based cohort.
Methods
Design and participants
Data for this study were collected from the ALSPAC.324 ALSPAC is a longitudinal birth cohort study, based
in Avon, England, which includes all women who were willing to participate and who were due to have a
child between 1 April 1991 and 31 December 1992.
A total of 14,663 women were initially enrolled in the study when they were 9 weeks pregnant. Using
postal questionnaires, data were obtained from 14,472 women. In the current studies we only included
singleton live births (n = 12,254) and excluded all women who were missing information on psychiatric
history (n = 2019).
Outcomes and measures
Eating disorder classification
At 12 weeks’ gestation women were asked questions regarding recent or past psychiatric problems, which
included depression, schizophrenia, alcohol abuse, AN, BN and other disorders. For all three studies
women were grouped according to their response to this question.
A total of 171 (1.5%) women responded yes to the question ‘Have you ever had AN?’, 199 (1.8%)
admitted to having ever suffered from BN and another 82 (0.7%) admitted to both AN and BN, with
10,636 (96%) forming the unexposed group (those who answered negatively to the questions on EDs).
In studies 1 and 2, women reporting a psychiatric disorder (n = 1166) other than an ED were excluded
from the analysis. To investigate whether or not differences in childhood growth are specific to maternal
ED status, this group is included in the analysis as a separate comparison group.
Sociodemographic variables
Highest education, household income, parity and ethnicity were collected via questionnaire from the
mothers during pregnancy. Child gender and maternal age were recorded at the time of birth.
Study 1 measures: time taken to conceive
At 12 weeks women were asked ‘if they had ever seen a doctor for infertility problems and if they had
received treatment or help to conceive the current pregnancy’. In a later stage, at 18 weeks’ gestation,
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they were asked how long it took them to conceive. This was a multiple-choice question with four possible
answers: < 6 months, 6–11 months, 1–3 years and > 3 years. For the current study, we collapsed the four
possible answers into two dichotomous variables: less/more than 12 months (to study rates of infertility)
and less/more than 6 months (to study underlying difficulties conceiving). The analyses in the current study
were restricted to women who had become pregnant intentionally (n = 7694).
Study 2 measures: dietary patterns
When the children were 38, 54, 81 and 103 months of age, data were collected from Food Frequency
Questionnaires and included in the current study. For ease of reporting, these time points will be referred
to by the child’s approximate age in years: 3, 4, 7 and 9, respectively. Each Food Frequency Questionnaire
contained questions asking about the frequency of consumption of a variety of foods and drinks. The
mother, or main carer, indicated how often the child was currently consuming a variety of food items on a
scale from one to five. All data were standardised, and a principal component analysis, which is described
by North and Emmett,325 and Northstone and Emmett,326,327 was performed on the standardised items.
The principal component analysis yielded three distinct dietary patterns: (1) ‘processed’, (2) ‘health
conscious’ and (3) ‘traditional’ at each time point. An additional dietary pattern was identified at the age
of 3 years and was labelled ‘snack foods’. For each child, a score was created for each dietary pattern,
which is used in the analysis described below to investigate adherence (whereby increasing scores implies
greater adherence) to each dietary pattern.
Study 3 measures: height and adiposity
Birthweight and length were obtained via different measures. From medical records, birthweight was
obtained and birth length was obtained by ALSPAC staff shortly after birth. Later height and weight data
were obtained through health visitor records, parental reports in questionnaires and research clinic
attendances. Objective weight and height data were collected from age 7 years onwards. PI was calculated
as weight (kg)/height (m3), and BMI was calculated as weight (kg)/height (m3).
Statistical analyses
Study 1: time taken to conceive among women with eating disorders
We used univariate and multivariate logistic regression models to investigate the role of predictors
(maternal lifetime ED: AN, BN, AN + BN and no ED) on our main outcome variables. These were frequency
of planned pregnancies, fertility-related problems, treatment and time taken to conceive.
Covariates hypothesised as confounders were included at a second stage in analytical models: maternal
and paternal age, pre-pregnancy smoking, maternal education level and parity.
Study 2: longitudinal dietary patterns in the offspring of women with eating disorders
Univariate ANOVA and binary logistic regressions were used to assess differences in participant
characteristics in groups of women who reported ever having AN, BN, and AN and BN, compared
with the unexposed group.
Longitudinal analysis of dietary patterns was investigated using linear mixed-effects models, with random
intercepts. Predictors were maternal lifetime ED group and the time point at which childhood dietary
patterns were assessed (i.e. mean time of completion at assessment as a continuous variable). A random
intercept was also included in the model to take into account the variance due to individual differences at
baseline in dietary patterns. All nutrient data were log-transformed to achieve a normal distribution prior
to analysis. As the dietary pattern ‘snacks’ was identified only in the 3-year-old children, a linear regression
model was used to assess group differences in pattern score. Owing to missing data we used a data set
derived from MIs for these analyses.
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The models were run unadjusted initially and then adjusted for potential covariates that have been shown
to potentially influence outcomes in the same sample: maternal age, education, ethnicity, household
income, parity and child gender.327 We were particularly interested in investigating the role of child gender
and age on the main outcome variables, therefore group-by-time point and group-by-child gender
interaction terms were tested in all models.
All analyses for studies 1 and 2 were performed using Stata (version 10) and all statistical tests presented
are two-tailed.
Study 3: growth trajectories in the offspring of mothers with eating disorders
Statistical modelling
We modelled individual growth trajectories using multilevel models, including two levels: a time and an
individual level in the statistical package MLwiN (version 2.02, MLwiN, Centre for Multilevel Modelling,
Bristol, UK). We used fractional polynomials to identify the curves that best fit the data. These models
allow use of all available data under the assumption of missing at random. They model the change in scale
and variance of growth over time, and the individual variance in growth trajectories, allowing each
individual to have a unique intercept and slope.
Given the complicated patterns of growth in childhood, we used PI (kg/m3) as the adiposity measure
between birth and 2 years. BMI was modelled from 2 to 10 years of age and height from birth to 10 years.
Growth trajectories were modelled by exposure group (maternal lifetime AN, BN and AN + BN). They were
estimated by fitting interaction terms between each exposure group and the constant (i.e. PI at birth,
length at birth, or BMI at 2 years of age), and each of the polynomial terms in the multilevel models. This
method generates specific average growth trajectories for children in each exposure group. z-tests were
used to determine statistical differences in outcomes, comparing each group with the unexposed group
(no maternal ED) at various time points.
Associations between maternal ED and offspring growth trajectories were investigated in unadjusted and
adjusted multilevel models, which included a priori confounders (e.g. maternal education, maternal age,
gestational age and parity).
Given known gender differences in childhood growth, and gender-specific effects of maternal lifetime ED,
we modelled trajectories separately by gender.
Results
Study 1: time taken to conceive among women with eating disorders
Fertility problems
More women across all four groups had never seen a doctor about treatments for problems with
conceiving (n = 9658; 88.1%), or had used any treatment of help to conceive for this pregnancy
(n = 10,693; 97.3%). However, women with AN had a higher chance of having been seen for fertility
problems during lifetime compared with the general population after we adjusted for pertinent covariates.
Women with AN and BN were also two times more likely (6.2%) to receive treatment to help them
conceive than unexposed women (2.7%) (Table 29).
Time taken to conceive
We examined time taken to conceive in our sample. A total of 7694 women had a planned pregnancy and
of those, 74.5% reported having conceived in the first 6 months, while 8.3% took longer than 1 year and
only 3.6% took over 3 years to conceive. Generally, women in all ED groups were no more likely to take
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longer than 12 months to conceive compared with women in the general population, and this remained
the same for both univariate and adjusted analyses. Women with AN and BN were more likely to report
having taken longer than 6 months to become pregnant compared with unexposed women and this
difference remained after adjusting for covariates (Table 30).
TABLE 29 Logistic regression of fertility problems and intentional pregnancy
Outcome
Model
Unadjusted Adjusted
AN
(n= 171)
BN
(n= 199)
AN+ BN
(n= 82)
General
population
(n= 10,636)
AN
(n= 171)
BN
(n= 199)
AN+ BN
(n= 82)
Seen a doctor for fertility problems
n (%) 35 (20.6) 22 (11.2) 16 (19.5) 1231 (11.7)
OR (95% CI) 1.9**
(1.3 to 2.8)
0.9
(0.6 to 1.49)
1.8*
(1.0 to 3.1)
Ref 1.6*
(1.1 to 2.5)
1.0
(0.6 to 1.6)
1.9*
(1.1 to 3.4), ref
Received help to conceive
n (%) 4 (2.3) 3 (1.5) 5 (6.2) 287 (2.7)
OR (95% CI) 0.8
(0.3 to 2.3)
0.5
(0.2 to 1.8)
2.3a
(0.9 to 5.8)
Ref 0.8
(0.3 to 2.3)
0.6
(0.2 to 1.9)
2.4*
(0.9 to 6.3), ref
Intentional pregnancy
n (%) 96 (58.5) 131 (67.1) 53 (66.2) 7414 (71.7)
OR (95% CI) 0.5**
(0.4 to 0.8)
0.8
(0.6 to 1.0)
0.7
(0.5 to 1.2)
Ref 0.5**
(0.4 to 0.7)
0.8
(0.6 to 1.0)
0.7
(0.4 to 1.1), ref
*p≤ 0.05; **p< 0.001.
ref, reference group.
a p= 0.07 vs. unexposed group.
This table is reproduced with permission from Easter A, Treasure J, Micali N. Fertility and prenatal attitudes towards
pregnancy in women with eating disorders: results from the Avon Longitudinal Study of Parents and Children. BJOG
2011;118:1491–8.328 © 2011 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2011 RCOG.
TABLE 30 Logistic regression of time taken to conceive
Time taken to
conceive
OR (95% CI)
Unadjusted Adjusteda
AN
(n= 89)
BN
(n= 116)
AN+ BN
(n= 48)
General
population
(n= 6883) AN BN AN+ BN
Longer than 12 months
n (%) 14 (15.7) 11 (9.4) 8 (16.6) 781 (11.3)
OR (95% CI) 1.3
(0.8 to 2.4)
0.9
(0.5 to 1.6)
1.5
(0.7 to 3.1)
Ref 1.0
(0.5 to 2.6)
0.7
(0.4 to 1.4)
1.5
(0.7 to 3.4)
Longer than 6 months
n (%) 23 (25.8) 21 (18.1) 19 (39.5) 1730 (25)
OR (95% CI) 1.0
(0.6 to 1.6)
0.6
(0.4 to 1.1)
1.7*
(0.9 to 3.1)
Ref 0.9
(0.5 to 1.5)
0.6
(0.4 to 1.1)
1.9*
(1.0 to 3.5)
*p ≤ 0.05.
ref, reference group.
a Adjusted for maternal age at delivery, parity, maternal educational level and pre-pregnancy smoking and partner’s age.
This table is reproduced with permission from Easter A, Treasure J, Micali N. Fertility and prenatal attitudes towards
pregnancy in women with eating disorders: results from the Avon Longitudinal Study of Parents and Children. BJOG
2011;118:1491–8.328 © 2011 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2011 RCOG.
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Intentional pregnancies
The odds of becoming intentionally pregnant were lower in women who had ever suffered from AN than
in women who were unexposed (41.5% vs. 28.3%). These differences remained after adjusting for
relevant covariates.
Study 2: longitudinal dietary patterns in children of women with lifetime eating
disorders
Results from full models are reported in Easter et al.329
‘Snack’ dietary pattern
Consumption of ‘snacks’ at 3 years among children of women in the three ED groups was similar to that
among the unexposed children. After adjusting for confounding variables there were no differences
between children in the maternal ED groups and the unexposed group [AN: adjusted coefficient = −0.461
(95% CI −0.227 to 0.135); BN: adjusted coefficient = −0.007 (95% CI−0.145 to 0.159); and AN + BN:
adjusted coefficient = 0.903 (95% CI −0.139 to 0.320)].
‘Health-conscious’ dietary pattern
Children of mothers in all three ED groups had higher scores on the ‘health-conscious’ dietary pattern
across the four time points than children in the unexposed group. After adjusting for covariates, these
differences persisted in the maternal AN and maternal BN groups (AN: adjusted coefficient = 0.355,
95% CI 0.162 to 0.547; BN: adjusted coefficient = 0.209, 95% CI 0.044 to 0.373; and AN + BN: adjusted
coefficient = 0.131, 95% CI –0.131 to 0.395).
Boys of women in the AN group were less likely to adhere to this pattern than girls; conversely boys of
mothers reporting both AN and BN were more likely than girls to have higher scores on the health-conscious
pattern. (Full models can be found in Easter et al.329)
‘Traditional’ dietary pattern
Children in all exposed groups scored lower on the ‘traditional’ dietary pattern across the four time points
than children in the unexposed group. After adjusting for covariates, these differences persisted in the
maternal AN and maternal BN groups, and a trend remained in the maternal AN and BN groups but not
in the unexposed group (AN: adjusted coefficient = –0.241, 95% CI –0.463 to –0.018; BN: adjusted
coefficient = –0.372, 95% CI –0.560 to –0.184; and AN + BN: adjusted coefficient = –0.279, 95% CI
–0.592 to 0.032).
‘Processed’ dietary pattern
Scores on the ‘processed’ dietary pattern were similar in the children of maternal ED groups and children in
the unexposed group, in both adjusted and unadjusted models. Full models can be found in Easter et al.329
Study 3: growth trajectories in children of women with lifetime eating disorders
Boys
The sons of women with AN and BN had greater predicted heights than the sons of women with no ED
between birth and 5 years of age, and between birth and 10 years of age (Table 31). These differences
remained after adjusting for potential confounders. For sons of women with BN, the group difference in
predicted heights became larger with age, reaching 1.88 cm by age 10 years (see Table 31). On the other
hand, the difference for sons of women with AN was in the opposite direction, as they were, by age
10 years, 0.75 cm shorter than the sons of unexposed women.
The children of women who reported having AN and BN, as well as the children of mothers with other
psychiatric disorders, were shorter from birth until aged 10 years. Specifically, we found that the biggest
difference in height compared with offspring of unexposed women was in children of mothers with other
psychiatric disorders.
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Girls
The daughters of women with AN (between birth and 5 years of age) and of women with both AN and
BN (between birth and 10 years of age) had lower predicted heights than girls in the unexposed group
(Table 32). After adjusting for covariates, daughters of women with AN were expected to be, on average,
0.47 cm shorter than the daughters of women in the unexposed group.
On the other hand, early in childhood, the daughters of women with BN were expected to be of similar
height to the daugters of mothers in the unexposed group. At the age of 5 years, the daughters of
women with BN were slightly shorter, and from 5 to 10 years of age the differences in predicted height
were larger, with the daughters of women with BN predicted to be 0.64 cm shorter than the daughters of
women in the unexposed group (see Table 32).
Children of women with other psychiatric disorders had a tendency to be shorter during childhood;
however, when compared with the daughters of women with AN, or those with AN and BN, these
differences were comparably smaller for this group (see Table 32).
TABLE 31 Mean predicted anthropometry for boys across categories of maternal ED, with adjustment for standard
confounders (gestational age, maternal age, maternal education and parity)
Anthropometry
Mean predicted
anthropometry
(SD) of offspring of
unexposed womena
Mean difference (SD) from unexposed for offspring of women with:
AN BN AN+ BN
Other psychiatric
disorders
Height (cm) n = 4588 n= 74 n= 85 n = 38 n= 501
Birth 50.3 (5.4) +0.14 (2.0) +0.17 (2.08) –0.10 (2.0) –0.20 (2.2)*
1 year 76.1 (5.4) +0.32 (2.4) +0.05 (2.4) –0.09 (2.4) –0.28 (2.5)**
2 years 87.3 (5.4) +0.40 (3.0) +0.01 (3.1) –0.10 (3.0) –0.32 (3.2)*
5 years 110.2 (6.8) +0.39 (4.5) +0.15 (4.5) –0.17 (4.4) –0.42 (4.7)*
10 years 140.7 (8.8) –0.75 (7.3) +1.88 (7.5)** –0.81 (7.1) –0.64 (7.9)b
PI (kg/m3) n = 4537 n= 73 n= 84 n = 38 n= 496
Birth 26.1 (5.4) –0.43 (2.5) –0.28 (2.6) +0.07 (2.5) +0.13 (2.7)
1 year 23.3 (4.7) –0.12 (2.1) +0.41 (2.2)b +0.27 (2.1) +0.22 (2.3)*
BMI (kg/m2) n = 4271 n= 68 n= 78 n = 35 n= 452
2 years 16.8 (3.9) +0.10 (2.0) +0.26 (1.9) +0.32 (1.7) +0.15 (2.0)b
5 years 15.9 (3.9) +0.34 (1.4)* +0.12 (1.3) +0.49 (1.4)* –0.02 (1.5)
10 years 17.7 (4.6) +0.09 (3.3) +0.12 (3.2) +0.08 (3.2) +0.09 (3.6)
*p< 0.05; **p< 0.01.
a Values are predicted from the multilevel models, and represent the predicted anthropometry for offspring of mean
gestational age (39.4 weeks) and with a mother with the following characteristics: mean age (28.2 years), less than
Ordinary level education, parity of zero. p-values are from z-tests comparing each group with the offspring of women
with no ED or other psychiatric disorder.
b p≤ 0.1.
This table is reproduced from Easter et al.330 This is an Open Access article distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon
this work non-commercially, and license their derivative works on different terms, provided the original work is properly
cited and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/3.0/.
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Boys
Figures 5 and 6 show group differences in the trajectories of PI and BMI in boys. There was no statistical
evidence of growth differences for all periods; in a large number of cases we found large SDs, which could
be attributable to the fact that maternal ED groups were small.
After adjusting for covariates, the sons of women with AN had lower PI than the sons of unexposed
women. The children of women across all exposed groups had a higher BMI between the ages of 2 and
10 years than the children of unexposed women. At 5 years of age, the predicted BMI of children of
women in the maternal AN group was 0.34 kg/m2 higher than the BMI of children of unexposed mothers.
The BMI of sons of women with AN, and women with AN and BN, at 10 years of age was similar to the
BMI of the sons of unexposed women (see Table 31). A tendency towards a higher PI at 2 years was found
in the sons of mothers with other psychiatric disorders; however, their BMI trajectories a few years later
were similar to those of the sons of mothers in the unexposed group.
Girls
The daughters of women with BN had a higher PI at birth than the daughters of unexposed women;
however, this difference was reduced by the time they turned 12 months of age.
TABLE 32 Mean predicted anthropometry for girls across categories of maternal ED, with adjustment for standard
confounders (gestational age, maternal age, maternal education, parity)
Anthropometry
Mean predicted
anthropometry
(SD) of offspring of
unexposed womena
Mean difference (SD) from unexposed for offspring of women with
AN BN AN+ BN
Other psychiatric
disorders
Height (cm) n = 4416 n= 65 n= 82 n= 30 n= 432
Birth 49.7 (5.3) –0.47 (1.9)b –0.08 (2.1) + 0.23 (2.0) –0.16 (2.2)b
1 year 74.3 (5.3) –0.27 (2.4) +0.05 (2.4) –0.73 (2.4)b –0.18 (2.6)b
2 years 85.6 (5.3) –0.24 (3.0)* +0.02 (3.0) –0.93 (3.0)b –0.18 (3.2)
5 years 109.6 (6.0) –0.31 (4.3) –0.18 (4.3) –0.94 (4.2) –0.17 (4.8)
10 years 138.9 (8.6) –0.57 (7.0) –0.65 (6.9) –0.32 (6.7) –0.12 (7.5)
PI (kg/m3) n = 4363 n= 64 n= 81 n= 30 n= 424
Birth 26.2 (5.3) –0.07 (1.9) +0.48 (2.2)* –0.16 (2.2) –0.09 (2.3)
1 year 23.2 (5.3) +0.39 (2.4)b +0.06 (2.5) +0.39 (2.7) –0.22 (2.7)b
BMI (kg/m2) n = 4117 n= 61 n= 78 n= 29 n= 398
2 years 16.6 (3.9) –0.35 (1.9)b +0.30 (1.9) +0.25 (1.8) –0.07 (2.1)
5 years 16.0 (3.9) –0.01 (1.5) +0.26 (1.5)b +0.32 (1.5) +0.16 (2.1)*
10 years 18.1 (5.1) +0.03 (3.5) –0.29 (3.4) –0.52 (3.3) +0.56 (3.7)**
*p < 0.05; **p< 0.01.
a Values are predicted from the multilevel models, and represent the predicted anthropometry for offspring of mean
gestational age (39.4 weeks) and with a mother with the following characteristics: mean age 28.2 years, less than
Ordinary level education, parity of zero. p-values are from z-tests comparing each group to the offspring of women with
no eating or other psychiatric disorder.
b p≤ 0.1.
This table is reproduced from Easter et al.330 This is an Open Access article distributed in accordance with the Creative
Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon
this work non-commercially, and license their derivative works on different terms, provided the original work is properly
cited and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/3.0/.
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The daughters of women with BN, and of women with AN and BN, continued to have higher BMI than
the daughters of unexposed mothers until the age of 5 (see Figure 6); however, their BMI was comparable
to the BMI of daughters of unexposed women by the time they turned 10 years old. On the other hand,
the daughters of women with AN had a lower BMI than the daughters of unexposed women during early
childhood; however, their BMI was comparable to that of the daughters of unexposed women years later
(late childhood) (see Figure 6). The BMI changes through childhood of the daughters of women who
reported other psychiatric disorders were comparable to those observed in children of women in the AN
group (see Figure 6); conversely, at the age of 10 years, their expected BMI was on average 0.56 points
higher than that of the daughters of unexposed mothers.
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FIGURE 5 Average fractional polynomial curve of PI trajectories for girls and boys by maternal ED, birth to 2 years,
adjusted for confounders. Note: values are predicted from the multilevel models, and represent the predicted
anthropometry for offspring of mean gestational age (39.4 weeks) and with a mother with the following
characteristics: mean age 28.2 years, less than Ordinary level education, parity of zero. (a) Boys’ PI and (b) girls’ PI.
This figure is reproduced from Easter et al.330 This is an Open Access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix,
adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the
original work is properly cited and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/3.0/.
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Discussion
The overall aim of the studies was to investigate the effects of maternal ED on fertility and on their
children’s dietary patterns and growth trajectories.
Eating disorders and fertility
Study 1 highlighted that women with an ED experience more difficulties conceiving. The results showed that
women with a lifetime diagnosis of AN (either AN or AN + BN) were more likely than unexposed women to
visit a doctor because they have problems conceiving. Although only a small percentage of women in this
sample actually received treatment during the time trying to conceive, and we found that women with AN
and BN were twice as likely to undergo treatment for problems with conception. Based on these results, it
could be hypothesised that problems with fertility in this sample may be secondary to low BMI, which is
present in both groups.
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FIGURE 6 Average fractional polynomial curve of BMI trajectories for girls and boys by maternal ED, aged 2–10 years,
adjusted for confounders. Note: values are predicted from the multilevel models, and represent the predicted
anthropometry for offspring of mean gestational age (39.4 weeks) and with a mother with the following
characteristics: mean age 28.2 years, less than Ordinary level education, parity of zero. (a) Boys’ BMI and (b) girls’
BMI. This figure is reproduced from Easter et al.330 This is an Open Access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix,
adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the
original work is properly cited and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/3.0/.
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Our results also showed that the odds of taking longer than 6 months to conceive were higher for women
who reported both AN and BN than for unexposed women. Importantly, women with both AN and BN
had lower BMI before conception and higher prevalence of lifetime purging than women in the other
two groups.318 The severity in this group may lead to a higher risk for both fertility problems and
delayed conception.
Approximately 40% of women in the sample who reported having AN reported that their pregnancy was
unintentional. Research has shown that ovulation and pregnancy can still occur in women with an ED who
have irregular cycles.331 Therefore, the large percentage of unintentional pregnancies found in this sample
may be due to erroneous beliefs about their ability to become pregnant.
Diet and growth in children of women with eating disorders
Studies 2 and 3 explored potential differences in diet and growth between the ages of 3 and 9 years,
and growth trajectories between birth and 10 years, in children of women with an ED.
The children of mothers with an ED were found to be less likely to adhere to a ‘traditional’ dietary pattern
than children of women without an ED. This pattern is synonymous with a British ‘meat and two veg diet’,
which would typically be eaten at mealtimes. Family mealtimes are particularly difficult for mothers who
have experienced an ED,332 and such women have been found to be less likely to regularly cook or eat
with their children.333 Reduced adherence to the ‘traditional’ dietary pattern in this study may reflect less
frequent mealtimes in families in which the mother has an ED.
In line with suggestions from previous research that children of women with an ED may consume less junk
food,316 the children of mothers reporting either AN or BN were found to consume a more ‘health-conscious’
diet. We have previously found that women with AN in this sample were more likely to follow this dietary
pattern in pregnancy themselves;334 these findings might imply a stronger maternal desire for women with
an ED to provide a healthy diet for their children.
It is currently not known what effects increased exposure to a health conscious/vegetarian diet during
childhood may have on the long-term development and health of the children of women with an ED;
previous evidence from this sample suggests associations with positive developmental outcomes.335,336
Changes across childhood
Over time, children of women with an ED were adhering to a more ‘traditional’ and less ‘health-conscious’
dietary pattern. These findings may reflect the influence of other societal effects on diet, such as school,
and consequentially children in the exposed groups having greater influence over their diet. Alternatively,
these findings may reflect differences in maternal feeding styles in early childhood. It has previously been
reported that mothers with an ED display more restrictive feeding styles;301,337 however, studies suggest
that parental restriction of high-fat and palatable foods may in fact increase their desirability.338–340
Gender differences
Some previous studies have indicated that maternal transmission of weight concerns and dieting behaviours
may be stronger for girls than boys.341,342 In the present investigation, girls of mothers with AN were more
likely than males to adhere to the ‘health-conscious’ pattern, suggesting a stronger maternal influence on
girls of women with AN.
Past investigations have proposed that the offspring of women with BN may be at risk of becoming
obese;315,343 findings from the present study showed that boys of women from all exposed groups had
higher adiposity than boys of unexposed women, with the difference being more pronounced at the age
of 5 years. Taking into consideration that boys of mothers with other psychiatric problems have similar
BMI trajectories to those of unexposed mothers, the differences we found in growth trajectories in the
offspring of mothers with EDs may be specific to maternal eating pathology. One possible hypothesis is
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that a fast increase in growth during earlier years may put them at higher risk for obesity, as well as other
health problems, later in life.
Body mass index trajectories in girls of women with an ED were different from those of boys and show
a fluctuating pattern throughout childhood. Specifically, girls of women with BN, and with AN and BN,
had a tendency for a higher BMI in early years but a lower BMI at 10 years old. On the other hand, girls of
women with AN had a higher BMI in earlier years and a more similar BMI to HCs by the age of 10 years.
We are not clear on the consequences of the growth trajectories in the long term. However, a recent
study found that growth patterns were predictive of later AN.344 A possibility is that differences in growth
trajectories in children of mothers with AN highlighted by this study are in some way related to dietary
patterns during childhood; however, we were not able to investigate this association.
Compared with boys of unexposed women, boys of women with BN from the age of 2 years onwards were
found to be taller. On the other hand, compared with boys of unexposed women, boys of women with AN
were taller only during early childhood, and were found to be shorter by the time they reached 10 years
old. Girls of women with ED, predominantly AN, had a tendency to be shorter than unexposed children.
These findings may show that this group is at specific risk of having a more restricted growth during
childhood. Furthermore, these results are similar to previous case studies and those with younger children
that show that children of women with AN do not grow as much as those of unexposed women.321,343,345
Past research has shown that mothers with an ED are more concerned with their daughters’ weight and
shape than with their sons’,346 and that their daughters may have a higher chance of becoming underweight
than thier sons.343 Results from the current studies support gender-specific growth trajectories; however, as
our growth models were built separately for each gender, we were unable to examine gender interactions.
Conclusions
In conclusion, the investigations described in this chapter highlight novel findings regarding the effects of
ED on women’s fertility and their children’s development. Women with an ED were found to experience
difficulties in the pre-conception period and postnatal differences in the dietary patterns and growth
trajectories of children born to women with an ED were highlighted.
Our study is the first to investigate longitudinal growth and diet patterns in the children of women with
lifetime EDs, and, therefore, replication and additional examination of the pathways are necessary.
Nonetheless, health professionals need to be conscious of the associations between EDs in women and
their children’s growth so that they can better guide both the mother’s health and the development of the
fetus. Continuity of care for this group of women is paramount from before conception into the postnatal
period. Furthermore, and at a public health level, it is of extreme importance to further analyse underlying
mechanisms of growth differences in children of women with an ED. Following on from this study, we are now
developing an intervention for pregnant women with an ED, aimed at preventing adverse child outcomes.
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Chapter 10 Specialist and non-specialist care
pathways for adolescents with anorexia nervosa
(work package 7a)
An abbreviated version of this chapter has been published in the International Journal of Eating Disorders.347
Abstract
Background
There is now a significant body of research demonstrating the efficacy of specific treatments for adolescent
AN. Little is known about the way in which different service contexts impact treatment outcome. The
present study investigates the role of specialist outpatient services and how the availability of such services
influences the rates of referrals, hospital admissions, continuity of care and service user experiences.
Methods
Mental health services in London were asked to identify adolescents who presented for treatment for an
ED over a 2-year period. Retrospective data about service use, including the need for hospital admissions,
were collected from clinical case notes. A small sample of adolescents and parents were interviewed about
their experiences of services.
Results
Direct access to specialist outpatient services was associated with higher referral rates, lower admission rates
and greater consistency of care. Service users identified a number of advantages of specialist service provision.
Conclusions
Data from the present study suggest that facilitating direct access to specialist services for adolescents with
AN may result in better outcomes, lower costs and higher satisfaction among service users.
Introduction
The rapid physical and psychological deterioration that can occur in young people with AN means that
early intervention with the potential for intensification of care is important. Clinical trials suggest that
outpatient family-based treatments are effective in the short and longer term.282,348–350 However, treatment
in inpatient settings is relatively common. Data from the UK suggest admission rates for children and
adolescents of 35–50%30,351 and, in one survey, young people with EDs occupied more child and adolescent
psychiatric beds than any other diagnostic group.31 Studies of inpatient care have found no evidence of
specific benefits arising out of hospital treatment in comparison with outpatient care,352 and there is some
evidence that prolonged admissions may result in poorer outcome,353 as well as being more costly.354
There is considerable variability in the treatment provisions for children and adolescents suffering from AN
in the UK, ranging from outpatient treatment provided within general CAMHS to highly specialised ED
services. The only RCT to compare general and specialist outpatient services, the Treatment Outcome for
Child and adolescent Anorexia Nervosa trial, found no difference in clinical outcomes between services.355
Prior to the present study, outcomes following TAU in general and specialist outpatient services had not
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been compared, so to date it has been difficult to separate the effects of specific treatments from the
effect of service specialisation.
The present study provides a naturalistic comparison of alternative service provisions for adolescent AN in
the UK, using Greater London, with a population of approximately 7.8 million, as an exemplar. We
hypothesised that we would find two main care pathways, shaped by the availability of different outpatient
services in the form of general CAMHS or specialist child and adolescent ED services. We aimed to explore
associations between these different care pathways and (1) the number of cases seen in services beyond
primary care and (2) rates of admission for inpatient treatment (excluding admission for acute medical
stabilisation only). We also aimed to explore the experiences of adolescent service users and their parents.
Methods
Study 1: quantitative study
The design of the study was a naturalistic, retrospective cohort study, using clinical case notes as the
primary data source. Our main hypotheses were (1) accounting for population size, more adolescents with
AN and restricting EDNOS from the specialist care pathway than from the general care pathway would
present to services beyond primary care and (2) controlling for severity of presentation, a lower proportion
of adolescents with AN and EDNOS from the specialist care pathway than from the general care pathway
would be admitted for inpatient treatment during the first year of treatment.
Service mapping, recruitment and categorisation
An initial phase was to identify existing services for adolescents with EDs in London. This included searches
of the websites of public and private health-care providers, the UK government-funded children’s service
mapping exercise (2007–8) and publications by the Royal College of Psychiatrists.26,356 The identified
services were asked to confirm arrangements for managing EDs in their area and return a questionnaire
about the treatments their service provided. This information was used to compile a list of eligible services
that were then asked to participate in the study.
Outpatient services were categorised either as general CAMHS or as specialist ED services, drawing on
existing criteria26,357 to define specialist outpatient ED services: a minimum of 25 new ED referrals per year;
a multidisciplinary team, including medical and non-medical staff and more than one person with
experience of treating EDs; a team with the expertise to deliver evidence-based treatments; and the
resources to offer routine outpatient treatment. Inpatient services were categorised into specialist ED units
and general psychiatric units.
Case identification
Each service was asked to identify individuals that met the following criteria:
1. having initial face-to-face contact with the service, or recontact after a treatment break of at least
6 months, between 1 December 2006 and 30 November 2008
2. aged 13–17 years at the time of initial contact (or recontact)
3. a primary diagnosis of an ED
4. being registered with a GP from a London primary care trust (PCT; the commissioning bodies at the
time, which determined service accessibility).
In each service, potential participants were identified through searches of electronic patient records,
correspondence with service users, clinical diaries, referral lists, funding records or audit data.
Participant recruitment and participant-level data collection
Potential participants were contacted by post, asking for permission for us to access their clinical case
notes. A standard item sheet was used to record data for each participant, including their PCT;
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demographic data, such as age and sex; details of symptoms; and use of treatment and services in the
12 months after entry into the service. Limited, anonymised, data (as agreed with ethics) were collected
from services about non-consenters to avoid inclusion of duplicates and enable comparisons between
consenters and non-consenters.
Data analysis
To evaluate the number of cases seen beyond primary care (hypothesis 1), pathways were defined
reflecting the agreements between PCTs and services defining the type of outpatient service that was
typically made available following referral from primary care. The care pathway for each adolescent was
therefore defined by the typical funding arrangements of the PCT in the relevant catchment area. For this
analysis, data for both consenters and non-consenters were included.
‘Presentation rates’ were calculated for each PCT, using the number of cases identified by services and
population statistics from the Office for National Statistics.358 Separate calculations for females and males
were done for each PCT using the following formula:
Presentation rate of N cases per 100,000 population of 13- to 17-year-olds per year
= ½N cases identified/(population of 13- to 17-year-olds in 2007 + 2008) × 100,000. (1)
Mean presentation rates were compared between PCT groups by ANOVA using diagnostic plots to check
that required assumptions held. In particular, when PCT groups were compared, we carried out two
planned comparisons of CAMHS PCT groups against the specialist service PCT group.
To evaluate differences in admission rates (hypothesis 2), only data from consenting participants could be
used. To assess the representativeness of the sample, comparisons of personal, symptomatic and service
variables were made between ‘consenters’ and ‘non-consenters’. Independent-samples t-tests were used
to compare groups on continuous variables. Chi-squared tests or Fisher’s exact tests were used to compare
groups on categorical variables. Care pathway groups were established in two ways: by PCT, as for
hypothesis 1, and by the actual care pathway that each participant followed. Binary logistic regression was
used to compare rates of admission for inpatient treatment between the groups controlling for the severity
of presentation (measured by degree of underweight).
Power calculation
A power calculation was performed, based on the expectation of two main care pathways (starting with
either a specialist outpatient ED service or a general CAMHS), and estimated admission rates of 10%
(from audit data) and 35%, respectively. A chi-squared test at a significance level of 5% to detect a
difference with a power of 80% indicated that 43 participants per group would be needed to show a
statistical difference.
Ethics approval
The study was reviewed by the Royal Free Hospital and Medical School REC (reference 07/H0720/119).
We were concerned that obtaining consent from participants would affect the extent to which general
CAMHS were represented. We anticipated that they would have fewer eligible patients and fewer resources
to dedicate to recruitment than specialist services, which could result in both a small total number of
participants and a lower proportion of those who were suitable being recruited from general services rather
than from specialist services. The Patient Information Advisory Group was approached for permission to
access case notes without obtaining consent, but the application was not approved. Subsequently, the
National Information Governance Board, which replaced the Patient Information Advisory Group, gave
permission to store non-consenters’ initials and dates of birth, enabling removal of duplicates from the
non-consenting sample [reference ECC 6-06(I)/209].
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Study 2: qualitative study
For the qualitative part of the study, a subsample of adolescents was selected from those who allowed us
to access their case notes for the quantitative study. The main aim of sampling was to select people with
experience of the different care pathways. Fifty-six adolescents were asked whether or not they would be
willing to take part in an interview about their experiences of treatment and services, and were also asked
for permission to contact their parents about taking part in a similar interview. Interviews were based on
an interview guide, rather than a fixed interview schedule. The focus was on the participant’s journey
through services and experience of each stage of treatment. Questions were non-directive and open ended.
Data were analysed by two researchers using thematic analysis. The procedure was based on six phases of
analysis, described by Braun and Clarke.359 In phase 1, interviews were transcribed verbatim, and each
researcher read through the transcripts multiple times to become familiar with the content, while making
notes about anything they found interesting at a descriptive or interpretative level. Phase 2 involved
labelling data with ‘codes’, which highlighted points of interest, and identifying areas of agreement and
disagreement between participants. The researchers discussed their coding and, if they had made different
interpretations of the data, revisited the transcripts together. Phase 3 involved tentative grouping of codes
into themes, which were reviewed and reorganised when necessary in phase 4, and finalised and defined in
phase 5. The data were organised to reflect patterns, similarities and differences in participants’ experiences.
Themes were then grouped into superordinate themes. Phase 6 was the production of a written report of
the findings, including sections of the transcripts (quotes) that led to the development of themes.
Results
Study 1: quantitative study
Service mapping, recruitment and categorisation
Forty-four eligible services were identified, of which 37 provided the required data. Table 33 shows the
services by category. Service mapping and recruitment revealed a potentially substantive difference
between general CAMHS; some defined themselves as non-specialist in EDs, whereas others described
having a specialist ED ‘mini-team’ within the general team. CAMHS were therefore categorised into
self-defined ‘specialist ED CAMHS’ and ‘non-specialist CAMHS’. To take this into account the original plan
TABLE 33 Services by category
Service
Service
Participating Non-participating
NHS outpatient services
Specialist child and adolescent ED services 2 0
Other ED services 3 (1 child, 2 adultsa) 0
Specialist CAMHS 7 2
Non-specialist CAMHS 15 2
NHS inpatient services
Specialist ED units 4 (1 child/adolescent, 3 adultsa) 0
General psychiatric units 2 1
Private services
Specialist ED units 6 (4 children/adolescents, 2 adults) 2 (1 child/adolescent, 1 adult)
a Two of these are the same service (i.e. two adult services provided both outpatient and inpatient care).
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of statistical analysis was modified to include pairwise comparisons between care pathways based on
specialist ED services and care pathways based on both types of CAMHS.
Presentation rates to services beyond primary care
Primary care trust groups
Three PCT groups were identified, based on the care pathway they typically commissioned to provide
outpatient treatment following referral from primary care: (1) a specialist Child and Adolescent Eating
Disorders Service (CAEDS), (2) a specialist CAMHS and (3) a non-specialist CAMHS. In the CAEDS group,
some PCTs allowed referrals to bypass CAMHS completely, some required CAMHS to authorise referrals,
and others required CAMHS to assess adolescents before referring them for treatment in an ED service.
In the specialist and non-specialist CAMHS groups, assessment and treatment were provided by the same
service. Specialist CAMHS differed from CAEDS in that they each served a single PCT, whereas CAEDS
each served a number of PCTs. All PCTs had access to general paediatric medical units. Depending on the
area, longer-term inpatient treatment was provided by public or private ED units or general adolescent
psychiatric units.
Cases by primary care trust group
Services identified 641 potentially suitable cases. Using initials, dates of birth and PCTs, duplicates were
identified and removed, leaving 489 cases. After checking eligibility for the study, 111 cases were
excluded. The final number of cases meeting the inclusion criteria was 378. Services from four PCTs did
not provide any data and were excluded from the analyses. Therefore, a total of 27 PCTs and 367 cases
were included in the subsequent analyses. The grouping of these is shown in Table 34.
The total number of males in the overall sample was small (n = 22), making it inappropriate to include
them in the analyses. Data from the services could be used to provide a clear diagnosis for 287 females.
Of these, 200 had AN or EDNOS-AN and 87 had BN or an eating disorder not otherwise specified – bulimia
nervosa subtype (EDNOS-BN). In some of the sample (58 females), however, the services gave a diagnosis
only of ‘eating disorder’ and there was insufficient data for a researcher to place these individuals into one
of the specific diagnostic groups. Presentation rates were therefore calculated in two ways: first, using cases
with a known diagnosis, to give an ‘observed presentation rate’, and, second, based on the assumption
that the same proportion of missing and known cases had either AN or EDNOS-AN (69.7%) and BN or
EDNOS-BN (30.3%) to give an ‘estimated presentation rate’. As the focus of this study is restricting EDs,
results are presented for this subgroup only.
Figure 7 shows the presentation rates of AN and EDNOS-AN by PCT group. Unadjusted pairwise
comparisons show that the presentation rates for the non-specialist CAMHS group were significantly lower
than those of the specialist ED service group (observed rate: p < 0.01; estimated rate: p = 0.04). The
presentation rates of the specialist CAMHS group did not differ significantly from those of the CAEDS
group (observed rate: p = 0.41; estimated rate: p = 0.98).
TABLE 34 Identified cases by PCT group
PCT group
AN and EDNOS-AN BN and EDNOS-BN EDa
TotalFemale Male Female Male Female Male
CAEDS (12 PCTs) 112 8 62 1 25 1 209
Specialist CAMHS (5 PCTs) 50 3 15 0 5 0 73
Non-specialist CAMHS (10 PCTs) 38 3 10 3 28 3 85
Total 200 14 87 4 58 4 367
a Cases when services did not provide a more detailed diagnosis than ‘eating disorder’.
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Comparison of participant characteristics of consenters and non-consenters
Of the 378 adolescents meeting entry criteria, 127 (33.6%) gave consent for a researcher to access their
clinical case notes, 15 (4.0%) actively refused consent, 235 (62.2%) did not respond and one (0.3%) had
died, having withdrawn from treatment in a non-specialist CAMHS. The distribution of diagnoses (AN,
EDNOS-AN, BN and EDNOS-BN) did not differ between the consenters and the non-consenters (p = 0.16).
Subsequent comparisons include only the 220 adolescents with AN or EDNOS-AN (the 214 cases shown
in Table 34, plus six cases from the PCTs that were excluded from the analyses of presentation rates), 93
(42.3%) of whom consented to participate in the study.
No statistically significant differences were found between consenters and non-consenters in mean age at
assessment; sex; ethnicity; proportion with a diagnosis of AN (vs. EDNOS-AN); mean BMI at assessment;
proportion who were binge eating or self-induced vomiting; first service attended following referral from
primary care; or proportion admitted as inpatients during the study period. A higher proportion of consenters
(47.3%) than non-consenters (31.8%) accessed more than one participating service during the study period,
but this difference did not reach statistical significance (p = 0.06). The only significant difference identified
between consenters and non-consenters was the PCT group to which they belonged. The proportion
consenting to be part of the study was significantly higher in the CAEDS service group (55.0%) than in the
specialist CAMHS group (26.3%; p < 0.01) or the non-specialist CAMHS group (23.3%; p < 0.01).
Characteristics of the consenting sample are shown in Table 35. The average weight is higher than would
be expected from a sample of adolescents with AN because of the inclusion of those with EDNOS-AN.
Average weight loss prior to assessment was 12.3 kg, which is substantial considering the relatively short
mean duration of illness (8 months). There were low rates of binge eating, self-induced vomiting and
laxative misuse. No statistically significant differences were found between the groups in mean age at
assessment, sex, ethnic background, per cent median BMI at assessment, proportions who were binge
eating or vomiting or source of referral.
Expected and actual care pathways
It became clear during the early part of the study that the PCT agreements did not always predict the
actual care pathway that individual patients followed. When the actual care pathways were examined,
the data suggested a greater similarity than expected between specialist CAEDS and specialist CAMHS
(in terms of the number of cases presenting for treatment and the proportion of admissions for inpatient
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treatment within 12 months). Therefore, these services were grouped for subsequent analyses, and the
following ‘actual care pathway groups’ were formed:
1. specialist assessment to specialist treatment: participants referred directly from primary care to a
specialist CAEDS (child and adolescent, or adult) or a specialist CAMHS for assessment and treatment
2. non-specialist assessment to specialist treatment: participants assessed in a non-specialist CAMHS and
then immediately referred on to a specialist CAEDS for treatment
3. non-specialist assessment to non-specialist treatment: participants referred from primary care to a
non-specialist CAMHS for assessment as well as treatment
4. Private assessment to private treatment: participants who moved from primary care into private ED
services (these were excluded from subsequent analyses, as the aim of the present study was to explore
care pathways within the NHS). Table 36 compares the actual care pathways with those that would be
predicted by PCT agreements. The main difference was that some of the CAMHS services that were in
TABLE 36 Actual vs. expected care pathways
Care pathway
Pathway, n
Expected (based on PCT) Actual
Specialist assessment to specialist treatment 71 53
Non-specialist assessment to specialist treatment 10 16
Non-specialist assessment to non-specialist treatment 9 15
Private assessment to private treatment 0 6
TABLE 35 Characteristics of the consenting sample at assessment
Characteristic Descriptive statistic
Mean age 15.1 years (SD = 1.2 years)
Sex 90 (96.8%) female; 3 (3.2%) male
Ethnicity 64 (68.8%) white British; 23 (24.7%) other; 6 (6.5%) missing
Social classa 62 (66.6%) I/II; 10 (10.8%) IIIN/IIIM; 3 (3.3%) IV/V; 18 (19.4%) missing
Parents’ relationship status 70 (75.3%) intact; 18 (19.4%) separated; 3 (3.3%) other; 2 (2.2%) missing
Diagnosis 57 (62.6%) AN; 34 (36.6%) EDNOS-AN; 2 (2.2%) missing
Mean weight for height (%) 82.8 (SD = 10.4, range= 63.3–131.9)
Menstrual status (females) 55 (61.8%) amenorrhoea; 18 (20.2%) irregular periods; 6 (6.7%) regular periods;
2 (2.2%) on hormonal contraceptives; 8 (9.0%) missing
Mean duration of illness (months) 8.1 (SD = 8.0, range = 1–36)
Binge eating 81 (87.1%) no; 9 (9.7%) yes; 3 (3.2%) missing
Self-induced vomiting 69 (74.2%) no; 21 (22.6%) yes; 3 (3.2%) missing
Laxative misuse 82 (88.2%) no; 27 (7.5%) yes; 4 (4.3%) missing
Exercise for weight loss 44 (47.3%) no; 43 (46.2%) yes; 6 (6.5%) missing
Primary care referrer 65 (69.9%) GP; 9 (9.7%) school/college; 6 (6.5%) paediatric inpatient unit;
3 (3.2%) hospital outpatient department; 5 (5.4%) CAMHS (seen for other issues);
1 (1.1%) counselling service; 1 (1.1%) parent; 3 (3.2%) missing
a Registrar-General Social Classes: I, professional occupations; II, managerial and technical occupations; IIIN, skilled
non-manual occupations; IIIM, skilled manual occupations; IV, partly skilled occupations; V, unskilled occupations.
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the catchment area of one of the CAED services did not automatically refer on following an assessment
and more people than expected were assessed and started treatment in generic CAMHS.
Admissions for inpatient treatment by actual care pathway
In the specialist assessment to specialist treatment group, 8 out of 53 (15.1%) adolescents were admitted
to hospital, compared with 3 out of 16 (18.8%) adolescents in the non-specialist assessment to specialist
treatment group and 6 out of 15 (40.0%) adolescents in the non-specialist assessment to non-specialist
treatment group. The binary logistic regression analysis (controlling for baseline percentage median BMI)
indicated that the chance of admission in the non-specialist assessment to specialist treatment group was
32% higher than in the specialist assessment to specialist treatment group (adjusted OR = 1.32, 95% CI
0.30 to 5.81; p = 0.71), and the chance of admission in the non-specialist assessment to non-specialist
treatment group was 261% higher than in the specialist assessment to specialist treatment group
(adjusted OR = 3.61, 95% CI 1.00 to 13.02; p = 0.049).
Continuity of care
The exploration of the actual care pathways identified an unexpected difference in continuity of care,
depending on where outpatient treatment started. In the specialist assessment to specialist treatment
group, 83% of participants completed their treatment in the same service, compared with 75% in the
non-specialist assessment to specialist treatment group, and 41.7% in the non-specialist assessment to
non-specialist treatment group. A post hoc analysis showed that the continuity of care was significantly
higher in the specialist assessment to specialist treatment group than in the non-specialist assessment to
non-specialist treatment group (χ2 = 6.93; p < 0.01).
Study 2: qualitative study
Participant recruitment and characteristics
Eight adolescents and 11 parents agreed to take part in interviews about their experiences. As with the
quantitative study, recruitment was more successful among those who had been to a specialist service.
Of the adolescents, five had started treatment in a CAEDS, two in a specialist CAMHS and one in a generic
CAMHS. The group of parents included one parent of each of the adolescents who took part in interviews
and three parents whose daughters did not want to participate: one of these started treatment in a
CAEDS, one in a specialist CAMHS, and one was assessed in a non-specialist CAMHS and then referred for
treatment in CAEDS.
The nature of the sample means that the views reported here are not presented as being representative of
any group other than that which took part in the interviews; however, they provide an insight into the
experiences of these families, and highlight factors that may impact on service user satisfaction. Full details
of the studies and results are available elsewhere,360 and only a small number of quotes are presented here
to demonstrate particular points.
Experiences of services
In nearly all cases of those we interviewed, help-seeking was prompted by a parent, rather than by the
adolescent themselves, with some adolescents describing great resistance to the idea of external
intervention:
I don’t really know what I thought was going on, I think I just thought I was losing a bit of weight and
everyone was making a massive fuss and I was absolutely fine and please don’t bother me because I’m
quite happy just running my own show.
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Although some GPs were supportive and facilitated access to treatment, others were viewed as decidedly
unhelpful by adolescents and parents. Some GPs appeared to be guided more by physical signs, such as
weight, than by parental concerns:
The doctor said [to my parents] ‘Oh no, your daughter’s fine’ . . . that’s when . . . I was like ‘Oh, I’m
fine, I can just lose loads of weight’.
The GP basically said that her BMI wasn’t low enough to be anorexic . . . she didn’t mention a referral
to CAMHS, she didn’t mention [specialist service] . . . if you got diagnosed with cancer, they would
treat it, they wouldn’t . . . wait until you had Stage 3!
Adolescents who received treatment in CAMHS described situations when they felt they were not receiving
the help they needed, but were temporarily unable to access more specialist services:
I wasn’t getting any better . . . I maintained a really frighteningly low weight for quite a long time . . .
I wanted to get better, I wanted some help . . . I sort of said ‘I’ve never had the opportunity to get
better because I’ve never had proper help’.
The parents of these adolescents expressed great relief when they were able to move to more specialist
services, and regret that this had not happened immediately:
CAMHS was like a holding bay.
All three of us say ‘If we hadn’t have got to [specialist service], [daughter] would be dead’.
Of course I feel sad when I think ‘Well, what would our story have been if we’d come straight
[to specialist service]?’ . . . I don’t think she’d have been allowed to get [as ill as] she got last year.
Adolescents described the difficulty of moving between services and switching therapists, and explained
that continuity with helpful relationships was valued:
It’s difficult to build that kind of relationship . . . I felt like I was getting somewhere with [therapist] and
then to start all over again with someone that didn’t know me and didn’t know the history . . . it was quite
frustrating because it’s kind of like stopping and starting all the time and never really getting anywhere.
Clinicians’ expertise in EDs was an important element of both adolescents’ and parents’ experiences of
inpatient and outpatient services:
A lot of it is expertise because I feel like ‘ah, finally someone gets me’ . . . like, everything I say is
something that [clinician] has already come across. She knows all of the symptoms so she doesn’t
make me feel like I’m a freak . . . she just, she understands.
You cannot compare [paediatric and specialist admission]. It’s chalk and cheese. [The eating disorders
unit] know what to look for, they know everything, you know, they know the natures of the beast.
For parents, one of the most unanimously positive experiences (for those who had taken part) was groups
with other parents who were in a similar situation – these tended to be organised by specialist services.
Those who did not have access to groups were frustrated by this:
It was a feeling that we were all . . . there were all different types of people and different everything
else, but we all had this problem.
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What I wanted was to talk to other people who were going through the same situation as me . . .
to meet up with somebody, to speak . . . to see them face to face.
Discussion
This is the first naturalistic study to examine outcomes following TAU in different types of service for
adolescents with an ED. The key findings are (1) once population size was taken into account, the number
of adolescents with AN and EDNOS-AN who were referred from primary care in areas with specialist
outpatient services for child and adolescent EDs was two to three times that in areas with no specialist
services; (2) patients who started treatment in generic CAMHS were 2.5 times more likely to be treated in
hospital during the following 12 months than those initially treated in a specialist service; and (3) continuity
of care was considerably lower in non-specialist services, in that only 42% of adolescents started and
continued treatment for the next 12 months without being referred on, compared with more than 80% of
those seen in specialist services.
The number of cases seen in services beyond primary care
This is the most robust finding as it is based on the full sample of 367 cases. The low level of case
identification in areas with no specialist services is consistent with previous research.26 The striking finding
from this study is that the rate of referral to specialist services is close to the level that epidemiological
studies suggest is the actual incidence of new cases seen in primary care.51,361 It is possible that GPs with
links to specialist services have better knowledge of EDs and their treatment and therefore identify and
refer more cases than GPs with no specialist links. Alternatively, the visibility and easy access to specialist
services may encourage referrals rather than a ‘wait and see’ approach that is sometimes seen in primary
care. The second explanation is supported by Currin’s362 primary care study, which showed that GP’s
working in areas where inpatient treatment was the only specialist service provision have higher referral
thresholds than those in areas with specialist outpatient services. Our own clinical experience in a specialist
context of receiving a growing number of very early referrals also supports this explanation. A third
explanation is that availability of services has an effect on patient and/or parent preferences and changes
the threshold for seeking help.
Admissions for inpatient treatment
Although there have been previous clinical reports of reductions in admission rates following the
development of specialist outpatient services,363 this is the first study that provides clear empirical support
for this. Our study showed that admission for inpatient treatment was not predicted by service-level
agreements between PCTs and service providers, but was predicted by participants commencing treatment
in a non-specialist CAMHS. The high level of admission in the non-specialist care pathway raises a number
of concerns. Inpatient treatment of AN is costly,354,364 has high relapse rates,228,365 and there is evidence
that hospital treatment is associated with poor outcomes in adolescent AN even when severity of symptoms
are controlled for.353
Continuity of care
In the present study, the differences in the continuity of care between the specialist care and non-specialist
care pathway was striking. This is important as continuity potentially reduces duplication of work, and
avoids the need for managing transitions between services, which can be problematic for patients and
their families.36
Service user experiences
Adolescent and parents highly valued the level of clinician expertise that they found in specialist services.
Those who were dissatisfied with CAMHS were frustrated by barriers to specialist services. Movement
between different services could disturb the delicate process of building and maintaining helpful
therapeutic relationships, and a lack of continuity of care could be experienced as being ‘sent from pillar to
post’ – this was one of the most frequent areas of dissatisfaction for those who were referred to CAMHS.
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Group interventions were particularly important for parents, and these are likely to be more easily
facilitated by specialist services because of the resources available and the greater number of families that
can be seen at any one time. Service user reports suggest that work may need to be done with GPs to
increase their understanding of EDs beyond the physical symptoms – again, specialist services may be best
placed to undertake such work.
Study limitations
Although the differences between the specialist and non-specialist care pathways found in the present
study are striking, a degree of caution is needed as we do not know the extent to which this will generalise
beyond London, as the study area differs from the rest of the UK in some important ways. The most relevant
is that London contains considerably more specialist ED services than rest of the country. We do not know
what impact this may have on the attitudes of referrers or the confidence of clinicians working in generic
CAMHS. The finding concerning the differences in the continuity of care is probably most susceptible to the
specific conditions in London and may not generalise well to areas with no specialist services.
The study did not include every service that could conceivably accept a referral of an adolescent with an
ED, but rather focused on services that handle the large majority of such referrals. Although the exclusion
of services such as specialist CAMHS targeted at other disorders may have resulted in comorbid cases
being excluded, the study was able to obtain data from most of the ED services, CAMHS that specialised in
EDs and non-specialist CAMHS in London, with 84% of eligible services providing data. The impact of the
different methods of participant identification used by different services is unclear.
Although the sample used to test hypothesis 1 was relatively large, and included cases from the majority
of the PCTs in London, the subsample of consenters used to test hypothesis 2 was comparatively small
(42.3% of eligible cases), and the analyses of admission rates were underpowered. The logistic regression
analyses did not take into account any PCT clusters, so the effect of belonging to an individual PCT on
admission was not explored. The differential recruitment rate for specialist and non-specialist services
could have biased the sample and influenced the results. However, comparisons between consenters and
non-consenters showed no significant differences in the number of services accessed or admissions for
inpatient treatment during the study period. Moreover, the findings of high admission rates from general
services is consistent with previous reports30,351 as is the lower rate in specialist services.363 The short
follow-up period for this study is a further limitation, as findings relate only to participants’ service use for
a year after presentation.
Although the results of the qualitative study cannot be taken as representative of a wider population, they
suggest a number of reasons why service users may find specialist services preferable to non-specialist
services. These are best described as hypotheses at present, and warrant further study.
Implications for service development and future research
The results of this study are potentially of considerable significance for the way treatment of child and
adolescent EDs is provided in the NHS. The data suggest that establishing care pathways in which referrals
from primary care go directly to specialist outpatient CAEDS could significantly increase levels of case
identification, while at the same time reducing overall costs by reducing admissions for inpatient treatment
and the associated readmissions, which are likely to increase cost differentials over time. This study did not
examine the nature of the treatments provided within different services or the impact that specific treatments
may have had on outcomes. However, it is likely that part of the explanation of the differences found is a
greater use of effective, evidence-based treatments by specialist services. One could argue that a further
factor in favour of developing specialist services is that this would facilitate dissemination of such treatments.
The fact that CAEDS and specialist CAMHS appeared to be relatively comparable in this study suggests
that general CAMHS may be able to achieve similar outcomes to specialist services if they contain some
organisation around EDs and clinicians have opportunities to develop necessary expertise. The disadvantage
of this arrangement, in comparison with specialist ED services, is that developing a truly multidisciplinary
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team is often difficult when only a small group of clinicians is involved and such teams are also more
vulnerable to the impact of staff turnover (in fact, during the service mapping exercise we heard of several
instances when a mini-specialist team was unable to continue when a key member of staff retired or
changed jobs).
Conclusion
The study presented here can be considered one of the first stages in the investigation of outcomes
following treatment in services with different levels of specialisation in EDs. Findings suggest that starting
treatment in a specialist outpatient service may have some advantages. Questions remain, however.
The difficulty in recruiting participants from CAMHS in particular raises the question of how to evaluate
treatment outside of specialist contexts. Future research will need to address this issue.
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Chapter 11 Cost of illness and cost-effective
treatments (work package 7b)
Abstract
Background
We aimed to identify services and treatments used by people with AN and associated costs, to estimate
the unit costs of ED treatments, to explore cost variations by patient characteristics, to explore the
economic consequences of AN and to estimate the annual costs of AN for England.
Methods
We analysed service use data collected alongside three clinical trials and estimated costs by attaching unit
costs to service use. Individual variations in costs were explored using regression analyses. Unit costs of ED
treatment and service costs for a cohort of young people with AN over 1 year were estimated using data
from the Care Pathways Study (see Chapter 10, Study 1: quantitative study). Economic consequences of
AN in adulthood were analysed using BCS-70 data,366 comparing women with lifetime AN and women
without eating problems. Combining publicly available data and results from the ARIADNE studies, we
estimated the annual costs of AN in terms of health service costs, private health-care costs, benefit receipt
and years of potential life lost (YPLL).
Results
Service costs were driven by hospital admissions and vary by age, illness severity and treatment history.
Those treated in non-specialist outpatient services incurred higher costs than those treated in specialist
services only, with no differences in outcome. Women with lifetime AN were more likely to be long-term
sick or disabled in adulthood, to receive benefits and to have completed a degree, with no differences in
weekly income or employment status compared with cohorts with no eating problems. The annual costs of
AN for England were estimated to be between £45M and £230M in 2011.
Introduction
Although it is clear that AN has a severe impact on the health-care system and people’s lives – including
patients, their carers, families and partners – to date there have been few attempts at quantifying the
economic impact in monetary terms.115,367 The implementation of cost-effective alternatives to inpatient
treatment across the country should be a priority to ensure equitable access and adequate treatment.26,368,369
Economics evidence can facilitate this by providing a sound ‘cost of illness’ estimate, and associated
cost-effectiveness analyses, that allow service providers and planners to estimate the monetary benefit of
implementing evidence-based services.
This chapter, therefore, attempts to provide some answers to the following questions:
l What services and treatments do people with AN use?
l What are the unit costs of various ED treatments?
l What are the costs associated with service use by people with AN?
l Do costs vary by participant characteristics?
l What are the economic consequences of AN?
l What are the annual costs of AN for England?
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The work was carefully integrated with other studies in the programme and therefore depended on data
from other WPs being available. During the first phase of the project, a pragmatic review of the evidence
was undertaken with the aim of identifying data on (1) the typical course of illness of AN, including age of
onset, duration and outcome; (2) negative outcomes associated with AN, such as negative health and
social consequences; (3) service use and costs associated with AN directly and its negative consequences;
and (4) cost-effectiveness studies. The review was based on a broad search of the PubMed database,
supplemented by snowball searches (clinical studies and policy documents, such as NICE guidance on
EDs279), expert submissions, as well as searches of the ‘grey’ literature using the Google search engine
(Google Inc., Mountain View, CA, USA). The findings from the evidence review informed the data
framework for the cost of illness study. The literature review also revealed that little evidence on the
economic consequences of AN was available, and a study using the BCS-70 was designed to fill this gap.366
In this early phase, we also designed instruments that would facilitate cost estimation within three RCTs
(MOSAIC, CASIS and iMANTRA studies; see Chapters 4, 6 and 8). The CSRI,153 originally devised in 1986,
is used to record information on participants’ use of services and was carefully adapted in the light of the
research questions, service context and participants. A self-report measure was selected as participants
were likely to use a wide range of services and there is no one central source of service use data across
different agencies.153 GP records, for example, are an unreliable source for data on hospital and
community services,370 but there is high agreement between GP records and self-reported GP contacts.371
We analysed the baseline service use and costs of people recruited to three RCTs (study 1) and the costs of
ED treatment provided in four London PCTs (the Care Pathways Study; study 2). We also present here our
analysis of economic outcomes associated with AN based on the BCS-70 (study 3) and our estimate of the
annual costs of AN for England (study 4).366
Study 1: service use and costs associated with anorexia nervosa
Little is known about the service use and costs associated with AN. A recent review of the costs associated
with EDs and the cost-effectiveness of treatments up to 2010367 identified just three partial cost-of-illness
studies for AN, and none was based in the UK.
There was only one full cost-effectiveness analysis.354,372 This compared the costs and outcomes of inpatient
treatment, specialist outpatient treatment and TAU and found that specialist outpatient treatment had a
higher probability of being cost-effective (up to approximately 60%). One limitation of this study was that
only 65% of patients adhered to the allocated treatment.
Our literature search identified one study that modelled the value for money generated by different types
of ED services in Sheffield, based on cost data provided by the PCT and using a narrow cost perspective.373
Potential savings to the PCT from preventing admissions were particularly high for residential units out of
area or in the private sector at an average of £60,700 per case. The authors of that study recommended
that a new commissioning strategy should invest in services that reduce costly inpatient admissions.
Given the paucity of evidence regarding service use, costs and cost-effective treatments, our service use
data collected alongside the MOSAIC128 (see Chapter 4), CASIS204 (see Chapter 6) and iMANTRA (see
Chapter 8) trials is an important addition to the UK evidence base. Here we present the baseline data
collected from patients before receiving any of the trial interventions, exploring patient service use and
associated costs (three trials), as well as predictors of total service costs (MOSAIC and CASIS).
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Methods
Service use
Participants completed the CSRI153 at baseline and at 6 and 12 months. Note that only baseline data are
reported here; full cost data and a cost-effectiveness analysis will be published elsewhere. The schedule
covered a retrospective 6-month period and was adapted for each study to include hospital services,
specialist mental health services, primary care services and community-based services such as social work
and alternative therapy alongside demographic information and details on employment.
Service costs
The costs of service use for each participant were calculated by identifying an appropriate unit cost and
duration for each service contact and multiplying these by the number of contacts each person reported.
For most hospital, mental health and primary care services as well as social work, unit costs were drawn
from publicly available sources.374,375 Others were taken from previous studies or estimated using an
equivalent method376 from data collected as part of the Care Pathways Study (see Study 2: economic
analysis of the Care Pathways Study). When service contacts were reported but the number of contacts
was missing, the mean for all people in contact with that particular service was entered.
Outcome measures and sample characteristics
Some of our analyses use sociodemographic information and outcome measures collected at baseline
in each study. These are described fully in the chapters reporting the outcome findings for each study
(see Chapters 4, 6 and 8).
Data analyses
Service use by participants for the 6-month period prior to the baseline assessment is described in terms of
the number using a service or providing a type of care and the percentage of the sample. Service costs are
presented as means with SDs and ranges by service category.
The relationship between costs, patient characteristics and outcome measures was explored using a
cost function approach.377,378 The aim was to identify if any particular characteristics of people with AN
raised or lowered costs as this may influence our cost of illness model. Total service costs are used as the
dependent variable, with patient characteristics and measures of clinical severity as explanatory variables
in a regression-type framework. To account for the skewed distribution of cost data, regression analysis
was performed with 10,000 bootstrap replications and clustering within individuals to obtain robust SEs.
Predictors of costs that were statistically significant were selected and a multivariate model was fitted by
stepwise removal of non-significant predictors from a full model. A 90% CI was chosen to determine
statistical significance because, in economic analyses, there is less risk associated with type II errors than,
for example, in clinical studies. Within our set of potential predictors, there are several sets of variables that
are closely related: duration of illness and age at onset, for example, are related to age in opposite ways
(i.e. age minus duration of illness is age at onset). Similarly, the highest level of education or qualification
achieved will be related to age, and the EDE-Q global score is by definition correlated with its subscales.
These sets of predictors typically cannot be fitted into the same model, but do give us several options for
the final model. In presenting results, we selected the variables that explained the highest proportion of
variance while retaining basic principles of parsimony and sense.
Results
Service use
Table 37 shows the number and percentage of participants in each trial using each type of service.
Participants reported the highest contact rate with GPs for their EDs in CASIS, followed by outpatient
services and dentists, whereas, in MOSAIC, the highest percentage of participants was in contact with
outpatient services, followed by GPs for EDs and for other reasons. In iMANTRA, in which participants
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TABLE 37 Service use for the 6-month period prior to baseline assessment (three trials)
Service
Trial
MOSAIC CASIS iMANTRA
n using % using n using % using n using % using
Inpatient: ED 11 8 78 50 41 100
Inpatient: other 15 11 24 15 1 2
Outpatient: ED 126 89 88 56 0 0
Outpatient: other 34 24 22 14 0 0
A&E: ED 27 19 50 32 2 4
Psychiatrista 32 23 51 33 7 15
Psychologista 28 20 64 41
CPN 17 12 40 26 0 0
Psychotherapist 10 7 25 16 0 0
Family therapist/MFDT 0 0 7 4 4 9
Individual therapist/CBT 2 1 0 0 4 9
CAMHS/AMHS 1 1 3 2 3 7
Crisis team 0 0 4 3 1 2
Residential rehabilitation 1 1 0 0 0 0
GP: ED 124 88 134 86 6 13
GP: other 96 68 55 35 3 7
Practice nurse: ED 32 23 72 46 4 9
Practice nurse: other 38 27 32 21 0 0
Other community nurse 6 4 13 8 0 0
Dentist 67 48 86 55 4 9
Optician 36 26 50 32 4 9
Dietitian/nutritionist 11 8 9 6 5 11
Counsellor 28 20 44 28 0 0
Alternative therapist 10 7 22 14 0 0
Solicitor/lawyer 7 5 7 4 0 0
Physiotherapist 2 1 1 1 1 2
Occupational therapist 1 1 2 1 0 0
Osteopath 1 1 0 0 0 0
Police 0 0 0 0 1 2
Self-help/support group 13 9 22 14 0 0
CAB 8 6 12 8 0 0
Helplines 15 11 16 10 0 0
Websites 3 2 2 1 0 0
Social worker 9 6 18 12 1 2
Outreach/family support worker 4 3 7 4 0 0
Family centre 0 0 0 0 1 2
Carer 0 0 1 1 0 0
A&E, accident and emergency; AMHS, Adult Mental Health Services; CAB, Citizens Advice Bureau; CPN, community
psychiatric nurse; MFDT, multiple-family day treatment.
a In iMANTRA, these professionals were combined in one question.
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were recruited from an inpatient population, the high use of inpatient services was followed – by a wide
margin – by GPs for EDs and psychiatrists/psychologists.
Service costs
Table 38 shows the costs associated with service use, summarising the service use data presented in Table 37
into service categories. Reflecting the pathways of recruitment and the location of the interventions to be
evaluated in the RCTs, average costs per person were highest for inpatient treatment in iMANTRA and
CASIS, whereas outpatient treatment costs were the largest contributor to total costs in MOSAIC.
The proportion of total cost absorbed by each cost category for each study can be seen in Figures 8–10.
Total costs over the 6 months prior to baseline were highest for the iMANTRA group, in which all
participants had used inpatient care over the previous 6 months; hospital costs accounted for 99% of total
costs. In the CASIS group, members of which were also recruited from an inpatient population, hospital
TABLE 38 Costs per person by service category (three trials)
Service
category
Trial
CASIS MOSAIC iMANTRA
Mean
(£) SD Range
Mean
(£) SD Range
Mean
(£) SD Range
Hospital 21,045 30,370 0–215,172 4547 14,403 0–87,794 81,304 12,029 21,672–87,651
Mental health 1687 2261 0–11,232 709 1564 0–11,458 1062 2894 0–13,224
Primary care 1650 1409 0–7360 1046 1304 85–12,272 229 493 0–2076
Community
services
286 489 0–1752 115 247 0–1460 3 16 0–105
Self-help and
advice
32 99 0–673 59 394 0–4500 0 n/a n/a
Social work 95 397 0–3780 70 383 0–3549 49 293 0–1872
Total costs 24,795 31,121 318–224,025 6546 15,316 138–96,287 82,647 11,296 25,200–95,124
A&E, accident and emergency; AMHS, adult mental health services; n/a, not applicable.
Note
Hospital includes inpatient, outpatient, A&E. Mental health includes psychiatrist, psychologist, community psychiatric nurse,
psychotherapist, family therapist, multiple-family day treatment, individual therapist, CBT, CAMHS, AMHS, crisis team,
residential rehabilitation. Primary care includes: GP, practice nurse, community nurses, dentist, optician, dietitian/nutritionist.
Community services include counsellor, alternative therapy, solicitor/lawyer, physiotherapy, occupational therapy,
osteopathy, police. Self-help and advice includes: self-help group, support group, Citizens Advice Bureau, helplines,
websites. Social care includes: social worker, outreach worker, family support worker, family centre, carer.
Hospital
Mental health
Primary care
Community services
Self-help and advice
Social work
69%
11%
16%
Service
FIGURE 8 Distribution of costs by service category: MOSAIC.
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costs still accounted for 85% of total costs, and only around 6% of this was due to outpatient visits, used
by over 60% the participants. In the MOSAIC group – recruited through outpatient services – only 16%
reported a hospital admission in the 6 months prior to the intervention. For all three studies, community,
self-help and social work services contributed a very small proportion to total costs even though some of
these services were used by over 10% of the study samples.
Predictors of service costs
We explored predictors of service costs in the MOSAIC and CASIS groups. Tables 39 and 40 show the
results of univariate regression models, relating participant characteristics to total costs, as well as a ‘full’
model which maximises the proportion of variance in total costs explained (R2).
Discussion
The data presented were taken from three studies each with a different recruitment pathway. This was
reflected in both the service use data and the costs, as, for example, all participants in iMANTRA reported
inpatient stays. The MOSAIC group, recruited through outpatient services, was the most diverse in terms of
the range of service use, and also reported the lowest average costs.
We found that factors associated with poor outcomes in AN,379 such as low BMI, higher age and longer
duration of illness, were also associated with higher treatment costs. These findings suggest that those
people with the highest needs in these domains are receiving the most intensive service response when
presenting to secondary or tertiary care.
There were some differences between the studies. Higher age was associated with slightly lower treatment
costs in MOSAIC. Previous treatment (number of previous hospital admissions in CASIS and a binary
indicator of previous hospital admissions in MOSAIC) were associated with higher treatment costs.
Hospital
Mental health
Primary care
Community services
Self-help and advice
Social work
85%
7%
7%
Service
FIGURE 9 Distribution of costs by service category: CASIS.
Hospital
Mental health
Primary care
Community services
Self-help and advice
Social work
99%
Service
FIGURE 10 Distribution of costs by service category: iMANTRA.
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Interpretation is difficult, as it is unclear whether this simply reflects treatment costs immediately prior to
the study, or a prolonged engagement with services due to severity or chronicity of AN.
English as a first language was also associated with higher treatment costs in CASIS, which may point to
differences in treatment uptake among minority population groups,360 but this is not reflected in a
significant cost impact of the ‘ethnicity’ variable.
TABLE 39 Predictors of total service costs (CASIS)
Predictor
Model
Univariate
n
Full (n= 114)
Coefficient SE p-value Coefficient SE p-value
Constant 39,138 22,154 0.077
Age –118 235 0.615 156
Gender: male 7615 9121 0.404 156
Ethnicity (other vs. white
British)
3054 15,637 0.845 151
English is first language 21,426 2811 < 0.001 153 18,685 5939 0.002
Cohabiting 1998 5033 0.691 153
Has children? –11,184 5060 0.027 154
Number of children –4783 1879 0.011 154
Years of education 704 996 0.480 145
Degree vs. no degree –4790 2696 0.076 153
Full- or part-time
employment
3516 5809 0.545 156
Diagnosis AN vs. other –17,193 3836 < 0.001 155
BMI (baseline) –1010 951 0.288 156
Lowest BMI ever –4640 1567 0.003 121 –4816 1747 0.006
Age of onset –635 681 0.096 155
Duration of illness –27 18 0.138 153
WHOQOL-100 quality of life
rating
7929 5025 0.115 149
WHOQOL-100 health rating 13,206 4812 0.006 150 12,932 5603 0.021
Depression score 355 264 0.178 150
DASS-21 anxiety score 287 193 0.137 150
DASS-21 stress score 614 171 < 0.001 151 596 189 0.002
Total DASS-21 179 73 0.015 150
EDE-Q restraint 17 1203 0.989 149
EDE-Q eating concern 1835 2057 0.372 149
EDE-Q shape concern 714 2346 0.761 149
EDE-Q weight concern 1665 1713 0.331 149
EDE-Q global score 1239 1861 0.505 149
Number of hospitalisations 3723 1246 0.003 149 2747 1143 0.016
Adjusted R2 0.24
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Study 2: economic analysis of the Care Pathways Study
Treatment for severe AN often relies on costly inpatient care.380 In a census of inpatient beds in 1999,
20% of all child and adolescent beds were taken up by ED patients,31 and ED admissions have the longest
median length of stay of all adult psychiatric admissions.28 More recently, in the UK there has been a shift
from inpatient to outpatient treatment, driven by a shift in treatment philosophy and to halt the flow of
money from the public to the private sector, which provided over 80% of inpatient units in 1998.31,381,382
However, little is known about the pathways through care in outpatient services, the associated costs,
outcomes and cost-effectiveness.
To help address this evidence gap, the Care Pathways Study360 (see Chapter 10) examined the care
pathways for adolescents aged 13–18 years with AN across four PCTs in the Greater London area. The
economic component of this study aimed to attach costs to the treatment received in each care pathway.
To this end, the costs of different types of outpatient treatment sessions were calculated based on the
information available from the Care Pathways Study service mapping exercise. These unit costs were then
applied to each instance of service use of a cohort of young people with AN to facilitate calculating
individual-level costs of care by care pathway. In addition, the study explored the types of ED treatments
provided in different services, the professionals providing them and variation in individual-level treatment
costs by participant characteristics and care pathway. We also calculated the cost of a ‘good outcome’
based on the Morgan and Russell criterion189 for each pathway.
TABLE 40 Predictors of total service costs (MOSAIC)
Predictor
Model
Univariate
n
Full (n= 140)
p-valueCoefficient SE p-value Coefficient SE
Constant 11,917 3725 0.001
Age –243 137 0.075 141 –303 125 0.015
Ethnicity (other vs. white British) 3142 3586 0.381 141
Living with partner –3371 1693 0.047 136
Degree vs. no degree –4790 2696 0.076 141
Diagnosis AN vs. other –5563 1781 0.002 141 –3980 1718 0.021
BMI (baseline) –850 614 0.166 133
Age of onset –317 147 0.031 131
Duration of illness –23 99 0.815 133
EDE-Q restraint –1448 1306 0.271 141
EDE-Q eating concern 617 847 0.466 141
EDE-Q shape concern –401 1005 0.690 141
EDE-Q weight concern –965 881 0.273 141
EDE-Q global score –850 1305 0.521 141
Previous hospital admission 16,254 5137 0.002 140 16,564 6882 0.016
Previous treatment for AN 5120 2018 0.011 139
Taking antidepressants 5433 2543 0.033 139
Adjusted R2 0.23
WORK PACKAGE 7B
NIHR Journals Library www.journalslibrary.nihr.ac.uk
128
Methods
Treatment costs (service level)
The information relevant to the economic analysis was compiled from the service-level questionnaires.
The cost of providing treatment was calculated for each service individually and an average for each group
of services (specialist ED service, including child and adolescent services and adult ED services; CAMHS with
ED specialisation; and non-specialist CAMHS). Private sector services were excluded from the economic
analysis as the main study focused on the public sector, and costs of private sector provision cannot be
estimated reliably. For each type of staff member, a unit cost was calculated based on their likely Agenda
for Change pay grade, working hours, ratio of client contact to other tasks, and overheads based on
service location (community or hospital), drawing on a compendium of public sector unit costs374 and using
a long-run marginal opportunity cost approach.383
Individual-level service use and costs
The patient-level data were re-entered to better suit the needs of the economic analysis, showing not
just the total number of service contacts for each person, but also what specific service provided each
treatment session.
Appendix 3, Data availability and assumptions for service-level cost analysis and Individual-level analysis of
treatment costs, shows the data available to the economic analysis in more detail.
Data analysis
At the service level, we present the number and per cent of services within each service category providing
each type of treatment and the type of staff involved in the most commonly provided treatments.
Differences in the odds that a treatment was provided or a professional provided a treatment were tested for
statistical significance using univariate logistic regression models. Differences in the number of treatments
were tested using simple regression models (equivalent to a t-test), whereas differences in the cost of
treatments between services were investigated using regression models with 10,000 bootstrap replications.
At the individual level, the number of participants from each care pathway receiving each type of treatment
is shown. The unit costs (calculated from the service-level information) were then applied to the number of
contacts reported for each participant to arrive at individual treatment costs over the 1-year period. The
unit costs of outpatient treatment, summarised by service type to match the types of outpatient sessions
recorded in the individual-level data set, are shown in Appendix 3, Average costs of treatment by ED
service type. These averages were used to estimate the cost of treatment for patients who were in contact
with services that were not taking part in the study, based on degree of service specialisation. Unit costs for
several other treatments were drawn from publicly available sources.374,375 These unit costs are shown in
Appendix 3, Additional unit costs from publicly available sources.
Results
Sample characteristics
Table 41 shows patient demographics, baseline diagnosis, clinical characteristics and distribution between
care pathways for the entire cohort (n = 90). Categories with at least five participants in the cell were
considered in the analysis of cost variations.
Table 42 shows the number of services in each service category that delivered the various treatments for
AN (left-hand column) on an outpatient basis. It also identifies the average costs for each treatment.
Across all services, CBT, individual family therapy (IFT) and dietary advice are the most commonly provided
treatments. There are differences in average cost per CBT session between service types, which are significant
at the 90% level (p = 0.096), but no significant differences in the average cost of IFT sessions (p = 0.667).
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The profession and grade of staff delivering the treatment influences the per-session cost of that
treatment. The percentages of services (by degree of ED specialisation) in which specific staff members are
involved in providing CBT and IFT are shown in Figure 11.
There are no statistically significant differences in terms of delivery of IFT, but psychiatrists are more likely
to be involved in CBT in services that are general CAMHS with ED specialisation than in non-specialist
CAMHS (p < 0.001). No specialist ED service reported that psychiatrists delivered CBT.
TABLE 41 Patient characteristics (full sample)
Patient characteristic n of N= 90 %
Demographics
Female 87 97
White British 62 69
Parents marital status
Married or cohabiting 70 78
Other 20 22
Living situation
Living with parents 79 88
Other 11 12
Baseline diagnosis
AN 40 44
EDNOS-AN 50 56
Clinical characteristics (baseline)
Other medical condition 11 12
Taking psychiatric medication 5 6
Any comorbid psychiatric condition 27 30
Comorbid depression 20 22
Comorbid OCD 1 1
Comorbid anxiety 6 7
Self-harm 6 7
Previous outpatient treatment for an ED 4 4
Dietary restriction 33 37
Bingeing 9 10
Vomiting 21 23
Care pathway
Specialist–specialist 53 59
Non-specialist–specialist 16 18
Non-specialist–non-specialist 15 17
Private services 6 7
Good outcome at follow-up 32 36
Mean (SD) Range
Age (years), n= 90 15.1 (1.21) 12–17
Duration of illness (months), n= 87 8.1 (7.98) 0–36
Baseline weight/height, n= 88 82.8 (10.37) 63–132
OCD, obsessive–compulsive disorder.
WORK PACKAGE 7B
NIHR Journals Library www.journalslibrary.nihr.ac.uk
130
TA
B
LE
42
Tr
ea
tm
en
ts
p
ro
vi
d
ed
an
d
co
st
o
f
tr
ea
tm
en
t,
b
y
se
rv
ic
e
ty
p
e
Tr
ea
tm
en
t
Se
rv
ic
e
Sp
ec
ia
lis
t
C
A
ED
S
in
cl
u
d
in
g
o
th
er
ED
se
rv
ic
es
(n
=
5)
G
en
er
al
C
A
M
H
S
w
it
h
ED
sp
ec
ia
lis
at
io
n
(n
=
6)
C
A
M
H
S
w
it
h
o
u
t
ED
sp
ec
ia
lis
at
io
n
(n
=
15
)
N
u
m
b
er
p
ro
vi
d
in
g
(%
)
M
ea
n
(£
)
(S
D
)
V
al
id
n
(c
o
st
)
N
u
m
b
er
p
ro
vi
d
in
g
(%
)
M
ea
n
(£
)
(S
D
)
V
al
id
n
(c
o
st
)
N
u
m
b
er
p
ro
vi
d
in
g
(%
)
M
ea
n
(£
)
(S
D
)
V
al
id
n
(c
o
st
)
A
ss
es
sm
en
t
5
(1
00
)
15
2.
79
(4
9.
53
)
5
6
(1
00
)
20
8.
75
(5
1.
86
)
6
15
(1
00
)
15
2.
48
(6
7.
99
)
13
C
BT
5
(1
00
)
13
5.
52
(2
0.
84
)
5
6
(1
00
)
17
0.
72
(2
6.
46
)
6
10
(6
7)
16
3.
85
(4
2.
28
)
9
PD
T
3
(6
0)
12
3.
91
(1
0.
24
)
3
3
(5
0)
12
9.
82
(n
/a
)
3
5
(3
3)
13
7.
12
(1
3.
91
)
5
N
ur
se
co
un
se
lli
ng
3
(6
0)
90
.6
0
(n
/a
)
2
1
(1
7)
71
.2
7
(n
/a
)
1
3
(2
0)
82
.0
9
(n
/a
)
2
O
th
er
in
di
vi
du
al
th
er
ap
y
2
(4
0)
12
9.
82
(n
/a
)
1
2
(3
3)
18
6.
17
(n
/a
)
1
5
(3
3)
12
0.
82
(n
/a
)
1
G
ro
up
w
ith
ou
t
pa
re
nt
s
2
(4
0)
40
.3
1
(1
1.
69
)
2
0
(0
)
n/
a
0
0
(0
)
n/
a
0
O
th
er
gr
ou
p
th
er
ap
y
1
(2
0)
n/
a
0
0
(0
)
n/
a
0
0
(0
)
n/
a
0
IF
T
5
(1
00
)
20
4.
67
(3
7.
63
)
4
6
(1
00
)
24
2.
26
(8
6.
03
)
6
12
(8
0)
24
6.
05
(9
9.
51
)
8
M
FT
1
(2
0)
52
5
(n
/a
)
1
2
(3
3)
52
5
(n
/a
)
1
2
(1
3)
52
5
(n
/a
)
1
O
th
er
fa
m
ily
th
er
ap
y
1
(2
0)
n/
a
0
1
(1
7)
21
.5
5
(n
/a
)
1
2
(1
3)
12
9.
54
(n
/a
)
2
Re
fe
ed
in
g
2
(4
0)
n/
a
0
2
(3
3)
n/
a
0
3
(2
0)
n/
a
0
D
ie
ta
ry
5
(1
00
)
40
.5
5
(1
8.
55
)
4
5
(8
3)
38
.9
5
(1
0.
78
)
3
8
(5
3)
10
8.
68
(n
/a
)
2
M
ed
ic
al
m
on
ito
rin
g
5
(1
00
)
12
1.
56
(8
9.
19
)
2
5
(8
3)
73
.8
5
(n
/a
)
1
10
(6
7)
17
7.
91
(7
7.
60
)
5
O
th
er
1
(2
0)
n/
a
0
3
(5
0)
11
5.
79
(n
/a
)
1
0
(0
)
n/
a
0
IF
T,
in
di
vi
du
al
fa
m
ily
th
er
ap
y;
M
FT
,
m
ul
tif
am
ily
th
er
ap
y;
n/
a,
no
t
ap
pl
ic
ab
le
;
PD
T,
ps
yc
ho
dy
na
m
ic
ps
yc
ho
th
er
ap
y.
DOI: 10.3310/pgfar05160 PROGRAMME GRANTS FOR APPLIED RESEARCH 2017 VOL. 5 NO. 16
© Queen’s Printer and Controller of HMSO 2017. This work was produced by Schmidt et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
131
The number of treatments offered differed significantly between service types. Specialist ED services
offered on average 2.6 individual treatments, whereas specialist CAMHS offered 2, and non-specialist
CAMHS offered 1.6 (p > 0.01). Similarly, specialist ED services offered more than 8 different individual
psychological or psychiatric treatments in total, whereas in specialist CAMHS it was 7 and in non-specialist
CAMHS it was 5.2 (p > 0.01).
Unit costs of eating disorder treatment
Table 42 also shows that there is some variation in unit costs (per session) between service types. Although
a statistical analysis is complicated by the small number of services involved and differences do not reach
levels of statistical significance, it is reasonable to conclude that this is due to variations in staff profession
(salary) and staff time. In the case of multifamily therapy, specialist services delivered this as whole-day
sessions, whereas in the non-specialist CAMHS the sessions lasted only 60–90 minutes. The high cost of
dietetic sessions in non-specialist CAMHS arises because psychiatrists provide dietary advice, whereas in
other types of services it is more likely to be provided by dieticians or nurses who receive smaller salaries.
In the case of parent sessions, the variation in unit costs is mainly due to group provision of sessions for
parents in some services (so staff costs per session are shared between several families).
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FIGURE 11 Professionals providing treatment by service type treatments for AN offered in outpatient services.
(a) CBT; and (b) IFT.
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Individual-level service use and costs by care pathway
Patient-level data are available for 84 young people. The main study (see Chapter 10) found that 53 of them
were assessed in specialist ED services and remained in specialist ED services for treatment (specialist–specialist
care pathway; S–S). Another 16 were assessed in non-specialist CAMHS and referred to specialist services for
treatment (non-specialist–specialist care pathway; NS–S), while 15 were assessed in non-specialist CAMHS
and remained there for treatment or were directly admitted as inpatients (non-specialist–non-specialist care
pathway; NS–NS). The details of service use for participants on each pathway are shown in Table 43.
Across all care pathways, outpatient single family therapy was the most commonly used form of
treatment. In the S–S and NS–NS, the next most commonly used services were individual outpatient
therapy and medical outpatient appointments. In the NS–S, the order of individual therapy and medical
appointments was reversed.
The costs associated with the service use described above are shown in Table 44, again by care pathway.
There were differences in the likelihood of admission and in length of stay between the pathways, driving
the differences in inpatient costs. Details can be found in House360 and Chapter 10.
The average costs of individual and family outpatient therapy are roughly similar across all pathways,
although the average cost of individual outpatient therapy is slightly (but not statistically significantly) lower
in the NS–S, and the cost of family outpatient therapy is slightly higher in the S–S. Although dietary advice
is a treatment reported to be commonly provided (see Study 3: economic outcomes of anorexia nervosa in
a British cohort), the cost of dietetic outpatient sessions for this group of young people is low compared
with other cost categories.
Figures 12–14 show the distribution of service costs by care pathway. The largest contributor to total costs
for all care pathways is inpatient admissions for an ED. This is followed by individual outpatient treatments
and the cost of family-based treatments. Although inpatient stays due to an ED make up a large
proportion of costs in the NS–NS, there is a lot of cost variation between individuals (note the large SDs),
TABLE 43 Service use by care pathway
Service
Full sample (n= 84)
Care pathway
S–S (n= 53) NS–S (n= 16) NS–NS (n= 15)
n % n % n % n %
Assessment 84 100 53 100 16 100 15 100
Individual outpatient 68 81 45 85 9 56 14 93
Family outpatient 82 98 51 96 16 100 15 100
Multifamily outpatient 13 15 8 15 2 13 3 20
Parent only outpatient 37 44 23 43 9 56 5 33
Dietic outpatient 40 48 26 49 6 38 8 53
Medical outpatienta 52 62 32 60 11 69 9 60
Telephone calls 52 62 31 58 11 69 10 67
Psychiatric review 34 40 22 42 6 38 6 40
Day patient 2 2 0 0 0 0 2 13
Inpatient (medical) 15 18 5 9 6 38 4 27
Inpatient (ED) 17 20 8 15 3 19 6 40
a Medical outpatient appointments include blood tests, bone density scans, pelvic ultrasounds, electrocardiography and
other physical tests.
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TABLE 44 Service costs by care pathway
Service
Care pathway
S–S (n= 53) NS–S (n= 16) NS–NS (n= 15)
Mean
(£) (SD) Range
Mean
(£) (SD) Range
Mean
(£) (SD) Range
Assessment 170 (36) 112–293 151 (43) 98–209 152 (40) 98–230
Individual outpatient 1341
(1195)
0–4206 955
(1229)
0–3923 1933
(1228)
0–4414
Family outpatient 2976
(2078)
0–8005 2998
(2944)
457–11,786 2909
(1135)
965–5099
Multifamily outpatient 443
(1080)
0–3829 479
(1323)
0–4376 474
(1149)
0–3282
Parent-only outpatient 174
(317)
0–1509 15 (172) 0–591 61 (151) 0–585
Dietic outpatient 90 (188) 0–847 15 (23) 0–71 78 (105) 0–382
Medical outpatienta 2998
(5296)
0–27,125 4892
(6993)
0–21,700 2583
(4023)
0–13,950
Telephone calls 43 (68) 0–314 53 (67) 0–240 37 (38) 0–108
Psychiatric review 1337
(2644)
0–12,255 784
(1389)
0–5160 562
(1166)
0–4515
Day patient – – – – 1619
(4952)
0–18,768
Inpatient (medical) 1529
(6520)
0–34,112 10,260
(22,998)
0–79,950 1421
(2752)
0–8528
Inpatient (ED) 6452
(18,073)
0–73,308 14,514
(36,791)
0–137,760 30,242
(44,199)
0–133,824
Total costs 17,544
(28,738)
1323–149,406 35,215
(53,575)
694–165,656 42,072
(48,277)
3649–168,941
Probability of good
outcome, %
39.6 31.3 33.3
Cost per good outcome 44,306 112,508 126,342
a Medical outpatient appointments include blood tests, bone density scans, pelvic ultrasounds, electrocardiography and
other physical tests.
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Individual outpatient (ED)
Family outpatient
Day patient
Medical outpatient
Inpatient (medical)
Inpatient (ED)
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FIGURE 12 Cost distribution: S–S.
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so the difference between pathways is not statistically significant. Similarly, in the NS–S the cost of medical
admissions are high, but this is at least in part due to two participants with unusually long stays (average
length of stay 63 days), and the differences in costs are not statistically significant. Together, ED and
medical admissions account for over 70% of total costs in both pathways for which the assessment is in a
non-specialist service. The lower proportion of costs due to inpatient admissions in the S–S reflects the
lower probability of admissions.
Predictors of treatment cost and cost per ‘good’ outcome
Table 44 shows the total costs over a 1-year period for each pathway (third row from the bottom).
Mean costs were lowest for the S–S, and highest for the NS–NS. However, in each case the SD is larger
than the mean, suggesting a wide variation in the total cost of treatment for the participants who
followed each pathway.
Table 44 also shows the probability of attaining a good outcome (Morgan and Russell criterion189) in each
pathway (penultimate row). Although the S–S shows the highest probability (39.6%), this was not a
statistically significant difference. The final row shows the cost per good outcome for each pathway.
Table 45 shows the results of the univariate regression analysis identifying whether or not any participants’
characteristics are associated with higher or lower total costs. Costs were positively associated with age and
duration of illness (significant at the 90% level), and negatively associated with having another medical
condition. There were significant differences by care pathway as a whole, and in pairwise comparisons
between the S–S and the NS–S (p = 0.088) and the S–S and the NS–NS (p = 0.016). There was no significant
cost difference between the NS–S and NS–NS.
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Family outpatient
Day patient
Medical outpatient
Inpatient (medical)
Inpatient (ED)
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72%
3%
6%
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FIGURE 14 Cost distribution: NS–NS.
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FIGURE 13 Cost distribution: NS–S.
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Discussion
Across all pathways, inpatient admissions are the main drivers of costs. The composition of total costs is
slightly different in the S–S, in which individual and family treatments combined account for almost 45%
of costs and the proportion of inpatient admissions is lower.
The service use patterns are reflected in the total costs, with the S–S incurring the lowest total costs and
having the highest proportion of cases with good outcome, although only the cost difference is statistically
significant. Although there is a difference in costs, caution is needed when interpreting this finding.
Given the small sample size and limited data available, in addition to the fact that data collected from
London-based services are not generalisable to the rest of England, it would not be appropriate to conclude
that this means that the S–S is the more cost-effective option. The data do not allow us to investigate which
individual- or service-level factors might have contributed to the observed differences in service use and
associated costs. In addition, there were missing data at both the service and individual levels, so that our
findings should be regarded as indicative rather than definitive.
Our analysis of treatment provision indicates that a higher degree of specialisation is related to offering a
wider variety of treatments, and specialist services appear to be more likely to provide a specific treatment
beyond CBT, IFT and dietary advice. Again, caution is advised; given the small number of services,
differences are hard to detect. However, our findings regarding the most commonly provided treatments
are broadly in line with an analysis of ED services by the Royal College of Psychiatrists.384
TABLE 45 Predictors of service costs from univariate models
Predictor n Coefficient (contribution to total costs) SD p-value
White British 56 –9442 7431 0.204
Parents married or cohabiting 62 5759 10,317 0.577
Living with parents 70 565 15,466 0.971
Parental social class
Class II 6 3631 14,965 0.808
Class III/IV 48 –2121 15,878 0.834
Class ≥ V 13 26,608 13,405 0.047
Baseline diagnosis EDNOS vs. AN 50 –687 12,213 0.955
Other medical condition 11 –19,991 5833 < 0.001
Any comorbid psychiatric condition 21 –5117 8544 0.549
Dietary restriction 29 1266 9529 0.894
Vomiting 18 –14,237 7040 0.043
Intense exercise 39 –1895 9028 0.834
Care pathway
S–S 53 17,474 14,017 0.213
NS–S 16 26,156 13,962 0.061
NS–NS 15 17,741 4103 < 0.001
Age (years), n= 81 15.48 (1.2)a –658 379 0.083
Duration of illness (months), n= 79 7.70 (7.3)a –858 507 0.090
Baseline weight/height, n= 80 83.11 (10.4)a –559 458 0.222
a Values are mean (SD).
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Although there were few differences in the type of professionals providing CBT and IFT, the probability that
a psychiatrist is involved in providing CBT is significantly higher in general CAMHS with ED specialisation than
in other service types. In part, this may be because generic CAMHS teams tend not to include psychiatrists.374
Specialist skills may also be important. Specialist ED services are likely to include more staff with expertise
specific to EDs, so that staff on lower pay bands (nurses, perhaps) can provide treatments that in specialist
CAMHS are more likely to be provided by a psychiatrist. Also, as House360 remarks, ED specialisation in
general CAMHS is often due to a consultant taking a special interest.
Although this study makes an important contribution to knowledge about the costs of ED treatment in
outpatient services, the small number of services and individuals participating and the focus on one
geographical area in south-east England limits the transferability of findings to other parts of the country.
The analysis of predictors of treatment costs in particular should be regarded as exploratory.
Study 3: economic outcomes of anorexia nervosa in a British cohort
A number of studies as well as data from this programme have shown the importance of inpatient care in
treating AN. Although there is commonly some on-site education, such long hospitalisations can mean
that young people spend long stretches of time out of education.354 It seems that, in the face of severe
illness, education often comes second, although this is a concern for parents385 and seen as an important
determinant of quality of life.386
There is some evidence that the illness does not affect educational outcomes in the longer term: there was
no statistically significant difference between young women with AN and their healthy co-twins 5 years
after recovery from AN,387 and a greater proportion of patients admitted to hospital with AN than of
controls had completed post-secondary education.388 In contrast, Patton et al.389 found young people with
EDNOS-AN more likely than cohort members without ED to be not in education or employment. However,
we are not aware of any study looking at educational outcomes controlling for other characteristics,
such as parental socioeconomic status.
There is evidence to suggest that the impact of current AN on productivity in adulthood is severe.
International studies found that between 21.4%388 and 35%390 of women with AN received state benefits.
Long duration of inpatient treatment and psychiatric comorbidity were significant predictors of benefit
receipt. It is less clear how a history of adolescent AN affects adult productivity.
Our study describes women who have a self-identified lifetime AN recorded in the BCS-70.366 We
investigate the economic outcomes associated with AN, controlling for risk factors and socioeconomic
characteristics, and estimate the size of the effect.
Methods
British Cohort Study (1970)
The BCS-70366 includes over 17,000 babies born in the UK in 1 week in April 1970 and is representative of
the UK population. Currently, data are available for seven sweeps up to age 38 years, so people can be
tracked well into adulthood. The use of the data for this study has been registered with the Economic and
Social Data Service. No formal diagnosis of ED is included in the BCS-70, but, at age 30 years, there is a
set of questions about self-reported lifetime ED, age of onset and type of ED.
Inclusion criteria and comparison group
Participants were included if they had answered the question about lifetime ED at age 30 years and
reported either AN only (anorexia group) or no eating problems (comparison group). Given that very few
males reported AN, analysis by gender was not possible and males were excluded from the analysis.
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Data analysis
Given the low population prevalence of AN and the often very detailed categories of outcomes recorded in
the BCS-70,366 categorical outcomes were summarised into dummy variables to facilitate analysis and
differences in outcomes were tested for statistical significance using Fisher’s exact test, which allows
statistical tests for cells with a count < 5.
We created a propensity score predicting the probability that a participant would report AN based
on risk factors of lifetime AN identified by Nicholls and Viner.391 This included frequent feeding problems
in infancy, maternal psychological morbidity (Malaise score), separation from the mother for more than
1 month at age 5 years, and child and maternal BMI, undereating, high self-esteem, conduct, hyperactivity
and attention problems (teacher-report) at age 10 years.
We then fit logistic regression models – adjusting for the propensity score – to estimate the effects of AN
on the following adult outcomes at age 30 years: economic activity (active vs. not), employment-based
social class (class I/II vs. lower); benefit receipt (yes/no) and weekly income. We also identified the highest
level of educational attainment at age 34 years. The models were estimated using the logit command in
Stata 12, with the vce(cluster) option to reflect the clustering within individuals across several time points
typical for longitudinal data, and controlling for risk factors of AN (propensity score). The difference in
weekly income was estimated using a generalised linear specification with a gamma family and log-link.
Missing values were accounted for using MI with chained equations and 20 imputations.
Results
Sample
A total of 116 participants reported lifetime AN. Of these, 101 reported AN only, and 96 were women.
In the comparison group, there were 5449 participants. Figures 15 and 16 show the distribution of father’s
or mother’s social class at birth of the cohort member (depending on availability) and level of maternal
education at age 5 years. There were no statistically significant differences between those with and without AN.
Economic outcomes of anorexia nervosa
Table 46 tabulates economic outcomes in adulthood for those with and without AN. ‘Economically active’
was defined as participation in paid employment or in other activities relating to skills and human capital
development. There is a statistically significant difference between those with and without AN for three of
the eight outcomes. The statistically significant difference in receipt of income-related benefits reflects the
I or II
III
IV, V, other
20%
40%
60%
100%
80%
120%
0%
No AN AN
Social class
FIGURE 15 Father’s/mother’s social class at birth.
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higher probability of those with AN receiving income support (17% vs. 8%) and housing benefit (17% vs.
10%). Mean weekly income at age 30 years was £298 for those with and £279 for those without AN, a
non-significant difference.
Table 47 shows the OR for each outcome, adjusting for AN risk factors (the propensity score). Although
there were some significant results, the overall models explain very little variation as expressed by the
pseudo R2 (final column). Those reporting AN were 6.25 times as likely to be long-term sick or disabled.
They were also more likely to be in a high social class (I or II; 1.85 times as likely), and have a degree (twice
as likely), although these differences were significant at the 90% level only. For those in employment,
there was no difference in weekly income.
Discussion
We found that, among those surviving into adulthood, a lifetime occurrence of AN does not appear to
affect employment prospects, despite the high hospitalisation rate for treatment. The information about
the highest level of education provides useful contextual information; Table 46 shows that 35% of the
women in the BCS-70 with lifetime AN had a degree, compared with only 29% of those without AN.366
Advanced/degree
Other
No qualifications
20%
40%
60%
100%
80%
120%
0%
No AN AN
Education
FIGURE 16 Maternal education at age 5 years.
TABLE 46 Economic outcomes for people with and without AN
Economic outcome
No AN AN
% n % n
Economically active vs. not 76 5449 72 96
Employed 74 5449 69 96
Sick/disableda 2 5449 10 96
Full-time work 51 5449 48 96
Class I or IIa 40 4033 54 65
Degree vs. nota 29 5449 35 96
Receiving income-related benefitsa 14 5449 22 96
Family-related benefits 53 5449 50 96
a Difference statistically significant at 95% level.
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However, as highest level of education was available for age 34 years, it could not be used when
estimating the probability of being employed at age 30 years. Having a degree probably increases the
chance of employment, leading to the expectation that employment rates should be higher for people
with AN. Unfortunately, this relationship cannot be investigated with the data at hand. Similarly, given the
higher level of education, a higher weekly income would be expected for those with AN.
In addition to these structural problems, there are issues with data reliability concerning the wage variable.
These have been addressed by Dearden et al.,392 but some unlikely values remain. Although concerns are
sometimes raised about the reliability of self-reported diagnoses, simple questions such as the ones used in
the BCS-70 have been shown to be as good as more elaborate screening instruments in identifying EDs
in community samples.366,393
The findings from this analysis add to the scant evidence base on the economic circumstances of people
with AN and the potential adult consequences of a severe disorder. As more data ‘sweeps’ from the large
cohort surveys become available, the relationship between educational attainment, employment and
income for those with lifetime AN can be investigated further.
Study 4: societal costs of anorexia nervosa
The final analysis presented here brings together the various strands of WP7b. We draw on our review of
existing literature, data collected alongside the RCTs and the Care Pathways Study as well as our analyses
of the BCS-70 to present an estimate of the annual costs of AN for England.366
A recent review of the societal costs associated with EDs and the cost-effectiveness of treatments367
identified several international cost of illness studies, but none included a comprehensive estimate of
outpatient service use or wider service use by patients with AN. An early study of the cost of EDs in the
UK394 adopted a health service provider perspective and used data from the third National Survey of
Morbidity in General Practice and the Hospital Inpatient Enquiry to estimate service use in general practice,
inpatient bed-days and prescriptions. Outpatient treatment and intangible costs were not included.
The total cost to the NHS was estimated at £4.2M per annum.
The King’s Fund395 estimated the service cost and lost employment due to AN in the UK. Based on the
Hospital Episode Statistics (HES), the cost of inpatient care was estimated to be £2.5M for people under
age 15 years and £8M for people aged 15–34 years. The cost of outpatient treatment was derived
assuming that only 34.4% of all people with AN are in contact with mental health services (following
Hoek and van Hoeken396), and that outpatient costs are 41% of inpatient costs (following Striegel-Moore
et al.397), or £4.4M. Lost employment was calculated on the basis that 1830 people received Incapacity
Benefits for EDs. Assuming a weighted annual salary of £19,051, the annual cost of unemployment was
estimated at £33M. The total cost was £48M per annum, with 69% due to lost productivity.
TABLE 47 Odds ratios for economic outcomes of AN, adjusted for propensity score
Outcome Age measured (years) OR (AN) p-value Pseudo R2
Long-term sick/disableda 30 6.25 < 0.001 0.016
Employed 30 0.94 0.831 < 0.001
Social class I or II if employedb 30 1.85 0.089 0.002
Receives income-related benefits 30 1.01 0.970 < 0.001
Has a degreeb 34 2.06 0.085 0.003
a Difference statistically significant at 95% level.
b Difference statistically significant at 90% level.
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More recently, the charity Pro Bono Economics estimated the annual cost of EDs to be between £1.26B
and £9.6B.75 This estimate does not distinguish between different types of EDs and estimates are to a large
extent based on the previous work by The King’s Fund, which in turn uses cost ratios from international
research to estimate cost categories in which English data are lacking. The estimate also includes a burden
of disease figure of £950M in the lower-cost scenario, so that only approximately £80M are due to
increased health-care costs and £230M due to productivity losses.
Our study endeavoured to reduce the reliance on international figures to reflect the structural
idiosyncrasies of the English health-care context more accurately. We present a conservative estimate
based on publicly available data such as the HES and benefit data from the Department for Work and
Pensions (DWP). In addition, we present a high-cost scenario, incorporating assumptions and results from
the literature and the ARIADNE studies. This second estimate includes potential additional admissions and
outpatient contacts due to AN recorded under different diagnoses, family (out of pocket or insuranc-
based) expenditure on private sector inpatient provision as well as accident and emergency (A&E) visits,
primary care costs and an estimate of YPLL. Given the limited availability of reliable data sources, we
combine top-down and bottom-up estimates.
Methods
Prevalence of anorexia nervosa
The likely prevalence of AN by age group was estimated based on recent analyses of incidence in the
General Practice Research Database,398 and parameters for the average duration399 and mortality72 rates
from AN based on a review of the recent literature using the freely available DISMOD II software [Epigear,
Sunrise Beach, Australia, URL: www.epigear.com/index_files/dismod_ii.html (accessed 3 July 2017)].
Costs of anorexia nervosa
The assumptions and data sources used to calculate the societal costs of AN are shown in Table 48.
Further details can be found in Appendix 3, Assumptions and data sources regarding societal costs of
anorexia nervosa.
TABLE 48 Assumptions informing the calculation of the annual costs of AN
Parameter Assumptions
ED inpatient costs children l 1370 admissions for females with AN (71% of ED admissions)400
l Average length of stay 55.1 days400
l 37% of FCEs for AN in people age < 18 years401ED inpatient costs adults
Additional inpatient costs l Medical inpatient costs were 29% of ED inpatient costs (the Care Pathways Study)
Privately funded treatment l 49% of beds provided by the independent sector384
l 90% of independent beds are NHS funded31
Outpatient costs children l 110 first appointments400
l 8025 subsequent appointments400
l 78 telephone appointments400Outpatient costs adults
Additional outpatient costs l Outpatient costs due to EDs account for 38% of inpatient costs (the Care
Pathways Study)
l Medical outpatient sessions account for 27% of inpatient costs (the Care
Pathways Study)
A&E l Distribution of treatment assumption
l A&E contacts (CASIS, MOSAIC):
¢ 32% of later inpatients with average 2.5 contacts for EDs
¢ 19% of later outpatients with average 1.8 contacts for EDs
GP costs l Three visits per person with AN (prevalence based)75
continued
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Results
Table 49 shows the results of our DISMOD II analysis, estimating a prevalence of approximately 12,000
cases. Combining these results with an analysis by Harbottle et al.,402 we estimate that 9000 life-years are
lost to AN each year (discounted to present value; see Table 49). Table 50 shows our low and high
estimates for 2010/11. Our low estimate shows the annual cost of AN in England to be £45M. At £230M,
our high estimate is five times the low estimate, with the value of YPLL absorbing around 60%. In our
conservative estimate, nearly 75% of costs are due to inpatient treatment (Figure 17). Outpatient
treatment accounts for only 3% or 4% of all health-care costs. In our high estimate, outpatient treatment
accounts for 29% of health-care costs (Figure 18).
TABLE 48 Assumptions informing the calculation of the annual costs of AN (continued )
Parameter Assumptions
Wider primary care costs l Distribution of treatment assumption24,400
l GP (CASIS, MOSAIC):
¢ 86% of later inpatients, average 8.9 contacts
¢ 88% of later outpatients, average 6.2 contacts
l Nurse (CASIS, MOSAIC):
¢ 46% of later inpatients, average 11.3 contacts
¢ 56% of later outpatients, average 6.2 contacts
l Dietitian (CASIS, MOSAIC):
¢ 6% of later inpatients, average 6.4 contacts
¢ 8% of later outpatients, average 6.4 contacts
Benefit receipt (lower) l Proportion of benefit claimants attributable to AN vs. other EDs is the same as the
proportion of ED admissions due to AN (71%400)
l ESA; DWP data:
¢ 810 claimants per quarter
¢ Average weekly amount £90.25
l IB/SDA; DWP data:
¢ 1308 claimants per quarter
¢ Average weekly amount £56.04
Benefit receipt (higher) l OR of disability is 6.25 for women with AN (BCS-70366)
l Female population of England is 26,974,000 (ONS figures)
l ESA; DWP data:
¢ 299,600 claimants per quarter → 824 claimants with AN
¢ Average weekly amount £76.75
l IB/SDA; DWP data:
¢ 850,300 claimants per quarter → 2399 claimants with AN
¢ Average weekly amount £57.39
YPLL l Life expectancy 82 years (ONS data)
l 50% of life-years lost from Harbottle et al.402
l Discount rate 3.5%
l Value per life-year £30,000
ESA, Employment and Support Allowance; FCE, finished consultant episode; IB, Incapacity Benefit; ONS, Office for National
Statistics; SDA, Severe Disability Allowance.
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TABLE 49 Estimated prevalence of AN in England
Age group (years) Incidence Number of new cases Prevalence Total cases % of total cases
10–14 24.0 359 46.1 690 6
15–19 47.6 773 146.6 2379 20
20–24 18.9 337 169.7 3021 25
25–29 18.9 346 137.4 2516 21
30–34 3.0 53 92.7 1636 13
35–39 3.0 53 49.9 882 7
40–44 1.1 22 27.7 543 4
45–49 1.1 22 15.3 301 2
50–54 0.0 0 7.8 135 1
55–59 0.0 0 3.1 47 0
60–64 0.0 0 1.2 19 0
65–69 0.0 0 0.4 5 0
70+ 0.0 0 0.1 1 0
TABLE 50 Conservative and high estimate of the annual costs of AN in England (2010/11 prices)
Parameter Conservative estimate (£) High estimate (£)
ED inpatient costs: adults 20.9M 20.9M
ED inpatient costs: children 12.7M 12.7M
Additional inpatient costs – 9.7M
Privately funded treatment – 1.6M
Outpatient costs: adults 860,000 13.7M
Outpatient costs: children 610,000 8.1M
A&E – 400.000
GP costs 5M –
Wider primary care costs – 7M
Benefit receipt (lower) 4.9M –
Benefit receipt (higher) – 10.4M
YPLL – 140M
Total costs 45M 230M
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Discussion
Any study of the social costs of AN is currently limited by poor data availability, in part due to the small
number of cases. Assumptions are therefore needed to come up with reasonable estimates. Although
there are many potential points of contention in our assumptions, a few are likely to have a significant
impact on results and are worth discussing.
It is unclear how many people with AN receive treatment and in what setting. Our assumption focuses on
the main treatment setting, but, in reality, there will be overlaps, with people admitted for inpatient
treatment who previously or subsequently receive outpatient treatment, and who may have concurrent
input from their GP.
Moreover, it is difficult to account for undetected cases. The ‘true’ prevalence of AN may be two to three
times as high as estimated from either self-report or within services,403 and it is unclear what the cost
implications of this may be. Similarly, we are unable to estimate costs related to subthreshold AN or
EDNOS-AN, as few data are available; there is a tendency to report research findings without
distinguishing EDNOS-AN and EDNOS-BN.
Estimating the value of benefits paid as a result of AN is difficult despite the availability of DWP data.
Although the majority of claimants received benefits for ≥ 5 years, we may overestimate benefits because
the data do not show how many people start or stop claiming benefits within a quarter.
Finally, there are uncertainties surrounding the data from HES. Data are available by diagnosis, but admissions
linked to AN may happen for various reasons, such as cardiac problems, self-harm or other medical problems.
Furthermore, the average length of stay reported in HES is much lower than that reported by a recent
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FIGURE 18 Distribution of costs, high estimate.
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FIGURE 17 Distribution of costs, conservative estimate.
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Royal College of Psychiatrists survey of ED services in the UK,384 which reported a length of stay of over
18 weeks, and a recent study on the duration of stay in UK specialist ED units reported an average length of
stay of 26 weeks for adults and of 29 weeks for adolescents.219 One possible explanation is that HES conflates
stays in psychiatric or ED units (typically for weight restoration or other mental health concerns such as
self-harm) and stays in medical or paediatric units often linked to acute medical issues, which tend to be
much shorter. In addition, HES data may not be entirely reliable.404 To account for this, we assumed that
inpatient treatment may be much more frequent that the diagnosis-based data suggest in our high-cost
scenario. Given that a high proportion of AN cases are likely to be treated on an outpatient basis, and given
that the number of sessions required is generally high, the small contribution of outpatient costs in our
conservative estimate is surprising, and it is possible that there are again issues with the underlying data.
We therefore estimated potential additional costs in our high-cost scenario.
It is difficult to compare our estimate with the recent work by Pro Bono Economics75 because it did not
distinguish costs by type of ED. However, some differences are due to different unit costs applied to
incidents of service use and differences in data sources. For example, while HES showed around
8000 outpatient contacts for 2010/11, the Pro Bono Economics estimate cites unpublished data suggesting
that the number may be much higher (18,000). Other differences arise from the way in which private sector
health-care costs were treated. Although HES reports data on both NHS beds and NHS-commissioned
private sector services, the Pro Bono Economics estimate assumed that the HES data referred only to NHS
beds, thus arriving at a much larger figure for additional private costs (£45M vs. £1.6M).
Two areas of costs outside the public sector should also be mentioned. Although our study of the
BCS-70366 was unable to show an impact on earnings in adulthood owing to a lack of data, there is reason
to believe that AN is associated with productivity losses both from absenteeism (time taken off due to
illness) and presenteeism (lower productivity when at work due to illness), and that the impact may be
large. Although no estimate of the reduction in productivity associated with AN is available, Goetzel et al.405
reported an average impairment of daily productivity due to depression, sadness or mental illness of 10.7%.
Moreover, with an average length of stay of over 50 days, the impact of hospitalisation on the ability to
attend work is clearly severe. These reductions in productivity probably affect not only patients, but also
carers and partners, who often experience high levels of psychological distress, depression and anxiety.198
Informal care costs have also been excluded from our model. It is provided to people with AN by parents,
carers and partners. The analysis of data collected in the CASIS study (see Chapter 6) shows that up to
three-quarters of carers spent nearly a full day per week providing ED-related care,406 with potential
impacts not only on their health and well-being but also on their capacity to engage in paid employment.
Although we attempted to integrate findings from the ARIADNE studies into our estimate, the limited data
available did not allow us to reliably estimate total costs by ethnicity, gender and ED severity, although we
did attempt to distinguish costs by broad age group when possible. As more data from the ARIADNE
studies and the large cohort studies become available, it may be possible to address the gaps in our
estimate highlighted here.
Conclusions
Although the research agenda on the economics of AN remains long, findings from this programme add
considerably to the small evidence base for treatment and support of people with AN in England.
What services and treatments do people with anorexia nervosa use?
To address this question we identified services used at baseline by participants in three ARIADNE trials:
CASIS, MOSAIC and iMANTRA. There are two central conclusions from our analyses. First, service use is
linked to the recruitment pathway of each study. The iMANTRA group, for example, was recruited from
an inpatient population; thus, all of the participants had been in hospital prior to the baseline interview.
As hospital admissions tend to be quite extended for people with AN, use of any other services was low.
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It is, therefore, important to use such data with caution when making inferences about service use for the
wider group of people with AN.
Our second conclusion comes from the CASIS and MOSAIC studies, in which participants used a wide
range of services and supports. Along with previous studies, we find that inpatient admission is often
the mainstay of treatment for AN, but these studies show that outpatient clinics and mental health
professionals all provide important components of a treatment package, as does primary care, with more
than four-fifths of these two samples seeing the GP about their ED and between one-quarter and a half
seeing their practice nurse. Community, self-help and community services all played a part in supporting a
small but significant minority of participants.
What are the unit costs of various eating disorder treatments?
Our analysis of the unit costs of ED treatments comes from the Care Pathways Study. The research
identified treatments delivered to patients in this cohort from case notes, rather than solely relying on
reports from services about what they could provide. CBT and IFT were the most common treatments.
Mean per session unit costs for treatment varied considerably. Average unit costs were lowest in the
specialist ED services (£136 for CBT and £205 for IFT), with IFT unit costs similar for the CAMHS with ED
specialisation and generic services (approximately £245). Unit costs are sensitive to the number and
profession of staff delivering the intervention, as well as duration of the session and whether the
intervention is provided in a group or individual setting.
What are the costs associated with service use by people with anorexia nervosa?
For the three trials analysed for this chapter mean costs varied, reflecting the recruitment path. However,
the range was wide in all studies indicating different intensities of service response. The lowest 6-monthly
cost was just £138 (MOSAIC study participant) and the highest was £224,025 (CASIS participant). In all
three studies, hospital services absorbed the highest proportion of total costs – between 69% and 99% of
total costs.
A similar wide range can be seen for the participants in the Care Pathways Study, which focused solely on
health service treatment for AN. The lowest annual cost was £700 and the highest was £169,000.
Do costs vary by participant characteristics?
The large variation in costs warrants further investigation. Our analysis of cost variations in the MOSAIC,
CASIS and Care Pathways Study data suggests that previous treatment history (perhaps a marker for severity
or chronicity) is associated with costs, alongside age, first language other than English and comorbidity.
However, none of these equations explained a large proportion of the cost variation and much, as suggested
by the findings of previous studies,24,384 may be related to service availability and pathways to treatment.
What are the economic consequences of anorexia nervosa?
Our study of the BCS-70366 suggests that people with lifetime AN who survive into adulthood have a
higher probability of being long-term sick or disabled, of having completed a degree and of being in a
high social class if employed. No differences in weekly income could be found, although this analysis was
not able to control for highest level of education, severely limiting the conclusions from the study.
What are the annual costs of anorexia nervosa for England?
Our final set of analyses brought together findings from the literature, the three trials, the Care Pathways
Study and the BCS-70366 to estimate the societal costs of AN. Our conservative lower-bound estimate
suggests an annual cost of AN in England of around £45M. Seventy-five per cent of this is for inpatient
treatment, despite the growing use of specialist outpatient clinics. Primary care and receipt of social
security benefits account for a further 10% each. Our high estimate is five times higher at £230M per
annum, with more than 60% absorbed by the value of ‘years of life lost’.
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Chapter 12 Overall discussion and conclusions
This research programme focused on AN, a perplexing and frightening illness affecting mainly youngfemales. In seven integrated WPs it aimed to (1) develop and test tools for ED prevention and early
intervention in schools; (2) develop and test targeted, disseminable and cost-effective treatments (first line,
adjuncts to inpatient refeeding and relapse prevention) for adults with AN, across the spectrum of illness
severity and based on empirical models of AN grounded in clinical neuroscience; (3) develop and test
targeted, disseminable and cost-effective interventions for carers of adults with AN; (4) better understand
perplexing core symptoms of AN (hyperactivity and its psychological and biological correlates) with the aim
of informing future intervention development; (5) better understand the needs of particular populations
(i.e. mothers with an ED and their offspring); (6) optimise care pathways for young people with AN; and
(7) identify the costs of services used by people with AN and estimate the annual cost of AN for England.
Throughout we worked with patients and carers to achieve these aims.
Below, we discuss key findings emanating from the integrated WP in relation to these aims and assess
their clinical and research implications. Rather than discussing each WP separately, when appropriate, we
have grouped WPs together. A list of the main clinical and research implications emanating from the WPs
is also provided in Boxes 1 and 2.
Key findings and their clinical and research implications
Eating disorder prevention and early intervention in schools (work packages 1a and 1b)
A 1-day training programme on early detection and strategies for managing ED in schools resulted in an
improvement in the self-reported knowledge, attitudes and confidence of school staff in identifying and
managing EDs in an uncontrolled, feasibility study (WP1a). Second, a teacher-delivered intervention was
feasible and improved risk factors for EDs (body dissatisfaction, thin-ideal internalisation and self-esteem) in
adolescent girls in a cluster randomised trial (WP1b).
Together these studies indicate that teachers and other key school staff can be trained to deliver efficacious
preventative interventions for EDs in schools and to feel more knowledgeable, more positive and more
confident in relation to identifying and supporting students with an ED. Of note, in both studies, training was
brief and fitted in with school staff’s work schedules. More research is needed on these interventions before
they are widely disseminated. The teacher training programme outlined in WP1a could best be tested using a
fully powered stepped wedge design,407 rather than a RCT. Such a study should develop and incorporate
objective measures of staff competence in dealing with common ED scenarios relevant to school settings and
also demonstrate the impact of the intervention on student outcomes. The teacher-delivered prevention
programme developed in WP1b should be tested in a large-scale, adequately powered cluster RCT to
determine the effectiveness of this programme in a range of school environments. This should involve the
programme being evaluated for boys as well as girls. Additionally, future research might assess the combination
of both interventions in a ‘whole school approach’ to prevention and early detection and management of EDs.
Development and testing of targeted, disseminable and cost-effective treatments
(first-line, adjuncts to inpatient refeeding and relapse prevention) for adults with
anorexia nervosa (work packages 2a, 2b and 5)
First, a multicentre trial of two first-line outpatient psychological interventions (MANTRA and SSCM) found
that both psychological therapies significantly improved ED and other clinical outcomes in outpatients with
AN. ED outcomes compare well with those from the only other large-scale RCT in a similar population.131
Of note, patients significantly preferred MANTRA to SSCM and found it more credible (WP2a). Second,
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in a quasi-experimental study in inpatients with AN, the addition of CREST to TAU was acceptable with
perceived benefits by patients, but it showed no benefits (in relation to EDs or other clinical outcomes)
compared with TAU (WP2b). Third, a feasibility RCT in AN patients discharged from inpatient treatment,
compared TAU plus an e-mail-guided relapse prevention programme (iMANTRA) with TAU alone, and
suggested that there are treatment effects of a medium size in relation to a higher BMI and to lower
distress in the experimental group at 12 months after discharge (WP5).
BOX 1 Key implications for practice
l The feasibility study in WP1a indicates that, in schools, staff knowledge, attitudes and confidence towards
EDs can be improved by brief face-to-face training. Following further effectiveness testing, detection and
management of EDs in a school setting may be improved by making this training available to school staff.
l WP1b shows that it is feasible to train school teachers to deliver efficacious preventative interventions for
EDs. How to develop interventions with sufficient flexibility to manage a range of school environments
needs further examination.
l The RCT in WP2a shows that at 6 and 12 months post randomisation both psychological treatments tested
(MANTRA and SSCM) significantly improve key clinical outcome measures in outpatients with AN. Patients
see MANTRA as more acceptable and credible. Further follow-ups are needed to determine maintenance
of treatment effects in the longer term. However, based on available evidence, both treatments can be
considered as efficacious first-line outpatient treatments for adults with AN.
l WP2b demonstrates that CREST is an acceptable therapy, valued by patients and clinicians; however, the
addition of CREST to TAU is not superior to TAU alone. Further work is needed to establish the benefits of
adding CREST as an adjunct to inpatient care.
l The RCT in WP3 shows that addition of an intervention for carers of people with AN to standard inpatient
treatment reduces carer time caregiving, burden and unhelpful caregiving behaviours. Patients being cared
for by those receiving the intervention show reduced ED psychopathology and improved quality of life.
Sharing skills and information with family members is of benefit for patients and carers.
l The observational study in WP4 shows that objectively measured activity levels are not higher in AN; it may,
however, be problematic because of their poor health. Patients with AN have an increased drive to exercise
that is linked to ED pathology and a desire to improve mood. Reducing this drive to exercise should be a
treatment objective.
l The pilot trial in WP5 indicates that iMANTRA is a feasible and safe intervention, which may have promise
in the aftercare of inpatients with AN.
l WP6 focused on the special population of mothers with EDs. The findings show that EDs are common in
pregnancy and are associated with unplanned pregnancies and fertility treatment. In addition, children of
mothers with an ED are at risk of growth difficulties and disordered eating patterns. Continuity of care
from pre-conception to the postnatal period is paramount for women with an ED and interventions
designed for this special population may benefit them and their children.
l The assessment of care pathways in WP7a shows that there are clear benefits in having specialist
community-based outpatient services which are easily accessible directly from primary care as they provide
good clinical outcomes with markedly lower rates of hospital admissions (and therefore are at considerably
lower costs) and better continuity of care than generic services can deliver. Training in evidence-based
treatments should focus on developing skills in specialist multidisciplinary teams.
l Finally, the economic analyses in W7b demonstrate that AN is associated with a high risk of adult disability.
Effective prevention and early intervention to prevent long-term disability are therefore likely to provide
significant patient benefit and cost savings. Although inpatient treatment is the largest contributor to
treatment costs, participants with AN accessed a wide range of services (primary care, self-help, community
services). There may be scope to develop collaborations with community-based services to improve early
identification and ensure appropriate treatment.
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Findings from the large-scale RCT in WP2a suggest that both MANTRA and SSCM can be recommended
as first-line outpatient therapies for adults with AN, with the caveat that currently longer-term outcomes
for both of these treatments are unknown. Future research should focus on obtaining longer-term
(2- and 5-year) follow-up data from the RCT, to determine the relative longer-term efficacy of these two
psychological treatments. Moreover, mediators and moderators of outcome should be evaluated. To
ensure adequate sample size for mediator and moderator analyses, data from the present study can be
combined with those from an earlier pilot RCT.136 Furthermore, given the manual-based nature of
MANTRA (including lots of information, education and skills training), a future study evaluating this
approach in recent onset/first episode cases of adults with AN may be useful. Finally, MANTRA might also
be a useful adjunct to family-based treatments for adolescents with AN.
Preliminary evidence from WP2b suggests that CREST is an acceptable therapy that is valued by patients
and clinicians. The preliminary trial in WP5 indicates that iMANTRA is a feasible and safe intervention that
may have promise in the aftercare of inpatients with AN. Thus, both of these interventions should be
evaluated further.
BOX 2 Key implications for future research
l To carry out a fully powered stepped wedge study to test the effectiveness of the school staff training
programme developed in WP1a. This research should develop and incorporate objective measures of staff
knowledge and confidence and also demonstrate the impact of the intervention on student outcomes.
l To conduct a large-scale cluster RCT of the teacher-delivered prevention programme developed in WP1b to
determine effectiveness of this programme in a range of school environments. This should involve the
programme being evaluated for boys as well as girls.
l To gain longer-term (2-year) follow-up data from the RCT in WP2a, which are essential to determine the
relative efficacy of the two psychological treatments evaluated and the maintenance of treatment gains. Given
the manual-based nature of MANTRA a future study of recent onset/first episode cases of AN may be useful.
l To conduct a RCT to explore benefits of CREST (examined in WP2b) in comparison with other manualised
treatments of similar length. A larger study of the group format of CREST will be also desirable to
consolidate preliminary findings.
l To examine whether or not adding the carer intervention evaluated in WP3 to standard outpatient care
improves outcomes. Another step will be to examine whether or not adding a more intensive family
intervention (workshops) improves inpatient care.
l To conduct a replication of the work in WP4 in a larger study in patients with AN, using new actimetry and
physiological measures (e.g. internet based). Studies should test treatment interventions that target the
drive to exercise and seek to understand its origins and nature. Finally, studies should investigate how
graded exercise might be introduced as a means of reducing anxiety and improving affect.
l To carry out a large-scale RCT of iMANTRA (piloted in WP5), with economic analyses, longer-term follow-ups
and regular assessments to explore detailed relapse/recovery trajectories. A further study exploring the efficacy
of iMANTRA using facilitators that have an established therapeutic relationship with the patient would be
helpful to determine if this improves outcomes.
l To develop and test a tailored intervention for pregnant women with EDs. In addition, following the children
of women with EDs into adolescence will be essential in exploring the intergenerational risk of an ED.
l To evaluate the role of specialist ED services beyond the metropolitan London context using a larger-scale
study. Further research is also needed to explore the barriers to identifying adolescents suffering from BN,
who are poorly identified even in specialist areas, and a high proportion do not receive timely treatment.
l To conduct a longitudinal study investigating the impact of AN on education, employment and potential
earnings differential. It will also be helpful to gather longer-term follow-ups of clinical trials with
accompanying economic evaluation to better reflect the longer-term costs of treatment and allowing us to
estimate incidence-based costs of AN.
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For CREST, the next step would be to conduct a RCT to explore benefits of this intervention in comparison
with other manualised treatments of similar length. A larger study of the group format of CREST will be
also desirable to consolidate preliminary findings.
For iMANTRA (piloted in WP5), the next step would be to carry out a large-scale RCT including health
economic analyses, longer-term follow-ups and regular assessments to explore detailed relapse/recovery
trajectories. A further study exploring the efficacy of iMANTRA using facilitators that have an established
therapeutic relationship with the patient would be helpful to determine if this improves outcomes.
Development and testing of targeted, disseminable and cost-effective interventions
for carers of adults with anorexia nervosa (work package 3)
The large-scale, multicentre RCT in WP3 shows that the addition of a psychoeducational and skills sharing
intervention (ECHO) for carers of people with severe and/or enduring AN to standard inpatient care
reduces carer time spent caregiving, burden and expressed emotion. In addition, patients had reduced ED
symptomatology and improved quality of life at 6 months. These findings show that sharing skills and
information with family members benefits carers and patients.
Future research should examine whether or not adding the carer intervention evaluated in WP3 to
standard outpatient care for adults with AN improves outcomes. Another step will be to examine whether
or not adding a more intensive family intervention (workshops) improves inpatient care.
Improved understanding of hyperactivity and its psychological and biological correlates
in anorexia nervosa (work package 4)
Key findings from this observational study are that people with AN report that they engage in higher levels
of activity than HCs or people with an anxiety disorder, but that an objective measure (actimetry) shows
actual activity levels are similar across in- and outpatients with AN, anxiety disorder sufferers and HCs. The
study did find that the drive to exercise is significantly higher in AN patients than in HCs, and that it is tied
to ED pathology and a desire to improve mood.
The difference between actual and perceived levels of activity in people with AN may reflect the fact
that their pathological drive to exercise is resulting in them attempting to exercise even when they are
physically compromised by illness (i.e. at a time when they have significantly less skeletal muscle mass than
the control participants). Levels of activity did not appear to be related to endocrine measures, such as
plasma leptin or salivary cortisol, or to daily average temperature (i.e. activity is not driven by a desire to
keep warm). Taken together with other recent evidence, these findings suggest that exercise is driven and
rewarding to sufferers with AN.408 Studies should examine the nature and origins of the increased drive
to exercise in AN. Finally, clinicians should develop interventions that address the pathological drive to
exercise rather than exercise per se.
Improved understanding of the needs of mothers with an eating disorder and their
offspring (work package 6)
Work package 6 focused on a special population: mothers with an ED. Key findings of studies in this WP
were that EDs are common in pregnancy and they are associated with unplanned pregnancies and fertility
treatment. In addition, children of mothers with an ED are at risk of growth difficulties and disordered
eating patterns. A key implication of these findings is that continuity of care from pre-conception to the
postnatal period is paramount for women with ED. Findings from this study have provided data for future
intervention development. Future research should focus on developing and testing a tailored intervention
for pregnant women with EDs, focusing, for example, on giving them information and skills on how to
best manage their own nutritional needs during and after pregnancy and the nutritional needs of their
offspring in utero and after birth. In addition, following the children of women with EDs into adolescence
will be essential for exploring the intergenerational risk of EDs.
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Optimising care pathways for young people with anorexia nervosa (work package 7a)
The assessment of the Care Pathways Study in WP7a showed that direct access to specialist ED services for
young people with AN was associated with higher referral rates, lower admission rates, greater consistency
of care and greater user satisfaction. Thus, there are clear benefits in having specialist community-based
outpatient services which are easily accessible directly from primary care. They provide good clinical
outcomes with markedly lower rates of hospital admissions (and therefore are at considerably lower costs;
see Chapter 11), and better continuity of care than generic services can deliver. Training in evidence-based
treatments should focus on developing skills in specialist multidisciplinary teams.
Future research should evaluate the role of specialist ED services beyond the metropolitan London context
using a larger-scale study. Further research is also needed to explore the barriers to identifying adolescents
suffering from BN as they are poorly identified even in specialist areas, and a high proportion do not
receive timely treatment.
Estimating the costs of services used by people with anorexia nervosa and the annual
cost of anorexia nervosa for England (work package 7b)
A key finding from this WP is that being treated in specialist services is associated with lower costs.
Second, the annual costs of AN in England are estimated at between £45M and £230M. Moreover, the
economic analyses in WP7b demonstrate that AN is associated with a high risk of adult disability. Effective
prevention and early intervention to prevent long-term disability are therefore likely to provide significant
patient benefit and cost savings. Although inpatient treatment is the largest contributor to treatment costs,
participants with AN accessed a wide range of services (primary care, self-help, community services). There
may be scope to develop collaborations with community-based services to improve early identification
and to ensure appropriate treatment. Future research should include a longitudinal study investigating
the impact of AN on education, employment and potential earnings differential. It will also be helpful to
gather longer-term follow-ups of clinical trials with accompanying economic evaluation to better reflect
the longer-term costs of treatment and to allow us to estimate the incidence-based costs of AN. Caution
should be used when interpreting results that are based on small sample size, as they may not be
generalisable.
Overall strengths of the programme
The strength of the programme is that it took a life- and illness-stage perspective on a disorder that
typically starts in adolescence, but which often continues into adulthood. It was also a highly ambitious
programme of great depth and breadth. It included:
l a mixture of well-conducted large-scale adequately powered definitive trials (WP2a: MOSAIC;
WP3: CASIS trial)
l studies (including smaller RCTs, quasi-experimental designs and pre–post designs) assessing feasibility of
novel interventions (WP1a: school staff training; WP1b: Me, You & Us; WP2b: CREST; WP5: iMANTRA)
l longitudinal studies producing evidence that can form the basis for future intervention development
(WP4: to reduce the drive for thinness and exercise; WP6: for pregnant women with an ED)
l a study assessing care pathways for young people with AN (WP7a)
l studies on the cost of AN in different settings (WP7b).
Although the programme was led by a team from one unit, many of the studies had multiple collaborating
sites (WPs 1a, 1b, 2a, 2b, 3, 4, 5) from across the UK or across London (WP7a), thereby ensuring broad
generalisability of findings.
Most of the WPs used mixed methods including quantitative and qualitative components. The qualitative
components were used to either inform intervention development,63,65 or as process evaluations of the
interventions tested.158–160,167,409 Both approaches have been highly valuable and have added much needed
detail to inform the iterative process of intervention development and testing.
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The programme has yielded several manual-based interventions for prevention of, training in and treatment
of AN and related EDs. Table 51 shows the interventions that have emanated from the programme.
Most of these interventions are grounded in our model of AN, underpinned by clinical neuroscience
(WPs 2a, 2b, 3 and 5). Testing these interventions has involved using neurocognitive and social cognitive
measures as outcomes, an approach that is novel in AN treatment studies.
Central to all of the interventions developed and tested here is that they subscribe to the ethos of
collaborating with and sharing specialist skills and knowledge with patients, carers and school students
and staff. This collaborative approach empowers patients and carers to become experts in understanding
and managing their condition.
The interventions developed here can be easily disseminated within schools and the NHS either
immediately, or after further research.
Overall limitations
Given the ambitious nature of the programme and the confines of available resources and time, by
necessity all of the studies had to make compromises in terms of the size and nature of samples studied,
the control samples, number and duration of outcome assessments, and duration of follow-ups. Details of
these compromises and limitations are outlined in the relevant chapters of this report.
Conclusions
This programme has focused on development of interventions for prevention, treatment and training in AN
and related EDs. The results of the programme’s studies have important implications for the management
of AN (and EDs) across the full course of this disorder, from detection through to preventing relapse.
Future research is essential to increase our understanding of optimal disease management for AN.
TABLE 51 Interventions developed as part of the programme
WP Name Purpose, setting and support
1a Teacher training intervention A 1-day manualised training programme to improve teachers early detection and
management of EDs in schools
1b Me, You & Us Universal prevention programme for EDs in schools focusing on reducing
established risk factors and delivered by school staff
2a MANTRA A manualised outpatient treatment focusing on established maintenance factors
for AN delivered by therapists
2b CREST A manualised treatment focusing on emotion recognition, regulation and social
skills in people with severe AN
3 ECHO An intervention focusing on carers’ skills training and combining a self-help
manual with DVDs and coaching sessions
5 iMANTRA An online intervention to prevent relapse in severe AN following inpatient weight
restoration
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Appendix 1 Training school teachers
(work package 1a)
Student questionnaire
1. People with eating disorders can be very good at hiding their problems – do you think you would
know enough to tell whether a friend was at risk?
– Yes – I have spotted the signs in the past.
– Yes – I am confident I would know what I’m looking for.
– I’m unsure.
– No – I think it’s unlikely I would see the early signs.
– Other (free text).
2. Has your school ever taught you about eating disorders, and what to do if you’re worried about
yourself or a friend?
– Yes, I have been taught and it was helpful.
– Yes, I have been taught but it was NOT very helpful.
– No, I have never been taught at school.
– I can’t remember.
– Other (free text).
3. Can you think of anything your school could do to help you understand as much as you’d like to
about eating disorders and how to help your friends if they’re in difficulty? (Free text.)
4. If you were worried that a friend might have an eating disorder what would you do?
– My friend would probably talk to me, and I would listen and try to help.
– I would approach my friend and raise the issue and we would work out together what to do.
– I would talk to a teacher I trusted and ask for advice.
– I would anonymously let a teacher know so they could help my friend, but my friend wouldn’t
know I had told on them.
– I would talk to an adult outside of school (e.g. my parents or youth group worker).
– I wouldn’t do anything at first, I would wait and see if things got worse or better.
– Other (free text).
5. If you told a teacher that you were concerned about a friend, what would you want them to do?
– Talk to my friend and find out what was wrong.
– Help me to help my friend.
– Tell my friend’s parents and get them to help.
– Make sure my friend got support from a counsellor or doctor.
– Nothing, just listen.
– Other (free text).
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6. If you told a teacher that you were concerned about a friend, what do you think they would
actually do?
– Talk to my friend and find out what was wrong.
– Help me to help my friend.
– Tell my friend’s parents and get them to help.
– Make sure my friend got support from a counsellor or doctor.
– Nothing, just listen.
– Other (free text).
7. If you felt you should tell a teacher about a friend you were worried about – how would you most like
to do it (even if it’s not possible at the moment)?
– Face to face.
– On the phone.
– Text/short message service.
– E-mail.
– Instant messaging.
– In writing.
– Other (free text).
8. If you were suffering from an eating disorder – do you think your school would feel like a safe and
supportive place to recover?
– Strongly agree.
– Agree.
– Neutral.
– Disagree.
– Strongly disagree.
– Other (free text).
9. Can you think of anything that would make your school an even better place for people recovering
from an eating disorder? (Free text.)
10. Has your school ever helped you, or a friend, when you’ve needed help with regards to an eating
disorder? (Please explain.) (Free text.)
11. Has your school ever failed to help/not noticed/made the situation worse when you or a friend needed
help with regards to an eating disorder? (Please explain.) (Free text.)
Staff questionnaire
1. Does your school/college have an eating disorders policy in place?
– Yes we have specific policies relating to eating disorders.
– Yes – eating disorders are covered in another policy (e.g. child protection).
– Unsure.
– No we definitely do not refer to eating disorders in any of our policies.
– Any further comments (free text).
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
194
2. Do you think that policies that refer to eating disorders are effective? (Only asked if answered yes to
question 1.)
– Very effective.
– Effective.
– Ineffective.
– Very ineffective.
3. Has your school offered any form of training/briefing about eating disorders?
– Yes.
– No.
4. Who’s attended the training? (Only asked if answered yes to question 3.)
– Just me.
– All pastoral staff.
– All middle and senior managers.
– Whole staff.
– Not applicable.
– Other (free text).
5. How was the training delivered? (Only asked if answered yes to question 3.)
– Written materials.
– Face to face – workshop or seminar.
– Face to face – lecture.
– Over the internet.
– Over the phone.
– Not applicable.
– Other (free text).
6. What did you find useful about the training? (Free text.) (Only asked if answered yes to question 3.)
7. What would have made the training more useful? (Free text.) (Only asked if answered yes to question 3.)
8. If you have not received any training on eating disorders. Do you think you would find some training
useful? (Only asked if answered no to question 3.)
– Yes – very useful.
– Yes – quite useful.
– No – not very useful.
– No – not at all useful.
– Any further comments (free text).
9. Are you aware of any current or past cases of eating disorders in your school/college?
– Yes, I have been directly involved with cases.
– Yes, I have been aware but not involved with any cases.
– No, I have not been aware of any cases.
– No, there have been no cases.
– Any further comments (free text).
10. What would you do if you were concerned that a student may be suffering from an eating disorder?
(Free text.)
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11. In your school/college; if a student is concerned that one of their peers may have an eating disorder –
what are they encouraged to do?
– All concerns are passed on to a specific member of staff.
– The student could talk to any member of staff.
– We have a texting/e-mailing/post box service that students can anonymously use.
– This is not something we have discussed with students.
– Other (free text).
12. Have you had any particularly positive or negative experiences when communicating with parents
regarding eating concerns? If so please briefly outline (free text).
13. Have you worked with any outside agencies to support students with eating disorders? Please outline
which agencies you have used and any particularly positive or negative experiences you have had (free text).
14. Has your school/college ever had to re-integrate a student following a period away from school caused
by an eating disorder?
– Yes.
– No.
15. Did staff or students receive any advice on how to best support the returning student? (Only asked if
answered yes to question 14.)
– Yes.
– No.
16. Can you think of any further support that could have been given to staff or students that would have
helped the returning student to reintegrate more successfully? (Please outline.) (Free text.)
17. When we develop our training materials for schools, we want to make sure they are as useful as
possible. In order to do this, instead of inventing examples, we are collecting anonymous case studies
from school staff which will be used for training purposes. If you have can think of any instances
surrounding students, staff and/or parents when dealing with eating disorders it would be helpful if
you could provide a brief outline below (free text).
Eating disorders attitudes and knowledge questionnaire
My overall knowledge about eating disorders
No knowledge Full knowledge
1 2 3 4 5 6 7 8 9 10
My knowledge about the risk factors and causes of eating disorders
No knowledge Full knowledge
1 2 3 4 5 6 7 8 9 10
My confidence in my ability to recognise the warning signs of an eating disorder in one of my students
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
196
My knowledge about the symptoms seen in eating disorders
No knowledge Full knowledge
1 2 3 4 5 6 7 8 9 10
My knowledge about how to support a student with an eating disorder
No knowledge Full knowledge
1 2 3 4 5 6 7 8 9 10
My confidence in my ability to support a student with an eating disorder
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
My confidence in my ability to work with the parent/carer of a student with an eating disorder
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
How confident would you feel teaching a lesson exploring student knowledge and attitudes about
eating disorders?
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
Please indicate how much you agree/disagree with the following statements about students with eating disorders
With reference to students with eating disorders
Strongly
disagree Disagree Agree
Strongly
agree
Symptoms of eating disorders are fairly common and will resolve over
time without treatment
Eating disorders are severe mental illnesses
Students with eating disorders are to blame for their own condition
Eating disorders have major consequences on the sufferer’s quality of life
Students with eating disorders cause difficulties for school staff
Students with eating disorders cause difficulties for their peers
Teaching students about eating disorders will make them more likely to
develop one
School staff should be involved in the treatment and recovery process for
students with eating disorders
Sufferers should not continue to attend school where other students
may copy their behaviour
School staff should review their academic expectations of students with
eating disorders
The school has a responsibility to support students suffering from eating
disorders
There is a lot the school can do to help during the recovery process
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Each of the following case studies is a real situation that has been outlined by a member of school staff in
the past. As such, there are no right or wrong answers – but please answer the questions following each
case study as honestly as possible.
12-year-old Zeena is a model student. She works very hard at everything she does and excels academically.
She is usually top of the class and is disappointed even to come second. She always submits her homework
on time and it is clear that she dedicates a lot of time to her studies at home as well as at school.
Zeena has recently been fasting for Ramadan and decided to show her dedication to her faith by fasting
beyond Ramadan. She has had her parents full support on this – they are very proud of Zeena’s dedication
to her faith. In fact, her parents play a huge role in her life; they are very encouraging of her academic
achievements too and always encourage her to achieve to her very best and believe that she can achieve
anything she wants to if she works hard enough.
Zeena is well liked by her classmates though she seems a little more withdrawn in class than usual and has
taken to spending many of her lunchtimes in the library alone. Although she is only in year 8, she has
ambitions to study veterinary science and she understands from her parents and older brother that in order
to realise her goal she must work very hard.
How confident would you feel in dealing with this situation?
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
15-year-old Simon is not a natural sportsman, but this year he has been putting his all into the football team. He
has been attending every practice and keeping his fitness up by frequently visiting the gym between practices.
The slightly chubby looks that earned him the nickname ‘Podge’ in Year 9 are a thing of the past and
instead Simon is building up quite a six-pack. He’s even beginning to get some rather giggly attention
from the girls – though he doesn’t seem interested at all, preferring to shy away from the attention and
work out in the gym during his lunch breaks and after school.
Simon lives with his younger brother and his mum, who has been a single parent to both boys for as long
as you have known them. She is very supportive of Simon and his brother, but isn’t always able to attend
parents evenings as she works long hours to support the family.
How confident would you feel in dealing with this situation?
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
16-year-old Karly is in your tutor group. She has recently been absent from school for half a term receiving
treatment for bulimia. She is due to start back at school soon. While her condition is much improved and her
physical health no longer in immediate danger, it has been made clear to you that Karly will require quite
significant support to ensure that she does not relapse. She is still in the process of recovery and will be for
quite some time, but her doctors and parents have agreed that, with an appropriately supportive environment,
it would be beneficial for her to continue her recovery in school. She’s a few months away from sitting her
GCSEs and has several good friends at school though they have not seen much of her during her absence.
How confident would you feel in dealing with this situation?
Not at all confident Completely confident
1 2 3 4 5 6 7 8 9 10
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Appendix 2 Inpatient treatment (work package 2b)
Detailed results from qualitative evaluation
Main category Generic category Subcategory Frequency Example
What have you
learnt about
yourself from
this therapy?
Things I have
learnt about
myself
Bottle up emotions 8 How I deal with emotions – that I
bottle them up until they explode . . .
Block/avoid my
emotions
6 How I used to block my emotions and
not be able to sit with them . . .
It’s OK to express
your feelings
6 It’s ok to talk about your problems, it
makes you feel better afterwards
Not getting needs
met
5 . . . run into difficulties when I don’t
look after own needs
Good at caring for
others
5 I have also learnt that I am a great
friend to others but not a great friend
to myself
Skills I have begun
using
Expressing/
communicating
more
7 . . . better at being able to express
feelings – more open in communicating
positive and negatives
Positive intentions of
negative emotions
6 Negative feelings aren’t always bad –
they teach/protect . . .
Identifying emotions 5 How to name emotions and how to
find the right words for how
I’m feeling
Look at the bigger
picture
4 . . . it’s alright not to worry about the
little details being perfect and to look
at the bigger picture
Emotions are fluid 4 . . . that emotions are fluid and change
throughout the day
Other people’s
perspectives
3 Being more aware of other people’s
perspectives
Acknowledging/
accepting emotions
3 . . . it is ok and acceptable to feel sad
at times
Skills I would like
to use
Be more assertive 3 Need to be assertive
Be more open 3 That I need to focus on communicating
my emotions to those around me . . .
Be more positive 3 I would like to be more positive. Being
more pro-active can make positive
things happen
Were there any
aspects which
were particularly
helpful?
Emotional
strategies learnt
Labelling 5 Looking more specifically at different
emotions (e.g. labelling)
Acting before
emotions spiral
4 Also for me looking at ways to reduce
emotions getting to that extreme point
by acting on feelings before they start
to spiral out of control
Communicating
feelings
3 . . . talking about your problems can
actually help you deal with them
Non-specific
strategies
3 Strategies to manage difficult situations
that occurred during the week
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Main category Generic category Subcategory Frequency Example
Recognising the
positive intentions
of emotions
3 Looking at emotions in a different way
e.g. positive meanings of negative
emotions
Learning about
emotions
Relation to needs 7 The idea that each and every emotion
is simply an indicator that I need
something, or a guide to determine
how I behave
Awareness of own
difficulties
5 . . . being more aware of the issues
and difficulties that need attending to
Fluidity of emotions 4 Knowing there are different emotions
that we feel, it is ok to have other
emotions rather than just feeling the
same all the time
Aspects of the
approach
Reflection time 6 Having time/space to reflect on
emotions and what they actually mean
to me in everyday life
Doing homework 5 Homework allows time to come up
with good examples/reflect more
Empathy of
therapist
4 I was met with a very caring and
compassionate approach and someone
listening to how it was for me
Structure/themes 3 Structure/having themes to each session
All sessions were
helpful
n/a 6 To be honest every session has been
beneficial . . .
Were there any
aspects that
were particularly
unhelpful?
Aspects of the
approach
Initially too basic 3 First few sessions seemed a little basic
Not personalised 2 Tasks [were] statistic based rather than
personal based
Too structured 1 Sometimes too structured
Ended too quickly 1 . . . it came to an end too quickly
Certain
tasks/sessions
Facial expressions 4 Didn’t gain a lot from the facial
expressions exercises
Cognitive
remediation therapy
sessions
2 Not sure at first – thinking about thinking
Physical
manifestations
2 Not helpful looking at how emotions
feel in the body
Emotion switching 1 Didn’t take that much from emotion
switching session – already aware of
switching emotions
No aspects
unhelpful
n/a 10 None – learned something from
everything
What could be
improved?
More sessions Longer therapy 8 The therapy here is the best I’ve
encountered, the only criticism is there
isn’t more of it
Follow-up sessions 1 . . . a follow-up course of CREST would
be highly beneficial
Tailored more to
individual
More in depth 4 Taking the therapy to a more in depth
level, relating emotions to an
underlying thinking and beliefs and
working from that level
More personalised 2 If it was personalised, tailored to me/
individual rather than generic to all
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Main category Generic category Subcategory Frequency Example
More on certain
topics
Managing emotions 2 More strategies – what to do in
emotional situations
Emotions and needs 2 More about emotions and their
relationship to needs
Less on certain
topics
Facial expression 2 A few less introductory sessions e.g.
looking at faces
Nothing could be
improved
n/a 4 Nothing. I found the number of
sessions to be just right and the length
of sessions appropriate
What strategies
have you learnt
to use in the
future?
Having emotional
awareness
Benefits of emotions 6 Negative emotions can have a positive
effect as they can alert me to the fact
that something needs to change and
inspire me to take positive action
Bottling up is not
helpful
4 Remembering bottling up doesn’t get
me anywhere apart from frustrated
and angry
Practical skills Talking/
communicating
17 . . . expressing emotions in relation to
difficult situations – voice what I am
thinking or feeling
Being more assertive 9 Being more assertive by speaking up
more when needed
Having a positive
attitude
7 Focusing on positive things – reflecting
on positives and being pro-active at
making positive things happen
Labelling 6 Able to identify feelings more accurately
Getting needs met 6 Asking for help when I need it
Acknowledging
emotions
6 Acknowledging how I feel
Looking at the
bigger picture
5 I have learnt to look at the bigger
picture when I am feeling anxious or
worried about a certain situation
n/a, not applicable.
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Appendix 3 Economic analyses (work package 7b)
Data availability and assumptions for service-level cost analysis
The service-level data available to the economic evaluation included:
l level of service specialisation with regard to ED
l service location (hospital or community)
l details on ED assessment
¢ typical length of assessment
¢ staff typically involved in assessment
¢ outpatient treatment provided for AN
¢ type of treatments available
¢ typical length of session
¢ typical number of sessions
¢ staff typically providing the session
¢ details of other treatments provided (e.g. inpatient, day patient).
The approximate cost of each type of treatment session was calculated by applying a set of assumptions:
l the unit costs for all staff members involved in the session were summed
l where the questionnaire stated that one or another type of staff member provided the treatment
(e.g. ‘psychiatrist or psychologist’), the average unit cost was used
l where the typical length of treatment was missing, the length from a similar service (e.g. other
non-specialist CAMHS) was applied
l for group treatments, a group size of six patients or families was assumed.
Individual-level analysis of treatment costs
The patient-level data provided the following information relevant to the economic analysis:
l patient characteristics
l patient clinical data (weight and height, Morgan–Russell criterion)
l outpatient treatment
¢ number of assessments
¢ number of individual or family sessions
¢ number of group, dietetic and medical outpatient sessions
¢ number and type of outpatient appointments for physical tests
¢ number of telephone consultations
¢ number of psychiatric reviews
l number of inpatient days for an ED or other reasons
l services that had provided treatments or assessments.
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Average costs of treatment by eating disorder service type
Treatment
Specialist
CAEDS
Other ED
services
Specialist
CAMHS
Non-specialist
CAMHS
Independent
CAEDS
Valid,
n
Mean
(£)
Valid,
n
Mean
(£)
Valid,
n
Mean
(£)
Valid,
n
Mean
(£)
Valid,
n
Mean
(£)
Individual 3 135 2 124 6 163 11 163 3 111
Group session 1 32 2 46 0 – 0 – 2 78
IFT 3 187 1 258 5 235 8 246 2 237
MFT day/session 1 547 0 – 1 547 1 114 0 –
Parent session 1 101 0 – 1 22 1 98 1 120
Dietic session 3 33 1 62 3 39 2 109 2 45
Occupational therapy 0 – 0 – 0 – 0 – 1 36
Physiotherapy 0 – 0 – 0 – 0 – 1 18
MFT, multifamily therapy.
Additional unit costs from publicly available sources
Role £ per hour Source374 Notes
Doctors
Associate specialist 166 PSSRU 2011, p. 202 Time ratio as consultant (medical)
Consultant (assume medical) 202 PSSRU 2011, p. 203 Time ratio from PSSRU 2009,
p. 170410
GP (hospital) 229 PSSRU 2011, p. 148
GP (community) 138 PSSRU 2011, p. 148
Paediatrician (hospital) 202 Medical consultant
Paediatrician (community) 138 As GP
Senior house officer 61 PSSRU 2011, p. 199
(foundation house officer year 2)
Time ratio as consultant (medical)
Specialist registrar 89 Based on PSSRU 2011, p. 201 Time ratio as consultant (medical)
Staff doctor/ward doctor 117 Based on medical consultant,
PSSRU 2011, p. 203
Time ratio as consultant (medical)
Nurses
CAMHS nurse 75 Based on CAMHS member schema
with band 5 median salary
Clinical specialist nurse 73 PSSRU 2011, p. 142 Community mental health nurse
Key nurse 120 PSSRU 2011, p. 192
Nurse (hospital) 104 PSSRU 2011, p. 193
Nurse (community) 71 PSSRU 2011, p. 141
Psychology nurse 104 As specialist nurse
Senior staff nurse 120 PSSRU 2011, p. 192
Specialist nurse 104 PSSRU 2011, p. 193
Specialist nurse (community) 89 Based on PSSRU 2011, p. 144
nurse specialist
Time ratio from RCN report411
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Role £ per hour Source374 Notes
Psychologists and psychiatrists
Child and adolescent psychiatrist 295 As generic psychiatrist
Child psychiatrist 295 As generic psychiatrist
Child psychiatrist (community) 293 As psychiatrists, overheads from
CAMHS team
Child psychologist (hospital) 156 As clinical psychologist, overheads
as psychiatrist
Child psychologist (community) 152 As clinical psychologist
Clinical psychologist (hospital) 156 As clinical psychologist, overheads
as psychiatrist
Clinical psychologist (community) 152 PSSRU 2011, p. 137 Face-to-face contact
Consultant psychiatrist (hospital) 295 PSSRU 2011, p. 205 Per hour patient related
Psychiatrist (community) 293 As psychiatrists, overheads from
CAMHS team
Psychologist (hospital) 156 As clinical psychologist, overheads
as psychiatrist
Psychologist (community) 152 As clinical psychologist
Psychology assistant 123 As clinical psychologist, median
salary grade 6
Therapists
Art therapist (hospital) 139 Clinical psychologist, AfC band 7
Art therapist (community) 136 Clinical psychologist, AfC band 7
Child psychotherapist 156 As clinical psychologist
Cognitive analytical therapist 139 Clinical psychologist, AfC band 7
Counselling psychotherapist 156 As clinical psychologist
Drama therapist 139 As art therapist
Family therapist (community) 183 Clinical psychologist, AfC
band 8b
Family therapist (hospital) 186
Psychotherapist (hospital) 156 As clinical psychologist
Psychotherapist (community) 152 As clinical psychologist
Systemic psychotherapist 156 As clinical psychologist
Therapist 156 As clinical psychologist
Dieticians
Dietitian (hospital) 36 PSSRU 2011, p. 184
Dietitian (community) 34 Based on UC volume (hospital),
capital overheads from CAMHS
teams
Paediatric dietitian 47 As specialist dietitian
Specialist dietitian 47 Based on UC volume (hospital),
salary band 6 (median)
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Role £ per hour Source374 Notes
Other
Behaviourist 156 As clinical psychologist
CAMHS professional (hospital) 101 See CAMHS professional
(community)
CAMHS professional
(community)
98 PSSRU 2011, p. 175 (targeted)
Occupational therapist
(community)
35 PSSRU 2011, p. 134 No time ratio applied
Occupational therapist (hospital) 36 PSSRU 2011, p. 182 No time ratio applied
Occupational therapist assistant 31 Based on occupational therapist;
AfC band 4 (assistant practitioner)
No time ratio applied
Physiotherapist (community) 35 PSSRU 2011, p. 133 No time ratio applied
Physiotherapist (hospital) 37 PSSRU 2011, p. 181 No time ratio applied
Social worker (child) 146 PSSRU 2011, p. 157
Therapeutic carer 104 As hospital nurse
AfC, Agenda for Change; PSSRU, Personal Social Services Research Unit; RCN, Royal College of Nurses; UC, unit costs.
Assumptions and data sources regarding societal costs of
anorexia nervosa
Distribution of treatment
Around a third of AN cases are treated exclusively in primary care.362 Based on HES, we estimate that
around 11% of cases are treated as inpatients each year. This suggests that 56% are treated primarily on
an outpatient basis.
Inpatient and outpatient treatment
The number of inpatient admissions, number of bed-days and number of outpatient contacts recorded
under a primary diagnosis of AN were obtained from the HES for 2010/11412 and the Special Interest Topic
on ED for the same year.401 As a detailed breakdown by age was not available, the ratio of adult (63%)
to child (37%) of finished consultant episodes from the Special Interest Topic report was applied when
costing inpatient stays. This served as a lower-bound estimate for inpatient costs because admissions that
are causally related to AN may not be recorded under a primary diagnosis of AN, such as cardiac problems.
To obtain a higher-bound estimate, we applied the ratio of costs for medical inpatient admissions to ED
admissions from the Care Pathways Study (see Chapter 11, Study 2: economic analysis of the Care
Pathways Study). For our higher estimate, we also included potential additional outpatient care costs,
based on the ratio of the costs of ED-related and medical outpatient appointments to ED inpatient costs
from the Care Pathways Study, across all three pathways (38% and 27%, respectively). This includes
treatment provided in community settings. Our provisional analysis of data relating to patients treated in
the private sector indicates that outpatient treatment makes up a much smaller proportion of costs than in
the public sector. We therefore apply this additional cost only to NHS beds (51% of ED inpatient costs).
Cost of independent sector provision
We identify the likely cost to the NHS of inpatient treatment provided by the independent sector, and
additional costs of privately funded treatment based on the assumption that 49% of ED beds are provided
by the private sector384 and 90% of independent beds are NHS funded.31
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Primary care costs
Our lower estimate of primary care costs draws on estimates from the Pro Bono Economics report, in
which it was assumed that each person with AN saw their GP three times per year.75 Little is known about
the service use of people with AN prior to entering treatment, but there is some evidence on elevated
service use up to 5 years prior to diagnosis.21,22 For our higher cost estimate, we draw on baseline
information from the three trials analysed in Chapter 11 to estimate a plausible range of primary care costs
(GP, nurse, dietitian) incurred prior to an inpatient admission or outpatient treatment. When treatment is
provided exclusively in primary care, we assume that each person is in contact with their GP three times
per year (NICE 2004 ED guidance162).
Benefit payments
The DWP provided data on social security benefit payments made to people because of an ED. There were
on average 810 females claiming Employment Support Allowance for an ED per quarter, receiving an
average weekly amount of £90.25. Incapacity Benefit or Severe Disability Allowance was paid to 1308
females each quarter, with a weighted average weekly amount of £56.04. As the statistic does not
distinguish between different EDs, we assumed that the proportion of benefits paid to people with AN
corresponded to the proportion of ED admissions for AN in HES (71%).
Years of potential life lost
Years of potential life lost were calculated based on a survival analysis by Harbottle et al.402 The study
assumed a standardised mortality rate of around 10. We assumed a standardised mortality rate of around
5 and halved the number of life-years lost to ensure a conservative estimate.72 We present the total annual
number of YPLL due to AN, discounted using a 3.5% rate and based on a life expectancy for females at
birth of 82.40.413 This is a simplified approach allowing a rough estimate only. YPLL were valued at
£30,000, the threshold commonly recommended by NICE for a healthy life-year gained. As it is unlikely
that these additional years will be lived at full health, we applied the disability weight for depression (46%
reduction414) to the final figure. The results of our analysis are shown in Table 52.
TABLE 52 Years of potential life lost
Age at onset (years)
Reduction in life
expectancy402
Number of new
cases per year
Life-years lost per case
(discounted at 3.5%) Total life-years lost
10–14 24.8 359 2.8 1005
15–19 24.6 773 3.55 2744
20–24 23.9 337 4.65 1567
25–29 23.3 346 5.96 2062
30–34 22.7 53 7.52 399
35–39 22.1 53 8.97 475
40–44 21.6 22 11.09 244
45–49 Assume 21.6 22 13.6 299
Total 8796
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